kusan tsawon lokacin ne waɗannan alamun ke gudana?
kuma ya kamata a yi jiyya ga duk ciwon ƙirji ta wannan hanyar, musamman saboda shekarun ku
kuma tare da zazzabi
sannan kuma yana bukatar a binciki hawan jini na cholesterol
kuma kuna da zazzabi yanzu
kuma kuna jin zafin wannan kirji yanzu?
kuma bayan haka kuna samun wahalar yin numfashi
kuma zaku iya fada mini wasu nau'ikan cututtukan da kuke da su tare da wannan?
kuma yaya ne zafin zazzabin yake?
kuma ina da tari ma
kuma ina da sanyi kadan da tari
kuma ina fama da mummunan ciwon kirji a yau
kuma wannan shine lokacin da ya dace da zazzabin ku
kuma yana jin zafin kirji
kuma ina tsammanin ina da zazzabi kaɗan
kuma ina so ka bayana inda ciwon kirjin yake
kuma suna da ciwon zazzabi shima
kuma tare da tarihin ciwon sukari
Kuma ka san yadda yake ji kirjina kamar zai murkushe
kuma ka san mutane suna tari ko da yaushe a kai na
kuma kana fama da ciwon kirji
kuma kun ce wannan matsin lamba ne a kirjin ku
akwai wani a danginku dake da matsalar zuciya ko cutar zuciya ko ciwon zuciya ko idan daskararren maiƙon cholesterol ya yi sama ko hawon jini?
akwai kuma wasu alamomin cututtuka ko matsaloli da kuka lura da ciwon ƙwayar tsokar?
akwai wasu mutanen da ba su da lafiya kamar yadda kuke a gida tare da alamomin ku iri ɗaya?
shin kana da wasu alamomi ciwo?
kana jin wani ƙarancin numfashi?
shin har yanzu kana jin ciwo a kirjinka
sabo da wannan lokacin mura ne
amma kuma bai kamata a sanya mu ba a gefe don ciwon kirjin zuciya
amma matsala mafi mahimmanci yanzu shine wannan ciwon kirji
amma ina da wahalar numfashi
amman na san mutane da yawa wanda suke min tari
amma ya kamata mubu dauke kowane ciwon kirji da matuƙar mahimmanci
amman yanzu kuna ninfashi lafiya haka ko?
na manta da sanadin wannan ciwon kirji
shin kana jin kamar wani yana matse kirjin ka
har yanzu kana jin kamar karancin numfashi
Shin suna gunagunin rashin lafiya irin wannan alamu?
Shin kana da wani ciwo mai tsanani kamar na cutar hawan jini ko wani abu makamancin haka?
kuna dauke da wani cuta mai tsanani damuwar asibiti kammar ciwon sukari?
kuna da rashin numfashi tare da wannan zafin kirji?
kuna da hawan jini?
kana fama da gajeren nufanshi tafiya da wan can?
Ka san irin alamun da take fama da ita?
Ku ga hoton?
ku sha ruwa mai yawa a yau
Duk da haka na yin gwaji don ciwon sukari
amma duk da haka tana da alamu kamarta sosai danawa
yaya zazzabin ku ta hawo?
yaya hawan jinin ku?
idan kunci gaba da yawan zazzabi mai zafi
idan kana da zazzabi da yakai dari da biyu ko sama da haka
idan kuna tunanin cewa alamominku ko matsalolinku suna da mahanga mafi kyau
na kamu da zazzabi jiya
Ina da zazzabi kaɗan ma
Na kamu da zazzabi Jiya
ina da ciwo sosai a kirji na
ina fama da wahalar numfashi ma
zan tura muku hoto
yau ina fama da ciwon kirji
Ina samun ciwon kai da zazzabi a yau
a ganina mura ce
a gani na wannan karamin mura ne
kamar wasu mutane masu nauyi sun zauna a kirji na?
ya fara ne da ciwon kai da kuma zazzabi kusan lokaci guda
yana zafi a tsakiyar kirji na
matsi ne kamar ciwon kirji
yana cikin kirji na
yana tsakiyar kirji na
yana tsakiyar kirji
ina da ciwo a kirji na
Na damu kwarai da wannan zafin kirji
Ina so ku fada min ta hanyar bayyanin wannan ciwon kirji
kamar hawan jini da ciwon sukari
kamar dama a tsakiyar kirj
yanzu ga zazzabi zaka iya ɗaukar tachipirina mai daɗi
mary yanzu kamar kwanaki nawa kike da alamun ciwon
Yanzu kun ce kuna da ciwon kirji
ina fama da ciwon kirji wasu lokuta
to kana jin wasu alamomi ciwo daban-bayan
ko wani yana zaunawa a kan kirjinka?
Da kyau sosai tare da zazzabi da tari da ciwon kai da jiwon jiki
daidai a tsakiyar kirji na
nuna min a wannan hoton inda kake jin zafin
tunda kana da zazzabi
kuna tunanin cewa wadanan alamomi ya danganci daukar ciki?
haka ne yaran ku ke da wasu alamun ciwo?
fada min yadda ciwon kirjin yake
zazzabi yana ƙaruwa da dare
zazzabin da ya dame ni a kwanaki biyun da suka gabata
zazzabin ya fara karuwa a daren jiya
wannan shi ne porter ne likita a cikin dakin binciken gaggawa
da kyau za ku iya gaya mani dan kadan game da zafin kirjin ku?
sannan ina jin zafi a gaban jikina anan a kirji
eh ina fama da ciwo cikin kirji na sosai
da kyau lokacin da nake da wannan zafi a kirji na
wane irin ciwo kake ji a kirjin ka?
yaushe ne wannan ciwon kirjin ta fara?
a ina kake jin ciwo a kirjin?
ina kuke jin ciwo a kirjin
ka ji kamar kirjin ka ya daure
kun san na kamu da cutar sukari da wasu abubuwa
ka ce kanada wannan ciwon kirji
Ana haɓaka yawan haɗarin cutar coronavirus (COVID-19) a cikin Tarayyar Turai/Tatalin Arzikin Yankin Turai da Ingila, ran 1 ga watan Janairu zuwa ran 15 watan Maris 2020
Lamarin da ya haifar da cututtukan Coronavirus (COVID-19) yana nuna irin wannan yanayin a cikin Tarayyar Turai/Yankin tattalin arzikin Turai da Ingila da ke tabbatar da cewa, yayin da a wani matakin daban dangane da ƙasar, cutar ta COVID-19 tana ci gaba cikin sauri a duk ƙasashe.
Dangane da shaida daga Italiya, ƙasashe, asibitoci da rukunin kulawa mai zurfi ya kamata su ƙara shiryawar su don karuwar marasa lafiyar COVID-19 waɗanda zasu buƙaci kiwon lafiya, kuma musamman kulawa mai zurfi.
A ranar 31 ga watan Disamba 2019, an ba da rahoton wani tarin cututtukan huhu da ba a san ilimin halittar sa ba a Wuhan, Lardin Hubei, kasar Sin.
A ranar 9 ga watan Janairu shekara 2020, Cibiyar Kula da Cututtuka da Rigakafin Cuta ta kasar Sin ta ba da rahoton wakili da ke kawo sabon cutar coronavirus ne wanda aka mai da shi a matsayin cutar hanyoyin numfashi mai tsananin coronavirus 2 (SARS-COV-2).
Tun daga wannan lokacin, cutar da ke haifar da kamuwa da cutar SARS-CoV-2 an sanya mata suna cutar coronavirus (COVID-19).
Shaida zuwa yau ita ce ca 80% na mutane tare da COVID-19 suna da cuta mai laushi, wato kamuwa da cutar hanyoyin numfashi tare da ko ba tare da cutar huhu ba, kuma yawancin waɗannan suna samun sauki.
A cikin kashi 14% masu cututtuka, COVID-19 yana haɓaka cikin mummunan cutar da ke buƙatar kwana a asibiti yayin da raguwar kashi 6% suna fuskantar mummunan cutar da ke buƙatar kulawa mai zurfi.
Yawan mutuwar marasa lafiya a asibiti sakamakon COVID-19 ya kai ca kashi 4%.
A cikin wannan binciken, muna tantance sauye-sauye game da abin da ya faru na COVID-19 a cikin kowace Europeanasashen Turai / Yankin Turai na Yankin Turai (EU/EEA) da Kingdomasar Ingila (Birtaniya) tare da kwatanta su da na lardin Hubei, Sin.
Hakanan muna kwatanta adadin masu kamuwa da cutarbCOVID-19 a kasachen EU/EEA da UK tare da na Italiya lokacin ranar 31 ga watan Janairu - ranar 15 ga watan Maris 2020.
Lamuran cutar COVID-19 a kasashen EU / EEA da UK
Bayan kasar Sin, COVID-19 ya ci gaba da yaduwar kasashe daban-daban da kuma saurin annban COVID-19 a cikin sauran duniya a halin yanzu tana bin wannan kasar.
A ranar 11 ga watan Maris 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar ta ranar 5 ga watan Maris na Eurosurveillance 2020, Spiteri et al. wanda aka ba da rahoto game da Turai ta farko ta tabbatar da lamarin cutar COVID-19 bisa ga bayyanar lamarin WHO.
A cikin EU/EEA, Faransa ta gabatar da farko lamarin cutar guda uku a ranar 24 ga watan Janairu 2020 a cikin mutanen da suka dawo daga Wuhan, Lardin Hubei, Kasar Sin.
Kamar yadda yake a ranar 15 ga watan Maris 2020, an gano lamarin cutar COVID-19 a cikin dukkan ƙasashe 30 na EU/EEA da UK, inda tsakanin ranar 31 ga watan Disamba 2019 kuma wannan ranar ta haɗa, masun kamu da cutar 39,768 da mutuwar mutane 1,727 wanda aka ruwaito, tare da lamarin 17,750. da mutuwar mutane 1,441 daga Italiya kadai.
Samun lambar tarawa da tarawar abin da ya faru na masun cututtukar COVID-19
A Cibiyar Yaki da Cututtuka ta Yankin Turai (ECDC), an sanar da ƙididdigar COVID-19 a cikin kowace ƙasa a duniya, wanda aka samo daga kawai kafofin hukuma kamar ma'aikatar lafiya ta ƙasashe, hukumomin kiwon lafiya na ƙasa da na WHO da WHO, ana sabunta su. kowace rana da karfe 8:00 na safe.
An yi amfani da waɗannan bayanan don tantance halaye na COVID-19 a EU/EEA da UK, da kwatanta su da na Italiya.
A matsayin wakili na abubuwan da ke faruwa na lamuran COVID-19, mun kirga kwanaki 14 tarawar abin da ya faru da aka yanke na lamurar COVID-19, don haka yin la’akari da tafarkin COVID-19, a cikin kowace kasar EU/EEA da Ingila, tsakanin ranar 1 ga watan Janairu - 15 Maris 2020.
Mun kuma gabatar da tarawar lambar sanarwa game da lamarin kamuwa da cutan a kowace kasa a ranar 15 ga watan Maris 2020 8:00 na safe idan aka kwatanta da na Italiya a ranar 31 ga watan Janairu - ranar 15 ga watan Maris 2020.
Hanyar COVID-19 cikin kasachen EU/EEA da Ingila
Sauye a cikin kwanaki 14 tarawar tsayar da abin da ya faru na lamarin cutar COVID-19 a cikin ƙasashen EU/EEA da UK gaba ɗaya sun bi ta lardin Hubei (Sin) (Siffa 1).
Don EU/EEA da Ingila gaba ɗaya, yawan abin da ya faru na COVID-19 ya fara ƙaruwa kusan ran 21 ga watan Fabrairu sannan kuma ya karu sosai a kusa da ranar 28 ga watan Fabrairu 2020 (kayan kari abubuwa).
Wannan ya jawu ta yawan saurin karuwa cikin lambar rahoton lamarin cutar daga Italiya, amma duk sauran kasashen EU/EEA da Birtaniya sun nuna irin wannan yanayin na kara yawan abubuwan COVID-19 (Karin kaya).
Siffa 2 yana nuna lamarin cutar COVID-19, a cikin EU/EEA da UK idan aka kwatanta da wannan a Italiya na ranar 31 ga watan Janairu - ranar 15 ga watan Maris 2020.
Yana nuna cewa, kamar yadda a ranar 15 ga watan Maris kafe 8:00 na safe, wasu ƙasashe EU/EEA 15 da Ingila sun riga sun bayar da rahoton masu kamuwa da cutar kwatanta da na Italiya kafin makonni 3 da suka shige ko ƙasa da haka.
Sakamakon binciken mu ya nuna cewa lambar masu kamuwa da cutar COVID-19 yana karuwa cikin hanzari a cikin EU/EEA da UK.
Abubuwan lura da aka gani a cikin abin da ya faru na COVID-19 sun ba da shawarar cewa annobar ta ci gaba da sauri a cikin sauri a duk ƙasashe.
Wannan duk da cewa ƙasashe sun kasance a matakai daban-daban, a cikin martanin lafiyar jama'a na ƙasa, kuma mai yiwuwa ƙararraki daban-daban a cikin ƙasashe da ƙa'idodi daban-daban don zaɓar marasa lafiya waɗanda dole ne a gwada su don tabbatar da COVID-19, gami da samun gwaji.
A farkon Maris 2020, likitoci a yankuna da abin ya shafa na Italiya sun baiyana halin da ake ciki inda ca 10% na marasa lafiya da COVID-19 suka buƙaci kulawa mai zurfi kuma kafofin watsa labaru sun ba da rahoton cewa asibitoci da rukunin kulawa mai zurfi a cikin waɗannan yankuna sun riga sun kai iyakar ƙarfin su.
Bayanai game da kai marasa lafiya a asibiti don COVID-19 da/ko sashin kulawa mai zurfi a halin yanzu akwai a matakin EU/EEA don kawai kashi 6% da kashi 1% lamarin cutar, bi da bi (bayanan ba su nuna ba).
Yakamata, duk da haka, a tattara su ta hanyar tsari don dacewa da bayanan sa ido na halin yanzu wanda ya mayar da hankali kan rahoton masu kamu da cutar da kuma yawan mutuwa.
Nazarin da aka yi a shekara ta 2010 zuwa 11 ya nuna babban bambanci a cikin kasancewar kulawa mai zurfi da gadaje na kulawa a Turai, kama daga 29.2 a Jamus zuwa gadaje 4.2 ga yawan jama’a 100,000 a Portugal.
Wannan yana nufin cewa ƙasashe na iya samun albarkatu ko ƙasa fiye da Italiya (12.5 kulawa mai zurfi da gadaje na kulawar dai-dai da cikin yawan jama’a 100,000 cikin 2010-11).
Yanayin tsarafawa wanda ya danganta ga cikawar cibiyoyin kiwon lafiya, da ƙididdigar kowace ƙasar EU/EEA da UK da mamayar zaman asibiti domin lamarin cutar COVID-19 wanda ya hadu da &gt; > 90% da hadarin fi yawan gadon kulawa, an samar da su a sabuntawa ta shida na ECDC saurin kimantawar hadari kan COVID-19.
Tunda yake masun kamuwa da cutan a tare cikin wasu yakin kasashen EU/EEA da UK, da asibitoci da kuma rukunin kulawa mai zurfin yawancin lokaci na taimaki jama’ar yankin da aka sani, bayanai game da lamarin cututtuka da gadajen kulawa zai fi dacewa a samo su a matakin Nomenclature na raka’ar yankunan ƙasa don ƙidaya 2 (NUTS-2) mataki.
Koyi daga Italiya da abubuwan da ake samu a halin yanzu a wasu ƙasashe sun nuna cewa annobar COVID-19 tana ci gaba cikin sauri a cikin EU/EEA da Ingila.
Kasashe, asibitoci da rukunin kulawa mai zurfi ya kamata su shirya kansu don yanayin watsawar al'umma na SARS-CoV-2 da karuwa a yawan masu haƙuri da COVID-19 waɗanda ke buƙatar kiwon lafiya, da kuma kulawa ta musamman, kamar wanda ke faruwa. a cikin yankunan da Italiya ta shafa.
Kamar yadda aka nuna a cikin ƙididdigar haɓakar haɗari na ECDC na baya-bayan nan, saurin aiki, cikakken aiki da cikakken tsari yana da mahimmanci don jinkirta yaduwar SARS-COV-2, tare da canzawa daga haɓakawa zuwa tsarin ragewa, kamar yadda saurin karuwa a yawan masu kamuwa da cutar ba zai iya samar da masun bada shawara da cikaken lokaci ma asibitoci domin fahimta, karba da daidaita hanyar aiwatarwa kafin lokacin.
Binciken saurin haɗari ya kuma lissafa matakan kiwon lafiyar jama'a don rage tasirin annoban.
Akwai gajeriyar tagar dama a yayin da ƙasashe ke da damar ƙara yawan ƙoƙarinsu na sarrafawa don rage yaduwar SARS-CoV-2 da rage matsin kiwon lafiya.
Fadar da wannan, wataƙila tsarin kiwon lafiyar na wasu ƙasashe EU/EEA zai iya fuskantar yawan marasa lafiya waɗanda ke buƙatar kulawa mai zurfi a cikin kwanaki masu zuwa ko makonni masu zuwa.
Barkewar cutar Coronavirus 2019 (COVID-19), wanda ya haifar da cutar hanyoyin numfashi mai tsanani (SARS) coronavirus 2 (SARS-CoV-2), ya zuwa yanzu ya kashe mutane fiye da 3,000 kuma ta kama fiye da mutane 80,000 a kasar Sin da sauran wurare a duniya, ya zama masifa ne ga mutane.
Mai kama da kwayar cutar guda ɗaya, SARS-CoV, wanda ya haifar da SARS a cikin dubban mutane a 2003, SARS-CoV-2 Hakanan za'a iya watsa shi daga jemage kuma yana haifar da alamun irin wannan ta irin wannan hanyar tsarin.
Duk da haka, COVID-19 yana da ƙananan rauni da kisa fiye da SARS amma yafi watsawa kuma yana rinjayar yawancin tsofaffi fiye da matasa kuma maza fiye da mata.
Saboda martani ga yawan lambar wallafewa cikin sauri a kan cutar da ke kunno kai, wannan labarin yayi ƙoƙarin samar da ingantaccen nazari game haɓaka batun bincike mai sauri.
Za mu koyi tushe game da epidemiology, etiology, virology, bincike, jinya, hangar zuwan cutar (Prognosis), da kuma hanawar cutan.
Kodayake tambayoyin da yawa har yanzu suna buƙatar amsoshi, muna fatan wannan bita ta taimaka a cikin fahimta da kawar da cutar mai barazanar.
Bikin bazara a ranar 25 ga Janairu, 2020 ya zama abin tunawa wanda ba a iya mantawa da shi ba ga duk Sinawa da aka nemi su kasance a gida a duk wannan hutu da kuma makonni da yawa bayan barkewar cutar.
Kwayar cutar ta yi kama sosai da coronavirus (CoV) wacce ta haifar da barkewar cutar hanyoyin numfashi mai tsanani (SARS) a cikin shekarar 2003; don haka, Hukumar Lafiya ta Duniya (WHO) ta ba shi suna SARS-CoV-2 a ranar 11 ga Fabrairu, 2020, kuma aka ba cuta mai haduwa da ita suna CoV Cutar-19 (COVID-19).
Annobar ta fara ne a Wuhan, kasar Sin, kuma cikin hanzari ya bazu cikin kasar baki daya kuma zuwa kusan wasu 50 a duk duniya.
Tun daga watan Maris 2, 2020, kwayar cutar ta haifar da fiye da lamari 80,000 da aka tabbatar da yanayin kamuwa da cutar COVID-19, da marasa lafiya fiye da 40,000 suka sami sauki kuma fiye da marasa lafiya 3,000 suka mutu.
"WHO tayi kashedin cewa COVID-19 shine ""lambar 1 na abokin gaba ta jama'a"" kuma mai iya karfi fiye da ta'addanci."
Dangane da PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga fiye da 200 takardu akan COVID-19 ciki har da virology, epidemiology, etiology, ganewar asali, da magani tun daga rahoton farko a Janairu 7, 2020 wanda ya kayyade jerin cutar ta ware daga marasa lafiya da yawa.
Wannan bita tana ƙoƙarin taƙaita ci gaban bincike a cikin sabo da kuma mai saurin bunkasa taken wuri.
Duk lokacin da zai yiwu, zamuyi kokarin kwatanta COVID-19 tare da SARS da kuma wani CoV wanda ya haifar da cutar, cutar numfashi na gefen larabawa (barkewar MERS, a 2012).
Hakanan zamu tattauna abin da muka koya zuwa yanzu game da rigakafin da haifar da cutar da kuma wasu tambayoyin da suka rage.
An dauki CoVs a al'adance cutar marasa guba ga mutane, akasarinsu yana haifar da kusan kashi 15% a mura 4.
Duk da haka, a cikin wannan karni, mun ci karo da cutar mutum ta mutum sau biyu, watau SARS-CoV da MERS-CoV, wanda ya haifar da asalin yaduwar a kasar Sin a shekarar 2003 da Saudi Arabia a cikin shekarar 2012, bi da bi, kuma nan da nan ya watsu cikin sauran ƙasashe tare da mummunan tashin hankali da mutuwa.
Sabili da haka, COVID-19 na yanzu shine yaduwar CoV na uku a cikin tarihi da aka ajiye na mutum.
Kamar yadda aka nuna a cikin siffa. 1,1, an fara samun cuwayoyin cutar huhu da ba ta da asasi da suka fara daga Wuhan a ranar 31 ga watan Disamba, 2019 ga Hukumar Lafiya ta Kasar Sin.
Kwana bakwai daga baya an sake bin jerin hanyoyin CoV.
A ranar 15 ga watan Janairu, 2020 an fara bayar da rahoton karar farko daga Wuhan.
A halin da ake ciki, cutar ta bulla cikin hanzari zuwa garuruwan makwabta, larduna, da kasashe.
A ranar 20 ga watan Janairu, an ba da rahoton ma'aikatan kiwon-lafiya, sun bayar da shawarar cewa yadawar mutum-zuwa-mutum abu mai yiwuwa ne.
A ranar 23 ga watan Janairu, an kulle birnin Wuhan tare da dakatar da jigilar jama'a.
A ranar 24 ga Janairu, binciken farko na asibiti game da cutar ya ba da rahoton cewa, a cikin mutane 41 da aka tabbatar da lamuran cutan, mutane 21 kawai suna da hulɗa kai tsaye tare da kasuwar cin abincin teku na Wuhan wanda aka yi la'akari da farkon wurin kamuwa da cuta daga asalin dabba.
A ranar 30 ga watar Janairu, WHO ta ba da sanarwar barkewar cutar ta gaggawa a duniya.
Ya zuwa lokacin hada wannan rahoto, cutar ta riga ta yadu a cikin kasar Sin da kuma kusan wasu kasashe 50 a duniya baki daya (Fig. (Fig. 2).2)
Yayin da yanayin ke gudana cikin hanzari, yanayin ƙarewa da tsananin yaduwar ya kasance za a gano.
A ranar 11 ga watan Fabrairu, 2020, wani bincike na cibiyar kan marasa lafiya 8,866 ciki har da 4,021 sun tabbatar da marassa lafiyar COVID-19 an gabatar da wani sabon bayanin da aka samu game da annoban kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
Cutar SARS tana kama mutane masu kowanne irin shekaru, amma ta fi kama 'yan shekara 30-65.
Kusan rabin kashi (47.7%) na mutanen da ke kamuwa da cutar sun wuce shekaru 50, kaɗan kalilan ba su kasa da shekara 20 ba, kuma mutane 14 ne kawai suka kamu da cutar waɗanda ke ƙarƙashin shekara 10.
SARS-CoV-2 sun fi kama maza (0.31 / 100,000) fiye da mata (0.27 / 100,000).
COVID-19 ya fadada cikin gungura a ciki da kewayen Hubei.
COVID-19 ya ɗauki tsawon kwanaki 5 (2-9) daga farko zuwa binciken ganewar sa.
Matsakaicin lokacin girman cutan shine kwanakin 4.8 (3.0-7.2).
Matsakaicin lokacin daga farko zuwa mutuwa ya kasance kwanaki 9.5 (4.8-13)
Lambar asali ta haihuwa (R0) ya kasance 3.77 (95% CI: 3.51-4.05), kuma daidaitawar R0 shine 2.23-4.82.
Yawan masu kamuwa da cutar sun karu sosai kafin ranar 23 ga Janairu 2020, wanda ya yi daidai da lokacin da ake daukar jigilar kayayyaki kafin bikin bazara a kasar Sin.
Yawan mutuwar marasa lafiya wanda aka tabbata da lamura kamu da cutan ya kai kashi 1.44% (95% CI: 1.10-1.86%), kuma daidaitawar mutuwar duk marasa lafiya shine kashi 3.06% (95% CI: 2.02-4.59%).
Manyan dalilan haɗarin uku don COVID-19 sun kasance jima'i (namiji), shekaru (≥60), da matsananciyar ciwon huhu.
CoVs dan rashen iyali ne na babban ambulaf ƙwayoyin cuta wanda ke dauke da ma'anar RNA guda daya.
Ana iya rarrabasu gida uku, i.e., alpha, beta, gamma, da delta, waɗanda alpha- da beta-CoVs an san su don kamuwa da ɗan adam.
Ambulaf ta kara daurin (S) glycoprotein a masu karɓar kwayar halittar sa angiotensin-mai canza enzyme 2 (ACE2) da pepeididly peptidase 4 (DPP4) don SARS-CoV da MERS-CoV, bi da bi, sannan kuma hadawar membrane yana faruwa.
An saki kwayar cutar RNA a cikin cytoplasm; bayan sake fasaltar kwayar halittar, RNA genomic rufe baya da ambulaf na glycofurotin da sunadarai na nucleocapsid suna samar da virion-dauke da vesicles, wanda sai ya hadu da membrane na plasma don sakin kwayar cutan.
An bayar da rahoton jerin kwayoyin halitta na farko na SARS-CoV-2 a ran 10 ga watan Janairu, 2020.
An gano SARS-CoV-2 wani sabon nau'in beta-CoV ne tare da fiye da kashi 99.98% asalin kwayoyin halitta tsakanin samfuran 10 da aka tattara daga asalin yaduwar, Kasuwar abincin teku ta Huanan a Wuhan.
SARS-CoV-2 ya fi kamani da SARS-CoV fiye da MERS-CoV.
Ta hanyar watsa microscopy na wutar lantarki, an samo barbashi na SARS-CoV-2 a sassan iskar jikin mutum na epithelium.
An samo ACE2 na mutum a matsayin mai karɓa wa SARS-CoV-2 kazalika da SARS-CoV.
Duk da haka, furotin S na SARS-CoV-2 ya danganta ga ACE2 na ɗan adam fiye da na SARS-CoV, wanda ya zo daidai da gaskiyar cewa SARS-CoV-2 yana haifar da ƙarancin kamuwa da cuta a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 na iya samar da gajeriyar sunadarin furotin da aka shigar ta orf3b da wani furotin da ke rufe da orf8.
orf3b na SARS-CoV-2 na iya taka rawa a cikin bada kwayar cuta da kuma hana bayyanar IFNβ; kodayake, orf8 ba ya da wani yanki da aka sani aiki ko motif.
A ranar 18 ga watan Fabrairu, 2020, Zhou, et al, sun ba da rahoton tsarin cryo-EM na cikakken ACE2 na dan adam a ƙudurin 2.9 Å ƙuduri cikin hadadden mai ɗaukar amino acid B0AT1.
Sun gano cewa hadadden, wanda an gano aka bude kuma an rufe, an taru a matsayin sinadari dimer kuma hadadden ACE2-B0AT1 na iya daurar sinadarai biyu na S furotin, wanda ke ba da shaida don ganewar CoV da kamuwa da cuta.
B0AT1 na iya zama makasudin warkewa don gwajin magunguna don murƙushe kamuwa da cutar SARS-CoV-2.
Asalin da kuma tsakiyar mazaman cutar.
An san cewa SARS-CoV da MERS-CoV sun samo asali ne daga jemagu kuma ana watsa su ga mutane ta hanyar kuliyoyi da raƙuma.
Ta hanyar kwatancen fitowar cututtukan na SARS-CoV-2 tare da sauran CoVs, an yi la’akari cewa jemage ne mazaunin SARS-CoV-2 kamar yadda sabon ƙwayar cuta ya kasance kashi 96% zuwa mai kamar-SARS CoVs biyu daga jemagu da ake kira bat-SL-CoVZX45 da jemage-SL-CoVZX21.
Duk da haka, wande mazaman tsakiya mai taimaka wa kwayar cutar ta keta shingen nau'ikan don kama mutane har yanzu ba a san shi ba, kuma har yanzu ba a fara sanin hanyar yada cutar ba.
Ji, et al., Sun gabatar da macizai a matsayin jigilar kwayar cutar daga jemagu zuwa mutane wanda ke da alaƙar yin ma'amala tsakanin S furotin.
Dangane da wani bincike, masu bincike a Guangzhou, China, sun ba da shawarar cewa pangolins - dogon-hanci da baki, dabbobi masu cin kyashi an cikia amfani da su cikin al’adar maganin Sinawa - su ne mazama SARS-COV-2 da ke yiwu wa bisa ga kashi 99% kwayar halitta a cikin wani CoV wanda aka gano a cikin pangolins da SARS-CoV-2.
Duk da haka bambancin kashi 1% ya bazu akan kwayoyin halitta guda biyu har yanzu babban bambanci ne; don haka, ana jiran sakamako na ƙarshe don tabbataccen hujja (Fig.(Fig.33).
Sunadarain kimiyyar kadarorin SARS-CoV-2 har yanzu ba a san su ba.
SARS-CoV da MERS-CoV zasu iya rayuwa cikin kwalban gwaji na tsawon awanni 48 a cikin busheshen yanayin har zuwa kwanaki 5 a ƙarƙashin 20 ° C da danshi kashi 40% -50%.
SARS-CoV-2 na iya mallakar kaddarorin iri daya.
An ba da rahoton cewa SARS-CoV-2 yana kula da haskoki na zafin rana da zafi a 56 ° C na minti 30; kashi 75% ethanol, chlorine-mai dauke da sinadarai, sinadarin peracetic acid, chloroform, da sauran abubuwan rage kiba, amma ba chlorhexidine ba, na iya lalata kwayar ta yadda ya kamata.
Yawan mutane gabaɗaya sun rasa garkuwa ga SARS-CoV-2 kuma saboda haka ana iya kamuwa da sabuwar ƙwaya cutan.
A halin yanzu, babu cikakken binciken da aka bayar da rahoton game da amsawar rigakafi ga SARS-CoV-2.
Don haka, zamu iya komawa ne kawai ga binciken da muka gabata akan wasu CoVs, musamman SARS-CoV da MERS-CoV (Fig. (Fig. 4).4).
Gabaɗaya, bayan da kwayar cutar ta mamaye mai watsa shiri, an fara gane ta hanyar rigakafin garkuwar jiki ta hanyar karɓa (PRRs) gami da masu karɓa na nau'in irin-C, kamar-Toll mai karɓa (TLR), mai karɓar kamar-NOD mai karɓa (NLR) , da kamar-RIG-I mai karɓa (RLR).
Ta hanyar hanyoyi daban-daban, kwayar cutar ta haifar da bayyanar da abubuwan da ke haifar da kumburi, matattarar ƙwayoyin dendritic, da haɓaka nau'in I interferons (IFNs) waɗanda ke iyakance yaduwar ƙwayar cuta kuma suna haɓaka matakan ƙwayoyin cuta na ƙwayoyin cuta.
Duk da haka, sinadarin furotin N na SARS-CoV zai iya taimakawa kwayar cutar ta tsere daga amsawar garkuwan jiki.
Ba da daɗewa ba, amsar rigakafin ƙwayar cuta ta shiga cikin yaƙi da ƙwayar cuta.
T lymphocytes ciki har da CD4 + da CD8 + T tantanin halitta suna taka muhimmiyar rawa a cikin tsaron.
Tantanin halita CD4 + T suna motsa ƙwayoyin B don samar da ƙayyadaddun rigakafin ƙwayoyin cuta, kuma sel CD8 + T tantanin halita na kashe kwayoyin cutar da suka kamu da ciwo kai tsaye.
Mai taimakon tantanin halita T ta samar da cytokines na kumburi don taimakawa kwayoyin da ke kare su.
Duk da haka, CoV zai iya hana ayyukan tantanin halita T ta hanyar gabatar da apoptosis na tantanin halita T.
Rigakafin ƙwaƙwalwar ciki har da haɗi kamar C3a da C5a da ƙwayoyin garkuwar jiki suna da mahimmanci don yaƙar kamuwa da cuta.
Alal misali, warewar kwayoyin garkuwar jiki daga wani mara lafiya mai warkewa ya watsar da MERS-CoV.
A gefe guda, wuce gona da iri na tsarin rigakafi yana haifar da babban adadin radadi kyauta a cikin gida wanda zai iya haifar da lahani ga huhu da sauran gabobin, kuma, a cikin mummunan yanayin, gazawar ƙwayoyin cuta da dama har ma da mutuwa.
Kamuwa da cutar SARS-CoV-2, wanda aka nuna ta hanyar haɗuwa, yana yuwuwar kama tsofaffi masun zama da wasu cututtuka da mata masu juna biyu.
Abu ne gama gari cewa ga mutanen da ke kamuwa da ɗimbin ƙwayoyin cuta ko waɗanda aka keɓance ayyukan su, suna da damar da za su kamu da ita fiye da sauran.
An kiyasta cewa lokacin girman SARS-CoV-2 shine ranakun 1-14, yawancin kwanaki 3-7 bisa ya danganta ga binciken farkon mutane 425 wanda suka kamu da cutar cikin Wuhan.
Duk da haka, binciken akan mutane 1,099 masu cutan ya nuna cewa kwanakin haifarwa shine kwana 3 a matsakaita kuma daga ranakun 0 zuwa 24.
Wani ƙarin binciken da aka yi kwanan nan, ya nuna cewa lokacin shiryawa ya kasance kwanaki 4.8 (3.0-7.2) kwanaki bisa ga tarihin kamuwar mutane 8,866.
Yana da matukar muhimmanci ga hukumomin kiwon lafiya su daidaita lokacin keɓancewa daidai gwargwado lokacin shiryayye, don haka hana kamuwa da cuta amma mutanen da ba su da kwayar cutar kwayar cutar ga wasu.
A matsayin al’adar yau da kulum, mutanen da ke a fili, ko masu kamuwa da cutar, yawanci ana buƙatar ware kansu na kwanaki 14.
Shin yakamata a tsawan lokacin keɓewa zuwa kwanaki 24?
Zazzabi shine babban kuma farkon nuna alamar COVID-19, wanda za'a iya haɗa shi ba tare da wata alama ba ko wasu alamomi kamar bushewar tari, gajeruwar numfashi, ciwon jijiyoyi, matsanancin ƙarfi, ciwon kai, ciwon makogwaro, rhinorrhea, ciwon kirji, zawo, tashin zuciya, da amarwa.
Wasu marasa lafiya sun sami dyspnea da / ko hypoxemia mako guda bayan farkon cutar.
A cikin mawuyacin hali, marasa lafiya sun sami saurin don haɓaka cutar hanyoyin numfashi mai tsanani, girgizawar jijiyoyin jiki, acidosis metabolic, da coagulopathy.
Marasa lafiya da zazzabi da/ko alamomin hanyoyin numfashi da zazzabi mai tsanani, koda ba tare da alamun cutar huhun ciki ba, yakamata a bincika kwayar cutan don gano shi da sauri.
Wani binciken alƙaluma a ƙarshen Disamba na 2019 ya nuna cewa kashiɗarin bayyanar cututtuka sun kasance kashi 98% ga zazzabi, kashi 76% don bushewar bushe, kashi 55% don dyspnea, da kashi 3% don zawo; 8% na marasa lafiya suna buƙatar tallafin iska.
An bayar da rahoton irin daya a cikin binciken biyu na kwanan nan game da tarin iyali da kuma tari wanda ya haifar ta hanyar watsawa daga mutum mai nunin alamar ciwon.
A kwatancewa, a binciken mutane a shekarar 2012 ya nuna cewa masu cutar MERS-CoV suma suna da zazzabi kashi (98%), bushewar tari kashi (47%), da dyspnea kashi (55%) a matsayin babban alamun su.
Duk da haka, kashi 80% daga cikinsu suna buƙatar tallafin shakar iska, fiye da marasa lafiyar COVID-19 kuma sun dace da mafi girmar kamuwar MERS fiye da na COVID-19.
An kuma lura da zawo kashi (26%) da ciwon makogwaro kashi (21%) tare da marasa lafiyar MERS.
A cikin marasa lafiya na SARS, an nuna cewa zazzabi kashi (99% -100%), tari mai bushewar kashi (29% -75%), dyspnea kashi (40% -42%), zawo kashi (20-25%), da ciwon makogwaro kashi (13 -25%) sune manyan alamu kuma ana buƙatar tallafin iska don kusan kashi 14% -20% na marasa lafiya.
Ya zuwa ranar 14 ga watan Fabrairu, mutuwar COVID-19 ya zama kashi 2% lokacin da aka tabbatar da masu kamuwa da chutar sun kai 66,576 a duk duniya.
Kwatancen, mutuwa don SARS daga Nuwamba 2002 shine kashi 10% na mutane 8,096 wanda aka tabbatar da kamuwa da cutar.
Ga MERS, dangane da binciken alƙaluma a watan Yuni na 2012, mutuwa ta kasance kashi 37% daga cikin 2,494 lamari da aka tabbatar.
Wani binciken da aka yi a baya ya ba da rahoton cewa R0 na SARS-CoV-2 ya yi sama da 6.47 tazarar amintace na kashi 95% (CI) na 5.71-7.23, yayin da R0 na SARS-CoV ya jera daga 2 zuwa 4 kawai.
An gabatar da kwatancen SARS-CoV-2 tare da MERS-CoV da SARA-CoV dangane da alamomin su, mace-mace, da kuma R0 a cikin Tebur Tebur1.1.
Abubuwan da ke sama suna ba da shawara cewa SARS-CoV-2 suna da iko mafi girma don yadawa fiye da MERS-CoV da SARS-CoV, amma ba shi da kasala fiye da na ƙarshen biyu.
Don haka, ya fi fuskantar kalubale sosai wajen shawo kan cutar SARS-CoV-2 fiye da MERS-CoV da SARS-CoV.
Gungura wuri daya yakan faru sau dayawa ne a cikin dangi guda ɗaya ko daga taro guda ɗaya ko abin hawa kamar jirgin ruwan.
Marasa lafiya galibi suna da tarihin tafiya ko zama a Wuhan ko wasu wuraren da cutar ta shafa ko kuma hulɗa da masu kamuwa da cuta ko kuma marasa lafiya a cikin makwanni biyu da suka gabata kafin an fara.
Duk da haka, an ba da rahoton cewa mutane na iya ɗaukar kwayar cutar ba tare da alamu fiye da makonni biyu ba sannan kuma warkewar marasa lafiyar da aka kwantar da su daga asibitoci na iya ɗaukar cutar ta sake, wanda ke aika ƙararrawa don ƙara lokacin keɓewa.
Marasa lafiya suna da daidai ko rage lambar yanki farin jini (musamman cututtukan lymphocytes) a farkon matakin.
Alal misali, lymphopenia tare da yawan farin jinin tantanin halita <4 × 109/L hade da yawan lymphocyte <1×109/L, kuma an daga matakan asotate aminotransferase da viremia a marasa lafiya guda 1,099 wanda suka kamu da COVID-19.
Matakin hanta da jijiyar enzymes da myoglobin sun karu a cikin jinin wasu marasa lafiya, kuma an karuwar furotin C-mai martani da dalakawarr erythrocyte a cikin jinin na yawancin marasa lafiya.
A cikin marasa lafiya da ke da tsananin cuta, matakin D-dimer, samfurin fibrin mai lalatawa da ke akwai cikin jini, ya haɓaka, kuma an rage adadin ƙwayar cutar ta lymphocyte.
Rashin lafiya cikin hoton rediyon kirji ana samun shi a cikin mafi yawan marasa lafiya na COVID-19 kuma an nuna su ta hanyar inuwa biyu na inuwa ko kuma gilashin ƙasa a cikin huhu.
Yawanci marasa lafiya kan haifar da ciwon huhu, raunin huhu mai tsanani, da cutar hanyoyin numfashi mai tsanani (ARDS).
Lokacin da ARDS ta faru, kumburin da ba a sarrafa shi ba, tara ruwa, da fibrosis mai ci gaba sun lalata mummunar musayar gas sosai.
Rashin daidaituwa na nau'in-I da nau'in-II na pneumocytes yana rage matakin surfactant kuma yana kara tashin hankali, ta haka ne rage ikon fadadar huhun da kara hadarin rushewar huhu.
Sabili da haka, binciken mafi munin hoton zuciya sau da yawa suna kama da mafi girman yanayin cutar.
A ranar 18 ga watan Fabrairu, 2020, bincike na farko na COVID-19 ya nuna rashin cancanci na pneumocytes, hyaline membrane, da kuma ƙwayar cuta ta mahaifa, da tantanin halita da yawa na ƙwayoyin cuta a cikin huhun masu cuta wanda ya mutu da cutar, ya yi daidai da yanayin kamuwar cutar makamacin ARDS da marasa lafiyar SARS da MERS.
Ganowar SARS-CoV-2 RNA ta hanyar juyawar sarkar polymerase wato (reverse-transcriptase) (RT-PCR) anyi amfani da shi azaman manyan ka'idojin gwajin cutar COVID-19.
Duk da haka, saboda kiyatsa girman babu-rashi, wanda zai iya hanzartawar annoban, an fara amfani da alamun bayyanar asibiti don ganewar asali (wanda bai dogara ga RT-PCR ba) kadai ba a kasar Sin a ranar 13 ga Fabrairu, 2020.
Hakanan irin wannan yanayin ya faru tare da bayyanar cutar SARS.
Sabili da haka, haɗuwa da tarihin cutar, bayyanar asibiti, dakin gwaji da kuma binciken radiyo yana da mahimmanci kuma wajibi ne don yin ingantaccen bincike.
A ranar 14 ga Fabrairu, 2020, kungiyar Feng Zhang ta ba da bayanin wata hanyar yin amfani da fasahar SHERLOCK ta CRISPR don gano SARS-CoV-2, wanda ke gano ƙwayoyin SARS-CoV-2 RNA roba a 20 × 10-18 mol / L zuwa 200 × 10-18 mol / L (10-100 kwafa ta microliter na shigar) ta amfani da dipstick a cikin ƙasa da awa ɗaya ba tare da buƙatar bayyanin kayan aikin ba.
Da fatan, sabuwar dabarar za ta iya bunkasa hankali da kwanciyar hankali matukar an tabbatar cikin samfuran asibiti.
Saboda ƙarancin ƙwarewa tare da sabon labari na CoV, likitoci na iya samar da kulawa ta musamman ga marasa lafiyar COVID-19, yayin da ake ƙoƙarin hanyoyin jiyya da dama waɗanda aka yi amfani da su ko aka gabatar dasu don jiyyar wasu CoV kamar SARS-CoV da MERS-CoV da sauran cututtukan (Tebur 2).2).
Wadannan hanyoyin jinya na yanzu da kuma yiwuwar jiyya tare da magungunan rigakafi, da immunosuppressants, steroids, plasma daga majinyatan da suka sami sauki, magungunan Sinawa, da tallafin tunani.
Ko da plasma daga majinyatan da sun samu sauki an gabatar dasu ne domin ayi amfani dasu don jiyya.
Kamfanonin magunguna suna yin tsere don haɓaka ƙwayoyin garkuwa da alluran rigakafin kan kwayar cutan.
SARS-CoV-2 suna kai hari sosai a huhu a farawa kuma mai yiwuwa kuma suna kaiwa hari, zuwa ƙarancin ƙima, sauran gabobin da ke bayyana ACE2, kamar tsarin gastrointestinal da kodan.
Duk da haka, lalatawar hanyar numfashi da gazawa sune babbar haɗari ga marasa lafiya da babban dalilin mutuwa.
Saboda haka, tallafawar hanya numfashi yana da mahimmanci don sauƙaƙe bayyanar cututtuka da kuma ceton rayuka kuma ya haɗa duk jiyya ta iska, iska mai saurin motsawa, samun iska daga na’ura, ya danganta ga tsananin cutar.
Marasa lafiya da bayyanar cutar hanyoyin numfashi mai tsanani dole ne a tallafa su da karin isaka (ECMO), wani ingantaccen dabarar bugun zuciya wanda aka yi amfani dashi don maganin cututtukan zuciya masu haɗari ko gazawar hanyoyin numfashi.
Bugu da kari, da daidaitawar ma'aunin electrolyte, rigakafin da lura da kamuwa da cuta da sakin jiki, da kuma kariya daga ayyukan gabobin jiki ma suna da matukar muhimmanci ga marasa lafiya na SARS-CoV-2.
An san cewa guguwar cytokine tana faruwa ne sakamakon wuce gona da iri na tsarin rigakafi a cikin marasa lafiyar SARS da MERS.
Guguwar Cytokine wani nau'i ne na yanayi amsar tsarin kumburi wanda aka gabatar ta hanyar jerin cytokines da suka hada da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Waɗannan cytokines tare da tantanin halita mai garkuwa su saki ɗimbin kwayoyi mara canzawa waɗanda sune babban dalilin ARDS da kuma gazawar gabobin jiki da yawa.
Danna rigakafi yana da muhimmanci a lura da guguwar cytokine, musamman a cikin majinyata masu rauni sosai.
Corticosteroids da tocilizumab, anti-IL6 monoclonal garkuwar jiki, an yi amfani dasu don magance guguwar cytokine.
Sauran jiyya danna rigakafi don guguwa ta cytokine sun hada da daidaitawa da amsawa kai tsaye na rigakafin tantanin halita T; toshewar IFN-γ, IL-1, da TNF; JAK hanawa; blinatumomab; mai danna alamar cytokine 4; da HDAC masu hanawa.
Maganin Steroids, kamar immunosuppressants, aka yi amfani da su sosai a cikin lura da SARS don rage tsananin lalacewa kumburi.
Duk da haka, shan steroids sosai ba su da fa'ida ga mummunan raunin huhu a cikin marasa lafiyar SARS da COVID-19.
Madadin haka, suna iya haifar da mummunar illa, musamman cututtukan osteonecrosis, da ke haifar da tasirin cutar.
Kodayake, gajerun darussan na corticosteroids a ƙarancin-zuwa-matsakaitan allurai an bada shawarar ayi amfani dasu da hankali don marasa lafiya COVID-19 marasa lafiya.
A lokacin rubutu, babu ingantaccen maganin rigakafi da aka tabbatar.
Duk da haka, badawa ta jijiya da remdesivir, wani nucleotide na analog, ana samun inganci a cikin marasa lafiyar COVID-19 na Amurka.
Remdesivir wata sabon maganin rigakafin ƙwayoyin cuta ne wanda Gidiyon ta kirkiro da farko don jiyyar cututtukan da cutar Ebola da Marlburg suka haifar.
Daga baya, sakatariya ya kuma nuna yiwuwar hana sauran kwayoyin cutar RNA guda da suka hada da kwayoyin cututtukar MERS da SARS.
Dangane da waɗannan, Gidiyon ya ba wa mahaɗin zuwa China don gudanar da gwaji guda biyu a kan mutane masu kamuwa da cutar SARS-CoV-2, kuma ana sa ran samun sakamako sosai.
Bugu da ƙari, an ba da shawarar baricitinb, interferon-α, lopinavir/ritonavir, da ribavirin a matsayin hanyoyin kwantar da hankalin marasa lafiya wanda ke da cutar hanyoyin numfashi mai tsanani.
Zawo, tashin zuciya, amai, lalacewar hanta, da sauran raunin azaba na iya faruwa bayan an haɗawar jinyar tare da lofinavir/ritonavir.
Hulɗawar waɗannan jiyya tare da wasu magunguna da aka yi amfani da su a cikin marasa lafiya ya kamata a sa ido sosai.
Plasma daga marasa lafiya da suka samu sauki da garkuwar jiki.
Tarin jini daga marasa lafiyar da suka murmure daga wata cuta mai yaduwa don yi wa wasu marasa lafiya da ke fama da wannan cuta ko kuma kare lafiyar mutane daga kamuwa da cutar yana da dogon tarihi.
Tabbas, mara lafiyar da aka dawo dasu galibi suna da babban matakin kariya daga kwayar cuta a cikin jinin su.
Garkuwar jiki sune rigakafi immunoglobulin (Ig) wanda aka samar daga B lymphocytes don yaƙar ƙwayoyin cuta da sauran abubuwa na ƙasashen waje kuma suna sane da kwayoyi na musamman a cikin cututtukan da ke cikin su.
Dangane da wannan, an karɓo plasma daga jinin gungun masu haƙuri waɗanda suka warke daga COVID-19 kuma an saka shi cikin marasa lafiya 10 mara lafiya sosai.
Alamar cutar su ta inganta cikin sa'o'i 24, tare da rage kumburi da rahusa da kuma inganta jijiyar oxygen a cikin jini.
Duk da haka, tabbatarwa da bayani wajibi ne don gabatar da hanyar don babban amfani kafin takamaiman hanyoyin kwantar da hankali ba su inganta ba.
Bugu da kari, da aka ba da tasirin warkewa, za a yi la’akari da wasu kasala da ke da alaƙa da plasma a hankali.
Alal misali, cututtukan rigakafi na iya wuce gona da iri kan hanyar kariya kuma suna haifar da sakin alamar alcytokine, wanda ke iya zama haɗarin rayuwa.
Taruwar garkuwar jiki cikin jini yawancin lokuta na ƙadan, kuma buƙatun plasma yana da yawa don kula da marasa lafiya da ke fama da rashin lafiya.
Yana da wuya a haɓaka da samar da takamaiman ƙwayoyin rigakafi cikin hanzari don yaƙi da annobar duniya.
Don haka, abu mafi mahimmanci ne kuma mai kyawu ne a kebe tantanin halittar jikin B (B cells) daga marassa lafiyar da suka warke kuma gano lambobin kwayar halitta wadanda ke hade da ingantattun garkuwar jiki ko duba garkuwa musamman a kan muhimman furotin na kwayan cutar.
Ta wannan hanyar, zamu iya haɓaka samar da magungunan garkuwar jiki.
An yi amfani da TCM don magance wasu cututtuka da yawa a kasar Sin har tsawon dubunnan shekaru.
Duk da haka, tasirin sa ya dogara ne akan haɗakar abubuwan haɗin da yawa a cikin tsari wanda ya bambanta dangane da binciken cutar da aka yi la'akari da tunanin TCM.
Yawancin ingantattun abubuwanda ake aiki dasu ba'a san su ba ko kuma marasa fahimta ne saboda yana da wahalar cirewa da tabbatar da irin waɗannan abubuwan haɗin ko abubuwan haɗin su.
A halin yanzu, saboda rashin inganci da takamaiman jiyyar COVID-19, TCM ya zama ɗayan daga cikin hanyoyin jiyyan marasa lafiya tare da haske zuwa alamu na matsakaicin alama ko ga waɗanda suka warke daga matsanancin matakai.
Alal misali, maganin kawan Shu Feng Jie Du da maganin kawan Lian Hua Qing Wen an samu sun dace don jinyar COVID-19.
Babban warkarwa marasa lafiyar COVID-19 a cikin larduna da yawa na kasar Sin wadanda ke amfani da TCM a cikin kashi 87% bisa dari na marasa lafiyar su, ciki har da Gansu kashi (63.7%), Ningxia kashi (50%), da Hunan kashi (50%), yayin da lardin Hubei, wanda ya yi amfani da TCM a kusan kashi 30% na masu cutar COVID-19, suna da mafi ƙarancin warkewa kashi (13%).
Duk da haka, wannan ya zama kwatanci mara kyau kamar yadda sauran dalilai masu tasiri kamar lamba da tsananin marasa lafiya yakamata a saka su cikin kimantawa.
A ranar 18 ga watan Fabrairu, 2020, Boli Zhang da abokan aikin ta sun buga wani bincike don kwatanta magani na yamma (WM) jinyar shi kaɗai tare da haɗin maganin WM da TCM.
Sun gano cewa lokutan da ake buƙata don murmurewar yanayin jiki, ɓarnawar alama, da kuma asibiti mafi ƙaranci a cikin rukunin WM + TCM fiye da ƙungiyar cikin WM ƙungiyar kawai.
Mafi ban sha'awa, rauni da yake ƙaruwa da cuta (daga haske zuwa mai tsanani) ya kasance ƙarancin ƙungiyar WM + TCM fiye da na ƙungiyar WM kawai kashi (7.4% kusa da 46.2%) kuma yawan mutuwa ya kasance ƙasa a cikin rukunin WM + TCM fiye da WM kawai rukuni kashi (8.8% a kan 39%).
Koyaya, inganci da lafiyar TCM har yanzu suna jiran ƙarin gwaji da aka sarrafa sosai a sikeli mafi girma da kuma a cikin ƙarin cibiyoyin.
Hakanan zai zama mai ban sha'awa don sanin yanayin ayyukan da bayyana ingantattun kayan aikin jiyya na TCM ko haɗinsu idan zai yiwu.
Marasa lafiya da ake zargi ko aka tabbatar da COVID-19 yawan lokuta suna fuskantar babbar fargaba game da cutar mai yaduwa har ma da kisa, kuma mutanen da ke keɓewa kuma suna fuskantar bacin rai, kadaici, da fushi.
Bayan haka, alamomin kamuwa da cuta kamar zazzabin, cututtukan rashin iska, da tari kazalika da illa dabam-dabam na jinyar kamar cutar rashin bacci wanda corticosteroids ke hadasa na iya haifar da ƙarin damuwa da damuwa ta hankali.
A farkon barkewar cutar ta SARS, an sami dumbin cututtukan kwakwalwa da suka hada da ci gaba da damuwa, damuwa, fargaba, tashin hankali, alamomin tabin hankali, tashin hankali, har ma da kashe kansa.
M lamba tuntuɓe da keɓe masu ciwo, a matsayin wani ɓangare na martanin lafiyar jama'a game da yaduwar COVID-19, zai iya sa mutane su zama masu yawan damuwa da masu laifi game da sakamakon yaduwar, keɓewa, da ki kan iyali da abokai.
Don haka, ya kamata a ba da kulawa ta lafiyar kwakwalwa ga marasa lafiya na COVID-19, waɗanda ake zargi, da mutanen da ke hulɗa da su da kuma sauran jama'a waɗanda ke da buƙata.
Taimakon tunani ya kamata ya haɗa da kafa ƙungiyoyin kiwon lafiyar masu tunani iri-iri, bayyanannun sadarwa tare da sabuntawa na yau da kullun game da fitowar SARS-CoV-2 da tsare-tsaren kulawa da kuma amfani da na'urorin lantarki da aikace-aikace don guje wa kusanci da juna.
Magungunan rigakafi suna da mahimmanci don katse hanyoyin yadawa daga jikin dabbobi da kuma kamuwar mutane zuwa masu bada cutar a saukake kuma galibi suna taimakawa ga maganin jinyar garkuwar kwayoyin cuta don magancewar anoba wanda ƙwayoyin cuta masu tasowa ke haifar.
An yi ƙoƙari don haɓaka alluran rigakafin mai-furotin S don samar da magungunan rigakafi na dogon lokaci da kuma watsewar garkuwa jiki da/ko kariya daga garkuwar kariya daga cutar SARS-CoV.
An kimanta allurar rigakafi masu rai cikin samfurin dabbobi SARS.
Koyaya, ingancin waɗannan maganin alurar rigakafi a cikin tsofaffi mutane da samfuran ƙarancin cuta da kariyarsu game da kamuwa da cutar ƙwayar cutar zoonotic har yanzu ba a ƙaddara su ba kafin fara nazarin asibiti.
Wataƙila saboda SARS ya mutu ƙasa 17 da suka wuce kuma ba a sake samun wani sabon mai kamuwa ba.
A hanya daban, lamari masu lalacewa da kuma gungu na MERS suna ci gaba da faruwa a Gabas ta Tsakiya kuma suka watsu zuwa wasu yankuna sakamakon dorewar hanyoyin zoonotic a cikin wurare masu cutarwa.
An tsara dabarun yin rigakafi don MERS ta amfani da ƙwayar cuta mara ƙarfi, abubuwan plasmids na DNA, ƙwayoyin cuta na viral, abubuwan nanoparticles, kamar-ƙwayoyin cuta barbashi da ƙananan abubuwan gina jiki da aka kimanta su kuma a wasu samfuran dabbobi.
Haɓaka ingantaccen maganin rigakafi daga SARS-CoV-2 ga mutane marasa garkuwa abu ne mai gaggawa da mahimmanci don magance annoba da ke ci gaba.
Duk da haka, yana da ƙalubale don shawo kan wahalar saboda tsawon lokaci (aƙalla watanni 18) da ake buƙata don haɓaka maganin alurar rigakafi da bambancin canji na CoVs.
A matsayin sabon cuta, COVID-19 ya fara bayyana cikakkiya a matsayin ciwon asibiti ta wurin dubban masu kamuwa da cutar.
A mafi yawacin alamari, marasa lafiya na iya murmurewa a hankali ba tare da sequelae ba.
Duk da haka, mai kama da SARS da MERS, COVID-19 shima yana da alaƙa da mutuwa sosai a cikin marasa lafiya da suke da tsananin lamarin cutan.
Don haka, kirkirar tsarin tsinkaye game da cutar yana da mahimmanci ga hukumomin kiwon lafiya don ba da fifikon ayyukanta, musamman a wuraren da ake wahalar samar da albarkatu.
Dangane da binciken asibiti wanda aka ruwaito har zuwa yanzu, abubuwan da ke ƙasa na iya shafar ko kuma za a iya danganta su da haɓakar marasa lafiya na COVID-19 (Tebur (Tebur33)):
Shekaru: Shekaru shine mafi mahimmancin hangen nesa na SARS, wanda gaskiya ne ga COVID-19.
COVID-19 ya faru ne sosai a cikin shekaru 30-65 tare da kashi 47.7% na waɗannan marasa lafiya sun fi 50 a cikin nazarin lamarin cutar 8,866 kamar yadda aka bayyana a sama.
Marasa lafiya waɗanda ke buƙatar tsananin kulawa sun fi iya samun wasu cututtuka na lokaci daya da rikitarwa kuma sun fi tsufa da waɗanda ba suyi (a cikin shekarun tsakiya na 66 da 51), suna ba da shawara ga shekarun a matsayin hangar zuwan cutar don sakamakon marasa lafiya na COVID-19.
Jima'i: SARS-CoV-2 ya fi kama maza fiye da mata (0.31 / 100,000 a kan 0.27 / 100,000), kamar yadda aka bayyana a sama.
Rashin daidaituwa da wahala: Marasa lafiya tare da COVID-19 waɗanda ke buƙatar kulawa mai zurfi sun fi fuskantar wahala ga mummunan rauni na zuciya da arrhythmia.
Aukuwar ciwon zuciya shima babban dalilin mutuwa a cikin masu cutar SARS.
An ba da rahoton cewa SARS-CoV-2 na iya ɗaure zuwa ACL2-tabbatacce cholangiocytes, wanda zai haifar da rashin aikin hanta a cikin marasa lafiyar COVID-19.
Yana da mahimmanci a lura cewa shekaru da cutar na da dangantaka sosai kuma suna iya tsoma baki ga juna.
Binciken dakin gwaji wanda ba a hanya ba ne: C-reactive protein (CRP) mataki a jini yana nuna tsananin zafin kumburi ko raunin nama kuma an gabatar da shi don zama mai yuwuwar asarar cutar, amsar jin magani, da murmurewa ta ƙarshe.
Hulɗawar matakin CRP zuwa ga tsananin da kuma hangar zuwan cutar COVID-19 shi ma an shawarta.
Bugu da ƙari, ɗaukaka lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) zasu iya taimakawa hango ko hasashen sakamakon.
Ana nuna waɗannan ƙwayoyin enzyme a cikin gabobin da yawa, musamman a zuciya da hanta, kuma ana sake su yayin lalata nama.
Don haka, su masun makin gargajiyar zuciya ko rashin aikin hanta da kyau.
Manyan alamun cututtukan asibiti: Hoto zuciya da ci gaban wucin gadin alamun asibiti na bayyanar cututtuka ya kamata a bincika tare da sauran maganganun don annabta sakamako da rikitarwar COVID-19.
Amfani da magungunan steroid: Kamar yadda aka bayyana a sama, steroids immunosuppressant ne da aka saba amfani da shi azaman hanyar haɗin kan jinyar cututtuka don rage tsananin lalacewa kumburi.
Tunda yawan magungunan corticosteroids an yi amfani dashi sosai a cikin majinyata na SARS, da yawa daga waɗanda suka tsira suka sha wahala daga cututtukan osteonecrosis tare da nakasassu na rayuwa da ƙarancin rayuwa.
Don haka, idan ana buƙata, ya kamata a yi amfani da steroids don sha kadan kuma don ɗan gajeren lokaci a cikin marasa lafiya na COVID-19.
Tabin hankali: Kamar yadda aka bayyana a sama, lokacin barkewar COVID-19 yawancin marasa lafiya suna shan wahala daga matsananciyar damuwa yayin da suke jure tsawon lokaci na keɓancewa da matsanancin rashin tabbas kuma suna ganin mutuwar dangi da kuma abokan rashin lafiyar.
Yana da mahimmanci a samar da shawarwari na tunani da tallafi na dogon lokaci don taimakawa waɗannan marasa lafiya su murmure daga damuwa kuma su koma rayuwan da aka saba yi.
Dangane da binciken alƙalumma har ya zuwa yanzu, da alamar COVID-19 na da fasalin cututtukan annoba daban-daban daga SARS.
Bugu da kari ga maimaitawa cikin hanyar numfashi na kasa, SARS-CoV-2 na iya rabuwa sosai a cikin hanyar numfashi na sama kuma ya haifar da karama ko babu nuna alamun farkon kamuwa da cutar, mai kama da sauran CoVs waɗanda ke haifar da mura na yau da kullun.
Sabili da haka, marasa lafiya masu kamuwa da cuta a farkon lokaci ko lokacin shiryawa na iya samar da adadin ƙwayar cuta lokacin ayyukan yau da kullun, yana haifar da babban wahala don magance annobar.
Duk da haka, an dauke watsar da SARS-CoV na faru lokacin da marasa lafiya ke fama da rashin lafiya, yayin da yawancin watsawa basu faru ba a farkon lokaci.
Don haka, barkewar COVID-19 na yanzu ya fi tsanani da wahala wajen sarrafawa fiye da barkewar SARS.
A yanzu haka ana ci gaba da yin kokari sosai a kasar Sin ciki har da kullewar Wuhan da biranen da ke kewayen ta da ci gaba da keɓaɓɓen jama'ar gaba ɗaya cikin fatan kawo ƙarshen yadawa kwayar cutar SARS-CoV-2.
Duk da cewa wadannan ayyukan sun lalata tattalin arzikin kasar da sauran bangarorin kasar, adadin sabbin masu cutar yana raguwa, yana nuna raguwar barkewar cutar.
Kyakkyawan tsammanin shine barkewar zata ƙare a watan Maris kuma yanayin saukar ruwan zaiyi tsawon watanni 3-4.
Duk da haka, wasu masana ba su da bege ba.
Paul Hunter, et al., Ya kiyasta cewa COVID-19, wanda alama yafi kamuwa da cutar fiye da SARS, ba zai ƙare a cikin 2020 ba.
Ira Longini, et al., Sun kirkiro wani abin ƙira don ƙaddara game da sakamakon annobar kuma ya ba da shawarar SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan jama'ar duniya.
Wata Kungiya daga Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin tsakiyar turbinate da makogwaron majinyacin da suka murmure kuma suka bar asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon kwayar cutar da ke nuna za ta iya zama wani abu mai kama da cutar mai kama da mura.
Duk da haka, alamu suka bada alama sun faru a kasar Sin bisa la'akari da raguwar sabbin lamurra cutan, wanda ke nuna dabarun da yanzu ke iya aiki.
An riga an annabta cuta ta Ebola wanda zai iya haifar da lamarin cutar miliyan guda tare da mutuwa rabin miliyan.
Duk da haka, ta hanyar keɓancewa da warewa, cutar ta ƙare a ƙarshe.
Mai yiyuwa ne, mai kama da SARS-CoV, SARS-CoV-2 na iya zama da rauni a cikin cuta kuma a ƙarshe ya mutu ko kuma ya zama ƙasa da kwayar cutar tare da mutane.
Ana ba da kwatancin annobar COVID-19 tare da na SARS da MERS yadda aka bada a ƙasa (Fig. (Fig. 55).
Ana yada SARS-CoV-2 sosai ta hanyar tari ko atishawa, kuma na yiwu kuma ta hanyar saduwa kai tsaye da kayan da kwayar cutar ta gurbata.
An kuma gano kwayar cutar a cikin kashi, wanda ke haifar da sabon yiwuwar yaduwar cutan daga kashi-zuwa-baki.
Wani binciken da aka yi kwana nan a kan lamarin masu kamuwa da cutan guda 138 ya ba da rahoton cewa kashi 41% daga cikin waɗannan cututtukan sun yiwu ne ta hanyar kamuwar nosocomial, ciki har da marasa lafiya 17 da wasu cututtukan baya da ma'aikacin kiwon lafiya guda 40.
Don haka, ya kamata a yi amfani da babbar kariya don kare mutane, musamman ma’aikacin kiwon lafiya, ma'aikatan zamantakewa, membobin iyali, abokan aiki, har ma da masu hulɗa da marasa lafiya ko mutanen da suka kamu da cutar.
Layin farko na kariya wanda za'a iya amfani dashi don rage hadarin kamuwa da cuta shine ta hanyar sanya fuskokin fuska; duka amfani da masks na tiyata da kuma nau'in mashin na numfashi N95 (jerin # 1860s) yana taimakawa wajen sarrafa yaduwar kwayar cututtuka.
Abin rufe fuska na tiyata na hana digan ruwa daga yiwuwar mutane da suka kamu da cuta daga tafiya cikin iska ko mannewa a saman kayayyaki, inda za'a watsa su ga wasu.
Koyaya, masai N95 (jerin # 1860s) abin rufe fuska zasu iya kare kai daga shaƙar virions da ke karami kamar 10 zuwa 80 nm, tare da kashi 5% na virions sun sami damar shiga gaba ɗaya; SARS-CoV-2 yana kama da SARS-CoV a girma kuma duka sunkai kusan 85 m.
Tunda barbashi na iya shiga ko da abin rufe fuskar tiyata guda biyar wadanda aka hada kansu, ma’aikatan kiwon lafiya a cikin hulda kai tsaye tare da marassa lafiya dole ne su sanya N95 (jerin # 1860s) abin rufe fuska amma ba abin rufe fuska na tiyata ba.
Kari ga abin rufe fuska, ma’aikacin samar da kiwon lafiya yakamata su sanya rigunan kadaici don a kara rage hulɗa da ƙwayoyin cuta.
Kwayoyin cuta kuma na iya kama mutum ta hanyar idanu.
A watan Janairu 22, 2020, likita ya kamu da SARS-CoV-2 duk da cewa ya sa abin rufe fuska N95; mai yiwuwa kwayar cutar ta shiga jikin sa ta kumburin idanuwan sa.
Don haka, ma’aikacin kiwon lafiya suma suna sanye da garkuwar fuska ko ƙyalli yayin da ana aiki tare da marasa lafiya.
Ga jama'a gaba daya a wuraren da abin ya shafa, ana bada shawara ga kowa da kowa ya wanke hannuwan sa tare da sabulun hanna yaduwar cutar mafi sau dayawa,yi ƙoƙarin zama a cikin gida don keɓancewar kai da taƙaita hulɗa da masu yiwuwar kamuwa da cutar.
An dauke kafa shida a matsayin nesa wanda ta dace mutane su zauna domin guje marasa lafiya.
Wadannan ayyuka sune hanyoyin ingantattu don rage hadarin kamuwa da cutar tare da hana yaduwar kwayar cutar
Kodayake SARS-CoV-2 ya zama sabon ƙwayar cuta ga duniyar ɗan adam, babban haɗarinsa ga SARS-CoV kamar yadda aka ruwaito a 7 Janairu 2020 Yakamata ya jawo babbar jijjiga ga kasar Sin dangane da zurfin tunaninta game da barkewar SARS a 2003.
Amma, har zuwa 19 ga Janairu 2020, darektan Cibiyar Kula da Cututtuka ta Wuhan ya ta'azantar da 'yan kasar ta hanyar cewa sabon littafin kwayar cutan na da karancin yaduwa da karancin haihuwa daga mutum zuwa mutum kuma ba matsala ba ne don hanawa da kuma tsayaya da cutar ba.
Wannan sakon ya shakata karar da jama'a ke yi, musamman lokacin da daukacin kasar ke shirye-shiryen bukukuwan bazara, kuma an dauki lokaci mai tsaho don dauke cutar a karancin sa a Wuhan.
Hukumomin kula da cutar a China na iya daukar wannan darasi tare da yin muhimmin ci gaba a nan gaba.
Misali, wadannan hukumomin yakamata su kasance (1) mai da hankali sosai yayin yin sanarwar jama'a kamar yadda kowace kalma take yiwa 'yan kasa kuma yana iya canza halaye da yanke shawara; 2) mai saurin dimauta da mayar da hankali ga bayanan da ba a sani ba daga asibitoci maimakon jiran cikakken bayani daga likitoci ko jami'ai; (3) ƙarin hanawa don ɗaukar cutar annoba a farkon matakinsa maimakon ƙoƙarin ta'azantar da jama'a; da (4) mafi yawan lokuta don samar da ingantattun bayanai da kuma ingantattun hanyoyin domin kara wayar da kan jama'a game da cututtukan annoba da kuma gwadawa da inganta tsarin amsawar al'umma a wasu lokuta.
Barkewar COVID-19 wanda ke haifar da ƙwayar cuta SARS-CoV-2 ya fara ne a ƙarshen watar Disamba 2019.
Kasa da watanni biyu, ya bazu ko'ina cikin China da kusan sauran ƙasashe 50 a duniya a lokacin wannan rubutun.
Tunda kwayar cutar tana kama da SARS-CoV kuma alamomin ma suna kama ne tsakanin COVID-19 da SARS, fashewar COVID-19 ya haifar da ma'anar sake dawo da SARS.
Duk da haka, akwai wasu bambance-bambance na ban mamaki tsakanin COVID-19 da SARS, waɗanda suke da mahimmanci don tsayarwa da annoban da kuma kula da marasa lafiya.
COVID-19 ya fi shafar tsofaffi fiye da matasa kuma maza fiye da mata, kuma ƙarancin mutuwa da yawan mutuwa sun fi girma a cikin tsofaffi mutum fiye da na matasa.
SARS tana da mutuƙar nisan mutuwa fiye da COVID-19 kashi (10.91% a kan 1.44%).
Marasa lafiyar COVID-19 na bada kwayar cutar koda kuwa ba ta da alamar sa yayin da marasa lafiyar SARS ke yin hakan yawanci lokacin da suke rashin lafiya mai ƙarfi, wanda ke haifar da babban wahala don ɗaukar yaduwar COVID-19 fiye da SARS.
Wannan wani bangare yana bayanin dalilin da yasa yadawar SARS-CoV-2 na da sauri da fadi fiye da SARS-CoV.
RNA na yau da kullun ba da tabbaci ga SARS-CoV-2 na iya zama mara kyau a wasu marasa lafiyar COVID-19.
A wata gefe guda, marasa lafiya da aka warke zasu iya zama tabbatacce ga sake cutar.
Wadannan binciken sun kara hadarin yadawa kwayar cutan.
Ganin irin wannan saurin ci gaba a cikin binciken COVID-19, batutuwa masu mahimmancin gaske ana iya warware su, kamar haka:
Daga ina SARS-CoV-2 ta fito?
Kodayake an samu kashi 96% na kwayoyin tsakanin SARS-CoV-2 da jemage biyu kamar-SARS CoVs, har yanzu ba za mu iya yanke hukuncin cewa SARS-CoV-2 daga jemagu bane.
Wace halitar dabba ce tsakiya ne don yada kwayar cutar daga ainihin mai mazaman cutar, cewa jemagu, ga mutane?
Ba tare da sanin amsoshin # 1 da na 2 ba, ba za mu iya yanke watsawar yadda yakamata ba, kuma barkewar na iya sake dawowa a kowane lokaci.
Kodayake samfurin ƙirar kwayoyin halitta da kuma tabbatarwar kwayoyin halitta sun nuna cewa SARS-CoV-2 yana ɗaurawa ACE2, ta yaya ne kwayar cutar ta ke shiga cikin hanya iskar tantanin halitar kuma ta haifar da canje-canjen cutar?
Shin kwayar cutar kuma tana ɗaukar ƙwayoyin bayyana ACE2 a cikin wasu gabobin?
Idan ba tare da amsoshin waɗannan tambayoyin ba, ba za mu iya samun ingantacciyar hanyar bincike da kuma ingantaccen magani ba.
Har yaushe annobar zata kai ga karshe?
Ta yaya ƙwayar cutar ke canza yanayi halita lokacin bazawa tsakanin mutane?
Shin zai iya zama annoba a duk duniya, ya mutu kamar SARS ko sake dawowa lokaci-lokaci kamar mura?
Yana da mahimmanci amma yana iya ɗaukar ɗan lokaci don bincika amsoshin tambayoyin da ke sama da sauran tambayoyi masu yawa.
Duk da haka, tare da kowane irin kuɗin da yake buƙata, ba mu da wani zaɓi amma tsayar da annoban da wuri kuma mu dawo da rayuwarmu yada aka saba.
Asalin zoonotic na coronaviruses na mutum
Maye gurbi da kuma daidaitawa ne suka haifar da juyin halittun coronaviruses (CoVs) da wajen zaman su, har ma da mutane, zuwa dubban shekaru.
Kafin 2003, CoVs na mutum guda biyu (HCoVs) an san su don haifar da ciwo mara tsanani, kamar sanyi na yau da kullun.
Barkewar cuta mai saurin kamuwar manufanshi da alamar (SARS) da cutar manufanshi ta Gabas ta Tsakiya (MERS) sun juya kuɗin don bayyana yadda ɓarkewar cutar HCoV zata iya zamawa.
Fitowar SARS-CoV-2 a tsakiyar ƙasar Sin a ƙarshen shekarar 2019 ya turo cuttutukar CoVs gaba kuma ya ba mu mamaki da cewa yana da sauƙin aikawa ga juna amma yawan ƙwayar cutar sun rage idan aka kwatanta da ‘yar uwarta SARS-CoV.
Cutar HCoV ana samun sa ne daga dabbobi kuma fahimtar tushen HcoVs taimaka gaya.
Galibin kwayoyin halittar HCoVs sun samo asali ne daga jemagu inda suka kasance ba masu cutarwa ba.
Ana sane da halittukan da ke rik'e wasu cututtukar HCoVs a tsakani suma.
Gano ainihin dabbobin da ke dauke da cutar zai taimaka kai tsaye wajen kare mutane daga cutar.
Bincikar mu’amalar mai dauke da cutar CoV da dabbobi watakila zai taimaka wajen gano yaduwar kwayoyin halittar cutar CoV a jikin mutane.
A cikin wannan bita, mun gabatar da wani bayyani game da ilimin data kasance game da HCoV guda bakwai, tare da mai da hankali kan tarihin gano su da yadda aka samo asalin zoonotic da kuma yada jinsunan halittar.
Muhimmin abu a nan shi ne, mu tantance banbanci tsakanin kwayar cutar HCoVs daga fahimtar yadda asalin kwayar cuta take rikada da kuma kwayoyin halitta suke rikida daga asalin tushensu.
Cutar CoV da ake fama da ita a 2019 mai suna (COVID-19) wacce annoba ce, an yi bayani game da ita a nan.
Bugu da ƙari, an jaddada yadda abunda ake buƙata domin ƙwayar cutar ta samu nasarar masauka wanda ke sauyawa kuma anlmm jaddada sakamakon yadda juyin halittar kwayar cutar ke tsananta cutar.
Kwayoyin cutar Corona (CoVs) sun kasance dangin Coronaviridae, wanda ya hada da tabbatacciyar rukunin kwayoyin cututtukan RNA mai zare daya.
Wadannan kwayoyin cututtukan sun kunsar da babban ma’adanin kwayar halittar kamaceceniya na RNA daga 26 zuwa 32 nasu, dalilin da yasa ake kiransu “CoVs” wanda ake iya gani a tabarau na microscope.
A gine dai, CoVs suna da kwayoyin halittar da ba a rarrabe su ba wanda ke da shiri kamar haka.
Kimanin kashi biyu bisa uku na halittar suna dauke da manyan furanni masu budewa biyu (ORF1a da ORF1b), wadanda ake fassara su cikin pp1a da pp1ab kwafin polyproteins.
Ana ƙara aiwatar da polyproteins don samar da furotin 16 waɗanda ba na tsari ba, waɗanda aka tsara nsp1~16.
Sauran bangaren tushen halittar mai dauke da ORFs domin abu mai gina jiki kamar su, nau‘in spike (S), envelope (E), membrane (M) and nucleoprotein (N).
Yawancin nau'ikan sinadaran zuriya, su ma ana lulluɓe su da wasu zuriyoyin CoVs daban.
Dangane da bambanci a cikin jerin abubuwan gina jiki, ana rarraba CoVs zuwa abubuwa huɗu (alpha-CoV, beta-CoV, gamma-CoV da delta-CoV), tsakanin abin da beta-CoV ya ƙunshi yawancin HCoVs kuma an rarrabasu cikin kashi huɗu (A, B, C da D).
Hujjojin halittun dabbobi sun nuna cewa jemagu da dabbobin suna aiki a matsayin tushen asalin yawancin alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune babban tafki na gamma-CoVs da delta-CoVs
Shekaru dubbai yanzu, CoVs sun shawo kan shingen jinsuna kuma wasu sun fito a matsayin mahimman ƙwayoyin cuta na mutane.
Har ya zuwa yau din nan, an san cututtukan na CoVs (HCoVs) nau’i bakwai ne a jikin dan adam.
Daga cikinsu HCoV-229E da HCoV-NL63 sune alpha-CoVs.
Sauran beta-CoV guda biyar sun hada da HCoV-OC43, HCoV-HKU1, cutar hanyoyin numfashi mai tsanani na coronavirus (SARS-CoV), cutar numfashi na gefen larabawa coronavirus (MERS-CoV) da SARS-CoV-2.
Cututtukan HCoV-229E da HCoV-OC43 da HCoV-HKU1 da kuma HCoV-NL63 galibi su kan haifar da alamomin cuta marasa karfi sosai kamar mura da ko kuma gudawa.
Saɓanin haka, SARS-CoV, MERS-CoV da subuwar cutar SARS-CoV-2 da aka gano sune cututtuka masu mafi yaɗuwa da ke haifar da mummunan rauni na jijiyoyin jiki a marasa lafiya tare da babbar damar haɓaka ciwo mai rauni na rashin damuwa na jiki (ARDS) da bayyananniyar cututtuka.
Nau'in HCoV-229E na farko, B814, ya kasance mai rabuwa daga fitowar hancin marasa lafiya masu fama da murar yau da kullum a tsakiyar shekarun 1960.
Tun daga lokacin, ake ta samun ilimi kan HCoV-229E da kuma HCoV-OC43, ta hanyar zurfafa nazarin alamun cutar.
Tabbas, an yarda da ra'ayin cewa kamuwa da cutar HCoVs gaba daya ba shi da matsala har sai fashewar SARS.
Barkewar cutar SARS da ta faru a cikin shekarar 2003, shi ne ɗaya mafi munin balaguro a cikin tarihin na yanzu, da ya kamu da mutane sama da 8,000 da ke cikin mummunan yanayin mutuwar kusan kashi 10%.
Shekaru goma bayan haka, barkewar cutar numfashi na gefen larabawa wato Middle East Respiratory Syndrome (MERS) ya haifar da annoba na yau da kullum a Kasashen Larabawa tare da yaduwa zuwa sauran sassan duniya.
Sabuwar cutar HCoV ta shekarar 2019 (2019-nCoV), wanda daga baya aka sake masa suna SARS-CoV-2, shine wakili na abubuwanda ke faruwa na ci gaba da cutar coronavirus 2019 (COVID-19), wanda ya yi sanadiyar rayuka sama da 3,120 kuma ya kamu da mutane sama da dubu 91,000 a cikin watan Maris 3, 2020.
Ƙararrawar tana ta kaɗawa kuma dole duniya ta shirya akan annobar cutar SARS-CoV-2 da ke zuwa.
Dukkanin HCoV guda bakwai suna da asalin fitowa daga dabbobi kamar su jemagu, beraye ko dabbobin gida.
Bayanan shaida da yawa suna tallafawa asalin juyin halittar dukkanin HCoVs daga jemagu, inda ƙwayoyin cuta suke dacewa da kyau kuma ba masu bada ciwon ba ne amma na nuna babban bambancin kwayoyin halita.
COVID-19 annobar cutar ta gabatar da babban kalubale na likita, kimiyya, zamantakewa da halin kirki ga kasar Sin da duniya.
Binciken asalin dabbobin da suka janyo HCoVs yana ba da tsarin fahimtar tarihin halitta, ƙarfin tuƙi da abubuwan da ke hana ƙetare na tsallen jinsin.
Wannan na iya jagorantar ko sauƙaƙe bincika tafkin, matsakaici da haɓaka rundunar garken dabbobi (s) na SARS-CoV-2, tare da mahimmancin tasiri cikin karewar abin da ke dawowa nan gaba.
A cikin wannan bitar, mun gabatar da wani taƙaitaccen bayani game da asalin cututtukar dabbobi (zoonotic), watsawarsu tsakanin nau’in jinsun kansu da gine-ginen HCoVs.
Musamman ma, muna karin haske da bayani kan tushen kwayoyin cutar HCoVs ba wai sun samo asali ne daga kwayoyin halittar da basa haifar da cuta a jiki bayan sun shiga jikin wani na daban.
Mun kuma sake nazarin yanayin cigaban HCoV wanda karuwa a watsawa sau da yawa yana zuwa tare da raguwa a cikin mai bada kwayar cutan.
Ana bayanin sakamakon da barkewar ita ma cutar SARS-CoV-2 a nan.
An san CoV na dabbobi tun ƙarshen shekarun 1930.
Kafin farkon warewar iri B814 na HCoV-229E daga zubar hancin wanda ya kamu da mura na yau da kullun, an ware CoVs a dabbobi daban-daban wanda suka kamu da cutar kamar tolotolo, ɓera, shanu, alade, kule da kare.
A shekara ashirin da suka gabata, an gano kwayoyin cuatr dangin HCoVs.
Takaitaccen tarihin gano cutar HCoV a jerin jadawalin farko na wannana teburi (Tebur 1) zai zama mai gamsarawa tare da bayar da cikakken bayani a kai.
Rashin HCoV-229E na farko ya kasance a kebe daga cutar hanyar numfashi na marasa lafiya da cutar sama hanyar numfashi a shekarar 1966, daga baya ya sami karbuwa girma cikin layin tantanin halitar huhu WI-38.
Marasa lafiya waɗanda ke kamuwa da HCoV-229E da aka gabatar tare da alamun sanyi na yau da kullun, gami da ciwon kai, atishawa, rashin jin dadi, zazzabi da ciwon-makogwaro, da zazzabi da tari da aka gani cikin damu’oin kashi 10~20%.
Daga baya a shekarar 1967, an ware HCoV-OC43 daga hanyar binciken ‘organ culture’ da kuma hanyar renon cuta (serial passage) da zai biyo a kwakwalwar jariran ɓeraye.
Siffofin asibiti na kamuwa da HCoV-OC43 suna kama da waɗanda HCoV-229E ke haifar, waɗanda ke alammar nuna bambanci daga kamuwa da wasu cututtukan ƙwayoyin cuta kamar mura da ƙwayoyin cuta da kuma rhinoviruses.
Dukansu HCoV-229E da HCoV-OC43 na yaɗuwa a duk faɗin duniya, kuma galibi suna watsawa a lokacin bazara, a cikin yanayi marasa dumi ko sanyi.
Yawanci dai, lokacin yaɗuwar waɗannan ƙwayoyin cututtuka guda biyu shi ne ƙasa da mako ɗaya, hakan na biye da sa rashin lafiyan kusan makonai 2.
Dangane da binciken masu ba da agaji na ɗan adam, mutane masu lafiya waɗanda suka kamu da cutar HCoV-229E sun kamu da sanyi na yau da kullun.
Kalilan marasa lafiya wadan da garkuwar jikin sub ba karfi ne ke nuna tsananin kamuwa hanyar manufanshi da cuta.
"SARS, wanda kuma aka sani da ""kwayar cutar huhu"", shine farkon bayanan da aka samu na cutar HCoV-da ke haifar da ƙwayar cuta a cikin tarihin ɗan adam kuma wakili na etiological shine SARS-CoV, HCoV na uku da aka gano."
Ana iya gano kamuwar SARS ta farko zuwa karshen 2002 a lardin Guangdong na kasar Sin.
Cutar ta SARS ta haifar da mutane 8,096 da aka ruwaito sun kamu da asarar rayuka 774, sun bazu cikin kasashe da nahiyoyi da yawa.
Ban da manyan gwaraza, an kiyasta hakan kowane damuwa na iya ba da kusan damu’oi biyu na, tare da lokacin shiryawa na kwanaki 4 zuwa 7 da gangar jikin kwayar cutar ta bayyana a ranar 10 ta rashin lafiya.
Marasa lafiya waɗanda ke kamuwa da SARS-CoV da farko suna kasancewa tare da myalgia, ciwon kai, zazzabi, zazzabin cizon sauro da tsananin sanyi, biyo bayan dyspnea, tari da matsananciyar damuwa kamar bayyanar cututtuka.
Lymphopenia, gwajin aikin hanta, da haɓaka sinadarin creatine kinase abubuwa ne na gama-gari wurin gwaji na SARS.
Diffuse alveolar damage (lalacewar huhu), epithelial cell proliferation (yaɗuwar ƙwayoyin halittar kan jiki), kuma an gano karuwar macrophages (ƙwayoyin halittar farin jini) a cikin marasa lafiyar SARS.
Aƙalla kashi 20-30% na marasa lafiya daga baya suna buƙatar kulawa mai zurfi da samun iska.
Bayan hanyar numfashi ta ƙasa, gabobin cikin jiki da yawa, ciki har da na ciki, hanta da koda na iya kamuwa da cutar a cikin waɗannan mummunan yanayin cutar, yawanci tare da hadarin cytokine, wanda kan iya kashewa musamman ga marasa lafiya marasa kariyar lafiya.
An fara ware kwayar cutar ne daga tarin kwayoyin cutar huhu na wani dan uwan mai cutar Ebola wanda ya tafi Hong Kong daga Guangzhou.
Tun lokacin kuma ake ta kokarin nazari kan cutar HCoV.
HCoV-NL63 an ware shi daga wani yaro dan watanni 7 daga Netherlands a ƙarshen 2004.
An samo shi ne da farko a cikin yara ƙanana, tsofaffi da marasa lafiyan mara garkuwa wato immunocompromised da cutan numfashi.
Gabatar coryza, conjunctivitis, zazzabi, da mashako ya zama ruwan dare a cikin cutar da HCoV-NL63 ta haifar.
Wani bincike mai zaman kansa ya bayyana warewar cutar guda daga samfurin hanci daga wani yaro dan watanni 8 da ke fama da ciwon huhu a Netherlands.
Ko da yake a gano ta ne a kasar Netherlands, amma tabbas dai an yada ta a duniya.
An yi kiyasin cewa kwayoyin halittar HCoV-NL63 sune keda alhakin akalla kashi 4.7 na cututtukan numfashi, kuma yana ganiyarsa a daidai shigar lokacin bazara da kaka da kuma hunturu.
HCoV-NL63 yana da alaƙar da cutar kumburin beli mai toshewa, wanda kuma aka sani da croup.
A shekara daya ce, cutar HCoV-HKU1 aka fara gano ta daga wani dattijo mai shekara 71 wanda aka garzaya da shi asibiti sakamakon cutar shakewar numfashi ta pneumonia da kuma cutar huhu a birnin Hong Kong.
Bayan ciwon huhu da na hanyoyin huhu wadanda al'umma ke samu, an ruwaito cewa HCoV-HKU1 yana da alaƙa da matsanancin rashin lafiyar asma.
Kama da HCoV-NL63, HCoV-229E da HCoV-OC43, HCoV-HKU1 an samu a duk duniya, suna haifar da karamin cutan manufanci.
Duk waɗannan HCoVs huɗu da al'umma suka samu wurin zama a mutane kuma galibi ba su da ikon canzawa don haifar da kwayoyin cututtuka sosai, kodayake hatsarori sun faru ne saboda dalilai da ba a san su ba kamar yadda a cikin mafi yawan yanayi mai kama da HCoV-NL63, wanda a kwanan nan aka ba da rahoton cewa yana haifar da cuta kasa hanyar numfashi mai tsanani a China.
Gabaɗaya, lokacin da waɗannan HCoVs suka sami damar iya watsuwa yadda yakamata kuma su riƙe kansu gabaɗaya cikin ɗan-adam, su kuma suna zama ƙasa da ɓarna ko kuma cutarwa.
An fara ware MERS-CoV ne a cikin 2012 a cikin huhu na wani mara lafiya mai shekaru 60 wanda ya kamu da matsananciyar cutar huhu da gazawar koda a Saudiya.
Ganin cewa mafi yawan kwayoyin da aka tabbatar da asali sun fito ne daga Gabas ta Tsakiya, an bayar da rahoton yaduwa ta biyu na gaba zuwa makusantan sadarwa a kasashe daban-daban na Turai da Tunusiya.
Wani fashewa ta sakandare ya faru a Koriya ta Kudu a cikin 2015 tare da tabbatarwan mutane 186 da cutar.
Bayyanannin asibiti na MERS sun yi kama da na SARS, wanda ke nunawa da mummunan ciwon huhu.
Sai dai ba kamar cutar SARS ba, da dama daga cikin majinyatan murar ta MERS sun kuma gamu da matsalar ciwon koda, wanda ya zama babban dalili da ya sa banbanta cuatr ta MERS da kuma kwayoyin cututtukan da ke samuwa daga HCoV.
Fiye da kashi 30% na marasa lafiya da ke tare da alamun gastrointestinal, kamar gudawa da amai.
Ya zuwa ranar 14 ga Fabrairu, 2020, kamuwa sama da 2500 da aka tabbatar a dakin gwaje-gwaje sun kasance tare da mutuwar kasha 34.4 cikin dari, wadda ya sa MERS-CoV ta zama daya daga cikin cututtukan da ke lalata mutane sosai da aka taba samu.
Daidai lokacin tsakiyar watan Disamban 2019, an samu wasu marasa lafiya masu fama da shakewar numfashi ko pneumonia da a lokacin aka yi tunanin tana kama da cutar SARS-CoV-2 wandanda aka gano a birnin Wuhan, lardin Hubei, da ke kasar China.
Hukumar Kiwon Lafiya ta Duniya ta ba da sanarwar ci gaban barkewar cuta kasan hanyar manufanci wanda haifar da SARS-CoV-2 da shi wanda ya zama babban kalubale ga lafiyar Jama'a na Kasa da Kasa kuma ya sanya sunan cutar COVID-19.
Ya zuwa ranar 3 ga watan Maris, 2020, as tabbatar da mutane masu kamuwa 90,053 a duniya, tare da yawan mutuwa saboda kamuwa wanda ya kai kashi 3.4%..
Musamman ma, yawan wadanda suka mutu daga cutar a Hubei, China ya kai kashi 4.2 cikin dari, alhali wanda yake waje da can kashi 1.2 cikin dari ne.
SARS-CoV-2 yana haifar da tsananin cutan numfashi kamar SARS-CoV da MERS-CoV, an gabatar da su azaman zazzabi, tari da dyspnea.
Ana kuma ganin cutar gudawa a wasu marassa lafiyan.
Cutar huhu na ɗaya daga cikin alamun bayyanar cututtuka kuma yana iya ci gaba cikin hanzari zuwa ciwo mai wahala na manumfashi.
Kodayake SARS-CoV da SARS-CoV-2 suna da kama sosai saboda halayyar ƙwayoyin nucleotide na kasha 82%, suna curewa cikin rassa daban-daban a cikin bishiyar kwayoyin halittar.
Idan aka kwatanta da SARS-CoV wadda yake da babban adadin maye gurbi, adadin maye gurbi na SARS-CoV-2 yana kasa sosai, wadda ke nuna girman matakin karbuwa ga mutane.
Wani mai nuna alamar kamu da SARS-CoV-2 wanda aka bada rahoton iya ba da gudummawa ga saurin yaduwa a duniya.
Kwatantawa da kuma musanya SARS-CoV-2 tare da sauran HCoV guda shida suna nuna kamanni da bambance-bambance masu babban mahimmanci.
Na farko dai, lokacin kyankyasar cutar da kuma yadda cutar ta HCoV ke samuwa na kama da juna.
A wannan batun, SARS-CoV-2 yana bin yanayin gaba ɗaya na sauran HCoV guda shida.
Na biyu shi ne zafin alamun cutar COVID-19 ya dogara ne tsakanin cutar SARS-CoV da kuma sauran ire-irensu guda hudu: HCoVs (i.e. HCoV-229E, HCoV-OC43, HCoV-HKU1 and HCoV-NL63).
A bangare guda, kamuwa da cuta SARS-CoV-2 yana nuna fasali waɗanda aka fi ganinsu yayin kamuwa da cutar HCoVs, da al'umma ke samu, gami da gabatar da marasa takamaiman, mai saukin kai ko ma babu alamun su.
A gefe guda, ana iya ganin ƙaramin kashin tsananin kamuwa da COVID-19 kamar yadda ake ganin ta a kamuwa da cutar SARS-CoV, duk da haka kashin yana da karanci.
Na uku, watsuwar SARS-CoV-2 kuma yana nuna alamun halayen ban sha'awa na samun HCoVs da al'umma kan yi da na SARS-CoV.
A bangare guda, bazuwar SARS-CoV-2 ya yi daidai da na HCoVs wanda al'umma suka samu.
A wata gefe guda, ya rage don tabbatar da ko yiwuwar rikicewar SARS-CoV-2 ya ragu bayan bayanan wurare a cikin mutane kamar yadda yake a yanayin SARS-CoV da MERS-CoV.
A ƙarshe, daidai da sauran HCoVs, SARS-CoV-2 za'a iya gano su a cikin samfuran fecal.
Nazarin cewa ko cutar SARS-CoV-2 ta yadu ta hanyar kashin da ya shiga ta baki ya taka muhimmiyar rawa wajen yada cutar SARS-CoV zai zama sai nan gaba za a tabbatar da haka a binciken da za a yi.
Hakanan yana da matukar sha'awar ganin ko SARS-CoV-2 na iya bayyanar da yanayi kamar yadda al'amuran al'umma suka samu HCoVs.
Koyaya, siffofin SARS-CoV-2 gami da wucewa, pathogenicity da ci gaba mai yadawa bayan wurare a cikin mutane zasu zama masu tasiri akan ƙarshen ƙaddarar barkewar COVID-19.
Dukkanin al'ummomin guda huɗu sun samo HCoVs waɗanda ke haifar da bayyanar cututtuka masu alaƙa sun daidaita ga mutane.
Ta wata hanyar, zai iya zama gaskiya ne cewa 'yan Adam sun daidaita da waɗannan HCoVs huɗu.
Ta wata hanyar, duka biyun zasu iya kasancewa daga rayuwar tsoffin anoban HCoV.
HCoVs waɗanda ke haifar da mummunan cututtuka a cikin mutane da mutane waɗanda suka kamu da mummunan cututtukan HCoV an kawar dasu.
Domin wannan ya faru, HCoVs na bukatar su rubanya a cikin mutane zuwa isasshen mataki don ba da damar tattaruwar maye gurbi da zai ci galabar dalilan ƙuntatawa na mafaka.
Ta wannan hanyar, tsawon lokacin fashewa da SARS-CoV-2 ya ci gaba kuma mutane da yawa suna cutar dashi, mafi girma damar cewa zai cikakken daidaita da ga mutane.
Idan har ta samu gindin zama sosai, yaduwarta tsakanin mutum zuwa mutum zai zama da matukar wahala ta hanyar killacewa ko kuma sauran matakan kare bazuwar cuta.
Shekaru da yawa, al'umma huɗu sun samo CoVs suna kewayawa cikin yawan mutane, yana haifar da sanyin mura cikin kwararun masun garkuwa.
Wadannan kwayoyin cutar basa bukatar zama a jikin mutum ko dabba.
Sabanin haka, SARS-CoV da MERS-CoV masu sanya cuta ba su daidaita da mutane ba da kyau kuma yaduwarsu a mutane ba za a iya cigaba da shi ba.
Suna da bukatar ci gaba da rayuwa a jikin dabbobin da ke dauke da su domin su sami damar shiga jikin mutane ta hanyar mutum guda ko fiye da samo ta daga dabbobin.
Cutar SARS-CoV-2 tana da kamanni irin na cutar SARS-CoV/MERS-CoV da kuma sauran masu dauke da nau’in cutar HCoVs.
Wannan abu ne da za'a iya yaduwa sosai kamar kamuwar HCOVs a cikin al'umma, aƙalla a lokacin da muke a ciki.
Duk da haka, ya fi zaman mai daukar kwayar cuta fiye da al’uma da aka sami HCoVs kuma ƙasa da mai daukar kwayar cutan fiye da SARS-CoV ko MERS-CoV.
Ya rage a gani ko zai iya dacewa da mutane sosai kuma ya kewaya cikin mutane ba tare da wurin ajiya ba ko mafaka ta tsakiya a jikin dabbobi.
Kafin tattauna asalin dabbobin dabbobi na HCoVs, zai taimaka mana sosai mu tattauna kan ma’anoni da halayen juyin halitta, na halitta, tafki, matsakaici da haɓaka mafakar HCoVs.
Dabba da ta zama wata mafaka ta juyin halitta ta HCoV idan ta tanadi asalin magabata mai kusanci wadda suke babban kama ta haɗin dangantaka a matakin jerin nucleotide.
Kwayar cutar ta asali galibi ana rayuwa da ita kuma bata zama illa ga inda dama take rayuwa.
Hakanan, mai yin tafki mai tashar jiragen ruwa HCoV yana ci gaba kuma tsawon lokaci.
A dukkan halayen, masu rukunin suna kamuwa da cuta ta dabi'a kuma sune ainihin rukunin HCoV ko ƙwayar mahaifa.
Sabanin haka, idan sabon HCoV ya gabatar da sabon matsakaici a gabanin ko a kusa da gabatarwar sa ga mutane, ba a daidaita shi da sabon mai masaukin ba kuma yawanci shine pathogenic.
Wannan da kwayar cutar ta samu gindin zama jikinsa, zai iya zama tushen da cutar da za ta shafa kuma ya taka muhimmiyar rawa wajen bai wa kwayar cutar damar ta hayayyafa inda za ta iya harbin dan adam daga nan.
HCoV na iya yin gwajin cutar mutu-karshen idan har ba zai iya ci gaba da yada ta ba a cikin matsakaiciyar mai watsa shiri.
Sai dai wani abin da zai zama wanda ya saba da hakan, cutar HCoVs kan iya rayuwa jikin wani abu na daban kuma ya iya haifar da illar gaske da za ta dauki lokaci gabanin bayyanarta.
A nan kuma, wanda cutar ta kasance a jikinsa na karshe to zai zama wanda ainihin inda cutar ta samo asali tun da farko.
Bayanan cututtukan dabbobi sun bayyana bita da kullun cewa yanayin binciken SARS yana da tarihin hulɗa tare da dabbobin wasa.
Binciken seroprevalence mai zuwa ya nuna cewa yan kasuwar dabbobi sun sami karuwar SARS-CoV IgG idan aka kwatanta da na sauran jama'a.
Dabbobin civet masu rufaffen tafi (Paguma larvata) da karen racoon dake cikin kasuwancin dabbobi su ne aka fara ganowa suna ɗauke da ƙwayoyin cuta masu kama da wadanda suke kusan iri ɗaya ne ga SARS-CoV.
Wannan ya tallafawa kai tsaye ta hanyar cewa ba a sake samun ƙarin rahoton SARS ba bayan kashe duk wasu dabbobin Sivets cikin kasuwannin.
Duk da haka, an ba da rahoton cewa dabban itacen giginya wato civets daga cikin daji ko gonaki ba tare da fuskantar kasuwannin dabbobi masu rai ba sun kasance da cutar SARS-CoV ba, wadda ke nunar da cewa civets masu rufaffen tafi watakila kawai su zama mafakar tsakiya mai fadadawa ga SARS-CoV amma ba mafakan sa ba.
Musamman ma, tunda kashi 80% na dabbobi daban-daban a cikin kasuwanni a Guangzhou suna da rigakafin SARS-CoV da yiwuwar cewa yawancin nau'in kananan dabbobi masu shayarwa suma zasu iya zama matsakaicin fadada rundunonin SARS-CoV ba za'a iya cire su ba.
Dukkanin wadannan sun kasance inda cutar SARS-CoV take mutuwa a jikinsu.
Bincike mai zuwa don rundunar dabba ta SARS-CoV sun nuna wata jemage mai zaman kusa da CoV da ake kira SARS-Jemagen Rhinolophus CoV HKU3 (SARSr-Rh-JemageCoV HKU3), wanda yake a cikin jikunan dawakai na kasar Sin.
Wadannan jemagun suna dauke da kwayoyin halitta masu maganin SARS-CoV da kwayoyin tsuhen halitta masu ajin SARSr-Rh-BatCoV HKU3.
Wannan da sauran CoVs na jemagu suna da nasaba kashi 88-92% ta jerin kwayoyin nucleotide tare da SARS-CoV.
Wadannan karatuttukan sun aza harsasai ga sabuwar manufar da jemagu ke karbar bakuncin cututtukan dan adam.
Yawancin CoVs (SL-CoVs) masu kama da SARS an kuma gano su daga jemagu, amma babu wani idan ba guda kawai da aka tsara WIV1 da za a iya warewa a zaman ƙwayar cuta mai rai.
Kayan mutum wanda yake canza enzyme 2 (ACE2) an san shi mai karɓar SARS-CoV.
Kwayar WIV1 da aka samo daga kashin jemagu an yi amfani da shi ne a jemagen da kyanwa da kuma ACE2 na mutum a matsayin masu karbar kwayar halittar.
Abin ban sha'awa, fama da cutar SARS wanda suna samun sauki sun iya wargazawar WIV1.
Har zuwa yau, WIV1 tana wakiltar asalin magabata na SARS-CoV a cikin jemage, yana kamanni mataki na 95% nucleotide jerin homology.
Duk da haka, akwai babban tsarin alaƙa tsakanin waɗannan ƙwayoyin cuta guda biyu, gabaɗaya an yi imanin cewa WIV1 ba ƙwayar cuta ce ta iyaye na nan take na SARS-CoV kuma jemagu ba shine reshe na kai tsaye na SARS-CoV ba.
Binciken ƙwayar Phylogenetic ta mahaɗar MERS-CoV zuwa rukuni guda na Jemage CoV-HKU4 da baton CoV-HKU5.
CoV-HKU4 na jemage da MERS-CoV suna yin amfani da mai karɓa guda, da dipeptidyl peptidase 4 (DPP4), don shigowar ƙwayar cutar virus.
Jerin kwayoyin halittar RNA-dependent da kuma na miyau RNA suna daga cutar MERS-CoV suna kama ne da jemagun da ake gani a nahiyar Turai da kuma Afirka.
Har ya zuwa maganan nan da muke yanzu, babu wata alamar kwayar cutar MERS-CoV da take rayuwa a jikin jemagun daji.
Kwayar cutar MERS-CoV da kuma wacce tafi kama da ita ta jemage mai suna CoV-HKU25 suna da nasaba ta kashi 87% a kwayoyin halittarsu masu kamanceceniya da juna.
Don haka jemagu watakila ba sune ke dauke da kwayar cutar MERS-CoV.
A gefe guda, bincike a Gabas ta Tsakiya ya nuna cewa raƙuman masu tozo guda suna da matsalar virus ga ƙwayoyin magance ƙwayoyin cuta na MERS-CoV, daidai da raƙuman masu asalin daga gabas ta Tsakiya wadanda ke cikin ƙasashen Afirka da yawa.
MERS-CoV mai raye daidai ne da cutar da aka samu a cikin mutane an ware ta daga kwarfatar hanci na raƙuman maso tozo guda, wanda ke cigaba da nuna cewa rakuma suna aiki a matsayin taskar mafaka ta MERS-CoV.
Hakanan abin lura ne cewa yawancin alamu masu saukin kai amma an lura da zubar da kwayar cutar a cikin raƙuma na gwaji yayin kamuwa da MERS-CoV.
Musamman, raƙuma masu kamuwa da cuta suna zubar da ƙwayoyin cuta ba kawai ta hanyar numfashi ba amma har ma ta hanyar fecal-na baka, wanda kuma shine babban hanyar cutar zubar da kwari daga jemagu.
Koyaya, tambayoyi har yanzu suna kasancewa tunda masu kamuwa da MERS su da yawa sun tabbatar da cewa ba su da tarihin hulɗa da raƙuma kafin farawa samun alamar cuta, wanda ake dangantawa watsuwa tskanin mutum-zuwa-mutum ko ta hanyoyi da ba a sani ba wadanda suka shafi nau'in dabbobi da ba a gano su ba wadanda suke dauke da MERS-CoV.
SARS-CoV-2 na raba kashi 96.2% na nucleotide homology tare da wata bature CoV RaTG13 da aka ware daga jemagun affinis Rhinolophus.
Kamar yadda ya faru da SARS-CoV da MERS-CoV, rarrabewa tsakanin SARS-CoV-2 da RaTG13 ya yi girma da yawa don sanya dangantakar iyaye.
Abin nufi shine, jemagu bazai kasance mai masaukin na kai tsaye na SARS-CoV-2 ba sai dai idan an samo kusan kwatankwacin batutuwan CoVs masu zuwa nan gaba.
Wataƙila, rundunan dabbobi masu matsakaici na SARS-CoV-2 ya kamata ya kasance cikin nau'in namun daji da aka sayar kuma an kashe shi a Kasuwar sayar da abincin teku, wanda yawancin farkon damuwar COVID-19 suke da alaƙa, alamu ne na yiwuwar watsawar cutan daga dabbobi-zuwa-mutum.
Yawancin binciken da aka yi kwanan nan dangane da jerin hanyoyin metagenomic sun nunar da wasu ƙananan dabbobi masu shayarwa dake haɗarin bata, wadanda aka sani da pangolins (Manis javanica) suna iya kasancewa masu dauke da magabata beta-CoVs wanda ya dangantaka da SARS-CoV-2.
Wadannan sabbin kwayoyin genome na pangolin CoV suna hadakar kwayoyin genomes 85-92% na tsarin kwayoyin nucleotide homology tare da SARS-CoV-2.
Ko yaya, suna da alaƙa da RaTG13 da kusan kasha 90 bisa dari Asali a matakin nucleotide.
Suna tattaruwa cikin sassan biyu na SARS-CoV-2-kamar ƙwayoyin cuta a cikin bishiyar phylogenetic, ɗayan wanda ya raba yanki mai ɗaukar nauyi mai rikodin mai karɓa (RBD) tare da SARS-CoV-2, tare da 97.4% shaidar asalin jerin amino asid.
Ko yaya dai, yawan maye gurbi RBDs na SARS-CoVs-2 da RaTG13 su na daban-daban kusan sau miliyan ne fiye da wanda ke daukar su.
Wani binciken da ya gabata a kan pangolins masu cutuka shi ma ya ba da labarin gano alamun kwayar cutar virus daga samfuran huhu, wanda ya yi kama da masu alaƙa da SARS-CoV-2.
Wannan binciken ya karɓi hanyoyi daban-daban na haɗuwa da kundin jagora don samar da jerin abubuwan genome wanda ya ƙunshi kimanin kashi 86.3% na cikakkiyar ƙwayoyin cuta ta genome.
Ba za mu kawar da yiwuwar cewa dabbar pangolin din tana daga cikin dabbobin da suke dauke da kwayar cutar SARS-CoV-2.
Duk da haka, a halin yanzu babu wata shaida a cikin goyon bayan asalin pangolin kai tsaye na SARS-CoV-2 saboda rarrabewar jerin tsakanin SARS-CoV-2 da pangolin hadedeyar-SARS-CoV-2 da beta-CoVs.
Kari akan haka, nisan da ke tsakanin SARS-CoV-2 da RaTG13 ya fi guntu fiye da wancan tsakanin SARS-CoV-2 da pangolin SARS-CoV-2 masu hade da beta-CoVs.
Rikidar cutar SARS-CoV-2 a jikin jemagu da kuma dabbobin pangolin da ma sauransu ya zama wani abi da za a kafa hujja kansa.
Ganin cewa mafi girman jerin kwayoyin an samo cikin RBDs tsakanin SARS-CoV-2 da pangolin, SARS-CoV-2-beta-CoVs, beta-CoVs masu alaka da SARS-CoV-2 da RaTG13 suna kama mafi girma a jerin kwayoyin halittar jini.
Abun hasashe ne babba cewa girman matsayin dake kamance tsakanin RBDs na pangolin SARS-CoV-2-beta-CoV-beta da SARS-CoV-2 ana haifar da shi ne ta hanyar juyin halitta wanda yake rikidewa.
Neman shawara ya dace da sake hadewa tsakanin SARS-CoV-2 da aka hada da beta-CoV da RaTG13 a cikin dabbobin daji na uku.
A matsayin ƙarfin tuki a cikin juyin halitta, sake haɗa abubuwa da ke yaɗuwa sosai tsakanin beta-CoVs.
Har yanzu masu yanke hukunci suna kan asalin SARS-CoV-2 na zoonotic.
Idan ka cire batun rikidar kwayar cutar HcoVs data samo asali daga jikin dabbobi an kuma nazarci na’ukan HCoV-229E da HCoV-OC43 da HCoV-NL63 da HCoV-HKU1.
Shaidar ilimin halittun dabbobi ya nuna cewa duka HCoV-NL63 da HCoV-229E za su iya samo asali ne daga jemage CoVs, yayin da aka sami ƙwayoyin cuta na iyaye na HCoV-OC43 da HCoV-HKU1 a cikin beraye.
An ba da rahoton cewa wata CoV ta jemage da ake kira ARCoV.2 (Appalachian Ridge CoV) wacce aka gano a jemage mai kala uku a Arewacin Amurka ta sami dangantaka mai kusanci da HCoV-NL63.
A wata gefe guda, HCoV-229E yana da alaƙar alaƙa da wani jigon CoV, ana kiran shi Hipposideros / GhanaKwam / 19/2008, wanda aka gano a Gana, yayin da kuma ana zargin raƙumin a matsayin mai ba da taimakon sa.
Don ba da haske, ilimin zamani game da asalin dabbobi na sananniyar HCoVs an taƙaita su a cikin Hoto na 1 da Tebur 2.
Nazarin Phylogenetic ya ba da hujja ga abubuwan da suka faru na watsa abubuwan HCoV a cikin tarihin.
Lokacin da HCoV-OC43 ya haɗu da jinsin don cutar da mutane daga dabbobin gida a shekarar 1890, an yi rikodin annoba ta numfashi.
Tarihin yaduwar cutar HCoV-229E ba wani karin haske sosai a kansa.
An gano kwayar cutar daga jemage CoVs wacce ta yi kama sosai da cutar HCoV-229E.
Tsakanin su akwai alpha mai suna 'alpaca-CoV.
Akwai hujjoji da dama da suke nuna cewa cutar ta yadu ne daga jemagu kai tsaye zuwa jikin dan adam.
Da farko, mutane amma ba almasas ba zasu iya hulɗa da jemagu a cikin raba kimiyyar muhalli.
Maimakon haka, mutane suna kusanci da alpacas.
Na biyu, HCoV-229E mai hade da batutuwan al-CoVs suna da bambanci kuma marasa tsari a cikin jemagu, alhali kuwa Alpha-CoV ya haifar da barkewar cutar ta hanu a cikin dabbobi masu kamuwa.
A ƙarshe, ba a sami alpaca alpha-CoV ba a cikin dabbobin feral.
Don haka, baza a kawar da tunanin yiyuwar cutar HCoV-229E ta samo asali ne daga kwayoyin halittar CoV daga dan jikin dan adam.
Hakika, jemagu sune tushen kai tsaye na ƙwayoyin cuta na mutum wanda ya haɗa da kwayar cutar rabies, ƙwayar cutar Ebola, ƙwayar cutar Nipah da ƙwayar cutar Hendra.
Don haka ba abin mamaki bane cewa jemagu na iya yada HCoV-229E ga mutane kai tsaye.
A wata hanya, yayin da alpha-CoVs suna aiki ne a matsayin hanyar samar da hanyar HCoV-229E, alpacas da raƙuman ruwa na iya zama matsakaiciyar runduna waɗanda ke aika ƙwayoyin cuta ga mutane, daidai kamar yadda yake a cikin yanayin MERS-CoV.
MERS-CoV ya zama wani kyakkyawan misali game da watsa sadarwa daga jemage zuwa raƙuman dabbobi da kuma raƙumi zuwa ga mutane.
Asalin juyin halitta na MERS-CoV daga jemagu an san shi a farkon ganowarsa kuma ya sami ƙarfafuwa sakamakon binciken da ya biyo baya.
A fili take cewa jemagu sune matattarar da ke dauke da cututtukan da za su iya yada su daga dabbobi zuwa mutane.
Dogon lokaci, dauloli masu cike da tarin yawa, kusanci da zamantakewa da kuma karfin ƙarfi don tashi duka yanayi ne da ya dace da jemage don zama kyakkyawan 'mai yada kwayoyin cutar.
A wata gefe guda, MERS-CoV an gabatar dashi ga raƙuman dromedary shekaru da yawa.
Ya dace da waɗannan raƙuma waɗanda suka juya daga matsakaici mai ban sha'awa zuwa barikin mai tsaro da na ɗabi'a na dabi'a.
MERS-CoV yana haifar da ciwo mai laushi kuma yana riƙe da ƙarancin maye gurbi a cikin waɗannan dabbobi.
Bazuwarta zuwa mutane ya faru haka kwatsam kmua mutane sune inda cutar MERS-CoV ba za ta iya sake fita ba sakamakon yadda bai iya fita daga nan.
Ya bambanta da rawar raƙuma a cikin watsa MERS-CoV, rawar pangolins, idan akwai wani, a cikin watsawar SARS-CoV-2 ya bambanta.
Musamman ma kwayoyin cutar jemagen pangolin beta-CoVs wanda sun fi rayuwa a jikin jemagun pangolins.
Zasu iya zama mafakar karshe ga SARS-CoV-2-beta-CoVs masu dangantaka, da kama da dabbobin civets a yanayin SARS-CoV.
Yawancin yuwuwar watsuwa tsakanin jinsuna na SARS-CoV-2 daga dabbobi zuwa mutane dole ne a yi watsi da su ko a amince da su a nazari gaba.
Na farko, jemagu za su iya zama babban reshin raunin da ke da alaƙa da ƙwayar SARS-CoV-2 kusan iri ɗaya ce ga SARS-CoV-2.
Yan-Adam na iya hadakar muhalli tare da jemagu ta hanyar yankan nama ko kuma hakar kwal.
Na biyu, pangolins na iya zama ɗayan tsaka-tsakin fadadawa wanda aka gabatar da sabon ƙwayar cuta ta SARS-CoV-2.
Yan-Adam suna kamuwa da kwayar cutar ta fannin yanka da cin naman dabba.
Yana yiwuwa yawancin dabbobi masu shayarwa ciki har da dabbobin gida suna da saukin kamuwa da SARS-CoV-2.
Lallai ne akwai bukatar gudanar da wani bincike kan dabbobin cikin gida da kuma na dawa/daji domin kariya ga jiki.
Na uku, kamar yadda aka ambata a sama, sake sakewa da daidaitawa da SARS-CoV-2 na iya faruwa a cikin jinsin na uku wanda ke da alaƙa tare da jemage da kuma pangolins.
Binciken asalin SARS-CoV-2 daga dabba har yanzu ana kan yi.
Baya ga mabanbanta dabbobin da ke daukar cutar, akwai wasu ababuwa uku muhimmai game da cutar wajen tsallakawa da halittun CoVs daga masu hana su fita.
Da farko dai, yawan adadin su na maye gurbi a cikin rabawar RNA.
Idan aka kwatanta da sauran ƙwayoyin RNA guda ɗaya, masu ƙididdigar adadin maye gurbi na CoVs za'a iya ɗauka su azaman “Matsakaici” zuwa “babba” tare da matsakaicin sauyawa mai aiki wanda ya zama ~ 10-4 sauyawa a kowace shekara ta rukunin yanar gizon 2, gwargwadon tsarin karbuwa na CoV zuwa runduna mai labari.
CoVs suna da hujjar sake-karantar exoribonuclease, sharewa wanda yake haifar da babban rikitarwa sosai da rashiwa ko mara dorewa.
Sai dai abin sha’awa a nan, asalin halittar cutar wanda galibi yake takura kwayar CoV ta hanyar haduwa da miyau ta sinadaran RNA.
Remdesivir yana daya daga cikin masu ba da rigakafin maganin SARS-CoV-2 da za a gwada su a gwajin asibiti.
Ko yaya dai, yawan maye gurbi na CoVs ya ninka sau miliyan sama da na ƙungiyar sojojinsu.
Bugu da kari, yawan maye gurbi yakan zama mafi girma yayin da CoVs ba su dace da mai zama da su ba.
Idan aka kwatanta da SARS-CoV da babban maye gurbi, adadin maye gurbi na SARS-CoV-2 na kasa sosai, bayar da shawarar mafi girman matakin karbuwa ga mutane.
Wataƙila, an riga an saba da shi ga wata mai zama da cutar da ke kusa da mutane.
Baya ga SARS-CoV-2, wannan kuma ya shafi MERS-CoV, wanda ya dace da raƙuma masu tozo guda.
A ka’idodi, ba lallai bane cewa tsaran kwayoyin halitta zai iya samar da alluran rigakafi da rigakafi akan SARS-CoV-2 marasa tasiri da sauri.
Na biyu kuma, babbar kwayar halittar RNA a jikin cutar CoVs ya nuna asalin sauyawa da rikida da tushen kwayoyin halitta suke yi, wanda hakan ke kara haifar da bazuwarsu tsakanin halittu wanda ya taimaka wajen bullar cututtukan CoVs masu shuhura a lokacin da suka samu dacewar yanayin da suke so.
Wannan yana da goyan bayan yalwar budaddun faifan karatu na musamman da amfanin furotin mai lamba ta wurin ƙarshen 3′ na genome.
Na uku, Covs na iya canza jiki barkatai da akai-akai lokacin rabuwar RNA ta hanyar “kwafin-zabi” na musamman.
A cikin mafakar da take zama wurin gaurayuwa, canzawar sassa yana faruwa akai-akai a lokacin kwafar CoV RNA.
Cigaba da cikakken-tsawon da bangarn genomic na RNAs mai sake haduwa don samar da sabbin abubuwan CoV.
An samu shaidar asalin halitta daga yadda aka halicce take a jikin duka HCoV-HKU1 da kuma HCoV-OC43, har ma da jikin dabbobi CoVs kamar su jemagu SL-CoV da batCoV-HKU9.
Mu’amalar kwayar cuta daga inda take zama da kuma na yadda take bazuwa.
Baya ga abubuwa guda uku da aka ambata a sama game da kwayar cutar, hulɗar kwayar cuta tare da mafaka mai karba wani abu ne dake tasiri akan watsuwa tsakanin jinsunar kwayar halittar.
Anan, an sake haɗawa da SARS-CoV a zaman misali na yau da kullum, wanda kuma ya nuna tabbataccen zaɓi na ɗabi'a yayin watsuwa tsakanin jinsuna.
Ta la'akari da gwajin kwatanci tsakanin keɓaɓɓun abu na SARS-CoVs din ɗan-adam da civet, Ana tunanin SARS-CoV zai iya yin saurin daidaituwa cikin mafaka daban-daban, musamman tare da maye gurbi a cikin furotin RBD na S.
Gabaɗaya, RBD a cikin furotin na S na CoV yana hulɗa tare da tantanin halita mai karban sako da mai martini abin kare jiki.
A cikin SARS-CoV, RBD yana cikin 318th zuwa 510 na amino acid din akan gungun S1, wanda ya daure wa dan Adam ACE2 kazalika hade da mai karban don shigar kwayar cuta.
RBD na SARS-CoV yana da ikon sanin masu karɓar ACE2 na dabbobi daban-daban, gami da jemage, civet, bera da karen raccoon, wadda ke ba da izinin watsuwa tsakanin jinsuna kwayar cutar.
A zahiri, amino acid guda 6 ne kawai da aka lura ya bambanta da na mutum kuma ƙwayar civet viral ta ware a cikin RBD kuma 4 daga cikinsu suna cikin motsi mai ɗaukar abubuwa don hulɗa da mai karɓar ACE2.
SARS-CoV na dabba Sivet yana da rikice-rikicen K479N da S487T a cikin RBD, wanda zai iya ƙara kusancin hulɗa da ma'adinin furotin tare da mai karɓar ACE2 na mutum.
A takaice dai, wadannan maye gurbi na amino acid na iya zama mai matukar mahimmanci ga karbar kwayar cuta a jikin mutum.
Abin lura ne cewa SARS-CoV-2 yana raba tantanin halita mai karban sako (cellular receptor) iri daya da SARS-CoV.
Bambanci kashi 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin sashin S1 na furotin S yana nuna cewa ƙarshen dangantakar S furotin da dan adam ACE2 zai iya canzawa.
Tabbas, binciken cryo-EM yana nuna dangantakar mafi girma ta 10 zuwa 20 daga wannan abin da aka ɗauka sama da wanda ke tsakanin ɗan adam na ACE2 da furotin na SARS-CoV S.
Hakanan zai kasance mai ban sha'awa don sanin ko za a buƙaci kowane sauran abokin karba don watsuwar SARS-CoV-2.
Mai ban sha'awa, HCoV-NL63 kuma yana ɗaure wa ACE2 amma tare da wani sashi na S.
Akwai sauran masu karɓar HCoV, kamar aminopeptidase N don HCoV-229E, da acid 9-O-acetylated sialic acid don HCoV-OC43.
Zasu iya dauka nauyin samun nasarar daidaita wadatar waɗannan CoVs a cikin mutane bayan watsa nau'in halittu daga wurin dakaru dabbobin su.
Baya ga tantanin halita mai karban sako, sakamakon watsuwar HCoVs ta tsakanin jinsuna shi ma ana sarrafa shi ta hanyar sauran abubuwan dogaro na mafaka da abubuwan ƙuntatawa.
Rarraba waɗannan sunadaran masu kariya tsakanin ɗan adam da rarar halitta na rukunin HCoVs kamar jemagu, raƙumi da bera na iya zama cikas ga watsawar ma'amala.
HCoVs dole su rinjayi dogaro kan mafaka sannan su fi karfin ƙuntatawar mafakarsu don nasarar watsuwa tsakanin jinsina daban-daban.
Dangane da wannan, masu fayyace kwayoyin halitta a wannan muhimmin fannin na hulɗar kwayar cuta da mafakarta sun kasance har yanzu ana gano su kuma za a iya sanin su.
Binciken yanayin rashin daidaituwa game da dogaro na mafaka da abubuwan ƙuntatawa don SARS-CoV-2 ta amfani da fasahar zamani ta CRISPR na iya zama mai amfani.
Fitowar HCoVs: Koma baya ga sifili
Bambancin CoVs na jemage yana bayar da isasshe dama ga fitowar sabon HCoVs da ke daban.
Bisa wannan hujjar, cututtukan jemage na CoVs sune tushen cututtukan HCoVs.
Bugu da kari, saurin maye gurbi da sake halittar gado shima yana fitar da cigaban HCoV kuma yana zama matakai biyu masu mahimmanci a wannan aikin.
Alal misali, siyarwa ko asarar kwayoyin halittar furotin dana duniya suna da damar canza kwayar cutar kwayar halitta ta wata hanya.
Daga cikin furotin na kariya na SARS-CoV, ORF8 ana tsammanin yana da mahimmanci a cikin dacewa da mutane, kamar yadda SARS-CoV masu hade da ƙwayoyin cuta jemage wanda aka keɓancewa amma an sami sinadarai masu bambam da furotin na ORF8.
An gano rugujewar kwayar halittar 29 daga yanayin SARS-CoVs a jini a farkon lokacin da aka fara gano annobar a jikin dan adam.
Wannan sharewa ta shiga ORF8 zuwa ORF8a da ORF8b kuma ana zaton shine maye gurbi wanda yake inganta canjin mafaka.
Bayan haka, SARS-CoV yana da yiwuwar sake duba tarihin tare da layin alpha- da gamma-CoVs, inda aka gano yawancin adadin yankuna masu rarrafe a cikin polymrase ɗin RNA da suke dogara da RNA.
An kuma gano wuraren sake canzawa a cikin nsp9, mafi yawan nsp10, da kuma sassan nsp14.
Hakanan, an nuna cewa annobar MERS-CoV ta sami abubuwan sake haduwa tsakanin layuka daban-daban, wanda ya faru a cikin raƙuman masu tozo guda a Saudiya.
Gefen wannan SARS-CoV da MERS-CoV, an kuma lura da abubuwan sake maye a cikin wasu HCoVs, wanda HCoVs suka sake haɗuwa da wasu CoVs na dabba a cikin abubuwan halittar da basu da tsari.
Hakanan ya kamata a yi gargaɗin cewa zaɓin ɗan adam zai iya ba da gudummawa ga canje-canjen da ba a yi tsammani ba a kwayoyin halittar, wataƙila ana haifar da sauƙaƙe ƙwayoyin cuta daga matsanancin zaɓi, kamar su tsarin garkuwar jiki.
Misalin waɗannan tasirin shine asarar cikakken tsawon ORF4 a cikin ƙwayar samfurin HCoV-229E, sakamakon shafewar nucleotide guda biyu.
Duk da yake ana iya lura da ingantaccen ORF4 a cikin ƙwayoyin cutar jemage da raƙumi waɗanda ke da alaƙa da HCoV-229E, alpha-CoV ta rakumin alpaca yana nuna guda ɗaya na nucleotide, wanda ya haifar da sauyin frameshift.
Daga ƙarshe amma ba ƙarami ba, juyin halittar sabbin HCoVs yana kuma faruwa ne ta hanyar matsi na zabin a cikin mafakar taskokinsu.
Mai nuna ya kamu da cuta ko kawai bayyanar cututtuka ne aka gano yayin da Jemagu sun kamu da cuta na CoVs, yana nuna daidaitawar juna tsakanin CoVs da jemagu.
Ta bayyana cewa jemagu sune matattarar kwayoyin halittar CoVs lura da yanayin jikinsu da kuma yadda gabobin jikin nasu ke aiki.
Alal misali, lahani a cikin faifan martani na maganin kumburi-kumburi a cikin jemagu yadda yakamata ya rage cutarwar da CoVs tayi.
Bayan haka, ayyukan kwayar halittar kisa a cikin jemagu tana lalacewa sakamakon hauhawar mai hana karbar kwayar halittar kisa NKG2/CD94 da ƙarancin matakin bayyana manyan kwayoyin halittun aji I hadaddu masu dacen jini.
Haka kuma, babban nau'in nau'in oxygen mai aiki (ROS) wanda aka samo asali daga ayyukan kwayoyi na jemagu na iya murkushe kwafin kwayar CoV kuma yana shafar karantawa ta hanyar karba-karba, ta haka ne samar da matsin zabi na tsararrakin kwayar cuta mai matukar birgeshi yayin gabatar da shi cikin sabon mai watsa shiri.
Haka kuma cututtukan CoV na pathogenic CoV na iya canzawa ta hanyar sake halittar, wanda ke haifar da sifofin furotin ko littafin fasalin furotin don karbuwa.
Don haka, babu wat hanya ba ne cewa uku na HCoVs sun fito a cikin shekaru ashirin da suka gabata.
CoVs ba cuta ba ne ko haifar karamin alamu cuta a cikin ɗakunan masu kamu da su kamar gemage da raƙuma.
Suna iya rarrabawa sosai ba tare nuna garkuwar jiki daga mai zama da ciwon ba.
Anan ne aka samu sirrin me ya sa marasa nuna alamar kamuwa ake ganinsu da kuma abun da yake haifar da mummunan lamura a kamuwa da cutar a mutum.
Radadin alamun cutar suna faruwa ne sakamakon yadda kwayoyin halittar jikin mutum masu yaki da cuta suke kokarin yakar cutar wanda idan aka samu karfin nasu sosai hakan zai kuma yi illar gaske ga huhun mutum.
Sabanin haka, a cikin marasa nuna alamar kamuwa da cutar, amsa rigakafi ya kasance kasa ga yaduwar Cov.
Dabarun iri daya ta raba cudanya da amsawar rigakafin iya samun sakamako masu amfani a cikin maganin anti-SARS-CoV-2.
Amsar interferon tana da ƙarfi musamman a cikin jemagu.
Don haka, gudanar da nau'in I interferon aƙalla a farkon kamuwa da cutar SARS-CoV-2 a cikin ɗan adam ya kamata ya zama da amfani.
Bugu da Kari, kunnawar NLRP3 cikin jemagu na da illa.
Lura da wannan dalilin, rayuwar kwayar halittar NLRP3 da kumburinsa da MCC950 zai yi tasiri wajen warkar cutar COVID-19.
Samuwar SARS-CoV-2 ya biyo bayan jigo ne wanda SARS-CoV da MERS-CoV suka tashi.
Ganin cewa wata beta-CoV raba 95% nucleotide homology tare da SARS-CoV, Hakanan akwai wanzuwar batirin-CoV wanda ke hade da kashi 96% na nucleotide homology tare da SARS-CoV-2.
Ganin cewa dabbar sivets da sauran dabbobi a cikin kasuwanni an same su dauke da ƙwayoyin cuta masu kama da SARS-CoV, ba a gano mafakar SARS-CoV-2 ta nan-kusa ba.
Pangolin beta-CoVs mai matukar alaƙar daidaituwa ga SARS-CoV-2 an samo, yana nuna cewa pangolins na iya zama ɗaya daga cikin tsaka-tsakin runduna ko pangolin beta-CoVs na iya ba da gudummawar gutsuttsuran jabu ga fasalin ƙarshe na SARS-CoV-2.
Kodayake tambayoyin suna wanzuwa, babu wata shaida da ke nuna cewa SARS-CoV-2 an yi mutum ne da gangan ko hadari.
CoVs sun dawo zuwa haskakawa sakamakon barkewar kwanan nan na SARS-CoV-2.
Nazarin cututtukan CoVs a jikin jemagu da sauran dabbobi ya sauya tunaninmu game da muhimmancin tushen cutar HcoVs ta samo asali ne daga jikin dabbobi wajen baza ta zuwa ga mutane.
Shaida da yawa ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 suna da asalin batir kuma ana tura su ga mutane ta hanyar runduna ta tsakiya.
Ganin cewa cutar SARS-CoV ta samo asali ne daga saduwa tsakanin mutane dabbar civets a cikin kasuwanni, rufe kasuwannin rigar da kashe biranen da ke faruwa na iya kawo karshen cutar ta SARS.
Ta hanyar dalilai iri ɗaya, ya kamata a cire pangolins daga kasuwannin nama don hana watsa cuta daga dabba zuwa mutum, ta la'akari da binciken gano asalin cutar a pangolin da yawa daga beta-CoVs masu kusancin dangantaka da SARS-CoV-2.
Koyaya, ko yaya kuma aka watsa SARS-CoV-2 ga mutane ta hanyar pangolins da sauran dabbobi masu shayarwa har yanzu za'a fayyace su a cikin binciken da za'a yi nan gaba.
A gefe guda, MERS-CoV ya wanzu cikin rakuman larabawa.
Waɗannan raƙuma suna da mahimmanci ga kayan sufuri da kuma babban tushen nama, madara, fata da kayan ulu ga mutanen yankin.
Suna nan ko ina a Gabas ta Tsakiya da Afirka.
Don haka, kusan abune da ba zai yiwuwa ba a ce a soke dukkan rakuma domin kawai a shawo kan cutar ta MERS, kamar dai yadda aka yi a kasuwar dabbobin dawa a qasar China domin shawo kan bazuwar cutar SARS-CoV da SARS-CoV-2.
Don dakatar da yawan yaduwar MERS, ya kamata a ɗauki cikakkiyar hanya don haɓaka rigakafin tasiri ga MERS-CoV don raƙuma, tare da sauran matakan kula da kamuwa da cuta.
Kasancewar ba mu iya kawar da kwayoyin cututtukan nan ba, watakila a iya samun bullar sabbin kwayoyin halittan da za su haifar da bazuwar cututtuka.
Yawancin CoV na zoonotic suna yaduwa a cikin daji.
Alal misali, cututtukan jemage na CoVs da suka samo asali daga jikin dabbobi suna nan birjik.
Akwai hujjoji da dama da ke nuna cewa cututtukan CoVs suna rayuwa tare da rikida zuwa cutar CoVs da take shafar dan adam cikin sauri kuma ta iya zama mai saurin kisa a nan gaba.
Ya kamata a watsar da al'adun cin namun daji a wasu wurare na China don rage hulɗa da ba ta dace tsakanin mutane da dabbobi.
Lura da yadda aka sha fama da cututtukan SARS da MERS da kuma COVID-19, lallai ne a yi shirin kwarai wajen tunkarar ta.
A zahiri, ƙwayoyin cuta da yawa sun wanzu a cikin duniyar ta dogon lokaci.
Suna zama a cikin ɗakunan ajiya na asali nasu har sai an sami damar yaduwa.
Kodayake jemagu suna da fasaloli da yawa waɗanda suka fi dacewa da yada ƙwayoyin cuta, damar da dan Adam zai iya hulɗa da jemagu da sauran nau'in dabbobin daji za a iya rage ta idan an ilmantar da mutane su nisanta da su.
Cigaba da sanya ido a cikin dabbobi masu shayarwa wajibi ne don kyakkyawar fahimtar yanayin ilimin halittu na CoVs da rundunonin su na halitta, wanda zai tabbatar da amfani wajen hana yaduwar dabbobi zuwa mutane da kuma barkewar gaba.
Hanya mafi sahihanci wajen kare bazuwar cututtuka daga jikin dabbobi zuwa mutane ita ce dan adam ya kaurace wa wadannan dabbobin da suke dauke da kwayoyin cututtukan.
Abubuwa da yawa a cikin wasan kwaikwayon game da asalin zoonotic na SARS-CoV-2 har yanzu sun ɓace.
Da farko, idan jemagu suna yada kwayar cutar magabata na SARS-CoV-2 zuwa pangolins, Zai zama abin ban sha'awa idan kaga irin yanayi da jemagu da kuma nau'ikan pangolins za su iya zamowa cikin muhalli iri daya.
Na biyu kuma, idan dai har jemagu suna taka muhimmiyar rawa wajen yada cutar zuwa mutane, yaya za a tabbatar da haduwar mutum da kuma jemagun.
Na uku, idan dabbobi masu shayarwa na uku suka zama mai masaukin gaskiya na tsakiya, yadda yake ma'amala da nau'ikan halittu gami da mutane, jemagu da pangolins ya zama dole a fayyace su.
A karshe dai, lura da galibin dabbobi masu shayarwa ciki har da na gida za su kamuwa da cutar SARS-CoV-2, ya kamata a gudanar da bincike hakika a kai.
Shin Jemage ne, ko pangolin ko wata dabba mai shayarwa, ana tsammanin SARS-CoV-2 ko ƙwayoyin mahaifan sa waɗanda suke kusan iri ɗaya ne za a gano shi a cikin masaukinsa na halitta a nan gaba.
Binciken da aka ci gaba a wannan yankin zai ba da damar hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, tare da mahimmancin tasiri a cikin rigakafin da kuma sarrafa COVID-19 a cikin mutane.
Ana sabunta ka'idojin gwaji na COVID-19 “wanda ake ganin sun kamu da cuta” da “da wanda an riga an gano na da cutar” ya zama dole
A 6 Fabrairu 2020, ƙungiyarmu ta buga jagorar shawara mai sauri don ganewar asali da lura da kamuwa da cutar 2019 noro coronavirus (2019-nCoV), kuma wannan jagorar ya samar mana da kwarewarmu kuma mu bayar da tunani sosai game da yakar wannan cuta ta duniya.
Koyaya, cutar coronavirus 2019 (COVID-19) sabon cuta ce, wayewarmu da iliminmu suna karuwa ne sannu a hankali bisa binciken ci gaba da ƙwarewar aikin asibiti; Saboda haka, dabarun ganewar asali da magani ana kuma sabunta su koyaushe.
A cikin wannan wasika, mun ba da amsa guda ɗaya game da jagorarmu kuma mun samar da sabon yanayin bincike na “wanda ake zargi da cuta” da “tabbataccen cutar” bisa ga sabon bincike da Jagororin Kulawa na COVID-19 (sigar na bakwai) wanda Kwamitin Lafiya na Kasa na jamhuriyar jama'ar Sin ya bayar.
A cikin watan Disamba na 2019, coronavirus na shekara ta 2019 (2019-nCoV) ya haifar da fashewa, wanda a yanzu an nada shi a matsayin cutar coronavirus 2019 (COVID-19) kuma an sanya sunan ƙwayar cuta mai ƙuna mai nauyi ta cutar coronavirus 2 (SARS-CoV- 2).
A ranar 11 Maris 2020, WHO ta kwatanta COVID-19 a matsayin annoba.
Don yin yaƙi da kamuwa da cututtukan SARS-CoV-2, ƙungiyarmu ta ɓullo da jagorar shawara mai sauri kuma an buga wannan kan layi a cikin Binciken Ilimin Kiwon Lafiyar Sojoji a ranar 06 ga Fabrairu 2020.
An jawo hankalin sosai tun lokacin da aka buga.
Ka lura duk da cewa COVID-19 sabon cuta ne, ƙwarewarmu da iliminmu suna ƙaruwa sannu-sannu bisa binciken ci gaba da ƙwarewar aikin asibiti; Saboda haka, dabarun ganewar asali da magani ana kuma sabunta su koyaushe.
Misali, Binciken Bincike da Ka'idodin Jiyya don COVID-19 wanda Kwamitin Kiwan Lafiya na Jamhuriyar Jama'ar Sin ya bayar (http://www.nhc.gov.cn/), tsakanin 16 ga Janairu 2020 zuwa 3 Maris 2020, sun ba da sanarwar total bakwai bugu tare da wasu mahallin da ake canza sosai.
Yanzu jagorancinmu ta karɓi sharhi ta hanyar Zhou et al., Sun gabatar da wani tsari mai sauƙi wanda ya danganci ƙwarewar asibiti.
Ayyukan su sun ƙara sabon shaida don jagorar mu kuma sun ba da ma'anar mahimmanci ga wannan anoba ta duniya.
Muna alfahari da muhimmiyar aikin su kuma muna nuna godiyarsu.
Duk da haka, aikin su ma yana buƙatar sabuntawa bisa ga sabon Ganewar asalin ciwo da Jagororin Jinyar COVID-19 (Sigar gwajin bakwai) da kuma binciken kwana nan.
Dangane da bugu na bakwai (3 Maris 2020), don tabbatar da tuhumar da ake buƙata na buƙatar haɗu da kowane abu guda na abubuwan tarihin annoba tare da abubuwa biyu na alamun bayyanar asibiti don yin cikakken bincike, ko kuma buƙatar haɗuwa da abubuwa uku na bayyanannin asibiti idan ba tare da bayyananne ba tarihin annoba:
Tarihin cututtukan cuta: (1) tarihin tafiya ko zama a cikin birnin Wuhan da kewayenta, ko wasu al'ummomin da aka sami rahoton cutar COVID-19 a cikin kwanaki 14 na ƙarshe kafin alamun farawa; (2) tarihin saduwa da SARS-CoV-2 cututtukan fata (tare da ingantaccen gwajin nucleic acid);(3) tarihin tuntuɓar marasa lafiya tare da zazzabi ko alamu na numfashi daga garin Wuhan da kewayenta, ko kuma sauran al'ummomin da aka sami rahoton COVID-19 a cikin kwanaki 14 na ƙarshe kafin alamun farawa;(4) tarihin hulɗa tare da tarin abubuwan da aka tabbatar(≥ 2 lokuta biyu da zazzabi da / ko alamun cututtukan numfashi sun faru a cikin makonni 2 a cikin ƙananan yankuna, kamar gida, ofis, aji na makaranta, da sauransu).
Bayyanuwar cututtuka na asibiti: (1) zazzabi da/ko alamun cutar hanyoyin numfashi; (2) tare da alamun fasahar kamuwa da COVID-19; (3) jimlar tantanin halitar farin jinin da ke nuna daidai, raguwa, ko raguwar yawan adadin kumburin lymphocyte a farkon matakin.
Binciken shari'ar da aka tabbatar ya kamata ya dogara ne akan tuhumar da ake zargi tare da kowane abu guda na pathogenic ko shaidar serological kamar haka: (1) gwajin PCR na hakika tabbatacce ga SARS-CoV-2; (2) hoto ko bidiyo mai zagaya yanar gizo da sauri duk tsarin halitta wanda yake nuna babban ɗabi'a ga sanannun coronaviruses; (3) tabbatacce ga takamaiman IgM antibody da IgG antibody zuwa SARS-CoV-2 a cikin gwajin serum; ko sauyawar SARG-CoV-2-IgG takamaiman IgG daga mummunan zuwa tabbatacce, ko titer yana tashi ≥4 sau a cikin lokacin dawo da sama wanda ke cikin mawuyacin lokaci.
Za mu iya ganin cewa ainihin gwajin PCR na ainihin acid na nucleic acid a cikin tsarin numfashi ko samfurori na jini sun kara zuwa na biyu (18 Janairu 2020) da na uku (22 Janairu 2020).
An ƙara gano ƙwaƙwalwar ƙwayar jini a cikin na huɗu (27 Janairu 2020) da na biyar (8 Fabrairu 2020); sannan kuma an kara tabbatar da shaidar serological zuwa bugu na bakwai.
Wadannan gyare-gyaren da aka danganta da masu binciken sun ci gaba da aikin da cewa don bincika ingantaccen ƙwayar cuta ta hanzari, da samfurori daga ƙwayar numfashi ciki har da samfurin jini, wanda ya haɓaka samar da samfurori daban-daban, kuma yana tallafawa samar da takamaiman sakamako na antibody. a cikin ka'idodin da aka tabbatar.
Bayan haka, akwai ƙarin tabbaci da yawa waɗanda ke tunatar da mu mai da hankali tare da marasa lafiyar marasa lafiya da marasa lafiyar asymptomatic.
Saboda haka, jerin gwanon Zhou et al. yakamata a sabunta shi, kamar yadda suke rarraba mutum ba tare da alamun asibiti kamar “ƙananan haɗari ba”.
Hakanan ana buƙatar tabbatar da tsarin ƙimar ci gaba a cikin aikin asibiti da kuma karatun.
Don kammalawa, muna fatan ƙarin tabbaci kai tsaye da ke zuwa tare da yin kira ga masu karatu su faɗi ra'ayoyinsu.
Don bincikar “ciwon da ba a gano ba” da “ciwon da aka gano”, muna ba da shawarar ganowa da yin biyayya da sababbin jagororin ƙasashen su.
Kungiyar mu su ma za su sabunta jagorar mu domin bayar da taimako.
Bangladesh ta ba da rahoton sabbin mutuwa guda biyar ta dalilin COVID-19, mafi yawa a rana guda.
Jiya, Bangladesh ta tabbatar da sabbin mutuwa har guda biyar saboda COVID-19 a ranar.
Wannan shine lamba mafi yawa na mutuwa a rana guda saboda kwayar cutan.
A jiya, Hukumar binciken kan cututtuka na Bangledesh, wato Disease Control and Research (IEDCR) ta ba da rohoton lambar wadanda suka kamu da cutan wanda ya hada da wasu wadanda suke da cutar su 114 da kuma wadanda suka warke su 33 wadanda suke zaman gida.
Adadin mutane 17 da suka mutu aka rubuta.
Cikin labarai kan layin intane, Darectan IEDCR, Dr Meerjady Sabrina Flora, ta ce wadanda suka rasa rayukansu sun hada da maza hudu da mace daya.
A cewar Dr meerjady, kararraki masun cutar biyu sun kai shekaru 60, biyu tsakanin 51 da 60, kuma daya shekaru 41-50.
Ta kuma ce biyu daga cikin wadanda cutar ya shafa sun fito ne daga Dhakar.
Hukumar Lafiya (WHO) ta bayyana COVID-19 a matsayin anoba ranar 11 ga watan Maris.
Wani jami’in asibitin ya fada wa kamfanin dillancin labarai na Anadolu, tashar labarai ta gida cewa daya daga cikin mamacin shi ne Jalal Safur Rahaman daraktan ne na hukumar cin hanci da rashawa na Bengali, wanda aka kula dashi a asibitin Kuwait Maitree.
A ranar Asabar, a cikin sanarwar bidiyo ta yanar gizo, Ministan Jigilar Hanya da Gadodi na Bangladesh Obaidul Quader ya ce za a rufe jigilar jama'a na tsawon lokaci fiye da yadda aka tsara tun farko, har sai ranar Asabar mai zuwa.
Rufewar wannan abun jigilar jama’a ya fara ne a ranar 26 ga watan Maris da kuma an shiya zuwa karshen Asabar, ranar 4 ga watan Afrilu.
Har yanzu an yarda da jigilar kayayyaki masu mahimmanci, magunguna, man fetur da kayan abinci.
An samu cutar COVID-19 na farko a Bangladesh ranar 8 ga Maris a mutane biyu da suka dawo daga Italy da kuma matar dayansu.
A ranar goma sha tara (19) ga Maris, wadannan uku sun riga sun warke.
SARS-CoV-2 ya zarce cututtukan miliyan daya a duk duniya
A ranar Alhamis, yawan adadin kamuwa da cutar coronavirus SARS-CoV-2  sun wuce sama da miliyan ɗaya a duk duniya, bisa bayanan Jami'ar Johns Hopkins.
Akalla an samu mutuwa dubu 52 daga cutan COVID-19, cutan da kwayar cutan korona ke jawowa.
Wannan nasaran ta samu ne a ranar da Malawi ta tabbatar da cutar korona na farko sannan Zambia ta samu mutuwa daga cutar korona na farko.
Koriya ta Arewa ta yi da'awa, a ranar Alhamis, ta na cikin kasashen kadan wadanda sun kasance ba su da kamuwar coronavirus
Daga jiya, hukumar Lafiya ta Duniya ta ba da rahoton maganganun guda 1,051,635 wadanda suka tabbatar, wadanda suka hada da kararraki 79,332 a cikin sa'o'i ashirin da hudu da suka gabata 10 na safe. Tsarin Turai na Tsakiya (0800 UTC) ranar 4 ga Afrilu.
A cikin U.S. an rikodin fiye da wadanda suka kamu da cutar coronavirus dubu 244 waɗanda ke da alaƙa da aƙalla mutuwar 5,900.
CBS News sun ba da rohoto daga John Hopkins University da cewa akwai mutuwa sama da 1, 000 a US ranar Laraba wanda cutar korona ta jawo.
A duniya baki daya, kananan hukumomi sun ba da sanarwar matakan dakile cutar don hana yaduwa.
Ranar Alhamis, Sergei Sobyanin, Mayor na Moscow, ya kara dokan hana fita waje zuwa ranar 1 ga watan Mayu.
A kasa, shugaban Vladimir ya ce zai ci gaba da biyan albashi ba tare da al'umma suna zuwa bakin aikiba har zuwa 30 ga watan afrilu.
Yan majalisar Portugal sun kada kuri’ar tsawaita dokar ta-baci cikin kwanaki 15; an jefa kuri'un da kuri'u 215 cikin son kai, ragi goma, da jefa kuri'a daya ba a yarda da su ba.
Saudi Arabbia sun kara kafa dokar hana fita a cikin garin mecca da medina mai tsarki har zuwa tsawon ranaku, a baya can, dokar hana fita ta kasance ne kawai tsakanin karfe 3 na yamma zuwa 6 na safe.
Thailand ta yi kokarin aiwatar da dokar hana fita tsakanin karfe 10 na yamma zuwa karfe 4 na safe.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihan ta kara kwanakin zauna a gida har zuwa 1 ga Mayu.
Kantuna a Ostiraliya sun rage takarda bayan gida ga kowane ma'amala
A yammacin ranakun Asabar da lahadi kantin Woolworths and Coles dake kasar Australia ta takaita adadin tolifefa zuwa daya ko biyu ga ko wani mai siya a ko wani kantin ta dake fadin kasar.
ALDI sun bijiro da iyakar nadi daya, ranar litinin
A wallafa ka’idojin ne a bangon fita da kuma shafin kantin dake kafar sadarwa na Facebook.
Rahoto ya nuna masu siyan kaya sun garkame kayayyaki bisa ga tsoron COVID-19 da daukar matakin killacewa waje guda.
A ranar Laraba, Woolworths ya siya takarda bayan gida kadan don kaiwa gida fakiti ɗaya kowane oda.
Wadannan canje-canje sun biyo bayan ƙuntatawar fakiti-hudu ko wace ma’amala wanda Woolworths da Coles suka gabatar a watan Maris rana 4 da 5 bi da bi.
Coles, a rahoton shi na ranar 8 ga watan Maris yake cewa da mataki na hudu da aka sanya mmafi yawan shaguna na sayar da kaya cikin sa’a guda da sauke kayan, kuma ya kira bukatar da zamto na rashin laakari shi kuma ALDI a wani rubutun shi na shifin sada zumunta na facebook na rananr talata ya kira shi da mara zato.
Ciniki ya hau cikin sauri a makon da ya wuce, a maganar kakakin woolworth.
Shagunan Costco's A Canberra Sun Takaita Yawan Sayarwa Zuwa Nadi Biyu Satin Da Ya Wuce.
Don ci gaba da rage ƙarancin, Coles ya ba da umarnin manyan kunshin daga masu kaya da ƙara yawan bayarwa, Woolworths ya ba da odar ƙarin jari, yayin da ALDI ya sanya hannun jari don shirin Laraba na musamman da za a fara da wuri.
Russell Zimmerman, shugaban kungiyar kakanan yan kasuwa, yace kanaken yan kasuwa na kokarin kara kaya, ammman matakan gida akan lokacin shigowar motocin su na zama da shi mai wahala.
Ya sa rai samun karuwar farashin sarrafa kaya a yayin kokarin biyan bukatu da makamanci haka na musamman.
A ranar Talata, ALDI ya sanar da cewa bayan farkon sakin hannun jari, wasu shagunan ba za su iya gudanar da ranar Laraba ta musamman ba.
A Cikin News.com.au., Dr Gary Mortimer ya bada rahoton cewa, Masanin Kananan Ciniki Daga Jami'ar kimiya na Queensland, Ya ce Shagunan Na Cika Kayakin Sayarwan a kowace Dare.
Yana Cewa Takardar bayan gida Abu ne Mai Yawa, Wanda Ke Sa Kaya Su Yi Karanci A Yawa, Kuma In An Sayar Duka, Su Kan Bar Guraben Ajiya Su Fayau, Hakan Na Matsantawa Karancin Su.
"""Coles da Woolworths suna da ra'ayi [cewa] idan akwai kayayyaki da yawa akan wurin ajiye kaya (shelf), idan kayayyaki kamar takardan bayan gida da abun tsabtacewa [sayi] kuma suna can da yawa, watakila za a rage yawan fargaba"" in ji Russell Zimmerman a cikin Labarai na ABC."
Mai sake saraffa takardar bayan gida Wanda ya bada Crap ya ce a ranar Laraba ta karshe zasu kare.
Kimberly-Clark, wanda ke yin Kleenex Toilet Tissue, da Solaris Paper wanda ke yin Sorbent, ya jaddada cewa suna aiki 24/7 don kula da wadatar, a cewa rahoton News.com.au.
Domain.com shafin chinikayyan gidaje, sun bada rahoton wasu masun sayarwa suna bada takardan bayangida kyauta ga wanda zai fara ciniki kan gwanjon a Melbourne, lokacin da aka gudanar da gwanjon kadan domin masun saya sun tafi hutu a dogon karshen mako ranar iyan kwadago.
Shirin ranar Alhamis na jaridar NT na dauke da shafuka guda takwas wanda ya kamace ya yanka domin yin amfani a matsayin tolifefa.
Da farko Shagunan Sun nuna Rashin aikata Daga Farko Wajen Sa Matakan, A Yadda Wani rahoto Na ABC Australia a ranar 3 ga Watan Maris Wanda Suka Ce Babu Wani Shiri Don Takaita Siyyayya.
Russell Zimmerman ya kara wasu kayakin da ake bukatar su sosai, harda kariyar fuska, sabulun hannu, busashen kaya, ruwan goge hannu da ma filawa.
A irin haka, a wajen Australia, a rananr lahadi da yamma an lura da cewa shafin kasuwanci na Birtania a yanar gizo Ocado na takaita sayarwan takadar bayan gida Andres zuwa fakitin biyu na nadi-12.
Kungiyar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba
Ranar hukumar lafiya ta WHO ta kaddamar da barkewar COVID-19 da ciwon da coronavirus SARS-COV-2 ke haifarwa a matsayin annoba.
Ko da yake ita kalmar anoba na nufin yanda cutar ke yaduwa, ba yanda hadarin wasu majinyatan ba, WHO ta bukaci sahalewar gwamnatoci wajen yakin.
“Dukanin kasashen duniya har yanzu na iya sauya fasalin wannan annobar.
idan kasashe suka gane, gwaji, warkar, binciko, da tura mutanen su izuwa agaji, “ inji Tedros Adhanom Ghebreyesus, shugaban kungiyar WHO.
"""Muna matukar damuwa da duka matakan tashin hankali da yaduwar cutar da kuma matakan rashin damuwa."""
A Cewar Dr Tom Frienden, Tsohon Shugaban Hukumar Kula Da Cuttutuka Da Ma Kariya Daga Kamuwa Cewa ita Wannan Annoba Ba a San Kan ta ba Tukun.
"Ya ce, a cikin jawabin da CNN ta buga a watan Fabrairu, ""ban da mura, ba wani kwayar cutar ta hanyar numfashi da ta bulla daga damuwa har zuwa yaduwar duniya."""
Ghebreyesus shima ya shaida inda ya kara da cewa ba’a taba samun annoba wanda coronavirus tayi sanadiyar yaduwar ta.
"Ya ci gaba da cewa, ""kuma ba mu taba ganin annoba da za a iya sarrafa ta a lokaci guda ba."""
Sabuwar matsayin annoba ta biyo bayan shawarar da WHO ta yanke a watan Janairu don bayyana barkewar cutar a matsayin matsalar lafiyar jama'a na damuwa ta kasa da kasa.
"Darektan Cibiyar Nazarin Cutar Jiki da Cuta mai Yaduwa wato (The United States’ National Institute of Allegy and Infectious Diseases) Dr. Anthony Fauci, ta ce game da barkewar, ""Karshen magana, zai kasance da muni."""
A halin yanzu jaridar Associated press ta kawo rahoto cewa an adadin wadanda suka kamu da COVID-19 a duniya ya kai 126,000 kuma mutane 4,600 sun mutu sakamakon kamuwa da ita.
Annobar coronavirus ta shekara 2019-20 annoba ce wanda ke cigaba da faruwa ta ciwon 2019 COVID-19 wanda 2 SARS-COV-2 ke haifarwa.
An gano bullar barkewar cutar a Wuhan, China, a watan Disamba na shekarar 2019, an ayyana shi a matsayin Babban Lafiyar Jama'a na Damuwar Kasa da Kasa a ranar 30 ga Janairu 2020, kuma an karbe shi da cutar a ranar 11 ga Maris 2020.
A ranar 10 ga watan Afrilu 2020, kimanin mutane miliyan 1.61 aka samu da cutar COVID-19 a kasashe 210 da ma yankuna, wadanda hakan sun kawo mutuwa guda 97,000.
Kimanin mutane 364,000 sun warke.
An kiyasta yiuwar mutuwa sanadiyar ta zuwa 4% a kasar China. A duniya kuwa kason ta rabu ne tsakanin 13.04% a Aljeriya zuwa .08% a kasar New Zealand.
Manyan alamomin cutar sun hada da zazzabi da tari tare da takaita shakar iska.
Rikitarwan cututuka zai iya haɗawa da ciwon huhu da cutar hanyoyin numfashi mai tsanani.
Lokacin daga bayyanar cutar zuwa farkon bayyanar cututtuka shine kusan kwanaki biyar, amma yana iya kasancewa daga kwana biyu zuwa goma sha huɗu.
Babu sanannen rigakafi ko wata kulawa domin kawar da ita.
Kulawa Ta farko Na da nasaba Da Kuma Bada Garkuwa Wajen kawo Sauki, Matakan Kare Kai Ciki Harda wanke Hannu, Rufe baki Yayin Tari, Bada tazara Ga Mutanne, Kula da kuma Kebe Kai wa Mutanen Da Ke Dauke da ko Ake Zargin Sun Kamu Da ita.
Hukumomi a fadin duniya sun mayar da martani ta hanyar daukar matakai kamar takaita safara, killacewa, dokar hana fita, bin ka’idojin rage hatsari a wuraren aiki da kuma kulle masana’antu.
annoban ta haifar da mummunar rikice-rikicen tattalin arziƙin duniya, dakatar da sokewa ko soke wasannin, addinai, siyasa da al'adu, da kuma wadatar kayayyaki da ke haifar da sayan ban tsoro.
Makarantu da jami’o’i sun rufe kodai a kasa gaba daya ko a wasu wurare a cikin kasashe 193, ya shafi a kalla kimanin kashi 99.4% na yawan daliban duniya.
Rashin fahimta game da kwayar cutar ta bazu a kan layi, kuma akwai lokutan maganganu na ƙabilanci da nuna wariya ga Sinawa, sauran mutanen Gabas da Kudu maso gabashin Asiya da bayyanar su, da sauran su daga wuraren da ke da muhimancin kamuwa da cutan.
Sakamakon dakatar da tafiye-tafiyte da kuma rufe manyan masana’antu an samu karancin gurbatattun iska.
Jami’o’in lafiya a Wuhan sun kawo rahoto cewa an gano taron cutar ta hanyar kwayar Pneumonia a 31 ga watan Disemba na 2019 bayan haka an kaddamar da bincike a farkon watan Janairu na 2020.
Yawancin lokuta suna da alaƙa da Kasuwancin kayan ruwa a Huanan don haka ana tunanin cutar tana da asalin zoonotic.
Kwayar cutar da ta haifar da barkewar cutar ana kiranta da SARS-CoV-2, sabuwar kwayar cutar da aka gano tana da alaƙa da coronaviruses na gemage, pangolin coronaviruses, da SARS-CoV. Wanda aka fara gano shi da alamun cutar daga baya an gano cewa ya kamu da rashin lafiya a ranar 1 ga Disamba 2019 , kuma mutumin bai da alaƙa da bayyane tare da tari mai rukunin kasuwa na baya.
Daga farkon tarin rahoton wadanda suka kamu da cutar cikin watan Disamba na shekarar 2019, an gano kashi biyu cikin uku suna da nasaba da kasuwa.
A ranar 13 ga Maris 2020, wani rahoto da ba a tabbatar da shi ba daga South China Morning Post ya ba da shawarar cewa, wata kara ta fara daga ranar 17 ga Nuwamban shekarar 2019, a cikin wani dan shekara 55 daga lardin Hubei, watakila shi ne na farko. A ranar 26 ga Fabrairu 2020, WHO ta ba da rahoton cewa, yayin da aka samu rahoton bullar sabbin maganganu a China amma ba zato ba tsammani ya karu a Italiya, Iran, da Koriya ta Kudu, Yawan sababbin shari'o'i a wajen kasar Sin sun wuce adadin sabbin maganganu a cikin kasar Sin a karon farko.
Zai yiwu a sami rahoto mai yawa, musamman tsakanin waɗanda ke da alamun karamin bayyanar cututtukan.
Ya zuwa 26 ga watan Fabrairu, ba a samu karancin lokuta ba a tsakanin matasa, wadanda shekarun su 19 kuma wadanda ke kasa da kashi 2.4 cikin dari na duk duniya. Babban mashawarcin kimiyya na Burtaniya, Patrick Vallance, ya kiyasta cewa kashi 60% na mutanen Birtaniya za su kamu da cutar kafin cimma wata ingantaccen garkuwa.
Yanayi ya nuna yawan mutane da suka gudanar da gwajin COVID-19 wanda kuma gwajin na nuna cewa suna dauke da cutar bisa tabbacin hukuma.
A 23 ga watan Maris ba’a samu kasar da ta gudanar da gwajin cutar na sama da 3% kuma akasarin kasashen sun samu tsari daga hukuma na yin gwaji har ga wadanda basu nuna kananan alamu ba. cikin kasashen akwai Italy da Netherlands da Spain da kuma Switzerland.
Wani binciken da aka buga a ranar 16 ga Maris ya gano cewa, a cikin kasar Sin, har zuwa 23 ga Janairu, an kiyasta kimanin kashi 86% na cututtukan COVID-19, kuma waɗannan cututtukan da ba a yarda da su ba sune tushen kamuwa da cuta kashi 79% na kamuwa da cutan yadda yake a rubuce.
Wani bincike na ƙididdigar da aka buga a ranar 30 Maris ya kiyasta cewa lambobin cututtukan cututtuka a Italiya sun fi girma fiye da rahoton da aka bayar.
Atesididdigar farko na lambar haifuwa ta asali (R0) don COVID-19 sun kasance 1.4 zuwa 2.4.
Bincike da hukumar dake dakile yaduwar cututuka na Amurka ta wallafa ta hakikance cewa wata kila 5.7 ne.
Mafi yawancin mutane da suka kamu da COVID-19 suna warkewa.
Ga waɗanda ba su yi hakan ba, lokacin daga bayyanar cututtuka zuwa mutuwa ya kasance tsakanin ranakun 6 zuwa 41, tare da mafi yawan kwanakin 14.
A ranar 10 ga watan Afrillu 2020 kimanin mace-macen aka alakanta da COVID-19 su kai 97,000.
A kasar Sin, ya zuwa ranar 5 ga Fabrairu kusan kashi 80% na wadanda suka mutu sun kasance a cikin wadanda suka wuce 60, kuma 75% suna da yanayin rashin lafiya da suka hada da cututtukan zuciya da cutar siga.Daidaito da mutuwa ta asali daga cutar COVID-19 gabaɗaya tana nufin mutanen da suka mutu waɗanda suka gwada tabbacin COVID bisa ga ka'idoji na hukuma.
Wata kila adadin wadanda ke mutuwa sanadiyar COVID-19 zai fi yawa saboda akwai yiuwar mutuwar mutane wadanda ba’a samu anyi masu gwaji ba misali wadanda ke gida da kuma wadanda ke gidan kulawa.
wani yanki na daga bayanai na kasar Italy ya gano yawon mutuwa yayin barkewar annobar ya wuce adadin mutuwar COVID da nasabar 4-5x.
"Mai magana da yawun Cibiyar Kula da Cututtuka da kawarwa ta U.S. (CDC) ta yarda ""Mun san cewa [adadin da aka bayyana na mutuwa) lamari ne mai ban tsoro"", bayanin da ya samo tushe daga rahotannin asirin abubuwan da ke faruwa a Amurka Irin wannan rashin sanin yakamata galibi yakan faru a cikin bala'o'i, kamar cutar H1N1 alade ta 2009. Wanda aka tabbatar da mutuwa ta farko ita ce a Wuhan ranar 9 ga Janairu 2020."
Mutuwa na farko da ya faru wajen China na faru ne a 1 ga watan Febreru a kasar Philipines hakazalika mutuwa ta farko a wajen nahiyar Asia ya faru ne a kasar France a ranar 14 ga watan Febreru.
A ranar 28 na Febreru a gabanin kasar China an samu rahoton mutuwar mutuwa fiye da goma sha biyu a ko wani na Iran da South Korea da kuma Italy.
A ranar 13 ga Watan Maris, kasashe da bangarori Fiye Da Arbain Sun Sanar Da Mutuwa, A Kowane Nahiya Banda Antarctica. Ana amfani da Matakai Da Dama Wajen Kimanta Mace-macen.
Waɗannan lambobin sun bambanta daga yanki da na tsawon lokaci, kuma ana rinjayar su da ƙimar gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tun lokaci barkewar farko, da kuma halayen jama'a kamar shekaru, jima'i, da kuma lafiyar gaba ɗaya. yana nuna adadin mutuwar da aka rarrabe ta hanyar adadin cututtukan da aka gano a tsakanin wani lokaci na wani lokaci.
Dangane da ƙididdigar Jami'ar Johns Hopkins, ƙimar mutuwa-ta-duniya shine 6.0% (97,039 / 1,617,204) kamar 10 na Afrilu 2020.
Lambobin ya banbanta tsakanin yanki.
A China kiyastawar da aka yi na nuna cewa mutuwa sanadiyar cutar ta ragu daga 17.3% ( Na wadanda suka nuna alamu daga ranar 1 zuwa 10 na watan Janairu 2020) zuwa 0.7% (Na wadanda suka nuna alamu daga ranar 1 na watan Febreru 2020). Sauran matakai da aka dauka ya kunshi matakin auna mutuwa wanda ke nuna yawar mutane da aka kwantar sanadiyar wani cuta da suka mutu. Hakazalika akwai matakin auna kamuwa da cutar mai nuna yawan mutanen (wadanda aka kwantar da akasin su) da suka mutu sakamakon cutar.
Waɗannan ƙididdigar basu da iyakar lokaci kuma suna bin takamaiman yawan jama'a daga kamuwa da cuta ta hanyar sassanci.
Da yawa cikin masana sunyi kokarin gano lissafa adadin na wani bangaren al’umma.
Cibiyar Nazarin Shaida ta Jami'ar Oxford ta yi kiyasin cewa yawan masu kamuwa da cutar yaduwar cutar gaba daya ya kasance tsakanin 0.1% zuwa 0.39%.
Manyan Kididdigar na wannan kewayon sun yi daidai da sakamakon daga gwaji na farko na COVID-19 a Jamus, da kuma nazarin ƙididdigar da ke nazarin tasirin gwaji akan ƙididdigar CFR.
WHO ta tabbatar da cewa za a iya sha kan annoban.
Tsananin Hauhawar da Yawan Lokacin Barkewar Ba Su Da Tabbas Kuma Za Su Iya Banbanta A Wurare.
Maciej Bony daga Penn State University ya bayyana cewa idan ba’a kula ba barkewar shafuwar ta zai haura sa’anan ya fara raguwa yayin da cutar ta rasa jiki da zata rayu a kai.
Amma kusan ba zai yiwu a yi wani tsinkaye ba game da lokacin da hakan zai kasance ”.
Babban jami’i mai baiwa gwamnatin China shawara a kan kiwon lafiya Zhong Nashan yana mai ra’ayi cewa akwai yiwuwar kawo karshen ta a watan Yuni mudin dukanin kasashen duniya sun lura da shawarar da hukumar WHO ta bayar na matakan takaita yaduwar kwayar cuta.
"A ranar 17 ga watan Maris, Adam Kucharski na London School of Hygiene &amp, Tropical Medicine ya bayyana cewa SARS-CoV-2 ""zai zagaya a kasashe, mai yiwuwa na tsawon shekara daya ko biyu""."
"Bisa ga Kwalejin Ilimi na Imperiyal Wani Bincike Wanda Neil Ferguson Ya Jagoranta, za a bukanci Nesantawar jama’a Da ma Wasu matakai “har ya zuwa lokacin da za a  sami maganin rigakafi (a kalla Watani 18 ko ma ya fi)""."
"William Schaffner na Jami'ar Vanderbilt ya ce, ""Ina tsammanin ba zai yiwu ba wannan coronavirus - saboda yana da sauƙin ɗaukar hoto - za ta shuɗe gabaɗaya"" kuma """" na iya zama cuta ta zamani, da ke dawowa kowace shekara ""."
Tsananin kwayar cutar na dangantuwa ne ga karfin kariyar jiki na kamuwa da cuta da kuma yanayin kwayoyin halittar jiki.
Alamomin COVID-19 na iya zama mara takamaiman rashin daidaito kuma mutane masu kamuwa da cuta na iya zama mara sa alamun cutar.
Mafi yawan alamun rashin lafiya su ne zazzabi (88%) da ma busashen tari (68%).
Wasu kananan bayyanuwar cutan ta hadar da gajiya, fitar da majina daga hanyar numfashi (phlegm), rashin jin kanshi, karancin numfashi, ciwon gabobi da na jiki, ciwon makogwaro, ciwon kai, rashin jin dadi, amai, da gudawa, ko canza launin fata wato cyanosis. WHO ta sanar cewa kimanin mutum daya a cikin shida ya kamu da rashin lafiya kuma yana da wahala yin numfashi.
Cibiyar Kula da Cututtuka da kawarwa ta U.S. (CDC) ta lissafa alamu na gaggawa kamar wahalar numfashi, tsayayyar ciwon kirji ko matsi, rikicewar kwatsam, farkawa mara wahala, da fuska mai kyau ko lebe; Ana ba da shawarar likita na gaggawa idan waɗannan alamu suna nan.Farin ci gaba na cutar na iya haifar da matsananciyar ciwon huhu, cuta hanyoyin numfashi mai tsananin gajiyar alamar cutan, tashin zuciya, sepsis, girgiza septic da mutuwa.
Wasu daga cikin masu kamuwa da cutar na iya zama asymptomatic, ba tare da alamu na asibiti ba amma tare da sakamakon gwaji da ke tabbatar da kamuwa da cuta, don haka masu bincike sun ba da shawara cewa waɗanda ke da kusanci da mutanen da suka kamu da cutar ya kamata a sa ido sosai kuma a bincika su kawar da kamuwa da cuta.
Kdiddigar Sinanci na jimlar mara alamun cutar yana daga kalilan zuwa 44%.
Lokacin da aka saba amfani da shi (lokacin tsakanin kamuwa da cuta da farawa) ya fara daga daya zuwa kwanaki 14; mafi yawan lokuta kwana biyar ne.To da misalin rashin tabbas, kimantawar ɓarkewar mutane da COVID-19 waɗanda suka rasa kamshin da ƙanshi ya fara daga 30% kuma daga baya ya faɗi zuwa 15%.
Wasu jawaban akan yadda cutar ke yaduwa ake kokarin ganowa.
Akwai yakinin farkon yaduwar ciwon at hanyar hulda da mai shi sai kuma ta hanyar digo da aka samu yayin tari ko atishawa ko yin magana tare da samun kusanci da mutum tsakanin mita 1 zuwa 2 (kafa 3 zuwa 6).
Bincike ya gano cewa tari da ba a rufe ba yana iya haifar da didiga wanda wand zai iya tafiya zuwa mita 4,5 (ƙafa 15) zuwa mita 8.2 (ƙafa 27).
Wasu sun kudurta cewa kwayar cutar na iya yaduwa ne ta hanyar dugon ruwa da ta zauna a iska a tsawon lokaci mai yawa bayan haka a kamu da ita ta hanyar magana. Haka zalika digo ta hanyar nunfashi na iya samuwa yayin da mutum ke numfasa iska waje ko yayin magana. Asali dai hanyar shigar kwayar cutar bai takaita a kan hanyar iska ba.
Digon na iya fadawa a baki ko hancin wanda ke kusa wata sa’i ma ana iya shakar ta zuwa ga hunhu.
Wasu dagag cikin hanyoyin samada da lafiya kamar saka bututu don shakar iska da kuma farfadowa ta zuci suna iya zama sila na yada cutar ta iska.
Hakanan yana iya yaduwa lokacin da mutum ya taɓa abin da ya gurbata, gami da fata, sannan ya taɓa idanunsu, hanci, ko bakin su.
A yayin da yaduwar ta na iya faruwa ta hanyar kashi ke razanar da mutane, hatsarin ta kuwa na da karanci matuka.
Gwamnatin China ta karyata yiwuwar yaduwar kamuwa da SaRS-CoV-2 ta hanyar takshi zuwa baki. Kwayar cutar ta fiye yaduwa rana uku da nuna alama sai dai akwai yiwuwar yaduwar ta kafin alamun sun bayyana ko kuma kafin ta ketara zuwa mataki na biyu na ciwon.
Bayan gwaji an gano mutane sun kamu da cutar har tsawon kwana uku kafin bayyanar alamomin ta. Wannan ke nuna cewa akwai yiwuwar kamuwa da cutar kafin bayyanar alamomin ta.
kadan dag cikin rahotannin dakin gwaji kae tabbatar da mmatsanancin hali da aka samu, amman tsananin yaduwar ya tabbata a wasu kasashe yayin binciken yaduwar da ma alaka.
Hukumar dakile yadduwar cututtuka na nahiyar turai ta sanar da cewa mutum daya yakan iya raba ma mutum biyu ko uku cutar. Kuma kwayar cutar na tasiri sa’o’i zuwa ranaku a fili.
Musamman, an gano kwayar cutar har zuwa kwanaki uku akan filastik (polypropylene) da 304 bakin karfe, na kwana ɗaya a cikin kwali, kuma har tsawon sa'o'i huɗu akan jan ƙarfe.
Wannan, duk da haka, ya bambanta dangane da ɗanshin yanayi da zafin yanayin jiki. An samu dabbobin gida da wasu dabbobin da cutar COVID-19 bayan gwaji.
Babu wata shaida mai nuna cewa dabba na iya zamo sanadiyar kamuwar cutar ga dan Adam. Sai dai hukumar Birtaniya ta shawarci da a wanke hannaye bayan hulda da dabba da sauran wurare da mai dauke da cutar ke iya tabawa.
Kwayar cutar 2 SARS-COV-2 kwayar cuta ce wanda ke da asali. An fara samo ta ne daga mutane uku masu dauke da cutar pneumonia dake tare da ciwon nunfashi mai tsanani a nan birnin Wuhan na kasar China.
Dukkan fasalin Wannan sabon kwayar cutan SARS-CoV-2 Sun Faru daga coronavirus dangi iri daya a yanayin su. A Wajen Jikin mutum, a kan kashe kwayar cutan da sabulun gida, Wanda ke Narkar Da Matakan Kariya. SARS-CoV-2 Na Da dangataka Da Ainahin SARS-CoV.
Ana tsammanin yana da asalin zoonotic.
Binciken kwayar halitta ta bayyana cewa coronavirus yana hade da kwayoyin halittar Betacoronavirus, a cikin subgenus Sarbecovirus (jinsi B) tare da nau'ikan baturi biyu da aka samo.
Kaso 96% na nuna kamala a wani bangare yayin gina kwayoyin hallita idan aka kwatanta da samfurin Bat coronavirus (BatCov RaTG13).
A watan Faburairu 2020, masu bincike yan chinese sun gano cewar akwai wani kwayar hallita a sassa na kawayr da alakar ta tsakanin cutar dama kwayar da kuma wanda ke jikin mutum.
Da aka kwatanta abubuwa da suke gina kwayoyin halitta na an gano cewa kaso 92% iri daya ne tsakanin pangolin coronavirus da na SARS-COV-2. Hakan dai baya tabbatar da pangolin a matsayin masauki na tsakani ba.
Ana iya gano da kamuwa da kwayar cutar kan alamu, kodayake tabbatarwa daga ƙarshe ita ce hanyar jujjuyawar kwayar polymerase (rRT-PCR) ta kamuwa ko hoton CT.
Wani bincike mai hada PCR Da CT a Wuhan Na Da raayin cewa CT Na Da Saurin Dauka akan PCR, Duk da rashin takaicewa, Dama Yawancin irin Ganin yadda Wasu cututukan Sanyi Da wasu Cuttutukan Suka gudana.
"ya zuwa Maris 2020, Cibiyar Nazarin Kama Hoton Jiki na Amurka wato American College of Radiology ta ba da shawarar cewa ""Bai kamata a yi amfani da CT don bincika ko a matsayin gwajin fari don gano da cutar COVID-19 ba""."
Hukumar WHO ta wallafa hanyoyi gwajin ta hanyar kwayar hallita na SARS-COV-2. Ta wallafa na farkon ne a ranar 17 ga watan Janairu.
Gwajin yana amfani da rikodin sarkar polymerase real-lokaci (rRT-PCR).
Za a iya gwajin daga layin numfashi ko ma samfurin jini.
Ana samun sakamako gaba ɗaya cikin 'yan awanni kaɗan zuwa kwanaki.
Kullum ana yin wannan gwajin ne a kan nasopharyngeal swab kodayake ana iya amfani da makogwaron makogwaro. Yawancin dakunan gwaje-gwaje da kamfanoni ke yin gwaje-gwaje na serological, wanda ke gano kwayoyin.
A ranar 6 ga watan Afrilu 2020, wannan duk ba a tabbatar da ingancin su ba wajen yawan yaduwar.
A cikin U.S. an yarda da gwajin serological da Cellex ya kirkira wanda an aminci da shi don amfani da shi lokacin gaggawa a dakin gwajin da aka amince da ita.
Siffofin kwaikwayo na halayyar hoto a cikin hotunan rediyo da kuma lissafin tomography (CT) na mutanen da ke da alamun cutar sun haɗa da yanayin gilashin ƙasa na asymmetric da kuma abubuwan rashin jin daɗin rayuwa.
Kungiyar Radiological na Italiyanci tana tattara bayanan yanar gizo na kan layi na binciken abubuwan binciken don tabbatattun shari'o'in a duniya.
Sakamakon kewayawa tare da wasu cututtukan irin su adenovirus, hoto ba tare da tabbatarwar PCR ba shi da iyaka takamaiman ganowa COVID-19.
Wani gaggarumin bincike a China ta kwatanta sakamakon hoton kirji da na kwayoyin halitta inda ta gano karancin samar da hakikanin hoton kumuwar cutar. Ta gano cewa kwayar cutar ta fiye sauri kuma ta fi hadari ta kara da bada shawara na a sauya hanyar wajen gwajin cututuka a wuraren da annobar ke da yawa.
An tsara cibiyoyin sadarwa na tsarin wucin gadi na fasahar mutum don gano fasali masu kwayar cutar tare da hotunan rediyo da CT.
Dabarun hana yaduwar cutar sun hada da kula tsabtacewar mutum gaba daya, wanke hannaye, gujewa taba idanu, hanci, ko baki da hannayen ku wanda ba a wanke ba, da tari ko atishawa cikin takarda da sanya takardan cikin kwandon shara.
An shawarci waɗanda su riga su ka kamu da wannan cutar su sanya abin rufe fuska na tiyata a cikin jama'a.
Guje ma musabiha tsakanin juna na daga cikin matakan magance yaduwar cuta da aka dauka. Mafi yawancin gwamnatocin kasashe sun shawarci da a hana tafiyar kai da kawowa zuwa kasashen da annobar ta shafa.
Amman cutar ta kai matakin yaduwa a cikin alumma a sassa na duniya.
Wannan Ya Nuna Cewa Kwayan Cutar Na Yaduwa A Cikin al’ummai, Kuma Wasu Mazuna Yankin basu San Ko Ta Ina Bane Ko Ta Yaya ne Suka Kamu Da Wannan Cutar. MaAikatan kiwon Lafiya Masu Kula Da Marasa Lafiya suna Umarta wadanda suka kamu da cutar Cewa Su Yi amfani Da kaidar Kariya, da kaidar huldawa, kariyar ido. Neman wadanda suka yi hulda da marasa lafiya hanya ce mai mahimmanci ga hukumomin kiwon lafiya su gano ainihin inda cutar ta bullo da kuma hana shi daga yaduwa.
Yin amfani da bayanan wuri daga wayoyin hannu ta gwamnatoci don wannan dalili ya haifar da damuwa na sirri, tare da Amnesty International da wasu kungiyoyi sama da 100 suna ba da sanarwa suna kiran iyaka akan wannan sa-ido.
An aiwatar da aikace-aikacen wayar hannu daban-daban ko aka gabatar don amfani da son rai, kuma daga ranar 7 ga Afrilu, 2020, gungun masana kwararru da yawa suna aiki akan hanyoyin sadarwar sirri, kamar yin amfani da Bluetooth don shiga kusancin mai amfani da sauran wayoyin hannu.
Masun amfani sun sami sako cewa idan sun hulda da wani wanda aka gwada kuma na dauke cutar COVID-19. Rashin fahimta na ta yadawa akan yadda za a kariya daga samun cutar; alal misali, wanke hanci da ma kurkurar baki basa kare mutu daga cutar ba.
Babu maganin cutar COVID-19 amman kungiyoyi na ta kokari samar da guda.
An shawarci wanke hannaye domin kiyaye yaduwar cutar.
Hukumar CDC Ta Bukaci Mutane da su wanke Hannayen su a koda Yaushe Da Sabulu Ma A Kalla Dakika Aishirin, mussaman Bayan Su Ziyar Ci Bandaki Ko In Hannun Su Na Da Datti; Dama Bayan Fece Hanci, Tari Ko Hatishawa.
Wannan na faruwa ne saboda a wajen jikin mutum ana iya kashe kwayar cutar da sabulu , sabulun ta kan fasa launin dake bayar da kariya.
CDC ta kara da cewa ayi anfani da man tsaftacewar hannu mai sinadarin alcohol kashi 60% idan ba bu ruwa ko sabulu a kusa.
Kungiyyar WHO Tana Shawartar mutane da su Kiyayi taba Ido, Hanci da bakin su Ba Tare da wanke Hannu Ba.
Za'a iya wanke kwayoyin cututtuka daga saman da yawancin hanyoyin magancewa (a cikin minti daya na bayyanuwa ga mai lalata ga bakin karfe), hade da kashi 62-71 bisa dari ethanol, kashi 50-100 bisa dari isopropanol, kashi 0.1 bisa dari sodium hypochlorite, 0.5% hydrogen peroxide, da kashi 0.2-7.5 bisa dari na povidone-iodine.
Sauran rigakafi kamar Benzalkonium chloride da Chrohexidine tasirin su bai yi karfi ba.
CDC ta ba da shawarar cewa idan ana zargin COVID idan aka tabbatar ko aka tabbatar da shi a wani ofishi kamar ofis ko kulawar rana, duk bangarorin kamar ofisoshin, wuraren wanka, wuraren gama gari, kayan lantarki kamar na allunan, allon taɓawa, keɓaɓɓun maɓallin, na nesa, da ATM injunan da marasa lafiyar ke amfani da su, ya kamata a warwatsa su.
Kungiyoyin kiwon lafiya sun shawarciu da jama’a suyi rufe baki da hancin ta hanyar lankewasa gwiwar hannaye ko kuma ayi amfani da tolifefa yayin da mutum ke tari ko atishawa kuma a tabbatar an zubar da tolifefa ba tare da bata lokaci ba bayan kammala hakan.
Ana ba da shawarar amfani da abin rufe fuska na tiyata ga waɗanda wataƙila sun kamu da cutar, domin sanya abin rufe fuska na iya taƙaita yawan tafiyar nesan tarwatsewar ɗigagga nufanshin waje a lokacin magana, atishawa, da yin tari.
Hukumar WHO ta ba da umarni kan yaushe da kuma yadda za a yi amfani da abin rufe fuskoki.
Bisa bayani kwararre a bangaren kwayar cuta a jami’ar Leeds Stephen Griffin sanya takunkunmin fuska na rake yiwuwar taba fusta da hannu wanda yin haka yana daga cikin manyan hanyoyin samun cuta matukar ba’a wanke hannu da kyau. “ Hakazalika an shawarci yin amfani da takunkumin fuska ga masu jinyar wadanda ke dauke da ciwon.
WHO Tana shwartar Sanya kariyar fuska ga masu lafiya in har suna daga cikin wanda ke iya fuskantar barazana, alal misali wanda ke kula da masu cutar COVID-19, duk da cewa sun amince da sanya kariyar fuska yana iya taimakawar mutane don hana su shafa fuskar su.
Kasashe Da Dama Sun Fara Daukaka Amfani Da Kariyar Fuska Ga membobin Al’umamn Su.
A cikin U.S., CDC ta ba da shawarar saka suturar fuska wanda ba na asibiti ba wacce aka yi da zane.China ta ba da shawarar musamman amfani da abubuwan rufe fuska wanda za a iya jefarwa ta hanyar wakilan jama'a masu lafiya, musamman idan suna cikin kusanci (1 mita (3 ft) ko lessasa da haka) ) da sauran mutane.
Hong Kong ta umarci da a sanya takunkumin fuska yayin shiga abun hawa kuma inda jama’a suka taru.
Ma'aikatan lafiyar Thailad suna kara karfafa mutane da su saka kariyar fuska a gida kuma su wanke su a kullum.
Jamhuriyar Czech da Slovakia sun hana fita a bainar jama'a ba tare da sanya abin rufe fuska ba ko rufe hanci da bakin mutum.
A ranar 16 Maris, Vietnam ta buƙaci kowa da kowa ya sanya abin rufe fuska yayin zuwa wuraren jama'a don kare kansu da sauran jama'a.
Gwamnatin Ostireliya ta ba da umarnin cewa duk wanda ya shiga kantin kayan miya dole ne ya sanya abin rufe fuska.
Israila Ta Umarci mazaunan ta Da a Sanya Kariyar Fuska Indan Zai Fito Cikin Jama'a.
Taiwan, wanda ke sakar Kariyar Fuska A Rana kusan guda milliyan Goma tun Tsakiyar watan Maris, Ta bukaci Fasanja a Jirgin kasa Da motoccin Haya Na Bas Da su sanya Kariyar fuska Daga 1 ga watan Afrilu.
Kasar Panama ta wajabta sanya takunkumin rufe hanci da baki ga ko wani dan kasa yayin fita waje. Ta bada shawarar na a sarrafa irin takunkumi na gargajiya idan babu halin siyan ainihin samfurin.
Akasarin mutane na amfani da takunkumin fuska a kasashen Japan da South Africa da Malaysia da Korea da kuma Singapore.
Nisantawar zamantakewa (wanda kuma aka sani da nesa da jiki) ya hada da ayyukan sarrafa kamuwa da cuta wanda aka yi niyya don rage yaduwar cutar ta hanyar rage kusancin tsakanin mutane.
matakai sun hadar da kebe kai, hana tafiye-tafiye, da rufe makarantu, da maaikatu, da filayen wasa, dandalin wasanni ko shagunan siyayya.
Mutane dayawa na iya amfani da hanyoyin nisanta daga jama'a ta hanyar kasancewa a gida, rage tafiye-tafiye, guje wuraren cunkoso, yi amfani da gaisuwa ba tare da wata ma'amala ba, da nisantar kansu daga wasu.
Yawancin gwamnatoci yanzu suna ba da izini ko bayar da shawarar nisantar jama'ar yankuna da cutar ta barke.
Mafi girman taro da hukumomin gwamnatin U.S da kungiyoyin lafiya suka saurin rage shi zuwa mutum 250 (idan har ba a samu yaduwar COVID-19 a yankin ba) zuwa mutum 50, daga bisani ma mutum 10.
"A ranar 22 Maris 2020, Jamus ta haramta haɗuwa da jama'a fiye da mutane biyu. Manyan manya da waɗanda ke da halayen kiwon lafiya kamar su ciwon sukari, ciwon zuciya, ciwon hanyar numfashi, hauhawar jini, da kuma tsarin jayyayar garkuwar jiki suna fuskantar haɗarin kamuwa da cutar rashin ƙarfi da rikice-rikice kuma sun kasance CDC ta shawarci su ci gaba da kasancewa cikin gida a duk lokacin da yankin ke barkewar cutar. A karshen Maris 2020, hukumar ta WHO da sauran bangarorin lafiya sun fara maye gurbin amfani da kalmar ""nisanta daga jama'a"" tare da ""nisantar jiki"", don fayyace cewa Manufar shine a rage yawan sadarwar jiki yayin da ake tsare haduwar jama'a, ko nesa gaske ko kusa."
Lakanin “Bayar da tazarar muamala” ya maye zukatan jama’a da killacewa baki daya ba tare da waiwaya baya wajen hulda da jama’a ta wata hanya daban. Hukumomi sun isar da shafuda jima’i masu amfani na kiwon lafiya yayin annobar.
Ciki akwai shawarar yin jima’i tare da wanda suka zamanto muhallin su daya kuma wanda/wacce ba’a samu kwayar cutar ko alamun ta a jikin su.
An shawarci masu dauke da cutar korona da su killace a gida tare da wadanda suke zaton sun kamu COVID-19 a sanadiyar su.
Hukumomin kiwon lafiya sun ba da cikakkun bayanai na yadda ya dace a kebance. Gwamnatocin da dama sun ba da umarnin ko bayar da shawarar keɓance kai ga dukkan jama'ar da ke zaune a yankunan da abin ya shafa.
An ba da umarni mafi ƙarfi na keɓancewar kai ga waɗanda ke cikin haɗarin mai karfi.
Wadanda watakila sun fallasa ga wani tare da COVID-19 da waɗanda suka tafi kwanan nan zuwa wata ƙasa ko yanki tare da watsawa masu yaduwa an shawarce su keɓe kansu na kwanaki 14 daga lokacin bayyanar ƙarshe.
Dabarun da ke cikin kula da barkewa sune garkuwa ko hanawa, da ragewa.
Ana gudanar da kokarin rage barkewar cutar a farko matakai da nufin ganowa da kuma ware wadanda suka kamu da cutar akazalika bullo da wasu matakan sarrafawar kamuwa da cutan da kuma rigakafin don hana yaduwar cutar zuwa sauran jama'a.
Lokacin da ba zai yiwu a iya ɗaukar yaduwar cutar ba, kokarin sai a matsa zuwa matakin ragewa: ana ɗaukar matakan rage jinkirin yaduwar cutar da kuma tasirin ta kan tsarin kiwon lafiya da al'umma.
Ana iya aiwatar da matakan kariya da ragewar cutan a lokaci guda.
Takaitawa na bukatar karin tsauraran matakai don sauya cutar ta hanyar rage lambar haifuwa ta asali da kasa da 1.Sashin gudanar da kamuwa da barkewar cutan na kokarin rage haurawar annoban, da aka sani da karkatar bakin hanyar annoban.
Wannan yana rage haɗarin ayyukan kiwon lafiya da ake fama da shi kuma yana ba da ƙarin lokaci don jinyar allurar rigakafi da jiyya.
Kariya wanda ba na magani ba wanda zai iya kare barkewar ta hada da matakan kariyar mutum, kamar, sanya abun rufe fuska, da kebewar kai; matakai na al’uma da nufin nisantar jiki kamar rufewar makarantu da hana babban taruka; hadin kan al’uma don karfafa karbuwa da gudanarwa a iri wadanan kariya; har da matakan yanayi kamar tsaftacewar saman ababe. An dauki ayyukan da aka yi niyya sosai domin rage barkewar cutan a China lokacin da tsananin barkewar ta bayyana a sarari, kamar kebewar dukan birane da  tilasta dokar hana tafiye-tafiye.
Wasu kasashen suma sun dau matakai da dama waje rage yaduwar cutar.
Koriya ta Kudu ta gabatar da gwaje-gwaje na taro da kuma keɓewa ta gida, tare da ba da sanarwar faɗakarwa game da ƙungiyoyin masu cutar.
Singapore ta ba da tallafin kudi ga wadanda suka kamu da kebe wadanda suka kebe kansu tare da sanya babbar asara ga wadanda suka kasa yin hakan.
Taiwan Ta Kara Yawan Hada Kariyar fuska Tare Da Hukunta Masu Boye Kayan Kiyon Lafiya. Matakan Kasar Birtania Da Na Kasar Amurka Na Nuna Yanayin (raguwan annoba Amman Ba a Hana Yaduwar ba) Da Ma Rage (Juya yaduwar annoba) Na Da manyan Matsaloli.
Tsarin rage kaifin cutar na iya haddasa raguwar bukatun harkokin lafiya zuwa 2/3 da kuma mace-mace zuwa rabi. Hakazalika tana iya haifar da mutuwa daruruwan dubbunan mutane tare da fin karfin tsare-tsaren kula da lafiya.
An fiye amfani da mataki na dannewa har tsawon lokaci da kwayar cutar ke yawo a jikin dan Adam (Ko kuma har sain an samu rigafi) domin yaduwa na iya canza salon ta yayi da aka sassauta matakin.
sa baki na dogon lokaci don kashe cutar na haifar da tsadarna zamantakewa da tattalin arziƙi.
Babu tabbatacciyar magani dake yakar kwayar cutar COVID-19 amma har yanzu ana yunkurin ganowa cikin yunkurin da ake akwai gwajin magunguna da aka riga aka sarrafa.
Shan magani da yawan shan abu mai malala tare da hutawa na iya taimakawa wajen rage girman alamomin ciwon.
Ya danganta da tsananin ta ana iya bukatar jinya ta hanyar iskar Oxygen da shigar sinadarin ruwa ta hanyar bututun jini tare da kuma shakar iska.
Yin amfani da magungunan steroids na iya tsanantar sakamako.
Yawancin mahadi waɗanda aka yarda da su don maganin wasu cututtukan gama gari ana bincikarsu don amfani da su wajen jinyar COVID-19.
WHO ta kara da cewa wasu maganin gargajiya na iya sassauta alamu da SARS-COV-19 ke haifarwa.
ingizawa tare da bayar da sauya tsarin kiwon lafiya domin biyan bukatar mara lafiya mai fama da ciwon COVID-19 ta kasance gaggarumi mataki na gaggawa kamar yadda WHO ta bayyana.
ECDC da ofishin yanki na Turai na WHO sun ba da jagororin asibitoci da sabis na kiwon lafiya na farko don canza albarkatu a matakan da yawa, ciki har da sabis na dakin gwaje-gwaje zuwa gwajin COVID-19, soke hanyoyin zaɓe a duk lokacin da zai yiwu, kebanta da ware marasa lafiya masu COVID-19, da haɓaka ƙarfin kulawa mai zurfi ta hanyar horar da ma'aikatan da kuma ƙara yawan wadatattun masu ba da iska da gadaje.
Akwai ra’yi da Dama Akan inda Cutar ta fara (ainahin Mai Dauke Da Ita) Wanda Ta Bulla Daga Wajen Shi.
Maganar farko da aka santa da cutar Coronavirus ana iya gano ta zuwa 1 ga Disamba 2019 a Wuhan, Hubei, China.
A tsakanin wata daya, yawan cututtukan coronavirus a Hubei sannu a hankali ya ƙaru.
Wadannan galibi ana alakanta su da Kasuwar Kayan Ruwan Huanan, wanda shima ya sayar da dabbobi masu rayuwa, kuma wata ka'ida ita ce cutar ta fito ne daga ɗayan nau'ikan dabbobi; ko, a takaice dai, yana da asalin zoonotic.An lura da tarin nimoniya wanda ba a sani ba a ranar 26 ga Disamba kuma likitan Zhang Jixian ya bayyana a Asibitin lardin Hubei, wanda ya sanar da CDC na Wuhan Jianghan a ranar 27 ga Disamba.
A Ranar 30 ga Watan December, wata Kungiyyar likitoci A Asibitin Tsakiyyar Wuhan Sun Sanar Da Abokan aikin Su Akan “coronavirus mai kamar da-SARS.
'Yan sanda sun kama takwas daga cikin likitocin, ciki har da Li Wenliang, saboda yada jita-jitar karya, sannan wasu manyan jami'anta, Ai Fen, sun tsawata mata game da batun kararrawa.
Hukumar lafiya na alkaryar Wuhan daga baya ta sanar da jama’a ranar 31 ga watan Disemba tare da bayana ma hukumar WHO.
An bada rahoton yanayin da ba a ganewa ba da dama ga hukumomin kiwon lafiya a Wuhan don haifar da bincike a farkon watan Janairu. A yayin farkon lokacin barkewar cutar, adadin cutar yana ninka kamar kowace kwana bakwai da rabi a takaice.
A farkon da tsakiyar Janairu na 2020, cutar ta bazu zuwa wasu lardunan kasar Sin, da yin amfani da Sabuwar kasar Sin da Wuhan su zama tashar sufuri da kuma babbar musayar layin dogo.
A ranar 20 ga watan Janairu, kasar Sin ta ba da rahoton sabbin masu kamu da cutar kusan 140 a cikin kwana guda, wadanda suka hada da mutane biyu a nan Beijing da kuma daya a Shenzhen.
Bayanai daga baya sun nuna cewa mutane 6,174 sun kamu da alamun cutar a ranar 20 ga Janairu 2020. Tun daga ranar 26 ga Maris, Amurka ta mamaye China da Italiya tare da mafi yawan adadin lokuta da aka tabbatar a duniya. A cikin 9 Afrilu 2020, an bayar da rahoton fiye da miliyan 1.61 a duk duniya; mutane fiye da 97,000 sun mutu kuma sama da 364,000 sun murmure.
Akalla a samun mutum daya wanda ya kamu da cutar a kasashe 200 da yankuna.
Saboda Annobar dake Europe, Kasahe da Dama dake karkashin Tsarin Schenghen sun Takaita Zirga-zirga domin Samar da Doka A Iyakokin.
Tunanin kasa ya hada da matakain ragewar cutan kamar kebe mutane don samun (wato umurnin zaman gida, wajajen mafaka, ko ma rufe gari) da ma dokar ta baci. A ranar 2 ga watan afrillu kusa mutane milliyan 300, ko kimanin kashi 90% na alumma, na kar kashi wata irin doka ta kulle a kasar amurka, fiye da mutane milliyan 50 na kulle a kasar phillipines, kusan mutane milliyan 59 na kulle a kasar africa ta kudu, da mutane billiyan 1.3 na fuskantar kulle a kasar india.
26 ga watan Maris, mutane biliyan 1.7 a duk duniya sun kasance a cikin wasu nau'ikan kullewa, wanda ya karu zuwa mutane biliyan 2.6 a cikin kwana biyu - kusan kashi ɗaya cikin uku na yawan jama’ar duniya.
Mutumin Farko Da Aka samu Da Cutar COVID-19 An Bibiya Shi ranar 1 ga Watan December Na 2019 a Wuhan; A Wani Rahoto Mara Tabbaci An Ce Na Farokon Tun 17 ga Watan Nuwamba.
Likita Zhang Jixian ya lura da lura da taruwar alamar pneumonia mara asali wanda a 26 ga watan Disemba. Samun haka ya sanya asibitin ta ya sanar da hukumar dakile cututtuka masu yaduwa ta Wuhan Jianghan a ranar 27 ga watan Disemba.
Gwajin Masarrafar kwayar hallita na farko na mara lafiya aka gudanar a 27 ga watan Disemba na 2019 ya nuna kasancewar kwayar cuta mai kama da SARS coronavirus.
An fitar da Sanarwa ta Jama'a baki daya daga Hukumar Lafiya na Wuhan A ranar 31 ga watan Disamba.
An sanar da hukumar lafiya na duniya (WHO) a ranar.
"Yayin da waɗannan sanarwar suka faru, 'yan sanda sun gargaɗi likitocin Wuhan game da ""yada jita-jita"" game da barakar."
Hukumar lafiya ta kasar China a farko tayi ikirari cewa babu tabbaciyar matsaya na kamuwa tsakanin Mutum zuwa wani.
"A karshen watan Janairu, gwamnatin kasar Sin ta bullo da wani shiri na daga baya wanda babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping ya bayyana a matsayin ""yakin mutane"" don shawo kan yaduwar cutar."
"A Abun da aka kimanta da Mafi Girman Kebe Alumma a Tarihin bil adama"",a Cordon sanitaire an Sanar A Ranar 23 gawatan Junairu Hana tafiye-tafiye a Ciki da Wajen Wuhan, Wanda Bisani Aka Kara Da birane 15 a Hubei, Wanda ya Shafi mutane kimanin Miliyan 57."
An hana amfani da motoci mutane a cikin birni.
An soke bikin Sabuwar shekarar kasar Sin (25 Janairu) a wurare da yawa.
Mahukuntan sun kuma ba da sanarwar gina wani asibiti na wucin gadi, asibitin Huoshenshan, wanda aka kammala cikin kwanaki 10.
An kara gina wata asibitin bayan haka,  Asibitin Leishenshan, za su kula da karin marasa lafiya.
Kari da sabbin asibitocin da aka gina, Sin ta mayar da wasu cibiyoyi 14 a Wuhan, kamar wuraren taron gasa da filin wasa, zuwa asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnatin ta kafa wasu matakai don dakile barkewar COVID-19, gami da bayar da sanarwar lafiyar matafiya da kuma tsawaita lokacin bikin bazara.
Jami'oi da makarantu a fadin kasar suma a kulle suke.
Yankin Hong Kong da Macau sun dau matakai musamman na dangane da makarantu da jami’o’i.
An bullo da matakan aiki da yawa a yankuna da yawa na kasar Sin.
A Saka ƙuntatawa Akan tafiye-tafiye A Ciki da wajen Hubei.
An canza fasalin safarar jama’a tare da kulle wuraren tarihi na takaitaccen lokaci a China.
"An yi amfani da ikon motsi a cikin birane da yawa, kuma an kiyasta cewa kimanin mutane miliyan 760 (sama da rabin yawan jama'a) sun fuskanci wani nau'in dokar hana fita daga waje. Bayan barkewar cutar ta shiga matsayinta na duniya a watan Maris, hukumomin kasar Sin sun dauki tsauraran matakan. hana cutar daga ""shigo da"" daga wasu ƙasashe."
Misali, birnin Beijing ya sanya dokar hana fita ta kwanaki 14 ga duk matafiya na duniya da suka shiga cikin birnin. A ranar 23 ga Maris, babban yankin kasar Sin daya ne ya ba da izinin shiga cikin gida a cikin kwanaki biyar da suka gabata, a wannan hanyar ta hanyar matafiyi da ya dawo Guangzhou daga Istanbul.
A ranar 24 ga watan maris 2020, Firimiyar Sinawa Li Keqiang ya bada rahoto cewa an toshe yaduwar kamuwa da cutan da kuma an lura da barkewar a China.
A wannan rana an sassauta dokar hana zirga-zirga a Hubei, ban da Wuhan, watanni biyu bayan da aka sanya takunkumin. Ma'aikatar Harkokin Wajen China ta sanar a ranar 26 ga Maris 2020 cewa, za a dakatar da shigo da visa ko kuma masu ba da izinin zama daga ranar 28 ga Maris din nan, tare da babu takamaiman bayanai kan lokacin da wannan tsarin zata ƙare.
Masu bukatar shiga kasar China zasu bukaci takardar izinin zama a offishin jakadancin China.
Gwamnatin kasar Sin ta karfafawa 'yan kasuwa da masana'antu damar sake budewa a ranar 30 ga Maris, tare da samar da kayan tallafin kudi don kamfanonin.Gwamnatin kasar ta ba da sanarwar ranar juyayin da za a fara daga wani yanayi na mintuna uku na kasa da karfe 10:00 4 ga Afrilu, a hade tare da bikin Qingming, kodayake gwamnatin tsakiya ta nemi iyalai don biyan bukatunsu ta hanyar layi don kiyaye damuwa ta jiki kamar gujewa sake bullar cutar COVID-19.
An tabbatar da cewa COVID-19 ya bazu zuwa Koriya ta Kudu a ranar 20 ga Janairu 2020 daga China.
Hukumar kula da lafiya ta kasar ta bayar da rahoton karuwar wadanda suka tabbatar a ranar 20 ga watan Fabrairu, wanda aka danganta shi da wani taro a Daegu na wani sabon darikar addini da aka sani da Cocin Shincheonji na Yesu.
Masu bautar Shincheonji da ke ziyartar Daegu daga Wuhan ana zargin su ne asalin barkewar.
Har zuwa ranar 22 ga watan Fabrairu, tsakanin mabiya cocin 9,336, 1,261 ko kusan 13% sun ba da rahoton alamu cutar. Koriya ta Kudu ta sanar mataki mafi girma a ranar 23 ga watan Fabrairu 2020.
An samu rahoton tabbutuwar mutum sama da 2,000 da suka kamu da cutar a ranar 28 ga watna Febreru a kasar Korea sai dai kuma adadin ya karu zuwa 3,150 a ranar 29 na watan.
An killace ko wani mazaunin rundunar soja nan kasar Korea ta kudu bayan labarin tabbatuwar sojoji uku da suka kamu da cutar.
An kuma shafi tsarin jigilar sufurin jiragen sama kuma saboda haka an canza su.South Korea ta gabatar da abin da ake ganin shi ne mafi girma kuma mafi kyawun tsari a duniya don duba yawan mutanen da ke dauke da kwayar cutar, da kuma ware duk wani da ya kamu da cutar da kuma gano wadanda suka tuntube su. .
Hanyar gwajin ya kunshi kai kara na dole na nuna alamu daga baki masu shigowa daga kasar waje ta hanyar na’urar waya. Akwai kuma gwajin bi-ta-mota wanda ana iya samun sakamakon ta washe gari. Bugu da kari wani daga cikin hanyoyin shine yin Kari ga yawan mutanen da ake iya gwadawa zuwa 20,000 a ko wace rana.
Ana ganin shirin Koriya ta Kudu a matsayin nasara a cikin saraffawa barkewan duk da yake ba a kebe biranen baki daya ba. Tun farko dai an ba da izini ga jama'ar Koriya ta Kudu game da martanin Shugaba Moon Jae-in game da rikicin cutar.
‘Yan Koriya da yawa sun sa hannu a takarda ko dai suna kiran a tsige Moon saboda abin da suka ce suna yi wa gwamnati ɓarnar barkewar, ko kuma yabon da ya yi.
A ranar 23 ga Maris, an ba da rahoton cewa Koriya ta Kudu ce ke da mafi karancin masun kamu da cutar kwana ɗaya a cikin makwanni huɗu.
A ranar 29 ga watan Maris an bada rahoton cewa daga ranar 1 ga watan Afrilu za a kebe sababin baki na tsawon sati biyu.
A kowace rahoton kafofin watsa labarai a ranar 1 ga Afrilu, Koriya ta Kudu ta sami buƙatu na taimako na gwajin ƙwayar cuta daga ƙasashe 121 daban-daban.
Iran ta bada rahoton mutumin ta na farko da ya kamu da cutar SARS-COV-2 a ranar 19 ga watan Faburairu a qom, inda, a cewar hukumar lafiya da ilimin lafiya mutum biyu sun mutu da yammacin wannan rana.
Matakan Farko Da Aka Sanar Na Gwanati ya Hadar Da Hana shagali da Ma Tarukan Gargajiyya, Wassani Da Sallar Juma'a, Dama Rufe Jami'oi,Da Makarantun Cigaba da ilimi, Da Makarantu.
Iran sun ware kudi tiriliyan biyar don yakar wannan cuta.
Shugaba Hassan Rouhani Yace A ranar 26 ga Watan Faburairu 2020 cewa Basu Shirya Kebe Bangaren Da Barkewar Ta Shafa ba, Cewa za a kebe mutane ne kawai
An ba da sanarwar takaita zirga-zirga tsakanin biranen cikin watan Maris, kodayake an sami cunkoso mai yawa tsakanin garuruwa gabanin Sabuwar shekarar Nowruz ta Farisa.
Hubbaren yan akidar Shia dake Qom na bude ne har zuwa 16 ga watan Maris 2020. Kasar Iran ta kasance cibiyar yaduwar kwayar cutar bayan China a cikin watan Febreru.
A yayin da ake zargin boye labari game da girman barkewar cutar a kasar Iran, fiye da kasashe goma sun gano tushen barkewar a kasarsu zuwa Iran a ranar 28 ga watan Febreru. Tare da nuna cewa girman barkewar na iya haurawa tare da yin tsananin fiye da mutum 388 da gwamnatin Iran ta bada rahoto a daidai wannan lokacin.
An rufe majalisar dokokin Iran, a bisa samu yan majalisar guda 23 cikin membobi 290 rahoto ta nuna su na dauke da cutar bayan gwaji a ranar 3 ga watan Maris.
A ranar 12 ga watan Maris, kungiyar kare hakkin bil adama wato Human Rights Watch ta bukaci hukumomin gidan yari na Iran da su saki masu kariyar hakkin jama’a wanda aka tsare yayin da suke zanga-zangar lumana, kuma da su saki dukkan yan firsina da suka dace.
Sanarwar na nuna cewa akwai hatsari babba wajen yaduwar kwayar cutar a wurare kamar gidajen kaso wanda kuma basu da isasshen kulawar magani.
A 15 ga watan Maris gwamnatin Iran ta kawo rahoton mutuwar mutane 100 a rana daya wanda shine mafi yawa da aka samu a kasar tun barkewar cutar.
Aƙalla jami’an yanzu 12 ko tsoffin yan siyasa na Iran da kuma jami'an gwamnati sun mutu daga cutar daga ranar 17 ga watan Maris.
A ranar 23 ga watan Maris, Iran na zaton mutane 50 sabbi suna kamu da cutan coronavirus da ma sabuwar mutuwa a kowanne mintuna goma.
A fadin jami’in hukumar WHO, ana iya samun labarin wadanda suka kamu da cutan cikin Iran fiye da rahoton da a ke kawo wa.
Anyi nazari cewa ladabtarwa da Amurka ke nuna ma kasar Iran yayi sanadiyar rage karfin kudin ta wajen yaki da annobar.
Babban Jami'in kare Hakkin Dan Adam na Majalisar Dinkin Duniya wato UN High Commission for Human Rights ya bukaci a sassauta takunkumin tattalin arziki ga kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da barkewar cutar zuwa Italiya a ranar 31 ga Janairu, lokacin da wasu 'yan yawon bude ido biyu na China suka gwada inganci ga SARS-CoV-2 a Rome.
Yaduwar tana ta hawowa wanda hakan yasa gwamnatin Italiya ta hana dukan jirage daga China sauka ko zuwan China ta kuma saka dokar ta baci.
Bangarori Marasa Haduwa Na Cutar COVID-19 Sun gano cutar Daga baya, an Fara Da Mutum 16 a Lombardy a ranar 21 ga Watan Faburairu. A Ranar 22 ga Watan Faburairu, Majalissar Ministoci Ta Fitar Da Sabuwar Doka Don Shawo Kan Barkewar, Ciki Harda Kebe Mutane guda 50,000 daga Sassa daban-daban guda Na Yankin Arewacin Italiya.
Firayam Minista Dokiki Glueseppe Conte Yace, “a yankunar yaduwar Cutan, ba za a bada izinin shiga ko fita ba.
Hana yin aiki dama wassani aka saka a wuraren a rananr 4 ga watan maris, gwamnatin italia ta kafa dokar rufe makarantu da ma jami’oi duk kasa sanidiyyar isa mace-mace guda 100.
Mafi yawancin masannin motsa jiki ciki har da Firemiyar kwallon kafa ta serie A an tsara su ne da su gudana ba tare da ma’abota masu kallo har zuwa watan Afrilu. Sai dai a 9 ga watan Maris an kaddamar da mataki na hana ko wani irin wasan motsa jiki na karancin tsawon wata guda.
11 ga watan Maris Firaiminista Conte ya bada umarni na a tsayar da kasuwanci banda shagunan dake siyar da kayan masarufi da shagunan magani. A 6 ga watan Maris Kwalejin magani ta wallafa ka’idoji na kiwon lafiya ciki ta bada shawara game da matakai da za’a iya aiki dasu.
A ranar 19 ga Maris, Italiya ta mamaye China a matsayin kasar da ta fi yawan kamuwa da cutar kwayar cuta a duniya bayan ta ba da rahoton mutane 3,405 daga annoban.
A 22 ga watan Maris rahoto ya nuna cewa Russia ta tura jiragen yaki guda tara dauke da kayan kiwon lafiya zuwa kasar Italy.
Ya zuwa ranar 5 ga Afrilu, akwai mutane 128,948 da aka tabbatar da cutar, 15,887 ne suka mutu, sannan 21,815 suka warke a Italiya, inda akasarin wadanda ke faruwa a yankin na Lombardy.
A wani rahoton CNN ya nuna cewa hadi da yawan dattawa a kasar Italiya da ma rashin samun yin gwajin ke haifar da yawan mace-macen da ake samu har ila yau a kasar.
Martanin da Birtaniya ta dauka game da kwayar cutar ta fara bayyana a matsayin daya daga cikin annashuwa daga kasashen da cutar ta shafa, kuma har zuwa 18 Maris 2020, gwamnatin Burtaniya ba ta sanya wani nau'in walwala na jama'a ko matakan tsarewa a gida kan 'yan kasarta ba.
A Sakamakon Haka, Gwanatin Ta Sha Suka Wajen Nuna Rashin Matsantawa Da Kula Akan Yanda Ta Dauki Damuwar Dake Alummar Ta. A Ranar 16 ga Watan Maris, Shugaban Majalissa Boris Johnson Ya Bada Sanarwa Akan Shawartar Tafiye-tafiye Marasa Dalili Da nesantar huldawa, Da bada shawarar Kowa Yayi Aiki Daga Gida In Da Hali Da Ma Gujewa Wuraren Shakatawa, Wurin Cin Abinci Dama Wajen Wassani.
A ranar 20 ga Maris, gwamnati ta ba da sanarwar cewa dukkanin cibiyoyin shakatawa kamar mashaya da wararen motsa jiki za su rufe da wuri, kuma ta yi alkawarin biyan kusan kashi 80 na albashin ma’aikata zuwa iyakokin £ 2,500 ko wace wata don hana rashin aikin yi a rikicin. A ranar 23 ga watan Maris, Firayim Minista ya ba da sanarwar daukar matakai masu nisantar da jama'a, da hana hadarin mutane sama da biyu da kuma takaitawar tafiye-tafiye da ayyukan waje zuwa abin da ake zaton ya zama tilas.
Ba kamar matakan baya ba, wannan dokokin na da tabbaci daga wajen yan sanda ta hanyar cin tara, dama wargata taruka.
"An ba da umarnin rufewar mafi yawan kasuwanai, ban da keɓaɓɓun kasuwancin da aka ɗauka ""mahimmanci"", ciki har da manyan kantuna, kantin magani, bankuna, kantuna kayan masarufi, gidajen mai, da kuma gareji."
A ranar 20 ga Janairu, an tabbatar da sanannen COVID-19 a cikin jihar Pacific ta arewa maso yamma a cikin wani mutumin da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rundunar tsaron Coronavirus ta White House a ranar 29 ga Janairu.
A ranar 31 ga watan Janairu, gwanati karkashin jagorancin Trump sun shellar matsalar lafiyar jama'a, da ma ƙuntatawa kan tafiye-tafiye na shigan kasa daga China.
A ranar 28 ga watan Janairu 2020, hukumar dake dakile cututtuka masu yaduwa na kasar Amurka wanda kuma shine ke kan gaba a ma’aikatun lafiya na gwamnatin kasar ta sanar cewa an samar da nata na’urar gwaji.
Duk da yin hakan, U.S. tana da jinkirin fara gwaji, wanda ya tona asirin gaskiyar cutar a lokacin.
An lalata gwajin da kayan gwaji wadanda suka baci wanda gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar Gwamnatin Tarayya na kayan aikin gwajin da ba na gwamnati ba (ta makarantu, kamfanoni da asibitoci) har zuwa karshen Fabrairu, da kuma ka'idojin hana mutane damar cancanci gwaji har zuwa farkon Maris (kuma ana buƙatar umarnin likita bayan haka).
A rananr 27 ga watan faburairu, Washington Post walafa rahoton gwajin mutum kasa da 4,000 wadanda aka yi a U.S.
Zuwa 13 Maris, Atlantika ya ba da rahoton cewa ba a gudanar da gwajin ƙasa da 14,000 ba.
A ranar 22 ga Watan Maris, gammayyar Yan Jarida wato Associated Press Sun Yi Rahoton: “Mutane Da Dama Wadanda Suna da alamun rashin lafiya sun jira sa’oi ko kwanaki Domin Gwajin Su daga umurnin likita. “Bayan mutuwar Farko Da Aka samu A Birnin Washington a ranar 29 ga Watan Faburairu, Gomna Jay Inslee Ya Kafa dokar Ta baci, Wanda Bisani Wasu jahohin Ma Suka Bi Sahu.
Makarantun da ke yankin Seattle sun soke azuzuwan a ranar 3 Maris, kuma a tsakiyar Maris, makarantu a duk faɗin ƙasar suna rufe.On 6 Maris 2020, an shawarci Amurka game da tsinkaya game da cutar sabon coronavirus a cikin kasar daga wasu gungun masana masu cutar cututtukan dabbobi a Kwalejin Imperial London.
A rana daya shugaban kasa Trump ya rattaba hanun kan Dokar shirye-shiryen da Martani Amincewar Kari, wanda zai bada kudi kimanin biliyan $8.3 na kai agajin gaggawa ga hukumomin kasa domin martani ga barkewar cutan.
Masana’antu sun sanya dokar hana tafiye-tafiye da soke taruka, da ma sanya ma’aikata su yi aiki daga gida.
An soke al'amuran wasanni da yanayi.Da ranar 11 ga Maris, Trump ya ba da sanarwar hana tafiye-tafiye mafi yawan Turai, ban da Burtaniya, na kwanaki 30, mai tasiri 13 Maris.
Washe Gari Ya Fadada ƙuntatawa Zuwa kasar Ingila da ma ireland.
Ya kaddamar da dokar ta baci a ranar 13 ga watan Maris wanda yin haka ya bada damar samun kudin takaita tsananin annobar.
Tun daga farkon 15 ga watan Maris yawanci kasuwanni sun rufe wasu kuma sun takaita lokutan budewa a fadin Amurka. Wannan na daga cikin matakin rage yaduwar kwayar cutar.
Daga ranar 17 ga Watan Maris, an sami tabbacin Annoban a Jahohi Guda 50  da gundumar Colombiya. A ranar 23 ga Watan Maris, An Fidda Rahoton Cewa Birnin New York Na Da mutum 10,700 wadanda su Ke Dauke da Cutar coronavirus, Fiye Da Yawan lamban masun cutar a Koriya ta Kudu.
A ranar 25 ga watan Maris, gwamnan ya ce an cimma nisantawar jama'a, yadda kimanin yaduwar cutan wanda ya hau yana fadiwa daga kwanaki 2.0 zuwa 4.7.
A 28 ga wtaan Maris an tabbatar da kamuwar mutum 32,308 a birnin New York kuma mutum 672 sun mutu sanadiyar kwayar cutar. A 26 ga watan Maris rahoto ya nuna cewa Amurka ta samu karin yawan mutane da suka kamu da cutar coronavirus fiye da sauran kasashen duniya ciki har da China da Italy. A ranar 8 ga watan Afrilu an samu tabbacin wadanda suka kamu da cutar su 400,335 a Amurka kadai yayin kuma mutum 12,841 suka rasu.
A gameda rahoton yan jarida na ranar 30 ga watan maris shuga Trump na anurka ya kara wa’adin dokar bada tazara zuwa 30 ga watan afrilu.
A wannan ranar, USNS Comfort, jirgin ruwan asibiti da ke da gadaje 1000, ya zama jagora a New York.
A ranar 3 ga watan Afrilu, Amurka ta sami rikodin mutuwar 884 sakamakon ƙwayar cuta a cikin sa'o'i 24.
A cikin jihar New York masun kamu da cutan sun ninka mutane 100,000 a ranar 3 ga Afrilu. An soki fadar White House saboda yin watsi da barazanar da kuma sarrafa sakon ta hanyar umarni jami'an kiwon lafiya da masana kimiyya don tsara bayanan jama'a da wallafe-wallafen da suka shafi cutar tare da ofishin Mataimakin Shugaban Mike Pence.
Gabaɗaya amincewar da gwamnatin Trump ta yi game da rikicin ya kasance an ba da izini ta hanyar ɓangarori daban-daban.
Wasu jami'ai da masu sharhi a U.S. sun yi sokin kasashen U.S. kan shigo da wasu kayan masarufi, gami da kayayyakin kiwon lafiya masu mahimmanci, daga kasar Sin.
Anyi amfani da bayanai na tafiya ta hannyar iskar sama wajen samar da taswira tare da yin hasashe kan yaduwar ta. An wallafa hakan ne a mujallar “The journal of Travel Medicine” na watan Janairu na shekarar 2020.
Dangane da bayanin 2018 daga Kungiyar Duniya Haɗin Jigilar Jirgin Sama wato Internation Air Transport Association Bangkok, Hong Kong, Tokyo, da Taipei suna da mafi yawan matafiya daga Wuhan.
Dubai, Sydney, Da Melbourne Suma Suna Cikin Rahoton Da Ke Cewa Wajen Zuwa Mutanen Da Suka Taho Daga Wuhan.
Birnin Bali shine mafi karanci ta fuskar shiryawa cikin jerin birane 20 da suka shahara a duniya yayin da birane a kasar Australia suka zamanto mafi shiryawa. Kasar ta fitar da tsarin bada agajin gaggawa na COVID-19 a ranar 7 ga watan Febreru.
Ya ce har yanzu ba a gano abubuwa da yawa game da COVID-19 ba, kuma Australiya za ta jaddada ikon kan iyaka da sadarwa a cikin martanin ta game da cutar.
A ranar 21 ga watan Maris an kaddamar da mataki na gaggawa na tsaron halittu nan kasar Australia.
Duk da samun tasirin kebe kai a motocin haya a wuhan da hubei, kasashe da dama sun shirya kwashe yan kasar su da ma’aikatan jakadancin su da ga bangaren, da fari ta hanyar shattar jiragen kasa, tare da hukumomin china su bada izinin fita.
Kanada da kasar amurka, japan, india, sri lanka, austrailia, fransa, argentina, jamus, da thailad su na daga cikin kasashen farko da suka tsara kwaso yan kasar su.
Pakistan tace baza ta fitar da yan kasar ta dake nan kasar China.
A ranar 7 ga watan Fabrairu, Brazil ta kori 'yan kasar Brazil 34 ko kuma wasu dangin ban da ‘yan folan huɗu, mutumin China, da kuma Ba’indiya.
Yan kasar Poland da China da India sun sauka daga jirgi a nan kasar Poland yayin da jirgin su wanda asalin masaukin ta Brazil ne ya tsaya domin hutawa.
‘Yan Kasar Brazil Wanda Suka je Wuhan An Kebe Su A Wani Sansanin Soja Kusa Da Brasillia.
A Rana daya, mutanen Kanada guda 215 (176 daga Jirgin Farko, da 39 daga Jirgi na Biyu Wanda Gwamnatin U.S. Ta Yi Shattar sa) An Fitad da Su Daga Wuhan Zuwa Sansanin Trenton CFB Don Kebe Su zuwa Sati Biyu.
Ranar 11 ga watan Febreru wani jirgi dake dauke da yan kasar Canada guda 185 daga birnin Wuhan ya sauka a filin jirgi na CFB Trenton.
Ma’aikatan Australia sun kubutar da yan kasar su 277 tsakanin ranar 3 da 4 na watan February zuwa tsangayar Christmas Island wanda aka gyara musamman domin killace jama’a. an killace su har tsawon kwana 14.
Wani jirgin tashi daga New Zealand ya isa Auckland a ranar 5 ga Fabrairu; Fasinjojinsa (ciki har da wasu daga Australia da Pacific) an keɓe su a wata tashar jirgin ruwa a Whangaparoa, arewacin Auckland.
A ranar 15 ga watan Febreru gwamnatin Amurka ta sanar cewa zata kubutar da yan kasar ta hanyar babban jirgin ruwa na Diamond Princess.
A ranar 21 ga Fabrairu, wani jirgin sama dauke da fasinjojin Kanada 129 wadanda aka kora daga Diamond Princess sun sauka a Trenton, Ontario.
A Farkon Watan Maris, gwamnatin India Ta Fara Kwashe Yan Kasar Daga Iran. A 14 ga Watan Maris, Jirgin Afifrka ta Kudu Wanda Gwamnatin Afirka ta KuduS Tayi Shatta Ta Kwashe Mutanen Guda 112.
Anyi gwajin likita kafin tashi, kuma 'yan Afirka ta Kudu hudu wadanda ke nuna alamun cutar Coronavirus an bar su a baya don rage haɗarin.
Yan kasar Afrika ta kudu da ba’a tabbatar da sun kamu da cutar aka mayar gida.
Sakamakon gwaji ya share dukkan 'yan Afirka ta Kudu, ciki har da ma’aikatan jirgi, matukan jirgi, ma’aikatan otal, ‘yan sanda da sojoji da ke da hannu a aikin agaji wadanda, a matsayin matakin kariya, dukkansu suna cikin kulawa kuma suna kebewa na tsawon kwanaki 14 a Ranch Resort.
A ranar 20 ga Maris, Amurka ta fara cire dakarunta daga Iraki sakamakon kamuwa da annoban.
A ranar 5 ga Fabrairu, ma'aikatar harkokin waje ta kasar Sin ta bayyana cewa, kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Egypt, da Iran) sun aika da taimako ga kasar Sin.
Wasu daliban Sinawa a jami'o'in Amurka sun hadu tare don taimakawa kan aika da taimako ga sassan kasar Sin da kwayar cutar ta kashe, tare da wata rukunin hadin gwiwa a cikin babban yankin Chicago da aka bayar da rahoton cewa za su tura mashin 50,000 na N95 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu. Kungiyar ba da agaji ta jin kai ta kai tsaye, tare da hadin gwiwar FedEx, sun tura kayan rufe fuska 200,000 tare da sauran kayan kariya na sirri, gami da safofin hannu da kayan kwalliya, ta hanyar saukar jiragen sama na gaggawa zuwa Asibitin Wuhan a ranar 30 ga Janairu.
A rananr 5 ga watan Faburairu, Bill da Melinda Gates sun sanar da tallafin millyan $100 ga WHO don samar da magani da waraka da ma kariya a alummar africa da kudancin asia wanda ke fuskantar barazanar cutar,
Interaksyon Sun bada Rahoton Cewa Gwamnatin Sinawa Sun Kai Tallafin Kayan Kariyar Fuska Guda 200,000 Zuwa Ga Philippines A Ranar 6 ga Watan Faburairu, Bayan Sanata Richard Gordon Ya Kai Kayan Kariyar Fuska Guda Milliyan 3.16 Zuwa Wuhan.
A ranar 19 ga watan febrairu, kungiyar agaji ta Red Cross ta kasar Singapore ta ba da sanarwar cewa, za ta aika wa kasar Sin taimakon miliyan 2.26.
Kasar Japan ta ba da abin rufe fuska miliyan daya ga Wuhan, Turkiyya ta tura kayan aikin likita, Rasha ta tura kayan agaji sama da tan 13 ga kasar Wuhan, Malaysia ta sanar da ba da gudummawar safar magunguna miliyan 18 ga kasar Sin, kasar ta Jamus ta ba da kayayyakin jinya daban-daban ciki har da rigar Hazmat 10,000, da kuma Kasar Amurka ta bayar da gudummawar tan ton 17.8 na kayayyakin kiwon lafiya ga kasar Sin, kuma ta yi alkawarin karin dala miliyan $100 na tallafin kudi ga kasashen da abin ya shafa.Bayan da yanayin da ake ciki a kasar Sin da alama ya daidaita, kasar tana ta aike da taimako zuwa ga kasashe daban-daban da suka kamu da annoban.
A Watan Maris, China, Cuba, Rasha Sun Tura Kayayyaki da Maiakatan Lafiya Don Taimakawa Italiya Shawo kan yaduwan Cutar Coronavirus.
Dan kasuwa Jack Ma ya aika da kayan gwaji miliyan 1.1, abin rufe fuska miliyan 6, da kuma rigar kariya 60,000 zuwa Addis Ababa, Habasha domin Kungiyar Tarayyar Afirka ta rarraba.
Daga baya ya tura kayan gwaji 5000, abin rufe fuska 100,000 da kuma na’uran bada iska guda 5 zuwa Panama.
Ma ya ba da gudummawar magunguna ga Kanada.The Netherlands, Spain, Turkiya, Georgia, da Czech Republic sun nuna damuwarsu game da abubuwan rufe fuska da na'urorin gwaji.
Spain ta janye na’urar gwajin coronavirus guda 58,000 kirar kasar China wanda sahihancin ta ya tsaya 30%. Kasar Netherland kuma ta mayar da takunkumin fuska guda 600,000 masu aibu.
Belgium ta tuna abin rufe fuska 100,000 da ba a ayi amfani dasu ba , waɗanda ake tsammani sun fito ne daga China, amma a zahiri sun fito ne daga Kolombiya.
A Wani Hanun, Tallafin chinese Ya Karbu Sosai A wasu yankunan Na Amurka masu Latin da ma Africa. A Ranar 2 ga Watan afrilu, Bankin Duniya ya Kaddamar Da aikin Tallafin Gaggawa ga Kasashe masu Tasowa.
Hukumar ta WHO ta yaba da kokarin hukumomin kasar Sin wajen shawo kan shawo kan cutar.
"WHO ta lura da sabanin da ke tsakanin barkewar SARS a 2002 - 2004, inda aka zargi hukumomin China da tona asirin da ke kawo cikas ga kokarin kare da hana kokarin, da rikicin yanzu inda gwamnatin tsakiya ""ta samar da sabuntawa na yau da kullun don guje wa fargaba kafin hutun sabuwar shekara."" ."
A 23 ga watan Janairu a yayin da yake mayar da martani game da matakin hana safara da hukumomin tsakiya suka dauka jami’in hukumar WHO Gauden Galea ya furta cewa “ A gaskiya wannan bata daga cikin shawara da WHO ta bada” kuma “ Matakin ne babba na jawo bala’in inda tafi taruwa. yace hakan hatsari ne a tarihin kiwon lafiya. Bayan tabbatuwar kamuwa da cutar tsakina mutum da mutum a 30 ga watan Janairu a wajen China tare da karuwar adadin wadanda suka kamu da cutar a sauran kasashe hukumar WHO ta kaddamar da barkewar a matsayin lamari na samar da lafiyar jama’a gaggawa wanda ta shafi kasashe, wannan shina kaddamarwa na shida bayan na farkon da ya faru yayin da aka samu barkewar annobar cutar swine Flu na shakarar 2009.
Babban direkta na hukumar WHO Tedros Adhanom yace an kaddamar da ita a matsayin bayar da lafiya ga jama’a na gaggawa wanda ta shafi kasashe bisa ga illar yaduwar ta musamman ga kasashe masu karancin tattalin arziki da kuma cibiyoyi neman lafiya nagari.
Cikin martanin sa game da matakin takaita tafiya Tedros ya sanar cewa “ Babu bukatar kaddamar da mataki wanda ke haifar da katsalanda da kasuwanci da tafiya kasashen waje. Ya kuma kara da cewa hukumar WHO bata bada shawarar tak, aita kasuwanci da kuma zirga-zirga.
A ranar 5 ga Fabrairu, Hukumar ta WHO ta yi kira ga kasashen duniya kan dala miliyan $675 don ba da gudummawar shirin a kasashe masu karamin tatalin arziki, tare da yin kira da a gaggauta tallafawa wadancan kasashen da “ba su da tsarin a wurin don gano mutanen da suka kamu da kwayar cutar , ko da kuwa zai fito ne”.
Tedros ya kara bayyanawa cewa “muna da karfi gwargwadon mahadi mafi rauni”, tare da yin kira ga sauran kasashen duniya da su dauki na gaggawa domin magance sakamako mara dadi nan gaba. A ranar 11 ga watan Febreru hukumar WHO a wata zantarwa da tayi da manema labarai ta kaddamar da COVID-19 a matsayin sunan cutar.
A rana daya, Tedros ya sanar da cewa babban Sakataren majalissar dinkin duniya UN Antonio Gueterres ya yarda zai samar da “ikon dukkan tsarin UN a cikin martani”.
"An tayar da Kwamitin Gudanar da Rikicin Majalisar Dinkin Duniya wato UN Crisis Management Team a sakamakon, an ba da izinin daidaitawar amsan dukkan Majalisar Dinkin Duniya, wanda ƙasashen WHO za su ba su damar ""mai da hankali kan amsar kiwon lafiya yayin da sauran hukumomin za su iya kawo ƙwarewar su don tallafawa mafi yawan zamantakewar al'umma, tattalin arziki, da cigaban nuna yada yaduwar annobar ta ke ""."
A anar 14 ga Watan Faburairu, wani Gammayar Kungiyar WHO MaI Jagoranci Da Wasu Yan China Aka Fitar Don Samar Da Kwarewa A Kasar China Domin Tallafin Cikun gida Na Gano “Tsananin da Ma Yaduwar Cutar” Ta Hanyar Daukan nauyin Taruka da Koyarwa Tare Da Hukumomin Kasa Na Mussaman Da kuma Su Ziyarci Alumma Don Tabatar da “ayukan agaji Da Ke Gudana a Yankunan Da Matakin Kauyuka, Daga Birni har ma da karkara a ranar”. A ranar 25 ga Watan faburairu, WHO Ta Sanar Cewa “Duniya Ta kokari ta Shirya ga Barkewar Amobar Coronavirus mai yiwuwa,” Da cewa tun Da Cutar Ba ta kai matakin Annoba Ba, Amman Kasashe “su Fara Shiri Don Kar Ko Ta Baci”.
Don kawo karshen barkewar cutar yayin da take yaduwa hukumar WHO ta tuwa tawaga ta musamman domin yin duba. A 28 ga watan Febreru jami’an WHO sun bayyana cewa hadarin coronavirus idan aka makala ta ga matakin duniya zata haura matuka haka zai zamanto kololuwar halin takatsantsan.
"Mike Ryan, darektan zartarwa na shirin kiwon lafiya na WHO, ya yi gargadin a cikin wata sanarwa cewa, ""Wannan bincike ne na gaskiya ga kowace gwamnati a duniyar nan: Farka."
"Wannan kwayar cutar na iya kasancewa a kan hanyarta kuma kuna buƙatar kasancewa a shirye, ""suna kira cewa matakan da suka dace na iya taimakawa duniya su guji"" mafi munin ta ""."
Ryan Ya cigaba da Cewa Wannan Bayanai Na Yanzu Bai ba wa Jami’an kiwon lafiya Su Tabbatar Da Cutar A Matsayin Annoba A Duniya ba, Cewa Wannan sanarwa Na Nufin “musamman muna yarda cewa ko wane mutun a Duniya Na Fuskantar Barazanar Daukar Wannan Cuta”.
WHO ta kaddamar da barkewar cutar Korona a matsayin annoba a ranar 11 ga watan Maris.
"Babban darektan ya ce hukumar ta WHO ta damu matuka game da matakan yaduwar cutar da kuma tsananin rauni, da kuma matakan rashin tsaro "". WHO ta fuskanci babban zargi game da abin da ake gani da rashin isasshen maganin cutar, ciki har da Bayanin sanarwar gaggawa ta lafiyar jama'a da kuma rarrabuwa da kwayar cutar a matsayin annoba."
Wadanda suka gabatar da kara sun hada da wata takarda kai tsaye ga babban daraktan hukumar ta WHO Tedros Adhanom don gabatar da murabus din nasa, wanda mutane 733,000 suka sanya hannu tun daga ranar 6 ga Afrilu.
Ranar 26 ga watan Maris 2020, da yawa daga cikin kwararrun Majalisar Dinkin Duniya suka jaddada mutunta hakkin kowane mutum lokacin annoban COVID-19.
kungiyyar masaman ta ce kowa na da damar matakan kare rayuwar shi kuma gwanati za ta rike wannan da huja.
Kungiyar ta jaddada cewa rashin abubuwa na bukata ko na insoran lafiya bai kamata ya zamanto sabbabi wajen aibanta wasu tsirarrun kungiya ba.
Kwararru sun bayyana cewa ko wani dan Adam na da yancin samun lafiyar jiki kama daga nakasaasu zuwa gajiyayyu da mara sa hali da masu gudun hijira da wadanda ke garkame da sauran makamacin mutane dake bukatar gudumawa daga gwamnati.
Kungiyoyin gwamnatocin duniya suna magance tasirin tattalin arziki da zamantakewar rikicin COVID-19.
Kungiyar haddin da bunkasa tattalin arziki ta kaddamar da tsari na fitar da kayyataccen labari cikin lokaci akan matakai da kuma matsaya tare da shawarwari daga kasashen duniya.
Daga manufofi don karfafa tsarin kiwon lafiya da tattalin arzikin duniya zuwa magance tasirin ƙulli da ƙuntatawa akan tafiye-tafiye, ƙungiyar dijital ta haɗa da Policyabilar Siyasar Countryasa, da nufin taimakawa ƙasashe suyi koyo daga juna da kuma sauƙaƙa matakan daidaitawa na duniya game da kalubalan coronavirus.
Gwamnatin China Ta Sha suka daga U.S., Da Ministan Harkokin Kasar ingila Micheal Gove, Da Shugaban Kasar Brazil Eduardo Bolsonaro Dan Jair Bolsonnaro Yanda Suka Dauki Annobar, wanda ta barke a Kasar China a lardin Hubei.
Da yawa daga cikin shugabannin lardi na jam'iyyar kwaminis ta kasar Sin(CPC) an kore su saboda yadda suke gudanar da ayyukanta a yankin tsakiyar kasar Sin, wata alama ce ta nuna rashin gamsuwa da yadda aka kafa tsarin siyasa game da barkewar annobar a yankunan.
Wasu masu sharhi sun gani ewa wannan yunkuri an yi shi ne domin kare sakatare janar na jam'iyyar kwaminis ta Sin Xi Jinping daga fushin jama'a game da barkewar cutar Coronavirus.
Wasu Ma'aikata Sinawa, Kamar Zhao Lijian SuN Ki Karbar Lamarin Bullar Cutar Corona A Wuhan, A Biyewa Rubuce-rubucen Da Akayi Akan COVID-19 Daya Fara A U.S Ko Italiya.
"Gwamnatin U.S. ta Donald Trump ta kira coronavirus a matsayin ""kwayar cutar China"" ko ""virus ta Wuhan"" tana mai cewa ""takukunmi ya habaka wata kwayar cuta wacce ta zama yanzu ta zama annoba ta duniya"", wanda a yayin haka wasu masu sukar lamiri ke suka a matsayin wariyar launin fata da ""nisan[tawa] daga gazawar gwamnatin sa na shawo kan cutar""."
Gidan watsa labarai na The Daily Beast ta kama tashar telibijin gwamnatin Amurka na musamman yayyin da take bayyana tsarin da za’a dauka wadda ta asalin daga majalisar tsaro na kasar. Ta ruwaito daya daga cikin tsarin da cewa “ Alkaluma sun karkata zuwa kasar China”.
An fada mana da muyi kokarin yada wannan sako a ko wata hanya, ciki harda taron manema labarai, fita gida talabijan, tarukan siyasa, dokokin waje kuma bloomberg na da yakinin china na kokarin tura tallafi kasashen da cutar tayi musu illa na daga cikin turin zuzzuta domin rinjayin alamuran duniya.
shugaban hukumar dokokin kasashen nahiyar Turai Josep Borell ya yi gargadin cewa akwai siyasay yanki mai hade da kokawa wajen samun rinjaye ta hanyar murdiyya da salon siyasa na jan hankali.
Borrel Ya Kara Da Cewa China Na Kokarin Tura Sakon Cewa ba Kamar Amurka, Ita Amintacciyar Abokiya Ce Wanda Za A Iya Dogaro Da.
China na kira da amurka da su daga dokokin da aka sa wa syria da venezuela da iran, tare da tura tallafi zuwa kasashen biyun farko.
U.S. ta toshe Tallafin Jack Ma Na Kariyar Fuska 100,000 Zuwa Cuba Da Dokokin US Na 3 Ga Watan Afrilu.
An zargi hukumomin US Da Karkata Tallafin Wasu Kasashen Zuwa Kasar Su.
Kuma an samu sabani game da abin rufe fuska tsakanin wasu kasashe , kamar su Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
Kari akan haka, Turkiyya ta kwace daruruwan na’aurorin ba da iska wadanda za a kai su a kasar Spain.
A farkon watan Maris gwamnatin kasar Italy ta kalubalanci majalisar kasashen turai da nuna rashin kulawa yayin da cutar ta bazu a kasar.
"Maurizio Massari, jakadan Italiya ga EU, ya ce ""China ce kawai ta mayar da martani baki daya."
"Tabbas, wannan ba alama ce mai kyau ba ta hadin kan Turai. """
A ranar 22 ga watan Maris, bayan kiran waya tare da Firayim Ministan Italiya Giuseppe Conte, shugaban Rasha Vladimir Putin ya shirya sojojin Rasha don aika da magungunan sojoji, motocin yaƙi na musamman da sauran kayan aikin likitanci zuwa Italiya.
"Jaridar La Stampa ta Italiya ta buga wani muhimmin ""matattarar siyasa"" da ke cewa kashi 80 na taimakon Rasha “ba su da wani amfani ko amfani ga Italiya”."
Tushen ya zargi Rasha da goyon bayan siyasar yanki da diflomasiya wato “geopolitical and diplomatic” mai barna matuka.
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun yi watsi da rahotannin kafafen yada labarai kuma sun nuna godiyan su.
Hakanan Rasha ta aika da jirgin sama mai daukar kaya tare da taimakon likita zuwa Amurka.
Kakaki mai maganan Kremiln wato Dmitry Peskov yace yayinda ake taimakawa abokan aiki zuwa U.S., [putin] ya na daukar cewa idan masana’antar kayayyakin asibiti a US sun sami karfi, za su iya mayar da gurbi in ta zama tilas.
"Wanan shirin NATO ""Defender 2020"" na ayyukan soja a Jamus, Poland, da kuma kasashen Baltic, mafi girman aikin yakin NATO tun karshen yakin Yaki mai Sanyi, za a gudanar da shi kan rage girman."
Babban Sakataren kamfe dake wayar da kai wajen hana amfani da nukuliya Kate Hudson ta soki wasu matakai da aka dauka a 2020. tana mai cewa “rikicin rashin lafiyar jama’a dake wakan ya saba ma rayukan dakarun Amurka da na sauran kasashen nahiyar turai haka zalika ta saba ma yan garin kasar da dakarun ke aiki. “ Barkewar cutar ya shafi gwamnatin Iran matuka yayin da aka samu yan majalisa sama da ashirin da hudu tare da yan siyasa na yanzu da tsofaffi da suka kamu.
Shugaban kasar Iran Hassan Rouhani ya rubuta wata wasika ta jama'a ga shugabannin duniya da ke neman taimako a ranar 14 ga Maris 2020, yana mai cewa kasarsa tana iya bakin kokarinta don yakar barkewar sakamakon rashin damar zuwa kasuwannin duniya sakamakon takunkumin da Amurka ta kakaba wa Iran. ya haifar da kira ga U.S. ta aiwatar da tsarin zamantakewar yau da kullun a wasu ƙasashe masu arziki, game da kula da lafiyar duniya, kula da yara baki ɗaya, biyan tafiyar hutun iyali, da kuma mafi bada kudaden girma lafiyar jama'a.
Masana siyasa na yan wani tunani akan samun nasarar Donald Trump a zabukan 2020 na shugaban kasa, huldar jakadanci da ke tsakanin japan da korea ta kudu ya baci sabosa wannan annoba.
"Koriya ta Kudu ta soki ""kokarin kwantar da hankali Japan"" bayan Japan ta ba da sanarwar duk wanda ya fito daga Koriya ta Kudu za a sanya shi cikin kebewa na makwanni biyu a wuraren da gwamnati ta tsara."
Kawunan jama’a ya rabu a kasar Korea ta kudu yayin da shugaba Moon Jae-in ke bada amsar barkewar cutar.
Yan koriya da yawa sun sanya hannu kan takarda ko dai suna kiran a tsige Moon saboda abin da suka ce gwamnati ne ke miskilanci barkewar, ko yabon amasar sa. Annoban ya sa kasashe da yawa su kafa dokar ta-baci cikin gaggawa domin amsawa.
Wasu masu sharhi sun bayyana damuwar cewa hakan na iya ba gwamnatoci damar karfafa ikonsu.
A Hungary, Majalissar Dokokin Ta Bada Dama Cewa Shugaban Majalissar Viktor Orban, Da Yayi Shugabanci Na Doka Na Dindindin, ya Bawa Majalissar Hutu Da Ma Zabuka Kuma A Hukunta Wanda Ke Yada Jita-jita Akan Cutar Dama Yanda Gwanati Ke Daukar Matakan Fadan.
Barkewar Cutar Coronavirus Yasha Korafi Da Dama Akan Yankewar Kaya, Farawa Daga Karuwar Yawan Bukatar Kayakin Fada Da Cutar A Duniya, Siyayya Na Rashin Zato, Dama Rashin Daidaito A Tafiyar Da Kamfanoni Da Ma Hada-hada.
Hukumar Kula da Abinci da Magunguna ta U.S. ta ba da gargadi game da karancin magunguna da kayayyakin asibiti sakamakon karuwar nema daga masun amfani da su don damuwar rashin rabawa
Yawancin yankuna sun shaida sayan tsoro wanda ya haifar karewar kayayyakin shaguna irin su abinci, takarda bayan gida, da ruwan kwalba, tare da haifar da karancin kowowa.
Tun ba yau ba fannin fasaha take jan hankali akan jinkiri na shigowar kayan fasaha daga kasashen ketare.
A cewar babban darecta na WHO Tedros Adhanom, bukatar kayan aikin kariya na mutum ya haura kashi 100.
Bukatar ta sanya karin farashi sama da kaso aishirin daga ainahin farashin kuma hakan ya sanya an samu jinkiri a wajen kawo kayakin kiwon lafiya na tsawon wata hudu zuwa shida.
Ya Kuma Kawo Karancin Kayan Kariya A Duniya, Da Gargadin WHO cewa Ma’aikatan Kiwon Lafiya Na Fuskantar Barazana A Bangaren Aikin Su A Sanadiyyar.
Daga bisani barkewar annobar a kasar Autralia ya baiwa yan kasuwar Daigou damar siyar da kayayyakin Australia zuwa China.
Ayyukan sun haifar da ƙarancin tsarin samar da jarirai a wasu manyan kantunan kuma daga baya gwamnatin Ostireliya ta dakatar da ita.Domin jin ƙarancin cutar ta COVID-19 a arewacin Italiya da yankin Wuhan, da kuma yawan bukatar kayayyakin abinci, ɓangarorin biyu suna da an kare shi daga matsanancin karancin abinci.
Matakan China da Italiya akan boye kayan amfani na sosai ya yi nasara, an rage rashin kayan abinci da akayi kintaci a nahiyar turai da yankin amurka ta arewa.
A arewacin Italy duk da tasirin noma da take dashi ba’a taba samun raguwar amfanin gona ba sai dai farashi na iya haurawa a bisa tsarin hukumomi na ma’aikata.
Rashin wajen ajiyar abinci yar matala ce wanda a ka samu na dan wani lokaci har ma a wuhan, sanda gwantin chinese ta fitar da ajiyar ta na aladu don samun kayan gina jiki ga daukacin alummar.
Wasu makamantan dokokin na nan a Italiya masu bukatar ajiyar abinci sabo da ko ta kwana.
Ɓarna ga tattalin Arzikin Duniya an Ji Shi A China: Bisa ga Rahoton Yan Jarida na 16 ga Watan Maris, Cewar Tattalin arzikin China Ya Jijiga A Watanni biyu Na Farkon 2020 saboda Matakan Da Gwamnati Ta Dauka Don Shawo Kan Cutar Cinnikayya Kanana Sun fadi Zuwa Kashi 20.5%.
Kasancewar kasar Sin babbar kasa ce kuma ta masana'antar samar da kayayyaki, ana ganin bullar cutar za ta iya zama babbar barazana ga tattalin arzikin duniya.
Ma’aikaciya a sashin basira ta jaridar Economist Agathe Demarais tayi hasashe cewa kasuwanni zasu kasance a cikin hali na rashin tabbas har sai an samu bulowar sakamako mai nuna habbaka.
A watan Janairu na 2020, wasu manazarta sun kiyasta cewa fadiwar tattalin arziki domin annobar kan ci gaban duniya zata iya fi barkewar SARS daga 2002 zuwa 2004.
Wani kintaci na wani kwarare a jami’ar washington na st louis yace illar hada-hada kimanin billiyan $300 ka iya samuwa a cikin shekara biyu.
Rahotanni sun nuna cewa Majlisar OPEC tayi jan jiki bayan darewar farashin man fetur sakamakon karancin bukata daga kasar China.
Hanun jari na duniya ya fadi a ranar 24 ga watan Faburairu saboda yawan masu cutar covid-19 a wajen kasar china.
A ranar 27 ga watan Fabrairu, saboda damuwa game da barkewar cutar coronavirus, U.S. bayanin jari wanda ya hada da NASDAQ-100, S&P 500 Index, da Matsayin Masana'antu na Dow Jones sun ba da sanarwar faduwarsu tun daga 2008, yayin da Dow ke faduwa da maki 1,191, mafi girma. kwana daya kasa tun lokacin da aka fara rikicin kudi na 2007-08.
Jerin guda uku sun kawo karshe a makon da ya gabata inda ta samu fiye da 10%.
A 28 ga watan Febreru ma’aunin GmbH ta gasgata hasashen daukar kasada na kasar China amma bata sauya mummunar fahimta da ake mata.
Hannun jari ya sha kayi kuma saboda tsoron cutar coronavirus, mafi munin faduwar shine na ranar 16 ga watan Maris.
Dayawa na duban yiwuwar rushewan tattalin arziki.
Masani a fannin tattalin arziki Mohammed EL-Erian ya yaba ma babban bankunan kasa da na jihohi bisa ga matakin gaggawa da suka dauka cikin lokaci.
Manyan banki na tsakiya suna yin hanzari da sauri fiye da yadda suka yi wa faduwar tattalin arzikin 2008.
Yawon shakatawa na fuskantar kalubale saboda hana shiga da fita,rufe wajen alamuran yau da kullum da ma takaita tafiye-tafiye don daukan hankali, da shawarar gwamnati akan ko wace irin tafiye-tafiye a duniya.
daga cikin sakamakon barkewar manyan kamfanonin jirgin sama sun dakatar da safara kasancewa bukatu sun ragu. Cikin manyan kamfonin da lamarin ya shafa akwai British Airways da China Eastern Airlines da Qantas ita kuma kamfanin Flybe dake nan Birtaniya ta tashi daga aiki.
Tasirin ta ga fanin safara ta hanya ruwa ta haura zuwa mataki wanda ba’a taba samu ba a fannin
Yawancin tashoshin Jirgin Kasa Da Na Jiragen ruwa su Ma Rufe Su.
Aukuwar annobar ta faru ne lokaci guda da bikin Chunyun. Wato bikin hutu na farin cikin shiga sabuwar shekara.
Da dama daga cikin gwamnatocin jihohi da na yanki sun soke abubuwa da yawa da suka hada da taron jama'a, wadanda suka hada da bikin Sabuwar shekara, tare da kamfanoni masu zaman kansu su rufe shagunansu da wuraren shakatawa irin su Hong Kong Disneyland da Shanghai Disneyland.
An rufe galibin wuraren murnar sabuwar shekara da na baki masu yawon bude ido domin hana taron jama’a. Cikin wuraren da matakin ya shafa akwai Forbidden city dake nan Beijing da kuma wuraren bauta na gargajiya.
A cikin 24 daga cikin lardi da alkarya da yankuna 31 dake kasar China hukuma ta tsawaita hutun sabuwar shekar zuwa ranar 10 ga wata Febreru tare da umurtan masa’antu kada su bude har sai wannan ranar.
Wadanan yankuna sun wakilta kashi 80% na tattalin arziki kasa wato GDP da cinikin waje kashi 90%.
Hong Kong sun daukaka matsayin mayar da martanin akan cutar su mai yadduwa ga mafi girma da kuma ayyana dokar ta-baci, rufe makarantu har zuwa Maris da kuma soke bikin sabuwar shekarar su.ya shafi sashin ciniki a duniya baki daya, tare da raguwar yawan sa'o'in aikin kanti ko kuma rufewa na wani dan lokaci.
Ziyara ga kananan yan kasuwa ta ragu a Turai da yanki Amurka na Latin ga kashi 40%.
‘Yan kasuwan yankin Amurka ta Arewa da Gabas ta Tsakiya sun ga fadiwa kashi 50-60%.
Hakan ya jawo raguwar cinkoson masu yawo da kafa a wuraren siyar da siyarwa daga 33% zuwa 43% tsakanin Febreru da Maris.
Ma'aikata kantin sayar da kayayyaki a duk duniya sun sanya karin matakan, irin wannan karuwar tsafta, shigar da na'urar sikirin na daskararru don duba zafin jiki na masu siyayya, da kuma soke abubuwan da suka faru.Bayan da kidayar Majalisar Dinkin Duniya ta Latin Amurka ta kiyasta cewa, annobar ta barke tsakanin mutane miliyan 14 zuwa 22 cikin matsanancin talauci a Latin Amurka fiye da yadda za ta kasance a wannan yanayin in ba tare da cutar ba.
A watan Janairu da Fabrairu na 2020, a yayin da cutar ta bulla a Wuhan, mutane miliyan 5 na kasar Sin sun rasa rayyukansu.
Yawancin ma'aikatan kasar Sin da ke ƙaura daga ƙauyuka kusan milliyan 300 sun ƙawance a gida a cikin lardunan ko kuma sun shiga tarko a lardin Hubei.A cikin Maris 2020, fiye da Amurkawa miliyan 10 suka rasa ayyukansu kuma sun nemi taimakon gwamnati.
Barkewar cutar Coronavirus na iya kashe ayyuka miliyan 47 a U.S. kuma yawan marasa aikin na iya kaiwa kashi 32%, in ji alkalumman da Bankin Reserve na St. Louis. kullewar a Indiya ya sanya dubun-dubatar bakin haure 'yan kasar Indiya (wadanda aka biya su ta hanyar albashi na yau da kullun) marasa aikin yi.The binciken daga Cibiyar Angus Reid ta gano cewa 44% na gidaje na Kanada sun sami wasu nau'in rashin aikin yi. Kusan ma'aikata 900,000 suka rasa ayyukansu a Spain tun lokacin da suka shiga cikin yanayin zaman wuri daya a tsakiyar Maris 2020.
A tsakiyar watan Maris ma’ikata kasar Faransa miliyan 4 suga shigar da takardar neman tallafi na rashin samun aiki na takaitaccen lokaci haka kuma mai’katan Birtaniya Miliyan 1 sun nemi tallafi daga gwamnati. Ma’aikata dab da rabbin miliyan a kasar Jamus sun shigar da ma’aikatan su ga tsarin aiki cikin karamin lokaci wanda ke da goyon bayan gwamnati kuma wanda aka fi sani da Kurzarbeit.
Faransa da Burtaniya sun karɓi tsarin aikin na ɗan gajeren lokaci na Jamus.
Bangaren Aladun gargajiyya dama na gado Sun Fuskanci kalubale a wannan annobar, ya Taba alamuran tafiyyar da Hukumar dama mutane Da Maaikata dama masu Zaman Kansu a duniya.
Kungiyoyin al’adu sun yunkura wajen tallafawa kamar yadda suka saba wajen samar asalin al’adar al’umma da kuma kare lafiyar ma’aikata da jama’ar gari tare da taimakawa yan nishadi iya bakin gwargwado.
A Maris 2020, a Duniya Da kewaye, gidajen Tarihi, dakunan karatu, Dandalin wassani, Da Wajen Bukukuwa na Gargajiyya, An Rufe Su Dindindin Da Alamuran Su Kamar nishadi da Ma Bikin Wasu An Soke Zwasu kuma An Dage.
A cikin martanin da aka samu akwai kokarin da ake yi na samar da wasu ayyukan ta hanyar dandamali na dijital. Wani sabo da ke hanzarta kawo karshen cutar shi ne soke ayyukan addini, manyan bukukuwan wasanni, da sauran wasannin zamantakewa, kamar bikin kida da kide-kide da tarukan fasaha, da kuma wasan nunan kayayyakin sa jiki.
Masana’antar wassani finafinai na fuskantar rushewa, Vatican ya sanar da makon addini don kiblacewa a Rome, wanda ya faru a makon da ya wuce a kakar ibada na kiristocin lent, da cewar an soke shi.
Da yawa daga cikin dattijan sun ba da shawarar tsofaffi Kiristoci su zauna a gida maimakon halartar Mass a ranar Lahadi; wasu majami'u suna sujada ta hanyar rediyo, bidiyon-take na kan layi ko talabijin yayin da wasu suke ba da wata sujadar zaman cikin mota.
Tare da Darikar Katolika ta Rome ta Rome tana rufe majami'unta da wuraren ibadarta da kuma filin St. Peter's Square da maharan kiristocin suka yi, sauran kungiyoyin addini ma sun soke aiyuka da iyakance taron jama'ar majami'u, masallatai, majami'u, gidajen ibada da gurdwara.
Ma’aikatar lafiya ta Iran ta sanar da soke sallar Juma’a yankunan da annobar ta shafa da wuraren bautar da abin ya shafa daga baya, yayin da Saudi Arabiya ta hana shigowa da mahajjata kasashen waje da kuma mazaunan ta zuwa wuraren tsarkakakku a Makka da Madina.
Annobar ta haifar da batawa mafi girma ga kalandar wasanni ta duniya tun bayan Yaƙin Duniya na biyu.
An soke ko dage mafi yawan wassani na guje-guje, ciki ma harda, kakar gasar cin kofin masu nasara na UEFA, 2019-20, kakar wassani ta firemiar 2019-20, UEFA euro 2020, 2019-20 kakar NBA, da kakar NHL 2019-20.
"Barkewar fashewar tsare-tsaren shirya wasannin Olympics na lokacin zafi na 2020, wanda aka shirya farawa a karshen Yuli; Kwamitin wasannin Olympic na kasa da kasa ya sanar a ranar 24 ga Maris cewa ""za a sake shirya bikin har zuwa ranar 2020 amma ba za a wuce lokacin bazara 2021 ba"". Casino da sauran wuraren wasannin caca a duk duniya sun rufe kuma an sake dakatar da gasar wasannin na cikin gida ko dai an dakatar da su."
Wannan ya haifar da komawar masu caca yanar giza inda kuma shafukar caca ke karuwa da yawan sabbin ma’abota. Lamarin dai ya shafi fannin nishaantarwa inda da mafi yawancin kungiyoyin mawaka sun takaita ko soke wasannin su.
Dandalin wassani da yawa kamar wanda ke kan titin broadway sun hana dukkan wasanni.
Wasu Gamayyar Masu Wasa Sun Samar Da Hanyoyin Cigaban Hada Da Kuma raba Ayyukan Su Ta Hanyar Yanar Gizo A Maimakon Hanyar Wasa a fili wanda aka saba da ita, Kamar kallon bidiyo nan take a Yanar Gizo Da Ma Kirkiro Bukkukuwa a shafukan Yanar Gizo Domin Masu Wasa Su Samu Su Yi Kuma Su Yada Wassanin Su.
A kafafen sadarwa an samu yaduwar hotunan barkwanci da lakanin coronavirus yayin da yawa a cikin su suka mayar a hankali zuwa ga nishadi domin dauke hankali na rashin tabbacin karshen annobar.
Tun bayan barkewar COVID-19, nuna bambanci, nuna wariyar launin fata, da wariyar launin fata ga mutanen Sinawa da Gabas ta Tsakiya, da kuma mutane daga wuraren fada a Turai, Amurka da sauran kasashe.
Lamari na tsoro, zargi, da garkuwa aka fuskanta a kasashe da dama musamman a nahiyar turai, gabashin asia, arewacin amurka da ma bangaren teku na asia.
Rahotanni daga watan Febreru (Yayin da adadin wadanda suka kamu da cutar ya kebanta a China) na dauke da bayanai na yadda sauran yan kasashen duniya ke nuna wariyar launi tare da aibata yan kasar China. Da yawa sun nuna cewa kasar ta cancanci sakamakon da ta same ta.
Wasu Kashashen a Africa sun Ga Karin Kabilanci akan yan China.
Yawancin mazauna Wuhan da Hubei sun ba da rahoton wariyar launin fata dangane da asalin yankinsu.
Ana bawa Sinawa goyon baya, a kan layi da kuma ba kan layi ba, da wadanda ke cikin wuraren da cutar ta fi kamuwa.
Bayan ci gaba da barkewar cutar a wasu sabuwar kasashe, mutane daga Italiya, farkon kasa a Turai da ta sami mummunar barkewar COVID-19, ana iya fuskantar shaka da nuna wariyar kasa. ‘Yan kasa cikin kasashe hade da Malesiya, New Zealand, Singapore, da Koriya ta Kudu sun fara sanya hannu kan koke-koken neman haramtawa Sinawa shiga cikin kasashen su a kokarin tsayarwa da cutar.
A cikin Japan, hashtag #ChineseDontComeToJapan yayi tasiri akan Twitter.
Mutanenen China da ma wasu yan nahiyar Asiya a Birtaniya da ma kasashen U.S. sun ba da rahoton karin nuna wariyar fata, da ma wasu hare-hare.
Shugaban Kasar U.S Donald Trump Ya Fuskanci Suka A Dalilin Kiran Cutar Coronavirus Da Suna “Kwayan Cutar Sinawa”, ajalin da masu sukar ke dauka a maseyin wariyar launin fata kin-Sinawa
Masu zanga-zanga a Ukrain sun kai hari ga motoci dake dauke da yan kasar da sauran wadanda neman tsira daga birnin Wuhan zuwa Novi Sanzhary.
Dalibai Da Suka Zo Daga Arewa Maso Gabas na India Wanda Ke Da iyaka Da China, wanda suke Karatu A Wasu Biranen India Sun Fuskanci Kyama A Dalilin Barkewar Cutar Coronavirus.
Shugaban Jam’iyyar na yankin Bharatiya Janata a West Bengal Dilip Ghosh ya bayyana cewa, Sinawa sun lalata dabi’ar kuma “shi ya sa Allah ya dauki fansa a kansu.”
"Daga baya ne qungiyar qwadagon ta China ta yi Allah wadai da jawaban da aka yi a Kolkata, tana mai cewa ""kuskure ne"". A China, barkewar nuna wariyar launin fata da wariyar launin fata game da mazaunan Sinawa ba su barke ba sakamakon barkewar cutar, inda aka bayyana 'yan kasashen waje a matsayin ""datti na kasashen waje"" da niyyar ""zubarwa""."
Mafi yawan jaridu sun Cire Labarun Bango A Dukkan rahotanin Su Daya Kula Da Cutar Corona.
Yawancin masu wallafa ilimin kimiyya sun sanya takaddun ilimin kimiyya mai alaƙa da barkewar da ke akwai a inda kowa zai karanta.
Wasu masan kimiya sun zabi fitar da sakamakon su cikin lokaci ta hanyar manhaja bugu na bioRxiv.
Aukuwar kwayar cuta mai saurin yaduwa - Aukuwar kwayar cuta mai saurin faruwa, sau tari a cikin yanayin barkewa ko yanayin watsawa
Duniya baki daya da cuta - Bayyanin duniya da yaduwar cuta
Jerin cututtukan annoba da cututtukan cuta - Jerin yawan mutane da suka mutu saboda cutar kwalara
Sumogar namun daji da cutar zoonoses - Hadarin lafiyan da ke alaka da kasuwancin namun daji masun tsada.
Dakin gwaji don cutar hanyar numfashin coronavirus 2019 (COVID-19) da mai alaƙa da cutar SARS-CoV-2 ya hada da hanyoyin gano kasancewar kwayar cutar da wadanda suka gano kwayoyin halittun kariya da suka samar sakamakon kamuwa da cuta.
RT-PCR ke tabbatar da kwayoyin cuta a cikin samfuri, wanda ke gano cutar coronavirus RNA.
Gwajin an yi shi ne na musamman akan ya gano RNA na cutan SARS-CoV-2.
Ana amfani dashi wajen tabbatar da ciwo wanda aka gano ko kuma yake ayanzu.
Gano garkuwar jikin (serology) akan yi amfani dashi ta wajen gwaji da sa ido kan jama’a.
Gwajin garkuwan jiki na nuna mutane nawane suka kamu da cutar, har da wadanda alamomin su kadan ne wanda aka sanar.
Samun adadin mace-macen da ciwon keyi da yanayin garkuwa a cikin mutane na iya samuwa a gwajin da akayi.
Saboda karancin gwaji, a watan Maris 2020 babu wata kasar da bayanan dogaro domin mamayewar kwayar cutan cikin yawan jama’ar su.
A ranar 23 ga watan Maris, Babu wata kasa da ta yi gwajin kashi 3% na yawan jama’ar kasa, kuma akwai bambanci sosai a yawan gwajin da aka yi a dukan kasashe.
Wannan saɓani kuma yana iya shafar mahimmancin rahoton yawan tsananin masun kamuwa da cutan, wanda yakan yuwuwar akan iya ƙimanta su fiye da ha a wasu ƙasashe.
Yin amfani da juyi na ainihin-lokacin haduwar plymerase chain (rRT-PCR) ana iya gwajin hanyoyin numfashi wanda an samo shi ta hanyoyi daban-daban, hade da juyin nasopharyngeal ko samfurin sputum.
akan samu sakamakon cikin sa’oi kadan zuwa kwana 2.
Gwajin RT-PCR anayin sane da swab din makogwaro amma yana yiwuwane kadai a farkon makon da aka kamu da ciwon.
daga bisani kuma kwayar cutar sai ya bance a makoshi lokacin da ya cigaba da hayayyafa a huhu.
Ga wadanda suka kamu da cutar kuma an gwada su a mako ta biyu, banda haka za a iya daukan samfuri daga cikin wurin numfanshi ta wurin amfani da catheter ko zubar da tari (sputum).
An haɓaka daya daga cikin gwajin PCR a Charite cikin Berlin a watan Janairu 2020 ta yin amfani da real-time transcription polymerase chain reaction (rRT-PCR), da tsara tushen kaya 250,000 don rabawa daga Hukumar Lafiya ta duniya. (WHO).
Nahiyar turai sun hada wani gwaji a 23 Janairu 2020. Kamfanin Koriya ta arewa Kogenebiotech ta samo sabon tsari, PCR-based SAR-CoV-2 abun gwaji (Powercheck Corona virus) a ranar 28 Janairu 2020.
"Yana neman ""E"" wanda aka raba ta duk beta coronaviruses, da kuma RdRp takamaiman kwayar halita ga SARS-CoV-2. A kasar Sin, kungiyar BGI ta kasance daya daga cikin kamfanoni na farko da suka samu amincewar amfani da gaggawa daga Hukumar Kula da Lafiya ta Kasar don PCS-CoV-2 gano kayan kitse-A Amurka, Cibiyar Kula da Cututtukan (CDC) tana rarraba kan ta sabuwar Coronavirus-2019 (2019-nCoV) Lokaci-Kai Tsaye RT-PCR Binciken Cibiyoyin lafiya ga wurin gwajin lafiyar jama'a ta hanyar International Reagent Resource."
Daya daga cikin kwayoyin gwajin na da wanda ya zama ba cikakkeba saboda matsala mahadi kuma a bakin kwalbar gwajin ta CDD a Atlanta; wannan ya kawo kusan samfuri 100 wanda sukai daidai a cikin watan Febrairu 2020.
Amfani da abun gwaji biyu bai nuna inganci ba har 28 Febrairu 2020, kuma har sai sanda aka ba jihohi da dakin gwaji damar yin gwaji.
An samu yarda gwajin ne da ga hukumar abinci da magunguna karkashin bangaren gudanarwa ta gaggawa. dakin gwaji na kudin a US sun fara gwajin a farko Maris 2020.
A ranar 5 ga watan Maris 2020 LabCorp ta bada sanarwar samun gwaji daga cutar COVID-19 a kasa gaba daya wanda ya danganta ga RT-PCR.
Quest Diagnostics wanda aka yi iri daya a duk fadin kasa akwai gwajin COVID-19 daga ranar 9 ga watan Maris 2020
Ba a sanar da babu iyakar yawan ba, samfurin da aka dauka kuma an yi aiki da su dole ne a yi shi ta hanyar yadda CDC suke bukata
A kasar Rasha an haɓaka gwajin COVID-19 kuma Binciken Jihar ne wato State Research na Virology da Biotechnolgy VECTOR suka sarrafa.
A ranar 11 ga watan Febrairu 2020 gwajin da aka shigar daga Federal Service for Surveilance a bangaren kiwon lafiya. A ranar 12 ga watan Maris 2020, Asibitin Mayo sun ruwaito cewa akwai tsarin gwajin ciwon COVID-19. A ranar 13 ga watan Maris 2020, Roche Diagnostics sun samu yardar FDA don yin gwajin da za’a yi cikin awanni 3.5 mafi yawa, duk da cewa zasu bar na’ura tayi gwajin kusan 4,128 a cikin sa’a 24
A ranar 19 Maris 2020, FDA ta ba da izini na amfani da gaggawa (EUA) ga Abbott Laboratories don gwaji akan tsarin m2000 na Abbott; FDA ta ba da izini iri ɗaya ga Hologic, LabCorp, da kuma Thermo Fisher Scientific.
A ranar 21 ga watan Maris 2020, Cepheid ya karɓi EUA daga FDA don gwaji da zai dauki mintuna 45.
FDA ta amince da wani gwajin da ke amfani da fasahar fadadarwa ruwan yacid isothermal nucleic a maimakon PCR.
Tunda wannan baya bukatar wani tsarin yanayi to hanyar ka iya haifar da sakamon tabbarwa mai yan mintuna biyar kuma sakamakon rashin tabbas cikin mintuna 13.
Ayanzu haka akwai kimanin 18,000 na nairan nan a US kuma Abbott na saran cewa za’a kara samar da gwajin 50,000 a rana. Gwajin da ke dauke da garkuwan jiki na monoclonal wanda ke gusar da nucleacapsid protein (N Protein) na cibiyar korona virus ana hadashi a Taiwan, tare da tsammanin cewa ai iya bada sakamako cikin mintuna15 zuwa 20 kamar ciwon mura mai hauhawa.
"Wani bita da aka yi game da wallafe-wallafen Maris na 2020 ya kammala cewa ""hotunan rediyo na kirji ba su da ƙima sosai game da ganewar asali a farkon matakai, alhali CT [ƙididdigar tomography] binciken na iya kasancewa har ma kafin bayyanar cututtuka. """
Sanene Sifofin CT sun hada da bilateral multilobar ground-glass opacificities da periheral, asymmetric da rarrabawar posterior.
yada cutar ke fitowa an haɓaka mamayewar Subpleural, tsagewar fata wato crazy paving da karfafawa.
Binciken gwajin PCR zuwa CT cikin Wuhan a matsayin asalin annoban ta yanzu ya nuna cewa CT ya fi kamuwa fiye da PCR, kodayake ba shi da takamaiman bayani, da yawancin fasahar hoto wanda ke hade da wasu cututtukan huhu da tafiyar matakai na cuta.
"A watan Maris shekarar 2020. Kolejin Daukar Hoton Jiki na Amurka wato American college of Radiology ta bada shawaran cewa ayi kada a yi amfani da CT wajen gwajin farkon COVID-19"". A watan Maris 2020, CDC ta bada shawarar yin amfani da PCR domin gwajin farko."
Bangaren garkuwan jiki dake kariya daga cutar shine a habakar da garkuwar jiki wanda suka hada da Igm da IgG.
Za a iya amfani da su domin gano mutanen da suka kamu da cutar wanda ya fara daga kwana 7 ko haka bayan farin alamar cutan, domin gano da kariya, da kuma kiyaye da yawan jama’a. Za a iya amfani da Assays cikin dakin gwaji (CLT) ko ta gwajin point-of-care (PoCT).
Na’urar sanya aiki da kai wato high-throughput cikin dakin gwajin asibitoci da yawa can iya aikata wadanan gwaje-gwajen amma samun su zai danganta ga nawa ake samarwa ga ko wace na’ura.
Don CLT samfurin guda ɗaya na jini na gefe wanda aka saba amfani dashi, kodayake za'a iya amfani da samfuran na yauda kullun don bibiyar maganin rigakafi.
PoCT samfurin jini daya na jini akan debane ta hanyar huda fata.
Ba kamar da hanyoyin PCR ba a buƙatar matakin haɓaka kafin assay ba. A ranar 26 ga watan Maris, 2020, FDA ta bawa mutane 29 damar bada sanarwa ga hukuma kamar yadda ake buƙata kuma a yanzu suna da ikon rarraba gwajin garkuwar jikin su.
FDA sun amince gwaji a watan Aprilu 7 2020, a karkashin amfanin gaggawar izini a karshen watan Maris 2020. Euriommum Medical Laboratory Diagnostics da Epitope Diagnostics sun samu Yardar European domin kayan gajin su wanda zai iya gano IgG da igAna garkuwan jiki akan kwayar cutar a samfurin jini.
Yanayin girman gwajin yana da yawan darukan samfuri cikin awanni kuma na da sauri sosai fiye da PCR assay na viral RNA wanda aka saba.
Ana iya gano garkuwan jikin kwana 14 bayan farawar cutan. A farkon watan Afrilu, kasar UK ba ta sami wani abun gwajin garkuwan jikin da aka saya da amfani ba.
"Hong Kong ta tsara wata makirci inda wadanda ake gani suna da cutar kan zauna a gida, ""sashen gaggawa za su bada bututun samfuri wa marasa lafiyan"", za su tofa miyau ciki, tura shi wurin su kuma a sami sakamakon gwajin nan gaba. NHS na Birtaniya sun sanar da makirci gwajin farko domin gwajin wadanda ake ganin suna da cutan a gida, wanda ya cire hadarin yaduwar cutan daga marasa lafiyan zuwa wasu idan suka zo asibitin ko ta wurin wankewar kwayar cutan daga motar daukan gawa wato ambulance idan an yi amfani da ita. A ta wuring gwajin COVID-19 na kowa ga wadanda ake zaton sun kamu da cutar, kwarare ma’aikatar kiwon lafiya zai dauke samfurin ta wuring yin amfani da ko wande irin matakan kariya."
Wuraren gwajin da suke kusa sun taimaka ma Kasar Korea ta Kudu yin gwaji mai sauri da tsada a kowace kasa. A Jamus, likitoci a National Association of Statutory Health Insurance sun ce a rana 2 ga watan Maris, cewa suna da damar yin gwaji guda 12,000 a rana a tsarin kuma 10.700 aka gada a makon da ya gabata.
Farashin wajen Ma’aikatan inshora lokacinda likita ya odar yin gwajin.
Bisa ga shugaban makarantar Robert Koch, Jamaus yana da karfin iya gwajin 160,000 a mako guda.
Daga ranar 19 ga watan Mari anyi gwajin mai yawa a manyan birane.
A ranar 26 ga watan Mari 2020 an samu adadin lambar gwajin da aka yi a Jamus ba’a san su ba, sai dai kawi wanda aka sani sun kamu da cutar.
"Binciken farko na dakin gwaji sun tabbatar da cewa a makon 12/2020 an gwada samfuri kimanin 483,295 har zuwa hade da makon 12/2020 da kuma samfuri 33.491 (kashi 6.9 bisa dari) wanda ya nuna akwai SARS-COV-2. A Isra’ila, masu bincike a Technion da Asibitin Rambam sun habaka da kuma yin wani salon gwajin don gwajin samfuri daga masu jinya 64 atare, ta hanyar gwajin samfurin da tabbatar da cewa hadadden samfurin ne kawai ya tabbata. A Wuhan an samu kimanin 2000-sq-meter a dakin gwaji na gaggawa wanda ake kira ‘’Huo-Yan’’ (da China: 火眼, ko ""Fire Eye"" a turance) wanda BGI suka budeshi a ranar 5 February 2020, wanda zai iya yin gwajin samfuri kimanin 10.000 a rana."
Tare da mai lura da ginin wato mai kafa BGI Wang Jian wanda ya dauka kwanaki 5, gwajin ta nuna akwai mai kamu da cutar a Hubei da zai fi kashi 47% da kuma daidai kudin da za a kashe domin kebewa da zai ninka kudin sau biyu inda yawan gwajin bai za kan layi ba.
Dakin gwajin Wuhan wanda dakin gwajin Hou-Yan ke bi a Shenzhen, Tianjin, Beijin, da Shanghai a cikin dukan birane 12 a kewayar kasar Sin.
A ranar 4 a watan Maris 2020 dukan gwajin ko wace rana sun kai 50,000. Origami Assays sun zana kuma sun saki Tushen budewa wato Open Source, Multilexed an saki su domin gwajin samfurin wadanda suka kamu da COVID19 dayawa kamar guda 1122 ta yin amfani da assays 93 ba tare da bukatar ruwan robotic handlers ba.
A watan Maris, karanci da rashin mahadin gwaji (reagent) ya hana yin gawji da yawa a kasashen turai (EU) da kuma UK da kasar Amurka.
Wannan ya sanya wasu marubuta su karanci shiryawar samfurin tsarin aikin wanda ya hada da dumawar samfuri a 98 °C (208 °F) na mintuna 5 don fitar da RNA genomes don karin gwajin. A ranar 31 ga watan Maris aka sanar cewa hadaddiyar daular larabawa sun fara gwajin coronavirus a cikin yawan jama’ar ta fiye da kowace kasa, kuma suna kan kokari domin kara yawan gwajin domin kai ga dukan yawan jama’a.
Wannan ya kasance ta hanyar haɗuwar karfin gwajin shiga wato drive-through, sayan na’uran gwajin population-scale mass-throughput daga kungiya 42 da BGI (bisa ga “Huo-Yan” dakunan gwajin ganowar gaggwa cikin kasar Sin).
An gina shi a kwana 14, dakin gwajin zai iya gudanar da gwaji dubu goma Na RT-PCR a rana kuma shine na farko da yake aiki a wajen kasar sin.
Kayayyakin gwaji daban-daban na sasan kwayoyin halitar coronavirus an haɓaka su a kasar Sin, Faransa, Jamus, Hon Kon, Japan, da kasar U.S.
Hukumar lafiya ta dunia ta dauki tsarin kasar Jamus na sarrafa abin gwaji wanda aka tura ƙasashe masu ƙarancin kuɗi wanda ba su da albarkun kasa domin sarrafa nasu.
An buga girke-girke na Jamusanci a ranar 17 Janairu 2020; ba a samu yarjejeniya da Cibiyar Kula da Cututtukan Amurka ba har zuwa 28 ga Janairu, jinkirta samar da gwaje-gwaje a cikin U.S.China da Amurka suna da matsaloli game da amincin kayan gwaji a farkon fashewar, kuma waɗannan ƙasashe da Ostiraliya sun kasa samar da isassun kayan sawa don gamsar da buƙatun da shawarwari na ƙwararrun masana kiwon lafiya.
Banda haka, masana sun ce taimakon yawan gwajin da akwai a Koriya ta Kudu ya taimaka wajen rage yaduwar cutar coronavirus.
Yanayin gwajin, yawanci dakin gwaji masu zaman kansu an gina su shekaru da yawa daga Gwamnatin Koiya ta Kudu.
Ranar 16 ga watan Maris, Hukumar Lafiya ta duniya tace yin gwaji shine hanya mafi kyau da inganci na wannan annobar COVID-19. Akwai bukatar gwai sosai don cutar yana yaduwa hakan ya kawo koma baya wajen gwajin a dakin gwajin U.S. da kuma bada samfurin da kuma sinadarin gwaji na da illa.
A watan Maris 2020 Kasar Sin ta rawaito matslolin wanda ya shafi kyawun kayan aiki.
A kasar Amurka,  abin gwaji da ka dabakar daga CDC yana da matsaloli sai gwamnati ta cire bangaranci wanda ke hana dakin gwaji masu zamna kasu suyi aiki. Kasar Spain ta sayi abin gwaji daga kasar sin wato Shenzhen Bioeasy Biotechnology co ltd sai ta samu cewa sakamakon bai da inganci.
Kamfanin ya bayyana cewa ba daidai ba sakamakon na iya zama sakamakon gazawar tattara samfurori ko amfani da kaya daidai.
Hukumar Spanish sunce zasu jany kayan gwanjin da bai da sakamako mai kyau, kuma zau sauya da wasu nau’in daban wan Shnghen Bioeasy 80% na abin gwajin na Czech Republic suka saya a kasar sin sun samu sakamako ba daidai ba. Slovakia sun say kusan abin gwaji miliyan 1.2 a kasar sin wan suka samu baiyi daidai ba.
Firayin Minista Matovic ya bada shawarar a aje shi cikin Danube Ates Kara na ma’aikatan kiwon lafiyar kasar Turkiyya yace abin gwajin da Kasar Turkiyya ta saya daga kasar Sin yana da kurakurai sosai kuma basa amfani dashi. Kasar UK ta sayi abin gwajin na kimanin miliyn 3.5 daga kasar Sin amma a farkon watan Aprilu 2020 sun ce wannan ba za’a iya amfani da su ba.
Gwadawa, da bin bayan kebewa wadanda aka same su da cutan da neman wadanda suka hadu da wadanda suka kamu da cutar SaRS-CoV-2 wadanda suka kamu da cutar suna da huldawa mara kyau wanda ke haifar kamuwa da cutan.
Masu bincike wadanda suke aiki a kasar Italy na VO a wurin da aka gano farin mutuwa ga CoVID-19 cikin Italy, sun gudanar da wasu gwaji kan dukan yawan jama’a guda 3,400, kusan kwanaki goma a rabe.
Kusan rabin masu dauke da cutar basa nuna alamomin ciwon kuma an kebe dukan wadanda aka same su da cutar.
Akan tsarin hana zirga-zirga, hakan sai ya kashe wasu ciwukan gaba daya.
Da bibiyan wanda suka hadu da marasa lafiya, tafiye-tafiye na cikin gida, gwaji da kebewa, cutar coronavirus na 2020 a Singapore na tafiya kadan-kadan fiye da wasu cikin kasashen da kasashen da suka yi girma, amma babu wata kuntatawa ba kamar rufewar dakin cin abinci da wuraren tsayar da kayayyaki.
An dakatar da duk wasu al’amuran, da kasar Singapore tayi ta sanar iyan gida cewa su zauna a gidan su ranar 28 ga watan Maris, amma an sake bude makarantu a ranar 23 ga watan Maris.
Kasashe da dama sun hana yaduwar annoban ta hanyar nemo wandanda sun cudanya da masu cutan, hana tafiye-tafiye, gwaje-gwaje da kuma tafiye-tafiyen masu cutar tare da kebancewar su amma banda hana mutane yawo kamar kasar Iceland da Koriya ta Kudu.
Binciken kididdiga ya nuna cewa kasashe wadanda suka yi gwaji sosai, abin da ya shafi adadin mutuwa, suna da karancin wanda suka jikata, watakila domin wadannan ƙasashen sun fi iya gano waɗanda ke da karami ko babu alamun kamu da cutan.
WHO ta ba da shawarar cewa ƙasashen da ba su da ƙarfin gwaji da dakunan gwaje-gwaje na ƙasa ba da ƙarancin kwarewa kan COVID-19 su aika farkon tabbatattun gwaji guda biyar da samfurin wadanda ba a tabatar ba duda goma COVID-19 samfurin daya daga cikin 16 na shaidar dakin gwajin WHO tabbatarwar gwajin.
Daga cikin shaidar dakin gwaji 16, 7 suna Asia, 5 a nahiyar turai, 2 a Afirka, 1 a Amurka ta arewada, 1 a Nahiyar Australia.
A wadanan ginshiƙi, al’amudi “tabbaci kamar % na gwaji” yana tasiri ta hanyar tsarin gwajin kasa.
Kasar da ke gwajin mutane kawai aka shigar da su a asibitoci za su sami inganci sosai a matsayin kashi % na gwaje-gwajen dukan ‘yan kasa, ko sun nuna alamun cutar ko babu, idan sauran abubuwa sun zama daidai.
Wanke hannu wadda aka sani da tsaftan hannu, hanya ce ta wanke hannye domin cire kasa, man shafawa, kananan halittu, ko kuma wasu abubuwa da ba a bukata.
"Wanke hannu da sabulu akai-akai ""Lokaci mai mahimmanci"" da rana yana hana yaduwar cututtuka da yawa, misali zawo da kwalara wanda ake yaɗa ta hanyar kashi-baki."
Hakanan mutane na iya kamuwa da cutar ta huhu ko kuma mura na yau da kullum, misali idan basu wanke hannayensu ba kafin su taɓa idanunsu, hanci da bakinsu.
Lokaci biyar da suke da mahimmaci a rana sune ayayin da wanke hannu da sabulu yanada mahimmanci hadi da:kafin da bayan fitowa daga bayan gida, bayan yiwa yaro tsarki kokuma canza wa yaro napkin, kafin bawa yaro abinci, kafin cin abinci, kafin da kuma bayan dafa abinci, dakuma bayan ta'ammali da danyen name, kifi ko gidan gona.
Idan ba'a samu ruwa da sabulu ba za'a iya wanke hannun da toka, WHO ta bada shawarar wanke hannu:
Kafin, lokacin, da bayan dafa abinci.
kafin ko kuma bayan lura da mara lafiya.
Bayan canza wa yaro zanin diapers ko tsaftace yaron da ya yi amfani da wurin bayan gida.
Bayan hura hanci, tari ko atishawa.
Bayan taɓa dabba, abincin dabbobi da kashin dabbobi.
Tsabtace hannu na tsarin likita yana nufin tsabtace aikin da ya shafi aikin likita.
Wanke hannu kafin bayar da magani ko jiyya kan iya hana ko ya rage yaduwan cutan.
Asalin dalilin lafiya na wanke hannaye shi ne domin cire wasu kananan halittu daga hannu (pathogens kamar bacteria, viruses, ko sauran kananan kwayoyin halitta masu kawo cuta) da sinadarai dake iya jawo illa ko cutuka.
Wannan yana da muhimmanci musamman ga mutane wadanda suke aikin abinci ko suna aiki a fannin lafiya, kuma yana da muhimmanci wa dukan al’umma.
Wanke hannaye nada anfani sosai game da ragewar cutar mura, cutar corona da sauran cututtukan da wani yakan shafawa wani, hana la'anar kamuwa da zawo da raguwar cutar lumfashi.
Da kuma rage mutuwar jarirai a haihuwar gida.
Wani bincike na 2013 ya nuna cewa ingantattun ayyukan wanke hannu na iya haifar da ƙananan ci gaba a cikin tsayi da girma a yara kasa da shekaru biyar.
A cikin kasashe masu tasowa, Ana iya rage yawan mace-macen kananan yara da suka danganci cutar numfashi da zawo ta hanyar gabatar da sauye sauyen halaye kamar wanke hannaye da sabulu.
Wannan matakin mai sauqi na iya rage yawan mace-mace daga wadannan cututtukan da kusan kashi 50%.
Kariya wanda ke kara matsayin wanken hannu na iya rage yawan zawo har kimanin kashi daya cikin uku, kuma za a iya kwatanta wannan da samar da ruwa mai tsabta a cikin matalauta.
48% na raguwar cututtukan zawo na iya haɗuwa da wanke hannu da sabulu. Wanke hannu da sabulu ita ce hanya mafi inganci kuma mai sauki don hana cutar gudawa da kamuwa da cutar huhu kamar yadda aka a cikin makarantu, gida da al'umma a duk duniya.
Kwayar cutar huhu, babbar cutar ARI, ita ce ta farko da ke haifar da mace-mace a tsakanin yara ‘yan kasa da shekara biyar, da ke ɗaukar kimanin yara miliyan 1.8 a shekara.
Cutar gudawa da na nimoniya suna kawo mutuwar yara kussan milliyan 3.5 a kowace shekara.
A cewar UNICEF wanke hannun da sabulu kafin cin abinci da bayan amfani da bayan gida yazama al'ada hakan zai ita ceton rai fiye da kowane allurar riga kafi kokuma magani, Yanke mace daga gudawa da kusan rabin kuma mutuwa daga kamuwa da cutar rashin iya lumfashi quater daya.
Wanke hannu koyaushe ana hade tare da sauran hanyoyin tsabtace ruwa a matsayin ɓangare na ruwa, tsabta da kuma tsabta (WASH).
Wanke hannu ma yakan kare daga impetigo (cutar fata) wadda ake samu ta wajen haduwa ta zahiri.
Karamin matsalar wanke hannu shine yawan wanke hannu na iya jawo lalacewar fatan jiki saboda bushewar fatan.
A wata binciken skarar 2012, an gano cewa yawan wanke hannu na iya jawo kaikayi, laushin hannu wanda ya fi yawa a cikin ma’aikatan lafiya.
Wanke hannu akai-akai shi ma ana ganinsa a matsayin daya daga cikin alamun yawan tunani mara fasali wato obsessive-compulsive disorder (OCD).
Akwai lokuta guda biyar duk rana da wanke hannu da sabulu ke da muhimmanci domin rage yaduwar cutan ta fuska da baki: bayan amfani da gidan wanka (fisari, ba haya), bayan gyara ma yaro ko yarinya duwawu (canza nafkin), kafin ciyar da yaro ko yarinya, kafin cin abinci da kuma kafin/bayan sarafa abinci ko rike danyen nama, kifi, ko kaza.
Sauran lokuta da ya kamata a dauki matakan wanke hannu da kyau domin guje wa yaduwar cutan ya hada da kafin ko kuma bayan jiyyan yanka ko rauni; bayan taba kashin daba ko rike dabbobi; da bayan taba datti.
A cikin ƙasashe da yawa akwai ƙarancin wanke hannuwa da sabulu.
Binciken wanke hannu a cikin kasashe 54 a shekarar 2015 ya gano cewa a matsakaici kashi 38.7% na mutanan gida suna wanke hannu da sabulu. Wani bincike na shekarar 2014 ya nuna cewa Saudiyya tana da mafi girman kaso na kashi 97% na jihar sai kasar amerika da ke kusa da tsakiya tare da kashi 77% sai china mai mafi karancin kashi 23%. Da yawa daga canjin yanayin canji yana karuwa da matakan wanke hannu da sabulu a lokaci mai mahimmanci Kungiyar wanke hannu na eh yara na makaranta a lokutan rana shine zaɓi ɗaya a cikin ƙasashe masu tasowa don sanyawa yara kudurin wanke hannu a cikin halayensu.
"""Shirin Tubalin Lafiya"" (“Essential Health Program”) wanda Hukumar Ilimi a Philippines ta aiwatar misali ne kan daukan matakin inganta lafiyar yara da iliminsu."
Ragewa sau biyu a shekara, wanda yake taimakawa da wanke hannu kullun tare da sabulu, goge baki yau da kullun tare da Fluoride, shine ainihin wannan shirin na ƙasa.
Hakanan an sami nasarar aiwatar da shi a Indonesia.
Cire kananan halittu da ido ba zai iya gani ba daga fata na kara ingantuwa idan aka hada da sabulu ko garin sabulu a ruwa.
Asalin mataki na sabulai da garin sabulu ana yi ne domin rage shinge ga nasara da karin narkewa.
Ruwa kadai muhimin abu ne na wanke fata ba domin mai da furotin, wadanda suna asali daga cikin kasa, wadda ba su narkewa cikin ruwa.
Ana tsarkakewa da taimakon ruwa mai gudu.
Sabulu na ruwa saboda shi za'a iya sake anfani dashi a kowane lokaci, zai iya riƙe kwayoyin cuta da aka samu daga amfanin da suka gabata.
ƙaramin nazarin karatu sun nuna canja wurin ƙwayoyin cuta daga gurbataccen sabulu an kammala canja wuri ba kamar yadda kwayoyin cuta suka tafi tare da kumfa.
CDC tana kan bayyana cewa “sabulun ruwa da hanyan zuba ruwa domin fitarwa ya fi kyau”.
Ana gargadin al’umma da su yi amfani da sabulu mai kashe kwayoyin cuta.
Zuwa yau, babu wata hujja da ke nuna amfani da ita don maganin rigakafin ƙwayar cuta ko kuma kwayoyin halittun da suke jure kwayoyin cuta a yanayi.
Duk da haka, Sabulun kariya daga kwayoyin cuta suna dauke da wakilai na kashe kwayar cuta irinsu triclosan, wanda yake dauke jerin abubuwa masu yawa na tsarin kwayoyin.
Don haka koda ba'a zabi kwayoyin juriyar garkuwan jiki ba don sabulun kariya daga kwayoyin cuta, yiwuwa ba za su zama da inganci yadda ake tallata su ba.
Bayan surfactant da fata mai wakilin kariya, Tsarin sararin samaniya yana iya ƙunsar ruwan yacid(acetic acid, ascorbic acid lactic acid) A matsayin mai tsara PH, antimicrobial active benzoic acid da kara yanayin fata (aleo vera, vitamin, menthol, plant extract) Takaitaccen bincike daga Jami'ar Orogon makarantar kula da lafiyar yanuna cewa sabulu a bayyane yake kamar sabulu masu kashe kwayoyin cuta mai kushe da triclosan don kariya daga rashin lafiya dakuma kashe kwayoyin cuta daka hannu.
Ruwan zafi da yake da dadin wanke hannu ba shi da zafin da zai iya kashe kwayoyin cutan.
Kwayoyin cuta sun fi girma idan jiki na da zafi wato a yanayin (37 °C).
Ko da shike, ruwan dumi, ruwan sabulu ya fi na sanyi aiki, ruwan sabulu ya fi cire mai da ke kasa, da kananan hallitu da ido ba zai iya gani ba.
Akasin abin da mutane suka gaskanta, bincike na kimiya ta nuna cewa amfani da ruwan dumi ba shi da wani amfani wajen rage yawan kananan halittu a hannaye.
Mai tsabtace hannu ko man kariya daga kwayar cuta wanda asalin wakilin tsaftar hannu mara ruwa.
A karshen sheakarun 1990 da farkon karni na 21, abubuwan tsaftace hannu masu sinadarin alcohol kuma wadanda ba ruwa a cikinsu (kuma akan kira su da man hannu mai sinadarin alcohol, man hannu na magani, ko man tsaftace hannu) sun samu shahara.
Yawancinsu sun dogara kan sinadarin isopropyl alcohol ko ethanol da aka hada tare da sinadarin sa abu ya yi kauri kamar Carbomer (polymer na acrylic acid) a cikin wani mai, ko hemectant kamar glycerin a cikin ruwa, ko kumfa don saukin amfani sannan don rage tasirin bushewa na sinadarin alcohol.
Dingara ƙara da aka samar da hydrogen-peroxide,, don ci gaba da ake dasu da ayyukan, sinadarin tsabtace hannu waɗanda ke ɗauke da mafi ƙarancin kashi 60-95% sune sukafi tasiri a kashe ƙwayoyin cuta.
Man shafawa a hannu maisinadarin kashe kwayoyin cuta, mai maganin juriya, Magungunan ƙwayoyin cuta masu guba da yawa(MRSA and VRE) cutar tarin fuka da wasu ƙwayoyin cuta (Ciki harda cutar HIV, cutar dabbobi, RSV, rhinovirus, vaccinia, mura da hepatitis) da fungi.
Mai tsftace hannu mai sinadarin Alcohol dauke da sinadarin alcohol kashi 70% suna kashewa kashi 99.97% (raguwar log 3.5, mai kama da raguwar decbel 35) na ƙwayoyin cuta akan hannaye secan 30 bayan shafawa da kashi 99.99% zuwa 99.999% (Raguwar log 4 zuwa 5) na ƙwayoyin cuta akan hannu minti 1 bayan bayan shafawa. Man tsaftacewan hannu suna da tasiri kan kwayoyin cutar bacteriya kuma da reshin tasiri kan kwayoyin cuta birus.
Man sabtace hannu na giya ba su da tasiri a kan cutar norovirus, mafi jawo gastroenteritis (ciwon ciki) mai yaduwa. Dole ayi amfani da antiseptic ko giya domin jika ko kuma rufe duka hannaye.
Ana goge gaba da baya na hannaye da kuma tsakanin iyakar dukkan yatsunsu kusan sekan 30 har sai ruwa, ta yi kumfa ko sinadarin tsaftar ya bushe.
Dole a wanke yatsa da kyau, a share duka tafin hannayen. US Center for Disease Control and Prevention sun ba da shawara da a wanke hannu tare da man tsaftace hannu, musamman idan hannaye sun nuna datti a zahiri.
kara amfani da wadannan wakilan Ya dogara ne akan sauƙin amfani da ayyukan kashewa da sauri akan kwayoyin cuta Koyaya ya kamata suyi amfani da matsayin sauyawa don wankin da ya dace saidai kuma idan babu ruwa ko sabulu.
Yawaita amfani da man tsaftace hannu mai sinadarin alcohol na iya jawo bushewar fata sai dai in an hada da sinadarin emollients da/ko sinadaran hana fata bushewa a cikin hadin.
Ana iya rage tasirin bushewar ko a cirewar sinadarin wanke hannu ta hanyar ƙara glycerin da/kokuma emollient ta dubara.
A cikin gwaji na asibiti, mayukan tsaftace hannu masu sinadarin alcohol waɗanda ke ɗauke da emollients sun haifar da ƙarancin kaikayin fata da bushewar fata fiye da sabulu ko sabulu mai maganin kananan halittu.
Rashin lafiyan kusanci dermatitis, kusancin urticaria ciwo ko rashin lafiyar jiki ga sinadari ko qari a cikin sinadarin wanke hannu baya faruwa.
Rashin karfin halin jawo matsalan haduwa da dermatitis ya zama abin jan hankali a bisan wanke hannu da sabulu da ruwa.
Duk da ingancinsu wakilin dabana ruwa bane baya tsabtace hannun, amma yana lalata su.
Dalilin haka ne man wanke hannu mai kashe kwayar cuta ba shi da tasiri kamar wanke hannu da ruwa da sabulu saboda hana yanduwar kwayoyin cuta da yawa, tun da ana samun sauran cututtukan a hannaye.
Aikin mai na tsaftace hannu ya dangana ga sinadaransa da inda aka sarafa shi, kuma bisa ga tarihi bai da wani amfani sosai da shafawa.
Kwanan nan, an nuna hanyoyin da ake hadin sinadarai benzalkonium chloride sun nuna suna da wadatarwa da kuma tarawar ayyukan antimicrobial bayan amfani, ba kamar sinadarin alcohol ba, ragewar inganci bayan maimaitawa amfani da ita, wataƙila sakamakon cigaban tsananin batawar fata.
Mutane da yawa cikin al’umma da ke da rashin kudi  ba za su iya siyan sabulu ba sai su yi amfani da toka ko ƙasa maimako su.
Toka ko kasa na iya zama da amfani fiye da zallan ruwa, amma ba zai kai sabulu aiki ba.
Wata abin damuwa shine idan kasa ko toka ta gurbata da kananan halittu da ido ba su gani, zai iya kara yaduwan cutan a maimakon ya rage ta.
Kamar sabulu, toka shima wakilin sabulune saboda yana iya fitar da kwayar cuta idan aka hada daruwa yana samar da sinadarin Alkaline.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawara ayi amfani da toka ko kasa a madadin sabulu idan babu sabulu.
Ingantattun hanyoyin wanke hannu da US Centers for Disease Control domin kiyaye yaduwar cuta suna nan kamar haka:
Jika hannaye da ruwan dumi ko ruwan tsanyi wanda ke gudu.
An ba da shawaran amfani da ruwa mai gudana saboda ruwa a cikin kwari na iya zama gurbatacce yayinda dumi ko sanyin ruwa ba zai canza komi ba.
Sa kumfa a hannu ta hanyar gaga su da sabulu sosai, hada da bayan hannu, tsakanin yatsu, da karkashin kusar yatsun.
Sabulu yana cire ƙwayar cuta daga fata, kuma bincike ya nuna cewa mutane sukan wanke hannayensu sosai lokacin da ake amfani da sabulu maimakon ruwa kaɗai.
Goge na tsawan akalla daƙiƙa 20.
Gogewa na haifar da karfin rikewa, wanda ke taimakawa wajen cire kwayar cuta daga fata, Kuma goga na tsawon lokaci yakan cire kwayoyi cutan da yawa.
A dauraye da kyau a ruwa mai gudana.
Daurayar hannaye acikin kwano yakan iya sake kama hannu.
Bushewa da tawul mai kyaw kokuma a shanya a iska a barshi ya bushe.
jikaken hannaye ko sukan saurin gurbantawa. Wurare da an fi samun haka sune babban yasa, wuyan hannu, tsakanin hannu da tafin hannu, tsakanin yatsu, da karkashen yatsu.
Yatsun hannu wanda mutum ya sa da sinadarin goge ƙusan yatsu na iya riƙe ƙwayoyin cuta.
An bada shawarar anfani da ruwan shafa fuska don hana hannayen daga bushewa, fata mai bushewa na iya haifar da lalacewar fata wanda zai iya lalata haɗarin kamuwa da cutar.
Akwai hanyoyi da yawa masu sauki wadda za a bi don inganta wanke hannu a inda babu ruwan famfo da/ko sabulu misali, zuba ruwa daga jarka da ke a rataye ko kwarya mai ramuka ko kuma amfani da jikin kankana da ramuka da/ko toka in bukata ta tashi a kasashe masu tasowa. A yayinda babu isashen ruwa (kamar makarantu ko kauyuka a kasashe masu tasowa), akwai hanyoyin kiyaye da ruwa kamar ratayayyen jarka da wasu hanyoyi masu sauki.
Magudanan ruwa na takawa da kafa ba tare da an sa hannu ba wata fasaha ce mai sauki wanda ya kunshi daura buta da igiya, da inda za a taka da kafa domin ya zubo ruwa kadan a hannaye da sandan sabulu.
Busar da hannaye da kyau hanya ce ta tsabtan hannu amma akwai muhawara a kan hanya mafi inganci a busarwa a gidan wankan jama’a.
Binciken haɓaka yanuna kuma yabada shawarar tawul ɗin takarda sun fi bada tsabta fiye da na'urar bushewar hannu ta lantarki da ake samu a ɗakunan wanka da yawa.
A shekarar 2008, wata bincike da University na Westminster, London, ta yi wanda masana’antan sarafa tawul takarda wato European Tissue Symposium, don kwatanta matakan tsabta da ake samu daga tawul takarda ta yi, dumin-iskar na’uran busar da hannu da na’urar iskar busar da hannu.
Bayan wankewa da busar da hannaye da warm-air dryer, an gano da cewa duka lambar kananan hallitu da ba a gani da ido na karuwa a kunbuna da akalla 194% da kuma tafin hannu da 254%.
Bushewa tare da na'urar iskar busarwa a karuwar matsakaicin yawan adadin ƙwayoyin cuta a kan yatsun hannu da 42% kuma a cikin tafin hannu da 15%.
Bayan wankewa da busar da hannu da tawul din takarda, duka adadin kwayar cutar bacteria kan kasan yatsu ya ragu da gwargwadon kashi 76% sannan kan tafin hannu har gwargwadon kashi 77%. Masanan kimiyan kuma sun yi wasu gwaje-gwaje domin tabbatar ko za a iya samun gurbata tsakanin masu amfani da bandaki da shi kanshi muhallin bandakin saboda kowanne irin hanyar busarwa.
Mabushin iska mai qirar jirgi mai sauqar ungulu, wanda ke busa iska daga cikin rukunin a kan gudu 180m/s (650km/h; 400mph) yana iya busar da kananun kwayoyin halitta daga hannu da na'urar kuma yakan iya lalata masu anfani da sauran wajan wanke-wanken da muhallin wajan wanke wanken har tsayin meter 2.
Amfani da na'urar bushewa da dumin iska yana yada kananan kwayoyin cuta har zuwa mita 0.25 daga na'urar bushewar.
Tawul tarkada ya nuna babu wani yaduwan kananan halittu da ido ba ya iya gani, wato micro-organism. A 2005, a wata bincike da kayyayakin TUV da yanayi, kimanta hanyoyin busar da hannu dabam-dabam.
Canje-canje masu zuwa a cikin ƙididdigar ƙwayoyin cuta bayan lura da bushewar hannaye:
Yawancin masana'antun kayan bushewar hannu sun wanzu, kuma an kwatanta na’urar bushewar hannu da bushewa da tawul ɗin takarda.
Wanke hannu ta hanyar amfani da tsabtace tsutsa hannu shine madadin yayin tafiya yayin da babu sabulu da ruwa.
Man tsabtace hannu mai dauke da sinadari alcohol yakamata ya ƙunshi aƙalla kashi 60% na sinadarin alcohol.
Wanke hannu na tsarin likita ya zama tilas wani dan kasar Hungary Ignaz semmelwais ya tabbatar da ingancin sa a shekara ta 1846 don hana yaduwar cutar a farfajiyar asibiti.
Akwai na'urorin lantarki waɗanda ke ba da ra'ayi don tunatar da ma'aikatan asibitin don wanke hannayen su lokacin da suka manta.
Nazari daya ta samo rage kamuwa da cuta tare da amfanin su.
Wankewar hannu na tsarin likitanci yana kai wa akalla tsawan dakikoki 15, tare da amfani da sabulu da ruwa mai yawa ko mai don kumfa da shafawa kowane bangare na hannu.
A shafa hannaye tare, ta yadda 'yan-yatsu za su yi tsifa.
Idan akwai tarkace a karkashin yatsun hanu, ana iya amfani da buroshi domin cire shi.
Tunda kwayoyi cuta na iya zama cikin ruwan da ya rage a hannayan mu, yana da mahimmanci a dauraye sosai kuma a goge da busasshen tawul mai tsafta.
Bayan busarwa, ayi amfani da tawul na takardan domin rufe ruwan (bude duk wani kofar fita in ta yiwu).
Wannan yana kiyaye sake gurbata hannaye da wadannan farfajiya.
Dalilin wanke hannu a cikin tsarin kula da lafiya shine a cire kwaya cututtukan jini wato pathogenic microorganisms (kwayar cutar) kuma su guji yada su.
Sabuwar mujalla na magani ta ba da rahoto da cewa wanke hannu a yawancin ma’aikatun lafiya ba abin karbuwa bane, yawancin likitoci da ingozomai sukan manta wanke hannu kafin taba marasa lafiya, wanda ke jawo yaduwan kananan halittu masu yada cuta.
Bincike ya nuna wanke hannu yadda ya dace kuma dabin sauran hanyoyin masu sauki zasu iya rage adadin catheter-cutar jini mai alaqa da kamuwa da cuta da kashi 66%, hukumar lafiya ta duniya (WHO) ta wallafa wata takarda dake nuna daidaitaccen wanke-wanke da kuma shafa hannu a sassan Lafiya.
Ana iya samun wannan ka’idoji na tsabtan hannu na kugiyan daga sashin yanar gizon ra’ayin jama’a.
Whitby et al. Sun gudanar da bita mai dacewa.
Na’urorin kasuwanci na iya auna tsaftan hannu, idan ana bukatan tsari, ana bukatan yarda.
Kungiyar lafiya ta duniya (WHO) na da lokuta biyar (Five Moments) na wanke hannaye:
bayan alaka da abin da ya kunshi jini ko ruwan jiki.
Kafin aiki aseptic, dakuma
"bayan jiyyan mara lafiya. Karin sinadarin kashe cuta a sabulu (sabulun ""maganin cuta"" ko ""maganin kwayoyin cuta) yana kara karfin kashe cuta ga man wanke hannu."
Ana iya son irin wannan kisan kafin a yi aikin tiyata ko a saiti, acikin kwayoyin juriya masu daukaka sosai, cuda hannuwa don aikin tiyata, wajibi ne a sami famfo wanda za'a iya kunna da kashewa ba tare da taɓawa da hannu ba, Wasu chlorhexidine ko aidin na wanke abu, bakararren tawul don bushewar hannu bayan an wanke, da bakararren burushi saboda cudawa da kuma wasu bakararren kayan aiki don tsaftace karkashin farce.
A cire dukan kayan ado.
Wannan hanya na bukatan wanke hannaye akalla mintuna 2 zuwa 6.
Dogon lokacin-gogewa (minti 10) ba lallai ba ne.
Yayinda ake wanke hannaye, kada a yarda a bar ruwa a gaban hannu yana komawa bayan hannu.
Bayan an gama wanke hannu, hannayen sun bushe da kayan mara tabarau kuma an yi wa kayan wanki tiyata.
Don rage yaduwar kwayar cuta, yana da kyaw a wanke hannuwa ko anfani da sabulun kariya kafin da kuma bayan dubawar mara lafiya.
Domin magance kamuwa da cutan staphylococcal a asibitai, an gano cewa babban amfanin wanke hannu har kashi 20% da karamar karin amfanin wanda aka samo lokacin wanke hannu kullum ya karu fiye da kashi 35%.
Wankewa da sabulu na yau da kullun yana haifar da sakamako sama da sau uku na ƙwayar cuta ta kwayar cutar zuwa abinci idan aka kwatanta da wanka tare da sabulu mai ƙwayar cuta. Kwatanta hannun-shafa tare da maganin shaye-shaye tare da wankewar hannu tare da sabulu na kwayar cuta na tsawon mintuna 30 na kowannensu ya nuna cewa barasa mai amfani da giya ya rage gurbatar kwayar cuta 26% fiye da sabulu na kwayar cuta.
Amma sabulu da ruwa yafi inganci akan sinadarin man alcohol wanda ake gogawa don raguwar H1N1 na cutar amai da gudawa dakuma clostridium defficile spores daga hannu, Ayyuka don inganta tsabtace hannu a cikin tsarin kula da lafiya na iya haɓaka ilimi ga ma'aikata a kan wanke hannu, da wadatar samar da sinadarin wanke hannu na goga wa da rubutattun fi'iloli da tunatarwa ga ma'aikatan.
Akwai buƙatar ƙarin bincike, a gano aciki wannen suka fi tasiri a tsarin kulawa da lafiya daban-daban.
A kasashe masu tasowa, ana ganin wanke hannu da sabulu a matsayin hanya mai sauki, hanya mai kyau na samun lafiya, da ma cin abinci mai kyau.
Ko da yake rashin ingantaccen ruwan sha, sabulu da kayan wanke hannu a gidaje, makarantu da wurin aiki ya sa yazama ƙalubale don cimma yanayin wanke hannu na duniya.
Misali a mafi yawan yankunan karkara na afirca famfunan wanke hannu na kusa da bayan gida na gwamnati kona gida yana da karanci, dukda cewa akwai zaɓuɓɓuka masu arha don gina tashoshin wanke hannu.
Kodayake ƙarancin filin wanke-wanke yana iya zama sakamakon al'ada maimakon rashin sabulu da ruwa.
Bayar da shawarwari a kan wanke hannu da sabulu na iya yin tasiri wurin yanke shawara, kara sani a kan muhimmancin wanke hannu kuma na iya kawo canjin halayan mutane.
Don wannan yayi aiki yadda yakamata, saka idanu da kimantawa wajibi ne.
A wata bita na bincike guda 70 ta nuna hanyan wayar da kai kan wanke hannu cikin al’umma ta fi inganci a wajen kara amincewa da wanke hannu a LMICs, sannan camfen na tallan jama’a ba shi da wani inganci mai kyau. Wata misali domin wayar da kai kan wanke hannu a makarantu shine “Three Star Approach” wadda UNICEF ta kago wanda ke karfafa makarantu su dauki matakai marasa sada domin ganin cewa dalibai sun wanke hannayensu da sabulu, tare da wasu hanyoyi na tsafta.
Idan aka iya cimma burin,makarantu na iya masawa zuwa fanni na tauraron karshe.
Gina wuraren wanke hannu na iya zama hanya ta kamfen da gabatarwa da ake yi domin rage cututtuka da mutuwan yara kanana.
Ranar wanke hannu na duniya wata misali ce ta kara sani da ke kokarin canza halaya. Sakamakon anobar cutan coronavirus 2019-20, UNICEF ta inganta amfani da emoji na wanke hannu.
''Yan nazarin kalilan sun yi la’akari da tasirin farashin wanke hannu a kasashe masu tasowa, a cikin alaƙar da aka hana DALY.
Koyaya, an bada shawara cewa inganta wanke hannu da sabulu yana da matukar tasiri fiye da sauran ruwa da tsabta.
Muhimmancin wanke hannu domin lafiya mutum musamman ma mutanen da ke mummunan yanayi kamar uwaye da suka haihu ko kuma sojoji da suke da rauni a asibiti tana da asali ne a tsakiyan karni ta sha tara (19th Century) ta wurin majagaba na tsabtan hannu guda biyu. ikitan Hugary Ignaz Semmelweis wanda ya yi aiki a Vienna, Austria da Florence Nightingale, baturiya “da ta kafa reno na zamani”.
A lokacin can yawancin mutane sun gaskanta cewa kamuwa da cutar na faruwa ne ta wurin wani wari mai suna miasmas.
A shekarun 1980, barkewar cuta daga abinci da haɗarin kamuwa da cuta don rashin kulawa da lafiya ya kai Cibiyar Kula da Cututtuka da Kariya na U.S. wato U.S Center for Disease Control and Prevention ga karfafawar tsabtacewar hannu a matseyin hanya mai dacewa ga kariya daga yaduwar cututtuka.
Cutar amai da gudawa a shekara ta 2009 da cutar ta COVID-19 a 2020 ta haifar da fadakarwa a kasashe da dama mahimmancin wanke hannu da sabulu don kare kai daga irin wannan cutar.
A misali, an rataya takaddan wayar da kai mai dauke da “hanyoyi ingantattu na wanke hannu,” kusa da inda ake wanke hannu a wurin bayi na jama’a da kuma wurin ba haya na ma’aikatu da filiayen jiragen sama a Jamus.
"Kalamai nan ""wanke hannun wani"" wani abu, yana nufin ayyana waɗanda basu yarda ba su ɗauki alhakin abin ko kuma suka yi tarayya cikin wahala."
Ya samo asali daga nassi na Baibul a cikin matthew, inda Pontius Pilate ya wanke hannun sa don giciye Yesu Kristi, amma sun zama zance tare da yawan yin amfani cikin al’uman Turanci.
A takaddan Shakespeare mai suna Macbeth, Lady Macbeth ta fara naciyan wanke hannaye da tunanin share tabo da take tunani, wadda ya nuna lamirinta ya kasheta a kan laifi da ta aikata kuma ta sa mijinta aikatawa.
An kuma gano cewa wasu mutane sukan wanke hannayensu sau da yawa, fiye da sauran jama’a bayan sun yi tunanin aikata wani abin da ya saba wa doka, kuma sukan martaba kayan wanke hannu fiye da saura.
Bugu da kari, wadanda aka barsu su wanke hannayensu bayan irin wannan ayukan ba a samani za su yi wani aikin tsaftacewa na ramako, kamar sadaukarwa.
Addinai suna gargadin wanke hannu domin tsabta da alaman ibada. Wanke hannu domin ibada, amfani da ruwa amma banda sabulu domin wanke hannaye, yana cikin wanke hannu domin ibada a addinai da yawa, ya hada da Imanin Baha’i, Hinduism, tevilah da netilat yadayim a Judaism, Lavado a Kiristanci, da wundu a Islam. Addinai su ma suna gargadin tsabtan wanke hannu, musamman bayan wasu ayuka.
Addinin hindu, juda da addinin musulunci sun yarda da wanke hannaye bawai anfani da bayan gida.
Sannan Hinduism, Buddhism, Sikhism, Judaism da Islam suna da umurnin wanke hannu kafin a ci abinci ko bayan kowanne cin abinci.
Kula da hadarin wurin aiki domin cutar COVID-19
Lura da hadarin wurin aiki daga CoVID-19 suna kariya a wurin aiki da hanyoyin kiwon lafiya don lura da hadari zuwa kare mutane daga kamuwa da cutar coronavirus COVID-19 shekarar 2019.
Lurawa na kwarai ga hadari a wurin aiki ya danganta ga yanayin wurin aikin da aikin, dangane da bincikan hadari dake tare da wurin yaduwan cutar, tsananin cutar a al’uma, da kuma hadari dake tare da ma’aikata wanda suna iya kamuwa da COVID-19.
Dangane da Hukumar Kula da Lafiya da Kiwon Lafiya wato Occupational Safety and Health Administration (OSHA), hadarin bayyana ga kankantan aikin huldawa tare da jama’a da wasu abokan aiki wanda ake bada shawarar matakan kariya na kamuwa da cuta, hade da wanke hannu, karfafa ma’aikata su kasance a gida idan ba su da lafiya, Da'awar numfashi, shara na yau da kullun, share da kashe kwayar cuta a yanayin wurin aiki.
Aiki wadanda suke da haɗarin cutar sun haɗa da waɗanda ke buƙata kulum ko huldawa da mutane ba a san su ba ko zaton suna da cutar COVID-19, amma suna iya kamuwa saboda yaduwar da ke kan faruwa cikin al’umma ko tafiya kasar waje.
Hakan ya hada da ma’aikata wadanda suke da hulɗa da jama’a kamar makarantu, yanayin da akwai yawan jama’a, da wuraren da ake yawan saye-saye.
Kulawar haɗari ga wadannan rukuni, bugu da kari game da hanyoyin karewar daga kamuwa da cuta ya hada da, na’urar bada iska wanda ke amfani da abun tacewar iska maikyau, abin rufe atishawa da samun kayayyakin sa a jiki idan har akwai wanda ya kamu da cutar COVID-19.
OSHA tana ɗaukar ma'aikatan kiwon lafiya da ma’aikatan gidan da aka fallasa ga sanannen mutum ko wanda ake zargi da COVID-19 kasance cikin haɗarin haɗari sosai, wanda ke ƙaruwa zuwa babban haɗarin haɗuwa idan ma’aikata suka bi ka’idar fesawar aerosl, ko tattarawa ko sarrafa samfuran daga, sanannu ko mutumin da ake zaton yana da cutar COVID-19.
Lurawar hadari wanda ke daidai ga ma’aikata na hade da lurar Injiniya kamar su dakin matsin na’urar iska, da kayayyakin kariyar ma’aikata wanda ya dace ga aikin.
Barkewar cOVID-19 na iya samun matsaloli dayawa daga wuring aiki.
Ma’aikata ka iya yin fashi aiki saboda rashin lafiya, ko don su kula da wasu, ko don tsoron kamuda da cutar.
Tsarin kasuwanci na iya canzawa, har ta bangaren wande irin kaya ake bukata, da yadda za ‘a samar da kayayyakin (Kamar sayen kaya a cikin dare ko ta hanyar drive-through sabis wato).
A karshe, kuma kayan da aka turo a nahiyoyi wuraren da ke da tsananin cutar COVID-19 na iya katsewa. Shiryawa don cuta wanda ke yaduwa za a iya amfani da tsarin amsa a mataseyin jagorar aikin kariya.
Tsari mai kyau ne yake rage hadarin dake tattare da wuraren ayuka da aikin yi, ya hada da inda aka kamu da cuta, lamuran tasowar hadarin daga gida da yanayin al’umma, da lamuran hadarin masun aiki kamar yawan shekaru ko wata yanayin lafiya mai tsanani.
Sun nuna tsarin lura wanda sun dace ga hadarorin, da tsarin gaba domin irin wannan hali wanda zai iya faruwa kum domin barkewar.
Shirin cututtuka masun yadawa da shirin amsawa za su iya zama taken shawarwarin kasa ko gefen kasa.
Manufofin samun bayanai idan an samu bulluwar cuta ya hada da rage yaduwarsa a tsakanin ma’aikata, kare lafiyar mutanen da ake ganin yafi saurin kamasu, gyara tsarin kasuwanci da muka rage cakuduwar wasu wanda suke kan tsarin.
CUtar na da tasiri a unguwani inda sana’o’i ke gudana.
Bibiyar lurawan hadari wata tsari ne wanda ake amfani da ita ko ina cikin lafiyar wuring aiki da lafiya zuwa hadarin rukuni ta muhimanci.
Inda baza a iya cirewar hadarin COVID-19 ba, lura mafi kyau su ne lurar injiniya, lurar gudanarwa ke bi, a karshe kayayyakin kariyar sa a jiki.
Lurar Injiniya ya danganta ga warewar ma’aikata daga hadarin da ta shafi aiki ba tare da dogara kan halayen ma’aikata ba, kuma zai zama mafita mai arha wanda aka aiwatar.
Hukumar lura na canja yanayin aiki da tsari da zai bukaci hobbasa na ma’aikaci.
Kayayyakin kariya wato Personal Protective Equipent (PPE) ana ganin kamar baida karfin kariya amma zai taimaka wajen rage wata cutar, amma zai iya rage kamuwa da cutan.
Duk na’uin PPE dole a zabe su kafin hadarin ya afku ga ma’aikaci, asa shi yadda ya kamata (Ms. abin numfashi), asahi akoda yaushe kuma da kyau, kuma a rika duba shi akai-akai, a kuma canja idan ya kama kuma a cire, a wanke, a addana shi da kyau don gudun shina ya jirkita.
Bisa ga Kariyar Wurin Aiki da Gudanarwar Lafiya wato Occupational Safety and Health Administration na U.S. (OSHA), karamin bayyana cikin hadarin wurin aiki na da kankancin huldawar ma’aikaci da jama’a da wasu ma’aikaci.
Asali tsarin kariya daga kamuwa da cuta ya bada shawarar ga duk wuraren aiki sun hada da cikakken wanke hanu kullum, karfafarwa ma’aikata su kasance a gida idan ba su da lafiya, da’ar hanyoyin numfashi tare da rufin tari da atishawa, samarwar rumbun takarda da shara, shirya wajen aiki daga gida ko kuma juyin jefi-jefi idan an buƙaci haka, hana ma’aikata daga amfani da kayan aikin da kayan wasu, da kiyaye tsabtatawar rage cutan da kuma lalata yanayin aiki.
Saurin Ganowa da kuma kebe wanda suke da cutar shine hanya mafi inganci wanjen kare lafiyar ma’aikat, kwastamomi. baki da kuma wanda suke wuraren aikin su.
Sashen bangaren kula da cututtuka da kariya na U.S. wato U.S. Centers for Disease Control and Prevention (CDC) tace ma’aikata da suke da alamomin ciwon numashi su zauna a gida har sai sun warke, idan alamun zazzabi ya dade har ya kai tsawon awa 24 batare da ya ragu ba ko alamar bai jin magani kuma hutun rashin lafiya yayi daidai to abar ma;aikaci ya zauna agida ya yi jinyar mara lafiyar tunda sun san tsare-tsaren.
A fadawar OSHA, aiki wadanda suke da haɗarin cutar sun haɗa da waɗanda ke buƙata kulum ko huldawa tsakanin ƙafa shida (1.8 m) na mutanen da ba a san su ba ko kuma waɗanda ake ganin suna da cutar COVID-19, amma suna iya kamuwa da SARS-CoV-2 saboda yaduwar cutar tsakanin al'umma a wuraren kasuwanci, ko kuma saboda wani yayi tafiya a wata ƙasa zuwa wani wuri mai wanda yaduwar COVID-19 ya faru.
Waɗannan sun haɗa da ma'aikata waɗanda ke da hulɗa tare da dukan jama'a kamar a makarantu, wuraren aiki mai yanayin aiki wanda akwai yawan jama’a kwarai da gaske, da wuraren da ake yawan saye-saye. Sarrafawar injiniya don wannan da rukuni masun hadari ya hada da girkawar ingantaciyar mataciyar iska, karin adadin na’urar iska, girkawar shingen zahiri kamar na’uran roba na kariyar atishawa, da girkawar tagar drive-through domin hidimar abokan ciniki. Lura na mai gudanarwa domin wannan da rukuni mafi hadari wanda suka hada da karfafa ma’aikacin da ba su da lafiya su zauna a gida, canza haduwar fuska-ta-fuska da sadarwar nesa, kaddamar da juying aiki, bar tafiye-tafiyen da babu kan ta zuwa inda akwai barkewar cutar COVID-19, haɓaka tsarin sadarwa na gaggawa hade da taron amsa damuwan ma'aikatan, samar da ma'aikata ingantaccen ilimi da horo kan dalilan haɗarin COVID-19 da halayyar kariya, ma'aikatan horo waɗanda suke buƙatar yin amfani da kare sutura da kayan aiki yadda za a yi amfani da shi, samar da albarkatu da yanayin aiki wanda ke inganta tsabtace mutum, buƙatar wanke hannu na yau da kullun, iyakance abokan ciniki da kuma damar samun dama ga masu aiki, da kuma sanya hannu kan batun Wanke hannu da sauran matakan kariya na COVID-19.Doke kan aikin, ma’aikatan da ke da hatsarin aƙalla na matsakaici na iya buƙatar sa kayan kariya na sirri da suka haɗa da wasu safofin hannu, gown, garkuwar fuska ko abin rufe fuska, ko goggles.
Ma’aikaci wanda suke a cikin rukunin masun hadari suna bukatar amfani da na’uran iska.
Idan mutum ya kamu da rashin lafiya a cikin jirgin sama, madaidaiciyar iko don kare ma'aikata da sauran fasinjoji sun haɗa da rarrabe mara lafiya da wasu tazara ta ƙafa 6, zayyana daya daga cikin matukan jirgin don bautar da mara lafiya, da kuma bayar da abin rufe fuska ga mara lafiya ko tambayar mai mara lafiyar ya rufe bakinsu da hanci da kyallen takarda yayin tari ko atishawa.
Masu bin jirgin ruwa su sa safar hannun asibiti lokacin da ake kula da matafiyin mara lafiya ko tabawar ruwan jiki ko yiwuwar gurbatan muhalli, da yiwuwar ƙarin kayan aikin kariya idan matafiyi mara lafiyan na da zazzabi, tari mai dauriya, ko wahalar numfashi.
Safar hannu da sauran abubuwan da za'a iya zubar dasu a cikin jakar hadarin kwayoyin, fuskar abubawa wanda suna da cutar yakamata a tsabtace shi kuma a cire cutar bayan haka. Don jigilar kasuwanci, hade da jiragen shakatawa da sauran jiragen fasinjoji, sarrafa haɗari sun haɗa da jinkirta tafiya lokacin rashin lafiya, da waren kai da kuma sanar da cibiyar kula da lafiya kai tsaye idan mutum ya kamu da zazzabi ko wasu alamun yayin da ake tafiya.
Mafi kyawu abi da tsarin kiwon lafiya a wurin da ake kebe mutane. A makarantu da wurin kula da yara, CDC tace yakamata a dan rufe su don a samu a tsaftace wurin koda an samu mai dauke da ciwon da makaratar batare da dubiya da yaduwarsa a unguwaba.
Idan akwai dan yaduwa cutar kadan a al-umma, sai a samu tsarin bada tazara kamar hana zirga-zirga, taro, harda manya tarurruka kamar daura or ajin choir, ko wurin cin abinci, sai a matsar da tebura, da lokutan tashi, rage masu ziyara wandanda basu zama wajibi ba, da kuma ware wani sashe na yare wanda suke da alamun mura.
Lokacin da akwai yaduwar cuta cikin al’umar gida, bugu da kari ga zaman nesa, dogon kwanakin hutu daga makarantu ana iya sa cikin lisafi. Ga ma’aikacin iyansanda wadanda su ke aikinsu na yau da kullum, hadarin kamuwa da cutan yana kasa haka CDC suka fada.
Jami’an mahukunta wadanda dole ne su hadu da mutanen da aka same su da cutar ko ake zaton suna da COVID-19 ana shawartarsu da bin dokokin gaggawa na masun aikin asibiti, tare da ingantaccen kayan aikin kariya.
idan an samu huldawa lokacin tsoro, ma’aikaci su share da tsaftace kayayyakin aikin su kafin a sake aiki da su ta amfani da abin fesawa na gida ko sharewa, da bin umurin amfani da su domin isawa da yarwa da PPE wanda aka yi amfani da ita da wanke kayan sa wa.
OSHA na duba yiwuwar wani bangaren kiwon lafiya da ma’aikata wurin ajiye gawa domin zama a tsaye domin hadarin kamuwa da cutan.
Hadarin ayuka wadanda ke da bayyanarwar mutum sun hadu da ma’aikan kiwon lafiya, tallafi, dakin gwaji da ma’aikatan jigilar asibiti wadanda a bayyanai suke ga mai kamu da cutan ko wanda ake zato na da COVID-19.
Sukan zama cikin hadari sosai idan ma’aikata suka bi ka’idar fesawar aerosl wato aerosol-generating, ko amsar abun gwaji daga wanda ake zargin nada coVID-19.
ka’idar fesawar aerosl wato aerosal generating pocedures ya hada da shigarwa, kakalo tari , da kuma ain da ya shafiy huhu da sauransu.
Wanda hadarin yafi akansu sune aikin gidan ajiye gawa sun hada da ma’aikaci wadanda ke gyara gawakin mutanen da aka san su ko ana ganin kamar suna dauke da COVID-19 a lokacin mutuwar su; wadanan suna da hadari sosai idan sun gwada gawan. Karin sarrafawar injiniya a wadannan rukuni masun hadarin cutar ya hada da dakunan kebe wadanda suka kamu da cutar ko wadanda ake zato suna da COVID-19 duk lokacin ka’idar fesawar aerosl wato aerosol-generating procedures.
Na’urar bada iska na musamman ya kan iya zaman daidai a wasu wuraren kiwo lafiya wuraren dakunan ajiye gawaki.
Ya kamata a rike dukan samfura da matakan kariya uku na lafiyar halita wato Biosafety Level 3 prcaution.
Hukumar lafiya ta duniya (WHO) sun bada shawarar cewa a kebe sabbin marasa lafiya a wasu wurare daban zai dangata ko wani ne wanda ya kamu da cutar COVID-19.. Bugu da kari zuwa wasu PPE, OSHA an shawarta yin amfani da na’urar bada iska ga wadanda suke aiki tsakanin kafa 6 ga marasa lafiyan da aka sani ko wanda ake gani na da cutar, SARS-COV-2, da wadanda ke yin ka’idar fesawar aerosl wato aerosol-generating procedures.
A kasar Amurka, NIOSH ta amince da N95 don tace abin numfashi ko ma yin amfani dasu da kyau, an samu kariya wanda ya hada da gwaji mai kyau, karantarwa da kuma gwajin asibiti.
Wasu na’uran iska suna iya karewa mai kyau tare da inganta jin dadin ma’aikata. WHO ba ta amince yin amfani da kabido ba, don COVID-19 ciwon ne na hanyar numfashi wanda ke yaduwa ta hanyar ruwan jiki.
WHO ta shawarta cewa abun rufe fuska na asibiti ya dace ga ma’aikan dubawa don point-of-entry.
Ga wadanda ke karban samfuring gwajin hanyar numfashi daga, lura wa, ko tafiyar da wanda ya kamu da COVID-19 ba tare da ka’idar fesawar aerosl ba wato aerosol-generating procedure, WHO ta shawarta cewa, abin rufe fuskar tiyata, tabarau, ko garkuwar fuska, babban riga, da safar hannu.
Idan an bi ka’idar fesawar aerosl wato aerosol-generating akayi, zai mayar da gurbin amfani da abin rufe fuskar asibiti wato N95 ko abin numfashi FFP2.
Ganin cewa wadatarwar PPE a duniya bai isa ba, WHO ta ba da shawarar rage buƙatar PPE ta hanyar ba da magunguna ta hanyar sadarwa, shinge na jiki kamar wani budadeyar abun rufe fuska, barin waɗanda ke da hannu cikin kulawa kai tsaye su shiga daki da mai kamu da cutar COVID-19 yake, yin amfani da PPE kawai don takamaiman aikin, ci gaba da amfani da na’urar bada iska wanda aka saba ba tare da cire shi ba yayin da kulawa da marasa lafiya da yawa da cuta iri daya, lura da daidaita wadatarwar yawan PPE, da kuma hana amfani da abin rufe fuska ga mutane da suke da alamar cutar.
DAGA: Katherine Maher, Shugaban Gidauniyar Wikimedia
ZUWA: Dukka Ma’akacin Gidauniyar Wikimedia
LAYIN TAKE: [Covid-19] Ragewar kayan da kuma shiri don gaba
TURA KWANA/LOKACI: Ranar 14 ga watan Maris, 2020, 00:24 UTC
Bada dama: CC0: No rights reserved
Mun samu kanmu cikin wani yanayi kwarai a wannan watan.
Annobar COVID-19 wani abu ne da ke bayyanarwar dangantakar mu a duniya da kuma nauyin da ya rataya ga kowanen mu.
Ba mu da fi son domin kalubale, amma mun tsani cewa, amsar mu ya danganta ga tausayawa, hadin gwiwa da ginan al’uma wanda yake zaune cikin zuciyar gungiyar.
Zaman tare da kulawa da muka gani a cikin dukkanin abokan aikin namu kan imel, kira, da taɗi wani tabbaci ne na tabbataccen mutane muna da sa’a sosai don aiki tare.
Bazan yi kasa a gwuiwa ba na insaku cikin abokan aikina ba.
Makon jiya, wani ya raba godiyar sa ga aikin mu
Sun tunastar da ni yaddan duniyar ta iya sauya Wikipea ayanzu, wanda ta zama zakaran gwajin dafi ta kasance bude a yanar gizo kuma ga kowa
Ayyukan ka sun sa wannan ya yiwu, shin ka kiyaye shafukan yanar gizon su tsaya ko abokan aikinmu sun biya ko kuma daga ajiyar al'ummomin mu.
Duniya tana bukatar bayanan da Wikipeidia ka bayarwa, fiye da haka yanzu.
Wannan lokaci ne wanda ba abin da mu ke yi ba ne, amma yadda muka yi shi, hakan zai tasiri sosai ga duniya.
Saboda amfani mqnufqr wannan da kuma irin rawar da zaka taka zamu yi wasu yan canje-canje a tsarin aikin namu wanda hakan zai fara a mako mai zuwa.
Daidaitawa ga aikin mu da tsarin aiki
Kamar yadda Robyn ya ce, su kungiya c wato c-team sun hadu a daren jiya sun tattauna kusantar mu da tsari don kwanaki da watanni masu zuwa.
A wannan zancen, mun duba abin da mu ka ga zai dace ga amsar abin da mu ke fuskanta da kuma kyakyawar hanya wanda zai rike kungiyar ta dace a wannan lokacin.
Muna so mu cire damuwa da tallafawa manufan mu ga dogon lokacin.
Idan kana son kara kira, shikenan.
Don duka ma’aikata, Yan kwangila da ma’aikatancu/
Zatan aikin mu na ko wace rana zai zama kamar sa’oi 4 a rana, ko sa’oi 20 a mako har sai sanarwan nan gaba.
Ba zamu ba da hutu ba - idan zaka iya aiki sosai a sa’oin da aka saba, kungiyar za to iya aiki da kai.
Duk da haka, ba za a iya annabtar duniya a yanzu ba, kuma ya kamata a lura da kaunattatu, saya kayan miya, ko je wurin likita, lafiyar ku shine fifikon mu.
Ba mu bi lokacin ka
Idan ba ku da lafiya, kada ku yi aiki
Wannan ya tafi batare da an yi magana ba, amma muna maganan sa.
Babu ranar ciwo ko bukatar PTO fada wa manajan ku da taimakon sake kalandar kungiyar ku da tsarin tabbatar muhimin panin aiki.
(Idan an maku gwaji aka tabbatar kuna dauke da cutar COVID-19, to kabar Bryan cikin T&amp;C Ops san haka T&amp;C zai taimaka wajen tabbatar da cewa lamarin ya samu kulawa ta mussamman).
Za a biya cikakke Jama'ar sa’oi.
Mun riga mun ce, kuma muna girmama dukkanin sadaukarwar mu ga iyar kwangilar mu da ma’aikata abokanin aikin sa’oi.
Za a biya kowa daidai da yanayin aikin da suka yi na awoyi kamar yadda yake.
Wannan ya hada da idan kana ciwo kuma ka kasa yin aiki.
Idan zaku yii aiki, zamu tallafa maka.
Mutane da yawa suna mafani da aiki a matsayin hanyar turo matsalolin su a duniya kewaye da mu.
Abin da muke yi na iya zama mai bada ladan gaske, musamman irin wadannan lokutan.
Haka kuma wannan game da kula da kaine
Aikin mu shine yin magana da manajanka, sabo da mu san me muke bukata da yadda za mu iya daidaita.
Wasu ayyukan suna da muhimmanci.
Akwai wasu abubuwan da ya kamata mu ci gaba da yi.
SRE, HR Ops, Dogaro da aminci, da teamsungiyoyin tara kuɗi (a tsakanin sauran) suna yin aiki mai mahimmanci wanda ke buƙatar ƙarin tallafi.
Za mu fara aiwatar da dukkan sashin don tantance manufofin yanzu kuma musanya hankali kan tallafawa abin da ke da muhimmanci a aikin mu.
Akwai sauran aiki mai yawa akanmu, amma zamu mai da hankali akan masu muhimmanci.
Raguwa yanzu ba zai cutar ba nan gaba.
Bama shirin tafiya “karo-lokaci sau biyu don a cimma buri” idan annoban ta kare..
Baza a so ku yin aiki da karin awa ba domin yanzu lokacin gama aikin ba abu ne mai yiwuwa ba.
Mun yardacewa yanayi ya canja, kuma zamu yi aikin da zai samar da sabbin tsare-tsare aka lokaci idan ya kama.
Me ya faru da APP (Tsarin Shekara)?
Don iya canza zuwa yanayin yanzu da sa’oin ayukan mu na yau da kullum, muna tunanin canza lokacin domin iya kai ga tsarin mu na shekara 2020-2021
NIyyarmu shine mu kara jan tsarin mu na shekara 2019-2020 wanda zai bada lokacin kasafin kudi sosai don barin ma’aikata su bada hankalin su ga muhimin ayyuka, kulawar kai, da kulawar kaunatattu yayinda ake barin wadanda suke bukatar ko son aiki a ragen tsarin lokaci a cikin makonai masu zuwa.
Karin wannan lokacin ya kara rage shirin nauyin aiki da matsi a fadin kungiyar.
Zamu tura tsarin mu ga tsangayarmu mako mai zuwa tare da sabbin jami’ai da kungiya a kan tsarin mu na gaba don tabbatarwa.
Na gode wa kungiyar APP saboda jagoranci ku a wannan.
Matsayin ofishi, cikin hadari, da tsaftacewa
A makon da ta gabata mun samu cewa daya daga cikin ma’aikacin na SF-BASEDya kamu da cutar COVID-19.
Duk da haka, cikin yawaltar kiyayewa, mun samo wata ƙungiya masu tsabtacewar kwayan cuta domin su share dukan farfajiya a ofishin mu na San Francisco.
A goge ko ina da abin kashe kwayoyin cuta don hana yaduwar cuta a wuri, harda hanyoyi da bangaren lungu na kasa.
Ginin na samun sabon yanayi na tsarin kulawa da lura na kayyayaki don tabbatar da lafiyar mutanenta.
Muna jin dadin cewa za a shirya ofishin duk lokacin da muka shirya dawowa.
Ofishin mu na DC wanda yake WeWork, wanda ya baiyanar da tsarin CoVID-19 damu da duk wani ma’aikacin DC-BASED
A makon da ta gabata, Ofishin mu na DC suka zama cikakken wuri tare da bayanan kariya daga San Francisco.
Kamar wasu abokan aikinmu wandanda ke da zama a NYC sun san,muna cikin tattaunawa game da bayar da wata wuri Brooklyn.
Ana cin gaba da wadannan zance amma ya kan yi jinkiri.
Wasu ma’aikatanmu suna aiki daga nesa akaro na farko.
Abokai aikinmu na nesa sun san cewar zai iya zaman daidaitawa ne, kuma suna son su bada shawara.
A rage tsawon tattaunawa zuwa dai awa daya ko biyu a jere.
Idan ana buƙatar tsawan lokaci, yi tunani yadda za a rarraba su a cikin kwanakin gaba da yawa.
Ƙayyade haduwar sosai, sami dalilin taron, da tura da kayayyakin karatu.
Ka sanya bidiyo yazama na ainihi, da kayan aiki irin su Google Docs da Zoom don sauƙaƙe saduwa da sadarwa na kai tsaye ta hanyar intanet.
Yi jagora don sauƙaƙewar kowane taro, wani don saka idanu akan tattaunawa don tambayoyi da bibiyar jerin masu magana, da kuma wani don taimakawa wajen daukar bayanan (ko hadin gwiwan daukan-rubutu).
Ka tura sakon imel ga tech support idan kan bukata na’urar sa a kune wato headset wanda ke da dadi.
Yi amfani da abin kara lafiyar ka a matsayin abun ciye-ciye.
Shiga tashar #remoties a Slack domin tatauna da abokan aiki game da rarrabawar aiki.
Ayyukan HR tana neman jagora cikin jagorar tushen ginin gizon ergonomics don tallafawa karuwan rarraba aikin a fadin Gidauniyar.
Mun tambayi dukan al’uma a makon da ta gabata su ba magajiya su sauke tallafin kudin Wikimedia ga jama’a, kamar editathons, har sai WHO tace annobar ya kare.
Mun sanar da cewa mun fahimta bukatun mu na dakatar da wasu ƙuntatawa zai sa gamawar yarjejeniyan tallafin kudin su da wuya da cewa babu wani wanda za a hukuna domin bata lokaci ko gyara manufofin.
Zamu sake bi da karin jagorori cikin mako mai zuwa kan Wikimedia da wasu yanki da taron al’uma yadda aka saba.
Tunanin mutane gabaki daya daga al’uman duniya ya nuna zaman a matsayin bakin ciki da rushewa amma an sake a ganawa maikyau da karfin mai da hankali a kan al’umai, Wikimedia da in ba haka ba.
Cin gaba, CRT tana aiki wajen samar da shafi ta META-WIKI don samar da fili don al’uma zasu lura kuma su rika bin dukkanin bayananmu da su.
Kasance cikin lura da duk abinda ya shafi COVID-19
Zamu tura muku da gayyatar ta kalanda Ranar Alhamis mai zuwa, 14:00 UTC/07:00 PT don taron na mussamma ga ma’aikatan mu.
Za mu yi amfani da wannan lokacin don raba ƙarin sabuntawa, amsa tambayoyin kuma kashe ɗan lokaci kaɗan don haɗu da juna.
Muna cikin wannan tare kuma muna nan mu taimaki duk yadda za mu iya.
A dan lokaci nan, zaku iya samun bayanan na ta wannan imel, da kuma wurin da ya shafi bayanai iri daya na COVID-19 kan Office Wiki,
CRT kan aje shafukan ne da kyau da dukan bayanaia wuri guda.
Muna aiki don ci gaba da sadarwa tare da ma'aikata waɗanda suke zaune a cikin ƙasashen da a halin yanzu suke shafa.
Idan kana da tambaya game da yin tafiya, ko wani sha’ani, ko wani aiki, ko cike gurbi ko wani abu to kana bukatar taimako kar kaji komai ka sanar damu ka ba CRT goyon baya.
Muna nan don mu bada taimakon mu da tallafi idan an bukaci hakan.
Idan kana da wani abu mai muhimmanci ko al’amari mai bukatar kulawa, don Allah ka tura sakon imel ga Bryan Judan - Darectan HR International Global Operations.
Kada a ga wadannan canje-canje a matsayin barin aiki gaba daya da takalifi.
Maimakon haka, suna sanen cewa a wannan lokacin, aikin mu da takalifin kan iya buƙaci daidaitawa ta hanyar da ba mu yi ba a da.
Wadannan sune matakan da muke gani yana da muhimmanci domin tallafawa juna sabo da mu ci gaba da gudanar da aiki, mu samar wa kungiyar mu da taimakon da suke bukata, da aikin da duniya ta dogara.
Tsarin aikin mu na nan kuma na kan jiran mu idan lokacin ya yi.
A yanzu, lokaci ne na kula da juna a kuma samar da wuri domin muhimancin aikin da ke zuwa cikin makonai da watakila watanai masu zuwa.
Muna bukatan goyon bayan ku wajen tabbatar da hakan ta yiwu, don haka muna so ku kula da kan ku da iyalan ku don kusamu damar taimakawar idan bukatan haka ta taso.
Yanzu, don Allah - ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, ita CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, and Tony S), tare da sauran shuwagabanni (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
Juyawar b’Angiotensin enzyme na 2 (ACE2) wani enzyme ne wanda aka haɗe zuwa saman farfajiya (membranes cell) na sel a cikin huhu, arteries, zuciya, koda, da hanji.
ACE2 yana ƙididdige ayyukan aikin enzyme mai alaƙa da haɗin gwiwa (ACE) ta hanyar rage yawan ƙwayar angiotensin-II da haɓaka Ang (1-7) yana sanya shi manufa mai mahimmanci don magance cututtukan zuciya. ACE2 kuma yana aiki azaman hanyar shiga cikin sel don wasu coronaviruses.
Irin ra’ayi enzyme na dan Adam ana kiransa hACE2.
Ingantaccen enzyme na Angiotensin 2 shine zinc wanda ke dauke da ironloenzyme wanda yake a saman endothelial da sauran sel.
Abubuwan gina jiki na ACE2 ya ƙunshi yanki na N-terminal peptidase M2 da yankin C-terminal collectrin renal amino acid transportar domain.
ACE2 nau'ikan furotin membrane ne mai wucewa, tare da yanki mai aiki na enzymatically wanda yake fallasa saman sel a cikin huhu da sauran kyallen jiki.
Yankin extracellular na ACE2 an barke shi daga yanki mai ƙwayar cuta ta wani enzyme da aka sani da zubar da jini, kuma sakamakon furotin mai narkewa ana fitar dashi cikin magudanar jini kuma a ƙarshe ya kasance cikin fitsari.
ACE2 yana nan cikin yawancin gabobin: ACE2 na haɗu da fatar mafi yawa nau’in huhu II na tantanin halitar alveolar, enterocytes na ƙananan hanji, jijiya da ƙwayoyin jijiyoyin tantanin halita na zuciya da kuma ƙwayoyin tsoka mai laushi a cikin yawancin gabobin.
ACE2 MRNA bayanana ana iya samun su a cerebral cortex, straitum hypotamalamus da briainstem.
Aikin farko na ACE2 shine tsaya a matsayin daidaita ma'auni ga ACE.
ACE ta kuntatawa angiotensin I hormone cikin vasoconstricting angiotensin II.
ACE2 bi da bi ya kuntatawa da carboxyl-terminal amino acid phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) da hydrolyses shi cikin vasodilator angiotensin (1-7), (H-Asp-Arg -Val-Tyr-Ile-His-Pro-OH).
ACE2 na iya share wasu peptides da suka hada da [des-Arg9] -bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 kuma yana daidaita fataucin membrane na tsaka mai ɗaukar amino acid SLC6A19 kuma yana da nasaba da cutar ta Hartnup.
A matsayin transmembrane furotin, ACE2 na aiki a matsayin babban hanyar shiga cikin tantanin halita (Cell) ga wasu coronavirus, hade da HCoV-NL63; SARS-CoV (kwayar cuta da ke haifar da SARS); da SARS-CoV-2 (kwayar cuta da ke haifar da COVID-19).
mussaman kamar dai hadewar protein spike s1 na sars-cov da sars-cov2 do hadewa majinyacin a ACE2 a sansanin kwayar halitta wanda sakakmakon haka na haifar da endocytosis da translocation na cutar da ma kwayar hallitar a cikin endosome wanda ce a cikin cells.
mashigar na tar-tare da dukkan kaidojin priming na S protein na daga maajin serine protease TMPRSS2, da samuwar wanda ake bincikawa a yanzua matsayin babban thrapeutic. wanan ya jagoranci saukar kintaci a matakin na ACE2, a cikin cells, wada ka iya taimakawa wajen kokawa da cutar.
ko da kuwa ya yawan su alummar kwarraru dama sun bukaci cigaba da tsarin ACE inhibitor dama ARB therapyh.
wane sake duba aka wallalfa a yuly 11 na 2012 wanda ya gano ACE inhibitiors nada alaka da kaso 34% na ragin sanyi in ka kwatanta da maaunan.
kura hadarin sanyi aka bawa majinyatan ACE inhibitors wanda ka daf da kamuwa da sanyoi. ko mutuwar jiki ko zuciya.
Amfani da masu hana kwayoyin cuta na ACE shima yana da alaƙa da rage yawan mace-macen huhu, kodayake sakamakon da aka samu ba shi da ƙima baya ga haɗarin cutar huhu.
Haduwar tantanin halita mutum wato Recombination human ACE2 (rhACE2) ana zaton zaman jinyar tsanani ciwon huhu, ya bayyana zuwa ingantawar aikin huhun da isashen iska a cikin kananan aledu da jawowar cututtukar lipopolysaccharide wanda ke haifar alamun tsananin gajiyar hanyar numfashi.
rabin ran RHACE2 a mutane na da sa’a 10 da aikin dakika 30 ciki harda karin aikin sa’a 24.
Yawancin binciken da aka samu sun nuna cewa rhACE2 na iya zama magani wadanda basa jureyar renin-angiotensin system inhibitors (RAS inhibitors) ko a cututtuka in da kewayewar anglotensin II na ɗaukaka. An kimanta rhACE2 wanda aka cika a gwajin asibiti domin jinyar alamun tsananin gajiyar hanyar numfashi.
"b'COVID-19 sune aikace-aikacen software na wayar hannu waɗanda aka tsara don taimaka wajan tuntuɓar ganowa don mayar da martani ga cutar ta coronavirus ta 2019-20, watau aiwatar da gano mutane (""lambobin sadarwa"") waɗanda wataƙila sun kasance suna hulɗa da mutumin da ya kamu."
neman shiga da dama aka kero ko samo, amman da tallafin gwamnati a wasu yankunan da mazaunan bayannane.
tsari da dama dan gano wanda aka yi alaka dasu aka bijiro.
An tayar da damuwar sirri, musamman game da tsarin da ya danganta ga bin wuraren kasashen masu amfani da manahaja.
karamin wani KAFAR na amfani da iska don shiga sansanin yanar wassu wayoyin.
A ranar 10 ga Afrilu 2020, Google da Apple sun ba da sanarwar cewa za su haɗu da ayyuka don tallafa wa irin waɗannan aikace-aikacen da ke cikin Bluetooth kai tsaye a cikin tsarin aikinsu na Android da iOS.
A cikin China, gwamnatin kasar, tare da hadin gwiwar Alipay, ta tura wani manahaja wanda barin 'yan ƙasa damar bincika idan sun kasance suna hulɗa da mutanen da ke da cutar COVID-19.
Ana amfani da shi sama da biranen China fiye da 200. A Singapore, ana amfani da wani app da ake kira TraceTogether.
"Al'umar gida na IT ne suka kirkiro manahanjar, an sake shi a matsayin budade ne kuma za a mika shi ga gwamnati. Arewacin Makidoniya ta ƙaddamar da ""StopKorona!"", Wata manahanja ce ta Bluetooth don gano haɗarin daga mutanen da ke kamuwa da kwaya cutar kuma suna ba da amsa ga hukumomin lafiya."
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Kiwon lafiya ne suka kirkiri app din.
Tun daga ranar 14 ga watan Afrilu 2020, app ɗin yana jiran amincewa daga Google Play Store da Apple App Store.
ranar 12 ga watan afrilu gwamnatin tace bibiyar muammal ta manhaja na ciki zanon jigaba kuma an kusa sakin shi cikin makwanin makamanciyar wannan manhaja ake kir kira a ireland da mma faransa stopcovid.
Dukansu Ostiraliya da New Zealand suna la'akari da aikace-aikacen da aka yi amfani da su dangane da TraceTogether app na Singapore da yarjejeniya ta BlueTrace. Rasha ta yi niyyar gabatar da wani babban juzu'i na kayan aiki ga marasa lafiya da aka gano tare da COVID-19 da ke zaune a Moscow, wanda aka tsara don tabbatar da cewa ba su bar gida ba.
Ross Anderson, farfesa a fannin injiniya na tsaro a Jami'ar Cambridge, ya lissafa wasu matsaloli masu yuwuwar aiwatar da tsare-tsaren aikace-aikacen na yanar gizo, gami da karairayi na karya da kuma yiwuwar rashin inganci idan shan kayan aikin zai iyakance ne ga karancin al'umma.
Magance damuwa game da yaudarar yaduwar ko cutarwar manhajar “coronavirus”, Apple ta seta iyaka a bisan irin na’uin da kungiya za su iya sa wanda ke da alaka da coronavirus a cikin shagon manhaja, iyakance su kawai “jami’oi” ko wasu kungiya da ke sananne.
Google da amazon sun aiwatar da ƙuntatawa iri daya.
Masu tallata bayanan sirri sun bayyana damuwar su game da tasirin sa ido tsakanin jama'a ta amfani da kayan aikin coronavirus, musamman game da ko kayayyakin aikin sa ido da aka kirkira don magance cutar ta Coronavirus za a watsar da zarar barazanar ta wuce.
Kungiyar kare hakkin dan adam ta Amnesty International da wasu kungiyoyi sama da 100 sun fitar da sanarwa suna kiran a takaita wannan nau'in sa ido.
Kungiyoyin sun bayana yanayi takwas a kan ayyukan gwamnati:
Dole ne ayyukan sa ido su kasance “bisa doka, sannan ya zama ana bukatar sa, kuma daidai gwargwado”.
buda ko kula da bibini na iya samun yammacin.
yin amfani da bayanai ya zama dole ne a taƙaice ga dalilai na COVID-19;
Dole ne a kiyaye bayanan sirri da kuma ba da ma'amala kuma a nuna a kiyaye shi bisa dalilai;
Saka ido kan marasa lafiya ta hanyar na’uran dijital dole ne a guje wariaya da raban kai.
duk wani musayar bayanai tare da wasu dole ne a ayyana shi a cikin doka;
Akwai kiyayewa daga zagi da kuma hakkin 'yan kasa don mayar da martani ga cin zarafin;
Shiga tataunawar da ma’ana ga dukkan masu fada aji ake bukata, dama na ma’aikatan kiwon lafiya da kungiyoyi gammayayar kungiyanr na’urar jamus CCC da ma yan jarida marasa iyaka (Reporter ohne Grenzen) RSF suma sun fidda sunayen dubawa.
Tsarin Google / Apple da aka gabatar ya yi niyya don magance matsalar ci gaba da sa ido ta hanyar cire hanyar ganowa daga cikin tsarin aikin na’urar su muddin ba a bukatar hakan.
wasu kasashen sun yi amfani da bibiyar inda ake a maimakon manhajojin wanda ke fitar da amfanin sauke manhajar da kuma kare bibiyar in da ake.
A cikin Isra’ila, an amince da bincika hanyoyin sadarwa.
Mafita hanyoyin sadarwa waɗanda ke da damar yin amfani da bayanan albarkatun wuri suna da mahimmancin nuna matsalolin sirri.
Koyaya, ba duk tsarin da sabobin tsakiya ke buƙatar samun damar zuwa wurin bayanan sirri ba; da yawa tsarin tsare sirri na sirri wadanda aka kirkira wadanda suke amfani da sabobin tsakiya kawai don sadarwa (duba sashin da ke ƙasa).
A Korea ta Kudu wata kafa ce ba manhaja ba akayi amfani da ita wajen gano muammala.
Maimakon yin amfani da tsararren manahaja (app), tsarin ya tattara bayanan bin diddigin abubuwa daga kafofin da yawa haɗe da bayanan waya da bayanan ma'amala na katin, da haɗa waɗannan don haifar da sanarwa ta hanyar saƙonnin rubutu ga mutane masu kamuwa da cuta.
Baya ga yin amfani da wannan bayanin don faɗakar da abokan hulɗa, gwamnatin ta kuma sanya bayanan wurin a bayyane, wani abin da aka ba da izini saboda canje-canje masu yawa ga dokokin sirri bayan fashewar MERS a waccan ƙasar.
Ana amfani da wannan bayanin ga jama'a ta hanyar wasu aikace-aikace da shafukan yanar gizo. Asusun da ya haɗa da Jamus an yi amfani da su ta amfani da tsarin tsarke da tsare sirri.
a ranar 6 ga watan Afrilu 2020, ba bayanin da aka saki tukkunna.
Tsare bayanan sirri na tuntuɓar ganowa ingantaccen tsari ne, tare da ingantaccen jikin littafin binciken waɗanda suka fara komawa aƙalla shekarar 2013. Tun daga 7 Afrilu 2020, sama da gwanayen kwararru goma sha biyu suna aiki akan mafita na sirri, kamar amfani da Bluetooth Low Energy (BLE) don rattaba kusanci ga mai amfani da sauran wayoyin salula.
Duk da haka, PEPP-PT ƙoƙari ne na haɗin gwiwar wanda ya ƙunshi duka hanyoyin tsakiya da kuma hanyoyin sassauƙa, ba yarjejeniya ɗaya ba. Ka'idojin da aka ba da sun hada da Kan Sirri na Shaida (DP-PPT / DP-3T), Lambobin Gida na Lokaci (TCN, fka ayyukar lambobin haduwa, CEN), Tsarin Sirrin da Tsarin Hanyoyi don Binciken Sadarwar Waya (PACT) da sauran su.
a wannan tsarin kamnceceniya akan bayanan ba a bari akan na’urar amman duk hadan akan na’urar ke faruwa.
gammayar rashin shiga hadi na dakin gwajin MIT suna ta kirkiro da hanyoyi wanda ke da kariya a kafar ta hanyar laakari da rashin shiga hadi wajen bibiya da ma amfani da wajen ko gurbin dake a ware na bayanan sirri don bibiya yaduwar covid-19.
yanada alaka da bincike na farar takardar Apps gone rogue bada tazara ta mussaman na hana shiga haddi a annoba wanda aka saki a watan maris 2020 a wani makamancin kokari na kafar safe trace na enigma mpc wani kamfani mai kirkrirar kimmiya wanda ya samo tushe dagss dakin gwaji na MIT.
safe trace na amfani da kimiyya wajen barin masu amfani da kafar ta hanyar bayanar da waje mai jan hankali da bayanan kiwon lafiya da ma’aikata ba tare da sun shiga haddin su ba.
Ranar 5 ga watan Afrilu 2020, kungiyoyin TCN na duniya suka kafa ƙungiyoyin da suka haɗa kan abin da ainihi hanya ɗaya suke bi kuma yawancin karɓar ladabi, tare da burin rage rarrabuwar kawuna, da kuma ba da damar ci gaba da ma'amala na duniya gaba ɗaya ta hanyar ganowa da faɗakarwa kantunan aikace-aikace, mahimmin ɓangaren cimma burin yaduwar.
A ranar 9 ga watan afrilu 2020, gwamnatin singapore ta sanar da bude tushen gano sanadin alaka ta manhajar ta na gwamnatin kasa.
A ranar 10 ga Afrilu 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na wayar salula na Android da iOS, sun ba da sanarwar wani shiri don ganowa, wanda suka ce za su adana sirrin, wanda ya danganta da haɗin fasahar Bluetooth Low Energy da kuma tsare sirrin sirri.
sun kuma wallafa tsari na ainahin kimiyyar da aka yi amfani da shi a cikin kafar.
Dangane da Apple da Google, tsarin yana da niyyar yin birgima a matakai uku:
fitar da kayan aiki don bawa gwamnati dama kirkiro mahaja ma bibiya da kuma hana shiga hadin mutane.
haɗa wadanan hanyoyin aikin kai tsaye cikin iOS da Android Google da Apple shirin don magance matsalolin kulawa da ci gaba ta hanyar rarraba tsarin ta hanyar sabunta tsarin aiki, kuma daga baya cire shi a cikin hanyar da zarar barazanar ta wuce.
sake zaman b’Drug wanda aka fi sani da sake neman, sake tsarin, sake aikin, ko chanjin kulawar shine sanu tsarin yardajen magani don warkar da cututuka daban-daban ko tsarin magani wanda ba dan haka aka kirkiro shi ba.
wannan binciken layi daya ne na ilimin fasaha wanda aka fara don samun ingantaccen maganin covid-19.
Sauran hanyoyin nazarce-nazarcen sun hada da haɓakar allurar rigakafin ƙwaƙwalwar ƙwayar cuta ta COVID-19 da ƙwayar cutar plasma ta convalescent.SARS-CoV-2 yana da kimanin sunadarai 66 na magani, kowannensu yana da shafuka masu ɗaukar nauyin ligand.
awun wannan shafuka na bada daman fito da aiki mai inganci dan cigaba da samar da magani covid-19 proteins.
Daya daga cikin muhimman SARS CoV2 kamun proteins sune Papain like proteins RNA dogaro RNA polymerse. helicase, s Protein da ADP ribophosphatase.
Hussein AA, da ma wasu sun karanci kowani kwayar halitar sannan suka auna tare da gwada kamanceceniyar kwarangwal da magunguna wanda suka fi karbuwa don gaggauta samar da maganin SARS Cov-2 a yayin gwajin kiwon lafiya dln shawarta a tsarin binciken kiwon lafiya.
Chloroquine magani ne na zazzabin cizon sauro wanda kuma ana amfani dashi akan wasu cututtuka na garkuwa.
a ranar 18 ga watan maris WHO ta sanar cewa choloroquine da dangin hydroxychloroqueen na daga ciki magunguna hudu wanda za a yi gwajin kiwon lafiya dasu na hadin kai.
Gwamnan New York Andrew Cuomo ya ba da sanarwar cewa gwaji na jihar New York zai fara aiki a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin yin amfani da hydroxychloroquine sulfate da chloroquine phosphate a karkashin Izinin Amfani na gaggawa (EUA).
Ba a yardada tsarin jinyar gwajin asibiti wanda FDA'S su ka yi ba kuma an ba shi izini a karkashin EUA kawai azaman jinyar gwaji don amfani na gaggawa a cikin marasa lafiya da ke asibiti amma ba su iya karɓar magani a cikin gwajin asibiti ba
"CDC ta ce ""ba a kafa amfani da, allura, ko tsawon lokacin hydroxychloroquine don maganin cizon prophylaxis ko kula da kamuwa da cututtukan SARS-CoV-2"" ba tukuna."
Likitoci Sun ce Suna Amfani Da Kwayar maganin In “Babu Mafita”.
Wata tawaga da ke bincike a Turkiyya a Istanbul na gudanar da karamin bincike kan amfanin chloroquine a hade da zinc, Vitamin A, Vitamin C da Vitamin D.
bincike babba na guddana a jami’ar duke da ma jami’ar oxford .
nyu makarantar karatun likita na gwajin wani matakin kariya da ma rsahin amfani da hydroxychloroquine.
"Gwajin asibiti na kasar Sin a Wuhan da Shenzhen sun ce sun nuna favipiravir ""a bayyanen inganci""."
Marasa lafiya 35 a Shenzhen gwajin ta nuna ba su da cutar ba a tsakiyar kwana 4, yayin da tsawon rashin lafiya ya kasance kwanaki 11 a cikin marasa lafiyar 45 waɗanda ba su kamu da shi ba.
A cikin wani binciken da aka yi a Wuhan a kan mutane 240 da ke fama da cutar huhu, rabi ne aka ba su fulopiravir kuma rabi suka karɓi umifenovir.
hukuma magani na italia na tiunasar wa akan tabacin tallafi na magani da gwajin shi.
A ranar 2 ga watan Afrilu, Jamus ta sanar cewa za ta sayi maganin daga Japan don ajiyar ta, kuma za ta yi amfani da sojoji wajen isar da maganin a asibitocin jami'a, inda za a yi amfani da maganin don yi wa marasa lafiya na COVID-19.
Bisa ga rahoton Morning Post na China ta Kudu, Shinzo Abe ya yi yarjejeniya ga gwamnatin Trump domin sayawar magani. Maganin na iya zama mara karfi cikin cututtuka masu tsanani inda kwayar cutan ta yadu.
Yana iya zama ba amintaccen amfani ga mata masu juna biyu ko waɗanda ke ƙoƙarin yin ciki.
"Daya daga cikin binciken lopinavir / ritonavir (Kaletra), haɗuwa da maganin rigakafin lopinavir da ritonavir, sun kammala cewa ""babu wani fa'ida da aka gani""."
an shiyar maganin ne ta yanda zai hana HIV zama a ciki da ma kamanceceniya da hadewar protese.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin sauya magungunan don samo wani fili wanda zai ɗaure tare da kariya ta SARS-CoV-2.Da akwai zargi a cikin ƙungiyar kimiyya game da ba da gudummawar albarkatun don sake dawo da magunguna musamman da aka tsara don cutar HIV / Kanjamau.
Hukumar ta WHO ta hada da lopinavir / ritonavir a cikin shari'ar Solidarity ta kasa da kasa.
Remdesivir ya kirkiro da haɓaka ta Gilead Sciences a matsayin kwayar cutar Ebola da kamuwa da cutar Marburg. Bayan haka, ilimin kimiyyar Gileyad ya gano cewa Remdesivir yana da aikin rigakafi a cikin fitsari a kan ƙwayoyin cuta masu yawa, ƙwayoyin cuta, paramyxo-, da ƙwayoyin cuta.
Daya daga cikin matsalolin warkar da irin wannan cuta shi ne yakan bijirewa magani ta hanyar sake launi wanda ka iya haifar da wasu cututuka masu tsanani da yaduwa.
Wasu daga farkon bincike da aka yi sun nuna cewa karatun zai iya samun babbar illa ta hanyar juriya. Akwai gwaji na asibiti da yawa, wadanda suka hada da asibitocin Jami'ar Cleveland guda biyu; daya na mutanen da ke da matsakaici na rashin lafiya da kuma wani don waɗanda ke da tsananin ciwo.
Akwai gwajin asibiti guda uku masu wanda ake gudanarwa na bitamin C ta cikin Jijiyar jini don mutanen da ke asibiti da rashin lafiya mai tsanani domin COVID-19; sarrafawar maganin gwaji guda biyu (Sin, Kanada) da daya wanda babu sarrafawa (Italiya)
Jihar New York ta fara gwajin garkuwan halita azithromycin a ranar 24 ga watan Maris 2020.
hukumar kasar japan ta lafiya da magani a duniya NCGM na shirin gwaji teijin alvesco ciclisionide abun shaka na corticosteriod na asthma domin warkar da kamun farko na cutar corona.
Wani nau'i na angiotensin-mai canza yanayin enzyme 2, an fara gwaji yeneyi Phase II tare da marasa lafiya 200 don ɗaukar su daga mummunan, cututtukan asibiti a Denmark, Jamus, da Austria don sanin tasirin magani.
Masu Bincike A Makarantar Zuciya Ta Montreal Na Kasar Canada Na bincikan matsayin Colchicine a ragewar kumburi da rikitarwa huhu a marasa lafiya wanda suke Fama Daga Karamin alamun ciwon COVID-19.
binciken mai suna colcorona na dauka sama da mutane 6000 masu shekara 40 sama wanda suka kamu da covid-19 kuma sun dana makarancin hali ba na asibiti ba.
Matan da ke da juna biyu ko masun bada nono ko kuma ba su da ingantaccen tsarin hana haihuwa, ba su cancanta ba.
da dama anticoagulants ana ta gwada su a ksar italy.
ana amfani da low molecular weight wajen warkar da majinyata, wanda hakan yasa hukumomin italia suka wallafa kaidojin amfani da shi.
wani bincikie ya nuna majinyata 300 na amfani da enoxaparin sodium da prophylaxix da therapautickimar da aka sanar a 14 a afrilu.
Tunda SARS-CoV-2 kwayar cuta ce, an mayar da hankali sosai kan batun kimiyya don mayar da martani don ƙaddamar da magungunan rigakafin da aka yarda da su wanda aka kirkira don barkewar cutar kamar MERS, SARS, da kwayar cutar ta West Nile.
Ribavirin: An bada shawarar jinyar COVID-19 da Ribavirin bisa ga bugun ka'idoji na 7 kasar Sin
Umifenovir: an ba da shawarar umifenovir don maganin COVID-19 bisa ga ka'idoji na 7 na kasar Chinese
wasu magungun na iya warkar da covid-19.
Tocilizumab (Anti-IL-6 receptor): China ta amince da shi.
kuma gwaji a italy da china ku kalli Tocilizumab #COVID-19.
allurar rigakafin b'A COVID-19 maganin rigakafin cutar coronavirus 2019 (COVID-19).
Kodayake babu maganin alurar riga kafi da ya kammala gwajin asibiti, akwai ƙoƙarin da yawa a cikin ci gaba don haɓaka irin wannan maganin.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin samun allurar rigakafin ƙwayar cutar SARS-CoV-2, ta zama ƙasa da watanni 18.
‘Yan maganin rigakafi su biyar na cikin Mataki I na karatun lafiya cikin Afrilu.
An gano covid-19 a december 2019.
A wa ni barkewar a duniya a 2020 yasa karin haniun jari a BINCIKEN NEMAN MAGANI.
Kungiya da yawa na amfani da kwayar halita genomes ta wajen haɓakawar maganin rigakafin SARS-CoV-2.
An fara shi a watan Afrilu, muhimancin himmar CEPI don haɓaka maganin rigakafi da wuri, yawan sarrafawa, turawa da yawa, da samun sa a duk duniya.
A watan Afrilu, masanan kimiyya na CEPI sun ba da rahoton cewa hanyoyin fasahar fasaha daban-daban 10 suna ƙarƙashin bincike da haɓakawa a farkon 2020 don ƙirƙirar ingantaccen allurar rigakafin COVID-19.
zauruka dayawa sun danawa sihag cigaban shashi na I akan karatun kariya kamar;
nucleic Acid (DNA Da RNA) (Mataki I mai haɓakawa da masun maganin rigakafii: Moderna, mRNA-1273)
viral vector (Tsarin I na haɓakawa kuma ɗan takarar alurar rigakafi: CanSino Biologics, adenovirus type 5 vector)
Wani rahoton cepi na masu fasaha a watan afrilu, magunguna 115 aka fara kerowa da 78 tabbatatu masu cigaba 79 a cewar makarantar miken 37 son sanar amman babu bayani a cikin alumma ana zaton suna tsari ko shiryawa a dakunan gwaji da dama.
A shashe na I-II na gwajin kiyayewar farko da gwajin garkuwa, ana hade sune ba zabi kuma ba riko da wajen kuma a waje dayawa, wanda ke bada sahihanci dama ingantacen kima.
Gwajin matakai na III yawanci ya ƙunshi ƙarin mahalarta, gami da rukuni na sarrafawa, da gwajin tasiri na cutar rigakafin don hana cutar, yayin sa ido don tasirin mummunar sakamako mafi kyau.
"Daga cikin 'yan gwajin rigakafin 79 a cikin ci gaba (wanda aka tabbatar da shi tun farkon Afrilu 2020), 74 ba su kasance cikin kimantawar ɗan Adam ba (har yanzu suna cikin ""preclinical” bincike)."
Kusan ran 24 ga watar Janairu shekarar 2020 a Ostiraliya, Jami'ar Queensland ta ba da sanarwar cewa tana binciken yiwuwar rigakafin ƙwayar cuta wanda zai iya canza kwayar furotin don ta tada tsarin garkuwa.
A kusan 24 Janairu 2020 a kasar Kanada, Cibiyar Kula da Alurar rigakafi ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta ba da sanarwar fara aiki a kan allurar rigakafin, da nufin fara gwajin ɗan adam a cikin 2021.
An sanar da Ayyukan haɓakawar Rigakafi A Hukumar Kula Da Karewar Daga Cuta A 26 ga watar Junairu 2020 A China, Da Jami'ar Honk Kong a ranar 28 ga watan Janairu.
A wuraren 29 ga watan junairu 2020 kamfanoni magungunna na jassen wanda henneke schuitemaker ke jagoranta, su sanar da fara kirkikra maganin.
janssen na kirkiro magani na rowa tare da abokin huldar shir wadan ya kware a dakin gwaji vaxart.
A ranar 18 ga watan Maris 2020, Emergent BioSolutions sun ba da sanarwar hadin gwiwan sarrafawa tare da Vaxart don haɓakar maganin rigakafi.
A ranar 8 ga Fabrairu 2020, dakin gwaje-gwaje na OncoGen a Romania sun buga takarda kan ƙirar rigakafin tare da fasaha mai kama da wannan don maganin rigakafin cutar kansa.
A ranar 25 Ga Watan Maris Shugaban Makarantar Bincike ya sanar cewa sun gama hadawar Rigakafin kuma and fara gwajin ta.
A ranar 27 ga Fabrairu 2020, wani kamfanin tallafi na Generex, NuGenerex Immuno-Oncology, ya ba da sanarwar cewa sun fara aikin rigakafin cutar don kirkirar wani allurar rigakafin Ii-Key a kan COVID-19.
Suna So Su Samar Da Rigakafin Da Za A Iya Gwada Shi A Kan Mutum “A tsakanin Kwanaki 90.”
A ranar 5 Maris 2020, Jami'ar Washington da ke St. Louis ta ba da sanarwar ayyukanta don bunkasa allurar rigakafi.
A rana 5 ga watan Maris 2020, aurka makarantar sojin ta su n vyi vbincvike a fort derick da walter reed da makarantar bincike na silver spring duk a western mary lant sun sanar da aikin ne man nagani.
A kusan 10 Maris 2020, Emergent Biosolutions ya ba da sanarwar cewa ta yi ma'amala tare da Novavax Inc.
a hadin da ma kir-kirar magani.
Abokan haɗin gwiwar sun kara ba da sanarwar shirye-shiryen gwajin fari da Mataki I na gwajin asibiti a watan Yuli 2020.
A ranar 12 Maris 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki tare da kebe guda 11, kuma koda akan saurin sauri zai ɗauki akalla shekara ɗaya da rabi zuwa shekara biyu don samar da maganin.
A ranar 12 ga watan Maris 2020, Medicago, kamfani a fannin ilimin halittu a Birnin Quebec, Quebec, ya ba da rahoton ci gaban coronavirus-kamar ɓarke ƙarƙashin ɓangare na kudade daga Makarantun Kanada don Binciken Kiwon Lafiya.
Maganin riga kafin da ake gwaji Na Cikin Dakin Bincike, Da tsarin gwajin a watan Yuly Ko AuGusta 2020.
A farkon makon nan, Jaridar The Guardian ta bayar da rahoton cewa Shugaban Amurka Donald Trump ya yi wa CureVac '' kudade masu yawa 'don damar samun damar yin amfani da allurar rigakafin cutar ta' 'Covid-19', wanda gwamnatin Jamus ta nuna rashin amincewarta.
Ranar 17 ga watan Maris 2020, Kamfanin maganin Amurka Pfizer ta sanar da hadin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka rigakafi irin ta mRNA.
magani irin na mRNA-based dan bNT162, wanda a yanzu ke cikin gwajin lafiya ana tsamanin shi a april 2020.
A Italiya a ranar 17 Maris 2020, Takis Biotech, wani kamfani na ilimin kimiyyar kere-kere na Italiya ya sanar da cewa za su sami sakamakon gwajin-asibiti a watan Afrilu 2020 kuma dan takarar na karshe na rigakafin cutar zai iya fara gwajin dan adam da faduwa.
A Faransa a ranar 19 Maris 2020, Kungiyar Hadin Gwiwa game da Cike da cuta (CEPI) ta sanar da saka hannun jari na dala miliyan $ 4.9 a cikin wata cibiyar bincike ta COVID-19 wacce ta shafi Institut Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, suna kawowa, Jami'ar Pittsburgh, suna kawowa Jami'ar Pittsburgh, suna kawo Kudaden hannun jarin CEPI a cikin ci gaban allurar rigakafin COVID-19 zuwa dala miliyan 29.
Sauran abokan hadin gwiwar CEPI don ci gaban allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris 2020, jami’an kiwon lafiya na kasar Rasha sun ba da sanarwar cewa masana kimiyya sun fara gwajin dabbobi daban-daban ‘yan takarar rigakafi shida.
Masu binciken Kwalejin Kwaleji ta Landan sun sanar a ranar 20 ga Maris 2020 cewa suna haɓaka maganin RNA na karɓar kansa don COVID-19.
Aka haɓaka maganin rigakafin cikin kwanaki 14 ya inda aka samo jerin gwajin daga China.
A ƙarshen watan Maris, gwamnatin Kanada ta ba da sanarwan miliyan C$275 a cikin kudade don ayyukan bincike na 96 a kan magungunan ƙetare game da COVID-19, hade da takara da yawa na allurar rigakafi a kamfanoni da jami'o'in Kanada, kamar ayyukan Medicago da Jami'ar Saskatchewan.
"A kusan lokaci guda, Gwamnatin Kanada ta ba da miliyan C$192 musamman don inganta allurar rigakafin COVID-19, tare da shirye-shiryen kafa ""bankin maganin rigakafin"" na ƙasa na wasu sabbin alluran rigakafin da za a iya amfani da su idan wani barkewar cutar coronavirus ya faru."
"A ranar 2 ga Afrilu 2020, masu bincike a Jami'ar Pittsburgh makarantar ilimin magani sun ba da rahoto game da gwajin PittCoVacc, yiwuwar maganin rigakafin COVID-19 a cikin beraye, yana mai cewa ""MNA ta ba da ƙarancin SARS-CoV-2 S1 allurar rigakafin ta nuna yiwuwar antigen-specific amsawar garkuwar jiki [a cikin bera] wadanda suka fara bayyana makonni 2 bayan alurar rigakafi."""
a canada a ranar 16 ga watan afrilu 2020, makarantar magunguna karkashin jamiar waterloo sun sanar da feshin hanci a matsayin maganin su na kwayar halittar DNA.
Amfani da kwayoyin cuta, ana tsara kwayar halitta ta DNA don yin kwayar cutar cikin jikin dan adam don samar da kwayoyin cuta marasa cutarwa, wadanda zasu iya tayar da tsarin garkuwar jiki don samar da kwayoyin kariya daga kwayar ta SARS-CoV-2.
A watan Maris 2020, gwamnatin amurka , masana’antu da ma wasu jami’oi guda uku sun hada karfi don samar da nau’rori dag kamfanin IBM da ma ayukan bayan sirri na yanar gizo daga kamfanin Hewlett Packard, amazon, microsoft da ma Google.
Wasu magungunan rigakafin suna da tasirin cutar heterologous, wanda kuma ake kira tasirin da ba na takamaiman sakamako ba.
Hakan yana nufin suna iya samun fa'idodi fiye da cuta wanda aka kare.
Wani ci gaban gwajin da aka yi barkatai a Australia Yana Neman shigarwan ma’aikacin kiwon lafiya guda 4,170
Yana yiwuwa rigakafin a cikin ci gaba ba zai zama da aminci ko tasiri ba.
Binciken farko domin samun ingancin rigakafin ta yin amfani da CoVID-19 ƙayyadaddu tsarin dabbobi, kamar ACE2-transgenic bera, da ma wasu dabobin dakin Gwaji da wadanda asalin su ba Mutum ba ne, sun nuna bukatar aunawar tsarewan mataki uku na lafiyar halita wato biosafety-level 3 na rikewar kwayar cuta masu rai, da daidaituwan duniya domin tabbatar da tsarin lafiya.
An yi maganin rigakafin cutar SARS da MERS a cikin samfurin dabba na mutane.
Har zuwa 2020, babu wani maganin warkarwa ko rigakafin kariya daga SARS wanda aka nuna yana da kyau da tasiri a cikin mutane.
Dangane da takardun bincike da aka buga a 2005 da 2006, ganowa da haɓaka allurar rigakafi da magunguna don magance SARS ya kasance fifiko ga gwamnatoci da hukumomin kiwon lafiyar jama’a duniya. Hakanan babu wani ingantaccen maganin alurar rigakafi kan MERS.
Lokacin da MERS ya zama ruwan dare, an yi imanin cewa bincike na SARS wanda akwai na iya samar da samfuri mai amfani don ci gaba da allurar rigakafi da warkewa game da kamuwa da cutar MERS-CoV.
Tun daga Maris 2020, akwai allurar rigakafi (bisa ga DNA) MERS wanda ya ƙare Matak I gwaji na asibiti a cikin mutane, da kuma wasu uku da ke ci gaba, dukkan waɗannan rigakafi ne na masu tafiya da kwayoyin cuta, adenoviral-vectored guda biyu (ChAdOx1-MERS, BVRS-GamVac ), kuma MVA-vectored (MVA-MERS-S).
Tura rubutu ta hanyar sadarwar sun inganta wata ka'ida tunani mai zurfi masu cewa an san kwayar cutar da ke haifar da COVID-19 kuma an riga an sami allurar rigakafi.
Abubuwan da aka ambata waɗanda aka buga ta hanyar kafofin watsa labarun daban-daban na kafofin watsa labarun suna ambatar bayanan da suka kasance game da jerin kwayoyin da kuma alurar rigakafin wasu ƙwayar cuta ta coronavirus kamar SARS coronavirus.
cututtukan b'coronavirus 2019 (COVID-19) cuta ce wanda ta haifar da matsananciyar rashin lafiya mai saurin kamuwa da cuta coronavirus 2 (SARS-CoV-2).
Alamun kullum sun hada da zazzabi, tari, da matsalar numfashi.
Sauran alamu na iya haɗawa da gajiya, ciwon tsoka, zawo, ciwon makogwaro, rashin kamshi da zafin ciki.
Lokacin kamuwa zuwa bayyanuwar alamun cutar kimanin kwanaki biyar ne amma zai iya bambanta daga biyu zuwa kwanaki goma sha hudu.
Yayin da yawancin lokuta ke haifar da karamar bayyanar cututtuka, wasu ci gaba zuwa cutar huhu da gazawar ƙwayoyin cuta da yawa.
A ranar 17 Afrilu 2020, an samu karin masu cutan fiye da miliyan biyu (2.24) daga kasashe dari biyu da goma (210) wadda ya jawo mutuwan fiye da miliyan dari da hamsin da uku (153, 000).
Fiye da mutane dubu dari biyar da sittin da takwas ne suka warke (568, 000). Cutan yana samun yaduwa ne tsakanin mutane yayinda suka kusanci juna, yawancin lokuta ta karamin digon yawu da ke zuwa ta wurin tari, atishawa, ko magana.
Yayin da ɗigagga na fitowa lokacin numfashi, yawancin su na faduwa zuwa kasa ko kan farfajiya maimakon zaman mai iya ba da cuta daga tsawon nesa.
Mutane na iya kamuwa da cutan ta wurin taba gurbataccen farfajiya sannan su taba idanu, hanci, ko baki.
Cutar na iya rayuwa a farfajiya har awa saba’in da biyu (72).
Ya fi yaduwa a rana uku na farko da fara nuna alamu, ko da yake yana iya yaduwa kafin alamun su bayyana daga baya. Hanyan ganewar asalin cutar ta wurin real-time reverse transcription polymerase chain reaction (rRT-PCR) daga daukan samfurin gwaji daga bayan hanci wato nasopharyngeal swab.
An ba da shawaran amfani da abin rufe fuska wadanda suke zaton suna da cutan, tare da masu kula da su.
Shawarwarin amfani da kariyar rufe fuska da jama'a sun bambanta, tare da wasu hukumomi suna ba da shawararin a guje amfni da su, wasu na shawarar yin amfani da su, wadansu suna buƙatar amfani da su.
A halin yanzu, babu maganin alurar rigakafi ko takamaiman maganin rigakafi na COVID-19.
An yi rikodin bazawar cutan a gida cikin yawancin ƙasashe kewaye da yankuna shida na WHO.
Wadanda suka kamu da kwayar cutar na iya zama nunin cutar ko haɓaka alamomin kamuwa da mura kamar zazzabi, tari, gajiya, da gazawar numfashi.
Alamun gaggawa sun kunshi wahalan numfashi, ciwon kirji ko matsi, rikicewa, wahalan tashiwa, da shudaden fuska ko lebuna; ana shawarar ganin likita da gaggawa idan aka ga wadannan alamu.
Wasu lokuta, alamu da suka shafi numfashi kamar atishawa, yoyon hanci ko kuma bushewar wuya na bayyanuwa.
Ana ganin kwayar cututtukan ciki kamar tashin zuciya, amai da zawo an lura da su a kashi dabam-dabam.
Wasu masun kamuwa da cutan da matsalar daurin zuciya da saurin bugun zuciya an same su a China.
A wadansu, cutar za to iya cigaba har zuwa ga cutar limonia, rashin aikin gabobi da mutuwa.
Wannan shine ake kira lokacin hayayyafar cutar.
Lokacin kwanci na COVID-19 kwanaki biyar zuwa shida me amma zai iya dauki kwanaki biyu zuwa 14.
Kashi 97.5% na mutane da suka nuna alamun sukan yi hakan ne cikin kwanaki goma sha daya da rabi (11.5) da kamuwa. Rohoto ta nuna cewa ba duka wadanda suka kamu bane suke nuna alamun kamuwa da ciwon ba.
Matsayin wadannan masu dauke da cutan wanda bai nuna ba a wajen yadar da shi ba a sani ba tukuna; ko da shike, wasu shaidu sun ba da alama cewa za su iya yaduwa da cutan.
A yanzu haka ba a san kimanin rabon mutane da ba su nuna alamun kamuwa da cutan ba, amma ana kan bincike. Korea Centers for Disease Control and Prevention (KCDC) ta ba da rahoton cewa kashi 20% na duka wadanda aka tabatar suna da cutar ba su nuna alamun ba a zamansu a asibiti.
Hukumar kula da lafiya ta kasar Sin ta fara hada wanda suke nuna alamun rashin lafiya cikin masun kamuwa da cutar a yau da kullun rana 1 ga Afrilu; daga cikin masun kamu da cutar su 166 a ranar, 130 (78%) sun kasance masun nuna alamun rashin lafiyar a lokacin gwaji.
Duk majina da yau na iya ɗaukar kwayar cuta da yawa.
Yin magana da qarfin yana bada damar fita sosai ba kamar yin magana yadda aka saba ba.
Wata bincike da aka yi a Singapore ta bayyana cewa tari na iya jawo faduwa da ke tafiya mita 4.5 (kafa 15).
Ko da shike kwayar cutan ba zallan iska yake bi ba, National Academy of Science ta ba da shawara cewa bioaerosol transmission na iya faruwa idan aka ajiye air collectors a farfajiya a waje, kusa da muhallin mutane wanda aka samu samfurin tabattace na RNA.
Wasu hanyoyin kiwon lafiya kamar su ciki da kuma farfadowa da zuciya (CPR) na iya haifarda gurbataccen iska wanda zai haifar da yaduwar iska.
Yayinda akwai damuwa ana iya yada shi ta hanyar bayan gida, an yi imanin wannan haɗarin ya yi ƙasa kaɗan. Kwayar cutar ta fi yaduwa yayin da mutane ke alamtawa, yayinda yaduwa zai iya yiwuwa kafin bayyanar cututtuka, hadarin ya yi ƙasa kaɗan.
Cibiyar Yaki da Cututtuka ta Yankin Turai (ECDC) ta ce yayin da ba a bayyana cikakke yadda cutar ke yaduwa cikin sauki ba, mutum daya yana cutar da biyu zuwa uku. Kwayar cutar na rayuwa tsawon awanni zuwa kwanaki a kan abu.
Musamman, an gano kwayar cutar ta kwana ɗaya a cikin kwali, har zuwa kwanaki uku akan filastik (polypropylene) da baƙin ƙarfe (AISI 304), kuma har zuwa sa'o'i huɗu akan 99% jan ƙarfe.
Koyaya, wannan ya bambanta dangane da zafi da zazzabi.
Sabulu na taimakawa idan an yi amfani da shi daidai; samfurin sabulu na tarwasa cutar kuma ya ciresu daga fata da wasu farfajiya.
Sauran mafita kamar benzalkonium chloride da chlorhexidine gluconate, basuda tasiri, A cikin nazarin Hong kong, samfurin yawun baki aka ɗaukar na kwana biyu bayan an fara bada kula a asibiti.
A cikin marasa lafiya biyar daga cikin shida, samfurin farko ya nuna mafi yawan cuta, sannan mara lafiya na shidan ya nuna mafi yawan nauyin cutar a rana ta biyu da aka yi gwajin.
Mai tsananin ciwo na numfashi cutar corona ta biyu 2 (SARS-CoV-2) matsanancin ciwo mai dauke da cutar corona, farko an killace mutane uku masu fama da cutar huhu da alaka da gungu da rashin lafiya na numfashi a cikin Wuhan.
Dukkanin abubuwan fasalin novel na cutar SARS-CoV-2 faruwa a cikin ƙwayar cutar ta corona a cikin yanayi.
A wajen jikin mutum ana kashe cutar da sabulu na gida wadda yake karya karfinsa. SARS-CoV-2 shi ke mafi kama da asalin SARS-CoV.
Huhu ne suka fi samun matsala daga COVID-19 saboda kwayar cutan na samun shiga sels ta wurin enzymes angiotensin-converting enzyme 2 (ACE2), wanda yake da mafi yawa a irin II alveolar sels na huhu.
Kwayar cutar ta yi amfani da Glycoprotein ta musamman da ake kira ƙaru (peplomer) don hadawa zuwa ga ACE2 don shiga host cell.
An gano raunin zuciya daga cikin kashi 12% na wadanda aka shigar asibiti a Wuhan, China, kuma ya fi yawa a masu tsananin cuta.
Yawan alamun ciwon zuciya na da yawa musamman, saboda tsarin kumburi da matsalolin rashin rigakafi yayinda cuta na girma, amma ciwon zuciya mai sanani yana da alaka da masu karba ACE2 a zuciya.
Masu karɓarACE2 na fitowa sosai a cikin zuciya kuma suna bada gudu mawa wajan aikin cikin zuciya.
An samu mummunan haɗarin thrombosis kashi (31%) da thromboembolism na venous (25%) a cikin marasa lafiya na ICU da ke fama da COVID-19 kuma yana iya kasancewa yana da alaƙa da mummunan ci gaba.Dukatan mutanen da suka mutu sanadiyar COVID-19 sun sami matsala ta lalacewar (DAD), da lymphocyte- wanda ke da kumburi ke shiga cikin huhu.
Ko da shike SARS-COV-2 yana da canza yanayi wa ACE2-expressing cells na hanyan numfashi, marasa lafiya da ke fama da COVID-19 na da alamun nuna babban kumburi.
A cikin sauki, an nuna cewa kwayar cuta GM-CSF-secreting T-cells na da alaka da daukan kumburi IL-6-secreting monocytes da sananin ciwon huhu a masu fama da COVID-19.
An gano lymphocytic da aka binciko gawaki.
Hukumar ta WHO ta buga dabarun gwaji da dama na cutar.
Tsarin hanyar gwaji shi ne reverse transcription polymerase chain reaction (rRT-PCR) na lokaci kai tsaye.
Ana gwajin ne samfurin hanyar numfashi da aka samo a gwajin nasopharyngeal, duk da haka, za'a iya amfani da samfurin da aka dauka daga hanci da kuma yawun baki.
Sakamakon gwaji yana samuwa tsakanin awa biyu zuwa kwana biyu.
Ana iya amfani da gwajin jini, amma wannan na buƙatar samfuran jini guda biyu waɗanda aka ɗauki makonni biyu baya kuma sakamakon ba shi da ƙima nan take.
Masana kimiyya na Kasar China ya sami damar ware nau'in kwayar cutar coronavirus da walafawar jerin kwayoyin halita sabo da dakunan gwaje-gwaje na fadin duniya za su iya haɓaka polymerase chain reaction (PCR) gwaji don gano kamuwa da kwayar cutar.
Tun daga 4 Afrilu 2020, gwaje-gwaje na rigakafin ƙwayar cuta (wanda ke iya gano kamuwa da cuta mai aiki da kuma ko mutum ya kamu da a baya) yana kan ci gaba, amma har yanzu ba a yi amfani da shi sosai ba.
Bisa ga ganewar Sinawa kan gwaji, daidaito yana kashi 60 zuwa 70% kawai.
FDA ta cikin jihar America ta amince da batun kulawa ta farko a ranar 21 ga wata Maris shekara ta 2020 don anfani a qarshen waccan watan. Jagorar ganewar asali ta fito daga asibitin Zhongnan na Jami'ar wuhan ta bada shawarwaru ga hanyoyin gano cuta dangane da sifofin asibiti da hadarin kwayar cutar.
Hadin multilubar, gilashin kasa opacitiea tare da yanki asymmetry dakuma rarraba gaba suna da yawa a farkon kamuwa da cuta.
Mamayewar subpleural, fasa hauka, da karfafawa na iya fitowa yayinda cutan na girma.
Babu bayani sosai a kan cutar COVID-19.
Babban ganowa da aka yi daga binciken gawaki sune:
Macroscopy: plerisy, pericarditis, inganci huhu da pulmonary oedema.
Za a iya lura da tsananin zafin cutar huhu guda hudu:
nimoniya wanda bai tsananta ba: pulmonary oedema, pneumocyte hyperplasia, babbar atypical pneumocytes, kumburin interstitial da kumburin lymphocytic da aukuwar babban tantanin halitar multinucleated.
matsanancin ciwon huhu: Rarrafa lalacewar alveolar (DAD) dakuma rarrafa alveolar exudate.
DAD shine sanadiyyar alamun tsananin gajiyar hanyar numfashi wato respiratory distress syndrome (ARDS) tsanancin hypoxemia.
warkas da namoniya: kungiyoyi na exudates a alveolar cavities da pulmonary interstitial fibrosis.
Jini: disseminated intravascular coagulation (DIC); amsawar leukoerythroblastic
Matakan rigakafin don rage yiwuwar kamuwa da cuta sun hada da kasancewa a gida, guje wa wuraren cunkoson jama'a, wanke hannu da sabulu da ruwa sau da yawa a kalla sekan 20, kulla da tsabtacen numfashi da kuma guje wa taɓa idanu, hanci ko baki tare da hannayen marasa wankewa.
CDC ta ba da shawarar rufe bakin da hanci da tolet papper yayin tari ko atishawa takuma badar da shawarar yin amfani da gwiwar hannu idan ba a sami tolet papper ba.
Tsabtacewar hannu bayan kowane tari ko atishawa ana ƙarfafa shi.
CDC ta ba da shawarar yin amfani da mayafin rufe fuska a cikin wurin zaman jama'a, a wani ɓangare don iyakance watsa cutar daga mai alamun cutar. Tsarin nesantawa daga jama’a nufin sa domin rage huldawa da wanda ya kamu da cutar da babban tarin mutane ta hanyar rufe makarantu da wuraren aiki da ƙuntatawa tafiye-tafiye da soke babban taron jama'a.
Ka’idojin nisanta sun shafi mutane su ba da ratan akalla kafa 6 (1.8 m) a gefe.
"Babu wani magani da aka sani da zai yi tasiri don hana COVID-19. Kamar maganin rigakafi, ba zaton sa yanzu sai farin shekara 2021, wani mahimmin sashi na gudanar da COVID-19 shi ne ƙoƙarin rage ganiyar annoban, da aka sani da ""karkatar da doron layin"" wato flattening the curve."
CDC sun bayar da shawarar cewa mutane su rika wanke hannaye sau da yawa da sabulu da ruwa na tsawon kimanin sakan 20, musamman bayan an je ba haya ko hannaye sun yi datti a bayyane, kafin cin abinci ko bayan an hura hanci, tari ko atishawa.
Ya kuma ƙara bada shawarar yin amfani da ruwan wanke hannu mai sinadarin kashe kwayoyin cuta mai aqalla sinadarai kashi 60%, Amma sai lokacin da babu sabulu da ruwa akusa, dakuma yankunan da basu wadata da amfani da sanidarin wanke hannu ba. WHO ta samar da tsari guda biyu don samar da abubuwan cikin gida.
A cikin wadannan tsari, aikin kashe karfin kananan halittu da ido ba ya iya gani ya taso ne daga sinadaran giya, wato ethanol ko isopropanol.
Ana amfani da Hydrogen peroxide domin cire ramukan kwayoyin cuta a cikin giya; ba shi da inganci domin tsaftace hannu.
An qara glycerol a matsayin humectant.
Ana sarrafa mutane da kulawa mai tallafi, wanda zai iya hadawa da ruwan magani, na'urar bada numfashi da tallafa wa wasu gabobin da abin ya shafa.
CDC ta bayar da shawara cewa wadanda ake zargi da cewa suna dauke da kwayar cutan su sanya abin rufe fuska.
An yi amfani da Extracorporeal membrane oxygenation (ECMO) domin taimaka wa masu matsalan zuciya bisa dalilin rashin samun numfashi, amma ba a tabbatar da amfaninsa ba.
An bada shawarar tsabtacewar mutum da ingantaccen tsarin lafiyan rayuwa da abinci don inganta garkuwar jiki.
Taimako mai taimako yana da amfani a cikin waɗanda ke da jiyya mai sauƙi a farkon kamuwa da cuta WHO da hukumar kula da lafiya ta kasar china sun wallafa shawarwari game da kula da asibiti da marassa lafiya dake dauke da kwayar cutar COVID-19.
Intensivists da pulmonologists a U.S sun samar da hanyoyin jiyya daga hukumomi dabam-dabam, wato IBCC.
Tun daga Afrilu 2020 babu takamaiman maganin ƙwayar cutar ta COVID-19.
Don alama, wasu ƙwararru likitoci sun ba da shawarar fara anfani da paracetamol akan ibuprofin.
Dole a dauki matakan kariya domin rage yaduwan kwayan cutan, musamman a ma’aikatun lafiya yayinda ake zatas da ayukan da ke iya kirkiro aerosols kamar su hand ventilators, wato injin shakar iska.
Masu kiwon lafiya da ke kula da mutane masu COVID-19, CDC ta bayar da shawaran sanya mutumin cikin AIIR, wato dakin da aka kebe tare da kiyayewa, kiyaye haduwa da kiyayewan iska. CDC sun bayyana ka’idoji na amfani da kayan kare kai (PPE) a lokacin anoban.
Kayan sa jiki wanda aka bada shawarar shine: PPE, na’urar numfashi ko kariyar rufe fuska, kariyar ido, da safofin hannu. Lokacin da akwai, na’urar numfashi (maimakon kariyar fuska) an fi son su.
Ana ba da izinin na’urar numfashi N95 ga wuraren masana'antu amma FDA ta ba da izinin kariyar rufe fuska a ƙarƙashin Izinin Amfani mai Gaggawa (EUA).
An tsara su don kare abubuwa daga barbashin iska kamar ƙura amma na da inganci akan takamaiman wakilin Halittu wanda bashi da lamunin ga shan magani ba tare da izinin likita ba.
Lokacin da babu takunkumi, CDC ta ba da shawarar amfani da garkuwar fuska or irin takunkumin da ake hadawa a gida.
Nau'in ƙwayar cutar ta COVID-19 batayi tsananin daya isa ta buƙaci samun iska ko kuma madadin haka, amman wasu lokata akan samu.
Ana yin nazarin nau'in tallafin na numfashi ga mutane da ke da cutar ta hanyar COVID-19 da ke fama da matsalar numfashi ga mutanen da ke asibiti, tare da wasu shaidun da ke nuna cewa za a iya hana intabalation tare da hauhawar hanci da jijiyoyi ko matattarar karfin iska.
Ba a sani ba ko daya daga cikin wadannan biyu zai iya samar da wani amfani iri daya ga mutanen da  suke fama da matsananciyar rashin lafiya.
Wasu likitocin sunfi son tsarin iska na invasive idan yasamu saboda wamnan tsarin yana tsaƙaita yaduwa abubuwan aerosol, idan aka kwatanta da wucewar nasal cannula. Matsananci cutar sunfi kamuwa da tsofaffi(wayanda suka zarce shekaru 60, mussan masu shekaru 80).
Kasashe masun tasowa dayawa ba su da isashen gadajen asibiti ko wace mallaka, wanda ya rage karfin tsarin lafiya ga iya rikewar tashin yawan masu kamuwa da COVID-19 mai tsananin sosai wanda ke bukatar gama gado a asibiti.
Wata bincike a China ta gano cewa an shigar da kashi biyar (5%) cikin dakin jiyya na masu mawuyacin hali, kashi 2.3% na bukatan taimakawa da injin shakar iska, sannan 1.4% sun mutu.
A China, kusan kashi talatin (30%) na mutanen da ke asibiti da COVID-19 kan samu shiga sashen gaggawa wato ICU.
Gudun iska yana zama mafi rikitarwa yayin da ciwo mai raunin numfashi (ARDS) ke tasowa a cikin COVID-19 kuma oxygenation ya zama da wahala.
Na’urar bada iska wato Ventilators mai tsarafawa ta hanyar matsin iska da PEEP, ana buƙatar su domin ƙara girmar ba da iska, yayin da an rage hadarin samun ciwon da ke da alaka da na’urar iska da pneumothorax.
Dogon PEEP ba zai iya samunwa ba a tsohon na’urar bada iska.
Bincike a kan hanyoyin jiyya ta fara a Janairu 2020, kuma ana kan gwajin magunguna na yaki da cututtuka da dama.
Remdesivir ya bayyana a matsayin mafi cikawa.
Ko da yake Sabbin magunguna za su iya ɗaukar lokaci har zuwa 2021 kafin a haɓaka su. An riga an amince da yawancin magungunan da ake gwaji domin wadansu amfani ko suna gwajin da ya yi gaba.
Za a iya gwada maganin jiyyan kwayan cutar mutane masu tsananin ciwo.
WHO ta shawarci masu sa kai su shiga cikin hanyoyin inganci, tasiri da amincin yiwuwar magani. FDA ta ba da izini na wucin gadi don convalescent plasma a matsayin gwajin daya shafi rayuwar mutum cikin hatsari.
Ba a riga an yi binciken asibiti wanda ake bukata ba don nuna cewa za a iya amfani da shi kuma tana da muhimanci ga cutar.
A watan Fabrairu na 2020 china ta ƙaddamar da manhajar waya don magance barkewar cutar.
Akan bukaci masun amfani su shigar da suna da lambar ID.
Manhajar nada daman gano mutane na kusa kuma nayin amfani da bayanan sa ido, don haka haɗari da iyuwar kamuwa da cuta.
Kowanne mai amfani zai iya duba matsayin masu amfani guda uku.
Idan an gano yiwuwar haɗarin, ba kebewar kai kadai manhajar ya shawarta ba, yana iya fadakar da jami’an kiwon lafiya na cikin gida. Nazarcewar babban bayanan kan bayanan waya, fasahar gane fuska, bin sawu da waya da fasaha na wucin gadi ana amfani da don gano mutanen da ke kamuwa da cuta, Kuma mutanen da suka yi tuntuba cikin Koriya ta Kudu, Taiwan da Singapore.
A cikin Maris 2020 gwamnatin Isra'ila ta ba hukumomin tsaro damar bin diddigin bayanan wayar hannu na mutanen da ke dauke da kwayar cutar Corona.
An dauki matakan domin tabbatar da killacewa domin tsare wadanda suke hulda da wanda suna da cutan.
Kuma a watan Maris 2020, Deutsche Telekom ta raba wurare na waya da data da hukuman gwamnatin tarayya na Gemany, Robert Koch Institute, domin bincika hanyoyi na yaki da yaduwan cutan.
Rasha ta tura fasahar amincewa da fasahar gano fuska don gano masu ketare dokan kebewa.
kwamishinar lafiya na Italy, Giulio Gallera, ya ce masu sarafa wayar hannu sun sanar masa da cewa kashi arba’in (40%) na mutane suna ci gaba yawonsu.
Gwamnatin Jamus ta gudanar da wani shiri na hutun karshen mako 48 tare da mahalarta taron sama da 42,000.
Hakanan shugaban Estonia, Kersti Kaljulaid ya yi kiran ga duniya don samun mafita, akan yaduwar cutar ta Corona.
Mutane na iya samun matsala a ta dalilin killacewa, dokoki a kan tafiye-tafiye, illan jiyya ko kuma tsoron kamuwa da cutan kanta.
"BBC ta nakalto Rory O'Connor yana cewa, ""Karuwar warewar jama'a, kadaici, damuwar rashin lafiya, gajiya da kuma durkushewar tattalin arziki sune cikakkiyar guguwa da zata cutar da lafiyar kwakwalwa mutane da kuma lafiyar jama'a."""
Wannan cuta na iya shiga ta hanya mai sauki tare da kaɗan ko babu alamun, masu kama da cutar lumphashi, irinsu mura na yauda kullum.
Masu nuna dan rashin lafiyar kan warke cikin sati biyu, sannan masu sananin cutar na iya daukan sati uku zuwa shida kafin warkewa.
Matan da ke da juna biyu na iya kasancewa cikin haɗari mafi girma ga kamuwa da cuta da COVID-19 dangane da bayanai daga wasu ƙwayoyin cuta masu kama da wannan, kamar SARS da MERS, amma bayanai don COVID-19 ba su da yawa. A cikin wasu mutane, COVID-19 na iya shafar huhun da ke haifar da cutar huhu.
A cikin wadanda cutar ta fi shafa, COVID-19 na iya ci gaba da hanzari zuwa cuta hanyoyin numfashi mai tsananin gajiyar alamar cutan (ARDS) (ARDS) wanda ke haifar da gazawar hanyoyin numfashi, girgiza septic ka gazawar gabobin jiki da yawa.
Wahalan da ke da alaka dai COVID-19 sun haɗa da sepsis, daskarewar jini wanda ba a ka’ida ba ne da lalacewar zuciya, koda da hanta.
Matsalan daskarewan jini, musamman karuwa na lokacin daskarewa. An bayyana cewa a kashi shida (6%) na wadanda aka shigar da su asibita da COVID-19, masu matsalan koda kuma suna kashi hudu (4%) na wannan rukuni.
Kimanin kashi 20-30% na mutanen da su ke da kwayar cutar COVID-19 suna nuna girman enzymes na hanta (Transaminases).
A cewar rahoton daya, lokacin tsakanin farkon bayyanar cutar da mutuwa ya kasance kwana goma ne, da shafewar kwana biyar a asibiti.
Duk da haka, marasa lafiya wanda aka juya zuwa ICU suna da tsawon kwanaki bakwai tsakanin bada gado a asibiti da mutuwa.
A cikin nazarin lokuta na farko, tsaka-tsakan lokaci daga nuna alamun farko zuwa mutuwa ya kasance kwanaki 14, tare da cikakken kewayon kwanaki shida zuwa 41.
A cikin binciken da Hukumar Kula da Lafiya ta Kasar China (NHC), mazaje suna da yawan mutuwa kashi 2.8% yayin da mata sukan mutu da kashi 1.7%.
Binciken Histopathological na samfurorin huhun gawaki ta nuna lalacewa alveola da tantanin halitar fibromyxoid wanda sun fito daga huhun biyu.
Kwayar cutar kuma an lura da canje-canje a cikin pneumocyte.
Hoton huhu ya yi kama da cuta hanyoyin numfashi mai tsananin gajiyar alamar cutan (ARDS).
A cikin kashi 11.8% na mutuwar da hukumar lafiya ta kasar ta ruwaito, an lura da lalacewar zuciya ta hanyar haɓaka matakan troponin ko bugun zuciya.
A cewar bayanan Maris daga kasar amerika kashi 89% na waɗanda ke asibiti sunada wannan yanayin. Kasancewar albarkatun likita da tattalin arziƙin yanki ma na iya shafar mace-mace.
Kimantawa na mace-mace daga wannan yanayi ya bambanta saboda bambanci tsakanin yanki da kuma wahalan gudanarwa.
Rashin kirga sabbin masu kamuwa da kananan cuta na iya jawo kirga mutuwar da yawa kuma zai wuce gona da iri.
Duk da haka, gaskiyar magana game da mutuwar shine sakamakon cuta da aka samu a baya na iya nuni an rena takamamman yawar mutuwa na yanzu.
Masu shan sigari sun kasance lokaci sau 1.4 mafi yiwuwar samun mummunar cutar COVID-19 kuma kusan sau 2.4 na iya buƙatar kulawa mai zurfi ko mutuwa idan aka kwatanta da wayanda basa shan sigari, an nuna damuwa game da dogon lokaci sequelae na cutan.
Hukuma Asibitin Hong Kong ta sami raguwar 20% zuwa 30% a cikin karfin huhun da wasu suka warke daga cutar, kuma binciken huhun yana nuna lalacewar jikin mutum mutane.
Wannan na iya jawo wata matsala bayan an warke.
A Maris 2020 dai, ba a riga an sani ko wadanda suka yi fama da cutan sun warke, ko suna da dogon kariya daga cutan ba.
An ga garkuwa, bisa ga halayan wasu coronavirus, amma akwai lamarin masu kamuwa da cutan wadanda suka warke daga COVID-19 an sake masu gwajin gaskiya don coronavirus a lokacin gaba aka bada rahoton.
Ana ganin wadannan damu’oin sun kara fadada kamuwa da cuta ne maimakon sake kamuwa da cuta.
Kwayar cutar ana tunanin halitta ce kuma tana da asalin dabba, ta hanyar kamuwa da cuta.
Ba a san ainihin asalin ba, amma har zuwa Disamba 2019 yaduwar kamuwa da cutar ya kusan karɓar watsa ta mutum-da-mutum.
Bincikan masun kamuwa da cutar COVID-19 su guda 41,wanda aka walafa a Janairu 2020 a Lancet, ya nuna cewa ranar farko na alamun cutan rana 1 ga watan Disamba 2019 ne.
Hukumar Lafiya ta Duniya sun sanar cewa farkon alamun cutan ya fito ne a ranar 8 Disamba, 2019.
Ana amfani da yawancin matakan domin sauƙaƙe mace-mace
Waɗannan lambobin sun bambanta daga yanki da kuma suna rinjaya da girman gwaji a kan lokaci, Ingancin tsarin kiwon lafiya, zaɓuɓɓukan jiyya, lokaci tun lokacin barkewa da yanayin yawan jama'a irin su shekaru, mace ko na miji da dukan lafiya.
A karshen shekara ta 2019, WHO ta sanya dokar ta baci ICD-10 lamba U07.1 don mutuwa daga tabacin dakin gwajin kamuwa da cutan SARS-CoV-2 da U07.2 Don mutuwar asibiti ko binciken epidemiologically COVID-19 ba tere da amincewar kamuwa da SARS-CoV-2 a dakin gwaji ba. Yawan mutuwa don kamuwa da cutar ya nuna lambar mutuwa wanda za a raba da lambar wadanda aka sami cutar a wata tsawon lokaci.
Dangane da ƙididdigar jami'ar John's Hopkins adadin mutuwar duniya shine kashi 6.9% (153, 822/2, 240,191)a 17 ga watan Afrilu 2020.
Lambobin sun bambanta daga yanki, Sauran matakan sun hada da yanayin yawan haihuwa (CFR) Wanda ya nuna adadin mutane,(wayanda aka binciki lafiyarsu dakuma wayanda ba'a binciki lafiyarsuba) wayanda suka mutu daga cutar.
Wadanan ƙididdigar ba su daɗewa ba kuma sun bi takamaiman yawan jama'a daga kamuwa da cuta ta hanyar warkarwar cutan.
Ko da yake ba duka mutane ke da garkuwar jiki da ke yakin cututtuka ba, kasancewan sinadaran na iya samar da bayani a kan yadda mutane masu yawa suka kamu da cutan.
A cikin barkewar annobar a Italiya, Castiglione d'Adda, ƙaramin ƙauyen 4600, 80 (1.7%) sun riga sun mutu.
A Genglet, cutar ta yaduwa neh a lokacin bikin Carnival, Kuma yaduwa ga matasa sanadin mace-mace mafi sauki kuma ba duk muttuwa don cutar COVID-19 bace aka tsara ta irin wanna.
Bayan haka kuma ba a shawo kan tsarin lafiyar Jamusawa ba.
A kasar Netherlands, kimanin kashi uku (3%) na da sinadaran yakan cututtuka, wato yadda aka tantance daga masu bayar da jini.
mutane 69 (kashi 0.004% na yawan jama’a) An tabbatar da cewa sun mutu daga kwayar cutar COVID-19.
Tasirin annoban da yawan mace-mace tana da bambanci tsakanin maza da mata.
A wata bincike da aka yi a China da Italy, ya nuna cewa mutuwa ya fi yawa a cikin maza
Mafi hadarin kamuwa a maza sune wadanda shekaru su ya kai 50 zuwa sama, da bambanci tsakanin maza da mata kusa da 90 kawai.
A cikin China adadin maza ya mutu kashi 2.8 ne ga maza kuma kashi 1.7 na mata ne.
ba a san dalilin da ya sa akwai bambanci tsakanin maza da mata ba amma kwayoyi da abubuwa da suka shafi halaya na iya zama dalili.
Bambancin karewan jiki tsakanin maza da mata, rashin yawan shan hayaki kamar sigari a mata sannan maza na kamuwa da hawan jini da wuri a bisan mata ya kara yawan mutuwa a maza.
A kasashen Turai, kashi 57% na masu dauke da cutan maza ne, sannan kashi 72% da suka mutu daga cutan COVID-19 maza ne.
Tun daga watan Afrilun 2020 gwamnatin Amurka ba ta banbance mace ko namiji da ke tattare da cutar COVID-19.
Bincike ta nuna cewa ciwo daga kwayoyin cututtuka kamar Ebola, HIV, mura da SARS na shafe maza da mata a lokaci dabam.
Kashi mafi yawa na ma’aikatan lafiya, wato masu aikin jiyya, mata ne, kuma suna da babban dama na kamuwa da kwayar cutan.
"Hukumar Lafiya Ta Duniya ta yi sanarwa ranar 11 ga watan Fabrairu 2020 cewa sunan cutar za ta kasance ""COVID-19"" bisa hukuma."
Shugaban WHO Tedros Adhanom Ghebreyesus yayi bayanin cewa CO tsaye ga corona, VI ga ƙwayar cuta, D don cuta, da 19 don lokacin da aka fara gano cutar: 31 Disamba 2019.
An zabo sunan ne domin a gujewa tunanin mika yasa a wuri guda (a misali, China), jinsunan dabbobi ko mutane, daidai da yadda tsarin ambatan sunaye da ke neman kawas da wariya. An sa wa kwayar cutan da ta jawo COVID-19 sunan severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Hukumar Lafiya ta Duniya na amfani da “kwayar cuta COVID-19” da kuma “kwayan cuta wanda ke jawo COVID-19” a sadarwan jama’a.
Dukkanin cutar da kwayar cutar ana kiranta azaman ƙwayar “cuta corona”
A lokacin ɓarkewan farko a Wuhan China, kwayar cutar da cutar ana yawancin kiranta da cutar “coronavirus” da “coronavirus ta Wuhan”.
A Janairu 2020, Hukumar Lafiya na Duniya ta ba da shawaran 2019-nCoV da 2019-nCoV, ciwon numfashi mai sanani a matsayin sunayen wucin-gadi na kwayar cutan da cutan bisa ga ka’idojin 2015 kan amfani da wurare a jinsin cuta da kwayar cututtuka.
An ba da sunan COVID-19 da SARS-CoV-2 ranar 11 Febrairu 2020.
Saboda ƙarancin iya aiki a cikin wadataccen tsari, wasu masana'antun dijital suna buga kayan Kiwan lafiya kamar safurin hanci da sasshen bada iska.
Awani misali, lokacinda wata asibit a qasar italiya ta buqaci na'urar iska da gaggawa, kuma wanda zaikawo ba zamu zuwa ba a lokacin da ake buqata, Injin juyawa na gida aka fitar da fitar da valve 100 da ake bukata a daren.
Bayan fitowan cutar COVID-19, ka’idar shirki, labarun karya sun fito a kan asali, sikeli, kariya da wasu bangarorin cutar da suka yadu da wuri a yanar gizo.
'Yan Adam suna iya yada cutar zuwaga wasu dabbobi.
Binciken ya gaza samun tabbacin kwayar cutar a aladu, agwagi da kaji.
Babu wani magani ko allurar da aka yarda da shi don magance wannan cutar.
Binciken kasa da kasa kan COVID-19 kungiyoyin gwamnati suna kan bincike, da kungiyar iliimi da binciken masana’antu.
A watan Maris, Hukumar Lafiya ta Duniya ta fara gwaji, wato “SOLIDARITY Trial” domin samun jiyya na maganin rigakafi guda hudu wadda ake sa zato za su yi inganci.
Babu rigakafi, amma hukumomi dabam-dabam suna kokarin samo rigakafin.
Ana kan amfani da aiki na baya a kan SARS-CoV saboda SARS-CoV da SARS-CoV-2 duk na amfani da ACE2 domin shiga jikin mutum.
Akwai hanyoyi guda uku da ake bi don gano wuri.
Da farko, masu binciken suna da niyyar samo maganin rigakafin kwayar cuta.
Amfani da irin wannan kwayar cuta ko mara illa ko matacce, na neman tabo karewa na gaggawa a jikin mutum da sabon kamuwa da COVID-19.
Hanya ta biyu, fannin rigakafi, ana neman samo rigakafin da zai taimaka wurin yakan wasu fannin cutar.
Game da SARS-CoV-2, irin wannan binciken yana maida hankali ne akan sinadarin S-Spike wanda ke taimakawa kwayar cutar kutsawa cikin karuwar enzayam ACE2.
Dabaru na uku shine na maganin rigakafi na nucleic acid (DNA ko rigakafin RNA, sabbin hanyoyin kirkiro maganin rigakafi).
Allurar rigakafi daga kowanne dole ne a gwada su don aminci da inganci 16 ga watan marus a shekarar 2020, Trawarin farko na kamfanin maganin alurar riga kafi tare da masu bada agaji huɗu a Seattle.
Maganin alurar rigakafi na dauke da lambar kwayan halitta mara illa da aka kofe daga kwayar cutar da ke kawo ciwon. An ba da shawaran habaka sinadarai masu yakan cututtuka a matsayin hanyar samar da maganin rigakafin SARS-COV-2, amma akwai gardama.
Akwai mutane fiye da 300 wanda ake son gwaji a asibitin daga watan Afrilu 2020.
Hanyoyi gwaji bakwai an riga ana kimantawa aminciwar jinyar zazzabin, har da bincike hudu akan hydrochloricquine da chloroquine.
Binciken Chinese ta kunshi magungunan rigakafin, an kuma samu matakai tara na gwaji kan remdesivir a kasashe da yawa saboda rohoto a karshen Afrilu.
Yin bita mai zurfi game da haɓaka asibiti don maganin rigakafin ƙwayar cutar COVID-19 da maganin gwaji suna nan. tun watan Afrilu 2020. Ana kimmantawa yawancin maganin kariya daga kwayan cutar don jinyar COVID-19, ya hada da remdesivir chloroquine da hydroxychloroquine, looinavir/ritonavir da lopinavir/ritomavir hadi da inyerferon beta.
Akwai alamun shaida na inganci ta wurin remdesivir, daga Maris 2020.
An ga alaman sauki a marasa lafiya da aka yi jiyya da amfani da remdesivir.
Ana gudanar da gwaji na asibiti na Phrase III a Amurka, china da italiya. Chloroquine A da can ana amfani da shi don maganin zazzabin cizon sauro, An yi nazarin karatun a cikin China a shekarar 2020 tate da saka mako na farko.
Duk da haka, akwai kira da ake yi domin tabbatar da wannan bincike.
Hukumomin lafiya na Koriya da China sun ba da shawarar yin amfani da chloroquine.
Koyaya, jami'ar Wuhan ta ilimin cututtuka, tabada shawarwarin maganin anfani nayau da kullun na gram daya, asani cewa anfani da guda biyu yana da matuqar hadari kuma yakan iya jawo rasarai.
A ranar 28 ga Maris 2020, FDA sun ba da rohoton gaggawa domin ba da dama domin amfani da hydroxychloroquine da chloroquine a jiyyan mutane da ke fama da COVID-19. Ka’idojin Chinese bugu na 7 ta hada interferon, ribavirin ko umifenovir domin amfani kan COVID-19.
Bincike na baya ta nuna cewa daukan babban kashi na ribavirin na da muhimmancin yakin SARS-CoV-2 a vitro.
An ba da shawaran amfani da Nitazoxanide domin karin bincike bayan nuna karancin yaki da SARS-CoV-2. Bincike ta nuna cewa farkon spike protein priming ta transmembrane protease serine 2 (TMPRSS2) na da muhimmanci domin shigan SARS-CoV-2 ta wurin alaka da mai karɓan ACE2.
Binciken chloroquine da hydroxychloroquine tare da koba tare da azithromycin yanada babban iyakancewa wanda ya hana alumman likitanci shiga cikin karbar wadanan hanyoyin jinya ba tare da sake wata bincike ba. Oseltamivir baya hanuwa cikin kwalbar gwaji SARS-CoV-2 kuma ba shi da rawar da aka sani a cikin jinyar COVID-19.
Guguwar Cytokine na iya zama matsala idan ciwon COVID-19 ta yi tsanani.
Akwai alama cewa hydroxychloroquine na da sinadaran cytokine storm. China ta hada da tociizumab a ka’idojin jiyya bayan wata karamar bincike.
Yana cikin gwajin sashe na 2 gwaji wanda ba daga ko ina ba ne a kasar Italy bayan nuna sakamakon mutane masu tsananin ciwo.
Hade da gwajin jini iri ta serum ferritin domin gano cytokine storms, aikinsa domin ya tsayar da wasu matsaloli wadda ake tsamanin ke jawo mutuwa a wasu mutane da ke dauke da cutan.
FDA ta yarda da kariyar interleukin-6 receptor antagonist dangane da nazarin yanayin da ake juyawa don magance cutarwar steroid refractory cytokine sakin alama wanda aka haifar da wani dalili daban, CAR T jinyar tantanin halitta, a cikin 2017.
Har wa yau babu bazuwar shaida da ta nuna tocilizumab na iya jiyyan CRS.
Canja wurin tsarkakewa da tattarawar garkuwan jiki wanda aka samo ta wurin tsarin garkuwan jikin wadanda suka warke daga cutar COVID-19 zuwa mutane da ke bincika a matsayin hanyar mara bada maganin rigakafi.
Anyi kokarin wannan tsarin don SARS tare da rashin isashen sakamako.
Rage karfin kwayar cuta shi ne tsaring aiwatarwa wanda ke kara karfin garkuwar jiki don hada kariya daga SARS-CoV-2.
Ana iya samun wasu hanyoyi kuma kamar masu dogara ga sinadarai masu yakin cututtuka wato cellular cytotoxicity da phagocytosis.
Wadansu siffofin kara karfin garkuwar jiki, misali, anfani da kerarran garkuwar jiki monoclonal wanda a ake habakawa.
samarwa da convalescent serum, wanda ya kunshi fanni ruwa na jini wanda aka samo daga masu jiyya kuma na dauke da sinadarai masu yakin cuta daga wannan kwayan cutan, ana iya karawa domin amfani da wuri.
Cutar coronavirus, rukuni ne na cututuka masu dangantakar alamu.
Li Wenliang, likita ne a Asibitin Tsakiya na Wuhan, wanda daga baya ya kamu da cutar kuma ya mutu ta COVID-19 bayan ya sanar da yaduwan cutar.
